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Regulatory!T!cells!(Treg)!are!enriched!in!tumour!tissue!relative!to!other!compartments.!AntiGtumour! immunity! is! promoted! through! their! depletion.! ! ! It! is! hypothesised! that!Treg! are! recruited! to! human! colorectal! cancer! (CRC)! via! a! specific! combination! of!chemokine! receptors! and! integrins,! blockade! of! which! reduces! tumour! Treg!recruitment,!ameliorating!the!antiGtumour!immune!response.!
A!systematic!examination!was!conducted!of!receptors!expressed!by!CRCGisolated!Treg!and! the! cognate! ligands! expressed! by! CRC.! ! The! effects! of! receptor! inhibition! were!tested!in!murine!models!of!colorectal!cancer.!
Human! CRCGinfiltrating! Treg! exhibit! a! specific! chemokine! receptor! signature,!expressing!significantly!higher!levels!of!CCR5!than!conventional!T!cells.!!CRC!expresses!the! ligands! for! CCR5! at! significantly! higher! levels! than! distal! tissue.! ! Isolated! Treg!migrated!towards!CCR5!ligands!in!vitro!and!suppressed!allogeneic!T!cell!proliferation.!!CCR5! inhibition! in!murine!models! of! CRC! led! to! delayed! tumour! growth! but! had! no!effect!on!tumour!Treg!infiltration!compared!with!vehicle!control.!











I! would! like! to! acknowledge! the! help,! support! and! direction! of! my! supervisors,!Professor!David!Adams,!Dr!Bertus!Eksteen!and!Professor!Antal!Rot,!and!the!assistance!offered! to!me!by!Dr!Christopher!Weston! and!Dr! Stuart! Curbishley.! ! I! thank!Mr!Tariq!Ismail!for!his!supervision!and!mentorship!over!the!entire!course!of!my!PhD.!
Funding!from!the!Bowel!Disease!Research!Foundation!and!Medical!Research!Council!is!gratefully!acknowledged.!




Ward!ST,!Weston!CJ,!Hepburn!E,!Damery!S,!Hejmadi!RK,!Morton!DG,!Middleton!G,!Ismail!T,!Adams!DH.! !Evaluation!of! serum! lysyl!oxidase!as!a!blood! test! for!colorectal! cancer.!!
EJSO!2013;!40(6):!731M8!!Ward! ST,! Li! KK,! Curbishley! SM.! ! A! method! for! conducting! suppression! assays! using!small!numbers!of!tissueGisolated!regulatory!T!cells.!!MethodsX!!2014;!1:!168M74!





















































!Figure!3G10:!!Integrin!expression!by!Treg!by!tissue!type!..........................................................!108!Figure! 3G11:! ! The! expression! of! various!markers! by! Treg! isolated! from! the! blood! of!control!subjects!and!patients!with!CRC!....................................................................................!110!Figure!3G12:!!Representative!flow!cytometry!data!for!CCR5!expression!............................!111!Figure!3G13:!!mRNA!expression!by!CRCGisolated!Treg!relative!to!Tconv!............................!113!Figure!3G14:!!Double!immunohistochemistry!for!CCR5!and!Foxp3!.......................................!114!!Figure!4G1:!!Absolute!quantification!(Cp)!of!reference!genes!..................................................!135!Figure!4G2:!!CCL17!and!CCL22!gene!expression!relative!to!GUS!and!IPO8.!........................!137!Figure!4G3:!!CCL3,!CCL4!and!CCL5!gene!expression!relative!to!GUS!and!IPO8!.................!138!Figure!4G4:!!CCL19,!CCL21!and!CCL20!gene!expression!relative!to!GUS!and!IPO8!.........!139!Figure!4G5:!!CXCL9,!CXCL10!and!CXCL11!gene!expression!relative!to!GUS!and!IPO8!...!140!Figure!4G6:!!Western!blots!for!chemokines!in!CRC!and!distal!colon!samples!...................!141!Figure!4G7:!!Summary!of!Western!blots!probing!for!CCR5!ligands!........................................!142!Figure!4G8:!!Western!blot!band!densities,!as!measured!using!ImageJ!..................................!143!Figure!4G9:!!Chemokine!concentrations!by!tissue!type,!measured!by!ELISA!....................!144!Figure!4G10:!!Immunohistochemistry!of!CRC!with!matched!distal!colon!(IMC)!..............!146!Figure!4G11:!!Immunohistochemistry!of!CRC!with!matched!distal!colon!(CCL3)!............!147!Figure!4G12:!!Immunohistochemistry!of!CRC!with!matched!distal!colon!(CCL4)!............!148!Figure!4G13:!!Immunohistochemistry!of!CRC!with!matched!distal!colon!(CCL5).!...........!149!Figure!4G14:!!Immunohistochemistry!of!CRC!with!matched!distal!colon!(CCL20)!.........!150!Figure!4G15:!!Immunohistochemistry!of!CRC!sections!for!endothelial!CCL4!....................!152!Figure!4G16:!!Immunocytochemistry!of!NEC!and!TEC!for!CCL3,!CCL4!and!CCL5!............!154!Figure!4G17:!!Immunocytochemistry!of!HUVEC!for!CCL3,!CCL4!and!CCL5!.........................!155!Figure!4G18:!!Chemokine!expression!by!CRCGisolated!cells!......................................................!158!Figure!4G19:!!Summary!of!chemokine!expression!by!CRCGisolated!cells!.............................!160!Figure! 4G20:! CCR5! expression! by! CRCGisolated! Treg! against! tissue! expression! of!chemokine!ligands,!measured!by!RTGPCR!...............................................................................!162!!
!Figure!5G1:!!Summary!of!6!transwell!experiments!........................................................................!179!Figure!5G2:!!Immunofluorescent!staining!of!transwell!membranes.!.....................................!181!Figure! 5G3:! CCR5! expression! by!Tconv! and!Treg! following! coGculture!with! CD3/CD28!beads!±!CRC/DC!supernatant!.......................................................................................................!184!Figure!5G4:!!Foxp3!expression!by!CD3+CD4+!PBMCs!following!activation!..........................!186!Figure!5G5:!!Measurement!of!CCL3,!CCL4!and!CCL5!in!coGculture!supernatant!...............!191!Figure!5G6:!!Foxp3,!CTLAG4!and!CD39!expression!by!CCR5low!and!CCR5high!Treg!...........!192!Figure!5G7:!!Suppression!assay!using!CRCGisolated!CCR5low!and!CCR5high!Treg!...............!194!Figure!5G8:!!Proliferation!and!apoptosis!markers!expressed!by!Treg!and!Tconv!...........!197!Figure!5G9:!!Helios!expression!and!TSDR!unmethylation!by!Tconv!and!Treg!...................!199!!Figure!6G1:!!LuciferaseGtransduced!CT26!cells!(CT26GLuc)!.......................................................!218!Figure!6G2:!!Subcutaneous!(sc)!tumour!experiment!schedule!.................................................!221!Figure!6G3:!!Gating!strategy!to!define!Treg!and!Tconv!in!blood,!spleen!and!tumour!.....!223!Figure!6G4:!!Chemokine!receptor!expression!by!tumour!cell!lines!........................................!225!Figure!6G5:!!In!vitro!proliferation!of!tumour!cell!lines!................................................................!226!Figure!6G6:!!CCR5!expression!by!TILs!isolated!from!control!group!tumours!....................!227!Figure! 6G7:! ! sc! osmotic! pump! delivery! of! metGRANTES! in! CT26GLuc! tumourGbearing!wildtype!mice!......................................................................................................................................!229!Figure! 6G8:! ! ip! osmotic! pump! delivery! of! metGRANTES! in! CT26GLuc! tumourGbearing!wildtype!mice!......................................................................................................................................!231!Figure! 6G9:! ! Daily! injection! of!metGRANTES! or! TAKG779! in! CT26GLuc! tumourGbearing!wildtype!mice!......................................................................................................................................!233!Figure!6G10:!!Twice!daily!injection!of!UKG484900!in!CMT93GLuc!tumourGbearing!hCCR5!KI!mice!....................................................................................................................................................!235!Figure! 6G11:! ! Twice! daily! injection! of! UKG484900! in! B16GF10GLuc! tumourGbearing!hCCR5!KI!mice!.....................................................................................................................................!237!Figure! 6G12:! ! Twice! daily! injection! of! UKG484900! in! B16GF10GLuc! tumourGbearing!hCCR5!KI!mice!G!commenced!at!time!of!tumour!implantation.!......................................!239!Figure!6G13:!!Absolute!number!of!cells!infiltrating!B16GF10GLuc!tumours!........................!240!






Colorectal!cancer!(CRC)!is!a!common!form!of!malignancy!in!developed!countries.!!In!the!United! Kingdom! (UK),! the! disease! incidence! is! approximately! 38,000! new! cases! per!year,!making!CRC!the!third!most!common!malignancy!after!breast!and!lung!(1).!!CRC!is!deadly! in! one! third! of! patients! due! to! metastases! at! the! time! of! diagnosis,! local!recurrence!or!the!development!of!metachronous!metastases!following!resection!of!the!primary!tumour!(2).!
CRC!genetics!Normal!colonic!glandular!epithelial!cells!can!transform!into!invasive!adenocarcinomas!due! to! acquired! genetic! and! epigenetic! changes! in! a! process! known! as! the! adenomaGcarcinoma!sequence.! !Genetic!alterations!at!different!stages!of!neoplastic!development!were!characterised!by!Vogelstein!&!Fearon!(3),! leading!them!to!propose!the!following!model!(see!Figure!1G1).!
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!
Figure! 1G1:! The! adenomaGcarcinoma! sequence.! ! Acquired! genetic! and! epigenetic! changes!transform!the!normal!colonic!epithelium!into!invasive!adenocarcinoma.!!!
!
The!two!major!molecular!pathways!that!lead!to!these!genetic!changes!are!chromosomal!instability! (85%)! and! microsatellite! instability! (15%).! ! The! typical! genetic! changes!associated! with! chromosomal! instability! are! alterations! in! chromosome! number!(aneuploidy),! losses!of!portions!of!chromosome!5q,!18q!and!17p!and!mutations!of!the!KRAS!oncogene.!!!









known! as! the! Wnt! pathway,! of! which! APC! is! a! key! regulatory! protein.! ! GermGline!mutations!in!the!APC!gene!result!in!familial!adenomatous!polyposis!(FAP).!!!
p53$mutations$Mutations! in! the! TP53! gene! occur! in! approximately! 50%! of! CRC.! ! The! p53! protein!mediates! cell! cycle! arrest,! activates! DNA! repair! enzymes! and! can! initiate! apoptosis!when!DNA!damage!has!been!detected!by!the!cell.!!Inactivation!of!both!TP53!alleles!often!coincides!with!transition!from!adenoma!to!adenocarcinoma!(5).!
MAPK$signalling$KRAS! is!mutated! in! approximately!30%!of!CRC!and! is! a! key! component!of! the!MAPK!(mitogenGactivated! protein! kinase)! signalling! pathway.! ! Binding! of! epidermal! growth!factor! to! its! receptor! (EGFR)! leads! to! activation! of! KRAS,! a! GGprotein,! which!subsequently!binds!and!activates!BRAF!(see!Figure!1G2).!!BRAF!mutations!are!found!in!approximately! 5%! of! CRC.! ! BRAF! phosphorylates! and! activates! MEK,! MEK!phosphorylates!and!activates!MAPK!and!MAPK!alters!the!activation!and!levels!of!many!transcription! factors! controlling! transcription! of! important! genes! involved! in! the! cell!cycle!(6).! !BRAF,!MEK!and!MAPK!are!all!serine/threonine!kinases.! !Mutations!in!KRAS!and!BRAF!in!CRC!lead!to!constitutive!activation!of!these!proteins!and!uncontrolled!cell!cycle! signalling.! ! KRAS! and! BRAF!mutations! are! profiled! in! CRC! tissue! to! predict! the!response!to!therapies!that!act!on!the!MAPK!pathway.!!Cetuximab!and!panitumumab!are!monoclonal!antibodies!that!block!the!EGFR!receptor!to!prevent!signalling!through!the!MAPK!pathway!but!are!ineffective!in!the!presence!of!RAS!or!BRAF!mutations!(7).!
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!
Figure! 1G2:! The!VEGF,!MAPK! and!PI3K! signalling! pathways.! ! VEGF! and!EGFR! are! targeted!by!monoclonal!antibodies.!!Figure!adapted!from!Bass!et!al!(6).!
!
VEGF$VEGF!is!known!to!mediate!tumour!angiogenesis!and!in!the!context!of!CRC,!is!associated!with!aggressive!disease!(8).!!The!monoclonal!antibody,!bevacizumab,!targets!VEGF!and!has!proven!efficacy!in!the!treatment!of!metastatic!CRC!(9).!
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TGF:ß$signalling$Mutations! in! the!TGFGßR2!receptor!occur! in!30%!of!CRC!and! in!80%!of!microsatellite!unstable! tumours! (10).! ! TGFGß! binds! to! TGFGßR2! which! then! attracts! and!phosphorylates!TGFGßR1.!!The!activated!TGFGßR1!receptor!then!phosphorylates!Smad2!and!Smad3!to!allow!them!to!form!a!complex!with!Smad4.!!Loss!of!Smad4!expression!has!been! reported! in! >50%! of! CRC! and! is! associated! with! lymph! node! metastasis! (11).!!Smad4! is! located! on! the! long! arm! of! chromosome! 18! which! is! an! area! commonly!deleted!in!CRC.!!The!Smad2/3/4!complex!can!translocate!to!the!nucleus!where!it!alters!gene!expression,!including!the!induction!of!p21,!leading!to!growth!arrest.!!Mutations!in!the!TGFGß!pathway!occur!in!the!later!stages!of!the!adenomaGcarcinoma!sequence.!The!DCC!(deleted!in!colorectal!cancer)!gene!is!also!sited!on!the!long!arm!of!chromosome!18!and!is!frequently!deleted!in!CRC.!!The!gene!encodes!a!receptor!for!the!neuronal!protein,!netrinG1.!!It!is!a!dependence!receptor,!in!that!the!absence!of!netrinG1!signalling!leads!to!apoptosis.!!Deletion!of!DCC!is!a!late!event!in!the!adenomaGcarcinoma!sequence!although!epigenetic!silencing!of!the!remaining!copy!occurs!early.!!
Mismatch$repair$genes$In! the! microsatellite! instability! (MSI)! pathway,! microsatellites! (repeated! nucleotide!sequences)! gain! substitution,! insertion! or! deletion! mutations! that! result! from!inactivation!of!mismatch!repair!genes.! !The!hMSH2!or!hMLH1!mismatch!repair!genes!are!usually!affected.!!A!germline!mutation!results!in!hereditary!nonGpolyposis!colorectal!cancer! syndrome! (HNPCC).! ! Sporadic! cases! of! microsatellite! instability! result! from!transcriptional! silencing! of! hMLH1!by! promoter!methylation! and! are! associated! both!with! carcinoma! development! from! sessile! serrated! adenomas! (as! opposed! to! tubular!and!tubuloGvillous!adenomata)!and!mutations!in!the!BRAF!oncogene!(11).!!MSI!tumours!
! 6!
are!more!commonly!rightGsided,!carry!a!better!prognosis!and!are!associated!with!dense!lymphocyte!infiltration.!
HNPCC! or! Lynch! syndrome! is! usually! caused! by! inherited! mutations! of! hMSH2! or!hMLH1! but! can! also! be! due! to! mutations! in! other! mismatch! repair! enzymes:! MSH6,!PMS2.!!The!condition!is!inherited!in!an!autosomal!dominant!pattern.!!Approximately!3%!of!CRC! is!due! to!HNPCC!and! the! condition! is! characterised!by!earlyGonset!CRC!with!a!predisposition! for! the!proximal!colon.! !There! is!an! increased!risk!of! synchronous!and!metachronous! tumours! and! half! of! affected! females!will! develop! endometrial! cancer.!!There! is! an! additional! risk! of! extraGcolonic! cancers:! ovary,! stomach,! small! bowel,!pancreas,! hepatobiliary! tract,! upper! uroepithelial! tract,! brain! (Turcot! variant)! and!sebaceous!adenomas/carcinomas!(MuirGTorre!variant).!
DNA$methylation$Both!DNA!hypomethylation!and!hypermethylation!of!gene!promoters!lead!to!epigenetic!instability! in! CRC.! ! DNA! hypomethylation! is! associated!with! chromosomal! instability.!!Hypermethylation!occurs!in!promoter!regions!that!contain!CpG!islands!leading!to!a!CpG!island!methylator!phenotype!(CIMP).!!There!is!an!association!between!CIMP!and!BRAF!mutations!and!most!sporadic!MSI!tumours!are!CIMP!positive.!!CIMP!is!more!frequent!in!proximal!tumours!of!the!colon,!an!effect!independent!of!MSI!status!(12).!
CRC!risk!factors!Family!history!is!a!risk!factor!for!the!development!of!CRC.!!The!relative!risk!when!there!is!one! firstGdegree!relative!with!CRC! is!2.3!(2.4! for!colonic!alone,!1.9! for!rectal!alone).!!When!there!is!one!firstGdegree!relative!with!CRC!diagnosed!under!the!age!of!45!years,!
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the! relative! risk! is! 4.0! (13).! ! HNPCC! carries! an! 80%! lifetime! risk! of! CRC! while! the!development!of!CRC!in!FAP!is!almost!inevitable.!
A!diet!rich!in!red!and!processed!meats!and!low!in!vegetables!and!fibre!has!been!shown!to!increase!the!risk!of!CRC!(14).! !These!were!the!findings!of!the!EPIC!study!which!has!investigated!the!diets!of!400,000!men!and!women!over!9!European!countries.!!Obesity!is!a!risk!factor!for!CRC:!!BMI!(body!mass!index)!is!associated!with!an!increased!risk!of!colon!cancer!in!both!men!and!women!but!an!increased!risk!of!rectal!cancer!in!men!only!(15).!!Physical!activity!reduces!the!risk!of!CRC!and!a!recent!metaGanalysis!has!shown!an!association!between!physical!activity!and!the!prevalence!of!colonic!adenomas!(16).!
Both!alcohol!intake!and!smoking!are!risk!factors!for!CRC!as!well!as!many!other!cancers!(17).!!NonGsteroidal!antiGinflammatory!drugs!(NSAIDs)!have!been!shown!to!reduce!the!risk! of! developing! CRC.! ! Furthermore,! NSAIDs! can! induce! regression! of! preGexisting!adenomas! and! prevent! the! formation! of! new! polyps.! ! This! effect! has! also! been!demonstrated!in!patients!at!high!risk!of!sporadic!CRC!(18).!
Patients!with!ulcerative!colitis! (UC)!and!Crohns!colitis!have!a!higher!risk!of!CRC! than!the! general! population,! with! recent! data! suggesting! a! risk! of! 7.5%! after! 30! years! of!disease.! ! The! British! Society! of! Gastroenterology! (BSG)! therefore! recommends!surveillance! colonoscopy! at! intervals! based! on! risk! criteria! (19).! ! Patients! with!extensive! colitis,! early! onset! of! disease! and! UCGassociated! primary! sclerosing!cholangitis!are!at!particularly!high!risk.!
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Polyposis$syndromes$Polyposis! syndromes! are! hereditary! conditions! that! are! associated!with! an! increased!CRC! risk.! ! FAP! is! classically! inherited! as! an! autosomalGdominant! disease! due! to! a!germline!mutation! of! the! APC! gene.! ! Adenomatous! polyps! develop! as! the! remaining!normal!copy!of!the!APC!gene!becomes!inactivated.!!Progression!to!malignancy!occurs!at!an!average!age!of!35G40!years!(20).!!Gardner!syndrome!is!a!variant!of!FAP!in!which!the!extraGintestinal! manifestations! of! the! disease! are! particularly! prominent:! osteomas,!dental! anomalies,! epidermal! cysts! and! desmoid! tumours.! ! Other! extraGintestinal!manifestations! include! periampullary! adenomas,! papillary! carcinoma! of! the! thyroid,!hepatoblastoma,!osteomas!of!the!mandible!and!skull!and!congenital!hypertrophy!of!the!retinal!pigment!epithelium!(CHRPE).! !Turcot!syndrome!is!the!association!of!colorectal!polyposis! (either! FAP! or! HNPCC)! with! central! nervous! system! tumours! such! as!glioblastoma!multiforme! and!medulloblastoma.! !MYHGassociated! polyposis! is! another!FAP!variant!that!is!autosomal!recessive!due!to!a!mutation!in!the!hMYH!gene!that!codes!for!a!mismatch!repair!enzyme.!!! !
PeutzGJeghers! syndrome! is! characterised! by! hamartomatous! polyps! throughout! the!gastrointestinal! tract! and! is! inherited! in! an! autosomal! dominant! manner.! ! The! gene!responsible! in! most! cases! is! STK11,! a! serine/threonine! kinase.! ! Mucocutaneous!pigmentation!is!an!almost!universal!feature!and!there!is!in!increased!risk!of!developing!CRC,!oesophagoGgastric!cancer!and!pancreatic!cancer.!
Familial! juvenile! polyposis! is! inherited! in! an! autosomal! dominant! manner! and! the!majority! of! cases! are! due! to! either! mutations! in! the! BMPR1A! or! SMAD4! genes.!!
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Hamartomatous! polyps! form! from! a! young! age! in! the! stomach,! small! intestine! and!colorectum,!increasing!the!risk!of!CRC.!
Cowden! disease,! also! known! as! the! multiple! hamartoma! syndrome,! is! an! autosomal!dominant!condition!due! to!a!mutation! in! the!PTEN!gene.! !Hamartomatous! lesions!are!present! in! the! skin! and! mucous! membranes! and! lead! to! an! increased! risk! of! many!cancers,!including!CRC.!
Presentation!Patients!with!CRC!may!or!may!not!be!symptomatic.!!CRC!can!give!rise!to!rectal!bleeding,!a! change! in! bowel! habit,! abdominal! pain,! tenesmus,! or! an! abdominal! or! rectal!mass.!!The! presence! of! CRC! can! lead! to! ironGdeficient! anaemia,! diagnosed! through! blood!testing.! ! Symptoms! may! be! noticed! by! patients! who! are! then! referred! for! further!investigation! by! their! doctor.! ! Alternatively,! patients! may! be! referred! for! further!investigation! following! the! results! of! screening! tests.! ! Bowel! cancer! screening! in!England! is! currently!offered! in! the! form!of!2!yearly! faecal!occult!blood!(FOB)! tests! to!patients! over! the! age! of! 50! years.! ! Patients! may! also! present! for! screening! or!surveillance!investigations!based!on!an!increased!risk!of!CRC.!
Investigations! include! endoscopic! examination! of! the! colon! and! rectum! (flexible!sigmoidoscopy,! colonoscopy)! and! imaging! of! the! abdomen! and! pelvis! (computerised!tomography,!magnetic!resonance!imaging,!virtual!colonoscopy).!!
The! majority! of! CRC! develops! from! preGexisting! polyps,! according! to! the! adenomaGcarcinoma! sequence! (21).! Polyps! identified! during! endoscopic! procedures! are! thus!removed! (polypectomy)! to!histologically! assess! for! foci! of!malignancy!and! to!prevent!
! 10!






TNM$Classification$of$malignant$tumours$This! system! is!maintained! by! the! International! Union! Against! Cancer! (UICC)! and! the!American! Joint! Committee! on! Cancer! (AJCC).! ! T! describes! the! size! of! the! tumour,!N!describes! the! regional! lymph! node! involvement! and!M! describes! distant! metastasis!(22).! ! Specifically,!T1! requires! the! tumour! to! invade! the! submucosa.! !T2! requires! the!tumour! to! have! invaded! the! muscularis! propria.! ! T3! denotes! that! the! tumour! has!invaded!the!serosa!layer!and!T4!requires!that!the!tumour!has!invaded!adjacent!organs!or!perforated!the!visceral!peritoneum!(see!Figure!1G4).!!Regarding!N!staging,!N0!means!that!no!regional!lymph!nodes!are!involved.!!N1!denotes!that!1G3!regional!lymph!nodes!are! involved!while!N2!means! that! 4! or!more! lymph!nodes! are! involved.! !M0! and!M1!denote!the!absence!and!presence!of!distant!metastasis!respectively,!usually!to!the!liver!or!lungs.!
T1!N0!and!T2!N0!tumours!are!also!known!as!AJCC!Stage!I.! !T3!N0!and!T4!N0!tumours!are!AJCC!Stage!II.!!Lymph!node!involvement!without!metastasis!is!AJCC!Stage!III!and!the!presence!of!metastasis!is!AJCC!Stage!IV.!




Surgery$Resection! of! the! segment! of! bowel! containing! the! primary! tumour! is! the! mainstay!treatment! for! CRC!with! the! aim! to! provide! cure.! ! ! The! segment! of! bowel! is! resected!along! with! its! vascular! pedicle! and! associated! lymphatics.! ! For! colonic! tumours,! the!choice! is! essentially! between! a! right! hemicolectomy! or! a! left! hemicolectomy.! ! Right!hemicolectomy!involves!division!of!the!ileocolic!and!right!colic!arteries!at!their!origins!from!the!superior!mesenteric!artery!while!a!left!hemicolectomy!involves!division!of!the!interior!mesenteric!artery!at!its!origin!from!the!aorta.!!The!ends!of!the!remaining!colon!are!then!anastomosed.!!!
Rectal!cancers!are!resected!either!by!anterior!resection!or!abdominoGperineal!resection!of! the! rectum.! ! Anterior! resection! is! soGnamed! for! historical! reasons! due! to! the!anatomical! anterior! approach! taken! to! resect! the! rectum.! ! The! rectal! stump! is!anastomosed!to!proximal!colon!and!a!defunctioning!stoma!may!be!performed!to!protect!this!anastomosis.!!In!an!abdominoGperineal!resection,!the!anal!canal!is!also!excised!and!the! patient! is! left!with! a! permanent! endGcolostomy.! ! The! choice! between! an! anterior!resection!and!abdominoGperineal!resection!is!primarily!dependent!on!the!height!of!the!tumour!above!the!anal!verge.!
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Resection!of!CRC!is!the!primary!treatment!of!the!disease!provided!that!a!patient!is!fit!for!surgery.! ! If!a!patient!has!advanced!disseminated!disease,!bowel!resection!may!also!be!indicated! to! provide! local! disease! control,! but! patients!will! also! require! treatment! of!their!metastases.! !In!the!context!of!advanced!disseminated!disease,!bowel!resection!or!surgical!bypass!procedures!may!also!provide!palliation!of!bowel!symptoms.!!In!the!case!of!locally!advanced!tumours,!a!cure!may!still!be!possible!with!the!resection!of!adjacent!viscera.!
Chemotherapy$In!the!UK,!approximately!one!quarter!of!patients!diagnosed!with!CRC!have!lymph!node!involvement! (AJCC!Stage! III,!Dukes!C,!TNM!N1+).! ! Such!stages!carry!a!50G60%!risk!of!recurrent!disease!following!surgery.!!5GFluorouracil!based!chemotherapy!is!used!as!an!adjuvant! treatment! in!such!patients!and! increases! the!diseaseGfree!survival!at!5!years!from! 42%! to! 58%! when! compared! to! surgery! alone! (23).! ! More! recently,! the!combination! of! oxaliplatin! with! 5GFU! regimes! has! been! shown! to! further! improve!diseaseGfree!survival!rates!at!the!expense!of!increased!toxicity!(24).!
Stage! II! CRC! (Dukes! B,! T3+! N0)! only! has! a! recurrence! rate! of! 20%! at! 5! years! postGsurgery! and! therefore! very! large! studies! are! required! to! ascertain! any! benefit! from!chemotherapy.!!In!an!RCT!conducted!on!such!patients,!the!absolute!survival!benefit!at!5!years! has! been! estimated! to! be! 3.6%! (25).! ! However,! within! this! group! of! stage! II!patients,!exists!a! subgroup!who!are!more! likely! to!experience!disease!recurrence!and!are!therefore!thought!to!benefit!from!adjuvant!chemotherapy!more!than!other!stage!II!subgroups.!
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Radiotherapy$The! colon! is! mobile! within! the! peritoneal! cavity,! which! it! shares! with! other! organs!including! (the! very!mobile)! small! bowel.! ! It! is! therefore! difficult! to! accurately! target!colonic!tumours!and!the!use!of!radiotherapy!is!limited!to!the!treatment!of!rectal!cancer.!!Neoadjuvant! radiotherapy,! given! as! a! shortMcourse! of! 25Gy! in! 5! fractions,! has! been!shown!to!reduce!the!risk!of!local!recurrence.!!This!is!obviously!of!benefit!to!the!patient!but!comes!at!a!cost!of!sterility,!increased!risk!of!sexual!dysfunction!and!impaired!bowel!function.!!NICE!guidelines!suggest!reserving!neoadjuvant!shortGcourse!radiotherapy!for!patients! with! extramural! vascular! invasion,! lymph! nodes! suspicious! of! malignant!involvement! on! imaging,! or! T3b! staging! (i.e.! satellite! deposits! in! the! pericolorectal!tissues).!
SoGcalled!longMcourse!radiotherapy!of!40G50Gy!over!5G6!weeks!is!used!to!shrink!locally!advanced! rectal! cancer.! ! This! may! enable! successful! complete! surgical! resection! or!permit!anterior!resection!in!place!of!abdominoGperineal!resection!for!rectal!cancer.!
The$immunology$of$colorectal'cancer!
There! is! evidence! from! both! animal!models! and! humans! that! the! immune! system! is!activated! in! response! to!primary! tumours! in! an! attempt! to! control! or! eliminate! them!(26).! ! Evidence! for! this! comes! from! studies! in! mice! and! humans,! showing! that!immunodeficiency! increases! the! incidence! and! severity! of! CRC.! ! Firstly,!immunodeficient!mice!are!more!susceptible!than!wildtypes!to!chemicallyGinduced!and!spontaneous! tumours! and! patients! with! primary,! and! particularly! secondary!immunodeficiency! in! response! to! immunosuppressive! treatment! in! organ!
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transplantation,! have! an! increased! risk! of! solid! nonGviral! tumours,! including! CRC,!compared! with! the! general! population! (27).! ! Secondly,! it! is! established! that! cancer!patients!can!develop!adaptive!immune!responses!as!seen!by!the!formation!of!antibodies!and! T! cells!which! recognise! tumour! antigens! (26,28).! ! Thirdly,! the! degree! of! tumour!lymphocytic! infiltration! correlates! with! survival.! ! Lymphocytic! infiltration! in! CRC! is!independently! associated! both! with! improved! overall! survival! and! recurrenceGfree!survival!(29).!!Fifteen!per!cent!of!CRC!exhibits!MSI!which!carries!an!improved!prognosis!compared!with!microsatellite!stable!disease!(30)!and!is!associated!with!dense!tumour!lymphocyte!infiltration.!
Further! analysis! of! lymphocyte! phenotype! has! shown! that! the! numbers! of! CD8+! and!CD45RO+! (a! marker! of! memory! cells)! T! cells! are! independently! associated! with!remission!rates!and!survival!and!may!be!better!predictors!of!disease!outcome!than!the!AJCC!TNM!Staging!system!(31).!!Densities!of!CD8+!and!CD45RO+!cells!are!determined!in!the! tumour! core! and! invasive! margin! to! derive! an! immunoscore.! ! The! challenges! of!standardising!this!score,!so!that!it!may!be!used!in!different!laboratories!and!therefore!introduced! as! a! prognostic! marker,! is! a! focus! of! active! research! (32).! ! There! is! no!proven!association!between!CD8+!and!CD45RO+!cell!counts!in!CRC!liver!metastases!and!patient! survival! and! this! has! been! highlighted! as! evidence! supporting! the!immunoediting!theory!that!cancer!metastases!have!formed!from!cancer!cells!that!have!escaped!immune!control.!
The!process!by!which! the! immune!system!regulates! cancer!development! is!known!as!immunoediting.! ! Three! phases! of! this! process! have! been! defined:! ! Elimination,!equilibrium!and!escape!(26).! !In!the!elimination!phase,!the!immune!system!mounts!an!
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inflammatory!response!to!the!tumour,!involving!the!generation!of!tumourGspecific!CD4+!and!CD8+!cells!which!home!to!the!site!of!the!tumour.! !The!adaptive! immune!response!leads! to! the! killing! of! antigenGpositive! tumour! cells.! ! ! However,! tumour! cell! variants!bearing!different!antigens!arise.! !The!equilibrium!phase!represents!a!balance!between!tumour! cell! killing! and! the! selective! growth! of! tumour! cell! variants.! ! Finally,! in! the!escape! phase,! tumour! cell! variants! are! able! to! grow! despite! an! intact! host! immune!system.! ! Thus,! the! development! of! variant! antigens! by! tumour! cells,! or! the!downregulation! of! MHC! antigens,! allows! the! tumour! to! escape! immunosurveillance.!!Other!mechanisms!exist!to!allow!the!tumour!to!escape!the!host’s!antiGtumour!immune!response.! ! One! such!mechanism! is! infiltration! of! the! tumour! by! immunosuppressive!regulatory!T!cells!(Treg).!
Regulatory!T!cells!(Treg)!Treg! were! originally! identified! by! their! ability! to! maintain! selfGtolerance,! thereby!preventing!autoimmune!disease!(33).!!They!are!characterised!by!the!expression!of!CD4,!high!levels!of!the!ILG2!receptor!CD25!and!low!levels!of!the!ILG7!receptor!CD127!on!the!cell! surface! and! the! expression! of! the! Foxp3! transcription! factor! (34).! ! Whereas!conventional! T! cells! (Tconv)! become! activated! and! proliferate! in! response! to!recognition!of!their!cognate!antigen!together!with!appropriate!coGstimulation,!Treg!act!to!suppress!T!cell!activation!and!proliferation!(see!Figure!1G5).!!!
TregGmediated! suppression! occurs! by! a! variety! of! different! mechanisms! and! the!predominant!in!vivo!mechanism!is!unknown,!perhaps!depending!on!the!target!cell!and!immune! microenvironment! (35).! ! Treg! can! both! transfer! cAMP! to! other! T! cells! and!mediate! immunosuppression! via! the! generation! of! adenosine.! ! Treg! consume! ILG2,!
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Evidence!that!Foxp3!is!the!master!regulator!of!Treg!differentiation!comes!from!studies!showing!high!amounts!of!Foxp3!mRNA!and!protein! in!CD4+CD25+!suppressive!T!cells!and! lossGofGfunction!mutations! in! Foxp3!were! shown! to! be! responsible! for! the!multiGorgan!autoimmune!disorder,!IPEX!(in!the!human)!and!scurfy!(in!the!mouse).!!Similarly,!forced! expression! of! Foxp3! in! CD4+CD25G! cells! leads! to! a! Treg! phenotype! and!suppressor!function!(39).!
Naturally:occurring$versus$induced$Treg$Two! populations! of! Treg! exist.! ! NaturallyGoccurring! (nTreg)! are! generated! in! the!thymus!and!are!present!from!13!weeks!of!gestation!in!the!human!(40).! !In!the!mouse,!nTreg!develop!in!the!neonatal!thymus.!!Treg!may!also!be!induced!from!both!murine!and!human! CD4+CD25G! cells! in! vitro! by! culture! with! TGFGß! (41).! ! These! are! known! as!induced!Treg!(iTreg).!!Both!nTreg!and!iTreg!express!the!canonical!Treg!markers:!CD25,!Foxp3!and!CTLAG4!and! it!has!therefore!proven!difficult! to!distinguish!the!two!subsets!(42).!!Helios!is!a!transcription!factor!that!can!reportedly!be!used!as!a!marker!for!nTreg!(43).! ! Thymic!Treg! emigrants! express!Helios,!while!peripherally! induced!Treg!do!not!(44).!!The!stability!of!Foxp3!expression!is!a!hallmark!of!nTreg:!!iTreg!lose!expression!of!Foxp3! on! reGstimulation! in! the! absence! of! TGFGß.! ! The! stability! of! nTreg! Foxp3!expression! has! been! linked! to! demethylation! of! CpG! motifs! in! a! highlyGconserved!element!of!the!Foxp3!locus!known!as!the!TregGspecific!determining!region!(TSDR)!(45).!!Thus,! it! is! possible! to! identify! nTreg! by! assessment! of! the!methylation! status! of! the!TSDR.!
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Other$suppressive$T$cell$populations$Other!populations!of!suppressive!T!cells!exist!but!further!study!of!their!role!in!disease!is!difficult!due!to!a!lack!of!consensus!regarding!specific!identification!markers!(46).!!TypeG1! regulatory! T! cells! (Tr1)! can! be! induced! from! naïve! T! cells! and! characteristically!express! high! levels! of! ILG10! in! the! absence! of! foxp3! expression.! ! Th3! cells! are! also!induced!from!naive!T!cells,!mediate!suppression!via!TGFGß!and!express!low!levels!of!ILG10!and!intermediate!levels!of!Foxp3!(47).!!A!population!of!suppressive!CD8+!cells!have!been! described! in! CRC,! which! express! CD25! and! Foxp3,! and! are! likely! induced! from!other!CD8+!cells!(48).!
Treg$and$cancer$There!have!been!a!number!of!studies!that!have!demonstrated!tumour!Treg!enrichment!relative! to! other! compartments! in! various! cancerGbearing! mouse! models,! with!promotion!of!antiGtumour! immunity! through!Treg!depletion!(49).! !This! is! the!basis!of!the!TregGmediated!tumour!immune!escape!hypothesis.!!According!to!this!hypothesis,!T!cells! infiltrating! a! tumour!attempt! to!mount! an!antiGtumour! immune! response! that! is!hampered! by! the! presence! of! Treg.! ! Certainly,! Treg! have! been! shown! to! inhibit!reactivity! of! tumourGspecific! T! cells! in! CRC! patients.! ! Treg! depletion! results! in! the!proliferation!of! a! tumourGreactive!T! cell!population! from! the!peripheral!blood!of!CRC!patients! in!vitro! (50).! !Accordingly,! increased!numbers!of!Treg! in!human!CRC! tissues!have!been!demonstrated!along!with!many!other!solid!and!haematological!malignancies.!!A!recent!study!has!demonstrated! that! the!proportion!of!Treg! in!peripheral!blood!was!increased! in! CRC! patients! compared! with! controls,! and! returned! to! normal! levels!following!bowel!resection.!!CD4+!T!cell!responses!were!identified!to!CRC!antigens!in!the!majority! of! patients! and! some! of! these! responses! were! suppressed! by! Treg.!!
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Interestingly,!the!existence!of!TregGmediated!suppressed!T!cell!responses!was!linked!to!disease!recurrence!at!one!year!(51).!
Given! the! hypothesis! of! TregGmediated! suppression! of! the! antiGtumour! immune!response,! it! might! be! expected! that! Treg! density! increases! with! advancing! tumour!stage,! thereby! enhancing! tumour! escape! and! allowing! progression.! ! One! study! has!reported! a! positive! correlation! between! Treg! density! and! advancing! disease! stage!although!the!relationship!did!not!reach!statistical!significance!(52).! !In!contrast,!larger!studies!have!shown!a!statistically!significant!negative!correlation!between!Treg!density!and!advancing!disease!stage! (53,54).! !The!published! literature! is!also!conflicting!with!regard!Treg! infiltration!of! the!tumourGdraining! lymph!nodes!(TDLN)! in!CRC,!with!one!study!reporting!an!association!between!higher!Treg!infiltration!and!improved!survival!(55)!while!another!has!reported!a!correlation!between!Treg!infiltration!and!advancing!tumour!stage!(56).!!!
This! reported! decrease! in! Treg! density!with! advancing! disease! stage! is! peculiar! to! a!small!number!of!solid! tumours,!notably!CRC.! !Rather,!a!high!density!of!Treg!has!been!associated! with! poor! outcomes! in! ovarian,! pancreatic! and! hepatocellular! carcinoma!(57–59).!!!The!suppressive!capacity!of!the!Treg!population!is!likely!to!be!more!relevant!than!Treg!cell!numbers,!but!more!difficult!to!study.!!!
Despite! these! reports! of! decreased! Treg! densities! with! advanced! disease! stage,! a!postulated! tumour! immuneGevasive! role! for! Treg! is! borne! out! from! robust! Treg!depletion! studies.! ! Depletion! of! Treg! in! mouse! models! has! been! shown! to! result! in!rejection!of!CRC!cell!lines!providing!durable!tumour!immunity!(60).!!There!is!now!also!
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direct! evidence! that! Treg! depletion! results! in! enhanced! tumour! vaccine! activity! in!patients!with!CRC!(61).!!
Lymphocyte!trafficking!If!Treg!are!to!be!effective,!they!must!migrate!to!the!correct!tissue!location!to!carry!out!their!functions.!!Hence,!it!is!important!to!study!how!they!migrate!and!localise!within!the!body.! !The!concept!of! lymphocyte! trafficking!was! first! suggested!by! James!Gowans! in!1963!and!then!demonstrated!in!the!late!1970s!when!T!cells!harvested!from!the!sheep!intestine!were!autologously! transfused!back! into! the!animal!and!were! found! to!home!back!to!the!intestine!(62).!!Lymphocytes!migrate!into!tissues!via!the!endothelium!lining!blood!vessels!which!acts!to!regulate!where!and!when!circulating!cells!are!recruited.!!To!cross!the!endothelium!into!tissues,!cells!must!first!interact!with!the!vessel!wall!and!be!captured!from!flowing!blood!in!a!process!of!rolling!interactions!which!allows!the!cells!to! be! activated,! leading! to! arrest! and! firm! adhesion! followed! by! transmigration! (see!Figure!1G6).!!These!interactions!are!a!process!of!sequential!molecular!steps!mediated!by!adhesion!molecules!and!chemokines.!!Some!of!these!molecular!players!are!generic!and!operate!in!many!vascular!beds!but!others!have!a!restricted!distribution!and!are!able!to!regulate!tissueGspecific!recruitment,!bringing!selectivity!to!the!process!of!trafficking.!
With! regard! intestinal! lymphocyte! trafficking,! specialised! dendritic! cells! (DCs)! in! the!intestine!sample!antigen!and!then!migrate!to! lymphoid!tissues.! !Here!the!DCs! interact!with! naïve! T! cells! to! generate! primed! effector! lymphocytes.! ! To! ensure! that! these!lymphocytes!home!to!the!small!intestine!where!the!antigen!was!encountered,!they!are!programmed!to!express!the!chemokine!receptor!CCR9!and!the!integrin!α4β7.! !This!is!a!retinoic! acidGdependent! process! and! the! presence! of! the! required! retinal!
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dehydrogenase!is!largely!restricted!to!intestinal!DCs!(63).!CCL25,!the!ligand!for!CCR9,!is!expressed! in! the! intestine! and! mediates! activation! along! with! the! ligand! for! α4β7,!namely!MAdCAMG1,!allowing!tissueGspecific!recruitment!of!primed!lymphocytes!to!the!small! intestine.! ! Following! lymphocyte! activation,!α4β1! binds! to!VCAMG1! in! a! process!known! as! firm! adhesion.! ! However,! it! is! not! clear! whether! CCR9! is! involved! in!lymphocyte! trafficking! to! the!colon.! !Although!a!quarter!of! lymphocytes! isolated! from!the!inflamed!colon!express!CCR9,!the!normal!colon!does!not!express!CCL25!and!CCR9+!T!cells!do!not!enter!the!colon!in!animal!models!(64).!
Naïve! T! cells! traffic! to! secondary! lymphoid! organs! by! first! becoming! tethered! and!rolling! using! T! cellGexpressed! LGselectin! interacting! with! its! ligand,! peripheral! node!addressin! (PNAd).! ! This! allows! CCR7! on! the! naïve! T! cells! to! be! activated! by! its!chemokine!ligand!CCL21!on!high!endothelial!venules.!!This!activation!allows!alteration!of! integrin! binding! affinities! to! form! a! firm! adhesion! interaction! between! αLβ2! and!VCAMG1.! ! CCL17! and! its! receptor,! CCR4,! are! thought! to! be! important! in! lymphocyte!trafficking! to! the! skin! (65).! ! Treg!migrate! from! the! skin! to! draining! lymph! nodes! at!steadyGstate!in!a!mouse!model!and!then!migrate!back!to!the!skin!from!draining!lymph!nodes!during!induced!dermatitis!(66).!!Adoptively!transferred!Treg!from!CCR7!G/G!mice!fail!to!home!to!lymph!nodes!while!CCR4!G/G!Treg!!fail!to!home!to!the!skin!(67).!
With!regard!to!other!tissues,!populations!of!gut!intraGepithelial!lymphocytes!expressing!CCR10! are! recruited! to! biliary! epithelial! cells! after! stimulation! of! the! epithelium! to!express!CCL28!by!LPS!and!ILG1β.!!These!recruited!lymphocytes!include!a!population!of!Treg!which!have!demonstrable!suppressive!properties!(68).!!Both!CCR4!and!CXCR3!are!
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expressed!on!Treg!recruited!to!the!inflamed!liver.!!FlowGbased!assays!have!shown!that!CXCR3!plays!the!dominant!role!in!recruiting!these!cells!to!the!hepatic!endothelium!(69).!!
Cell!Adhesion!Molecules!CellGsurface! proteins! that! are! involved! in! binding! to! other! cells! or! the! extracellular!matrix! are! known! as! cell! adhesion! molecules! (CAMs).! ! These! can! be! classified! as!immunoglobulinGsuperfamilyGCAMs,!integrins,!cadherins!or!selectins.!!The!first!two!are!calciumGindependent!proteins!while!the!latter!two!are!calciumGdependent.!
Selectins$The! selectins! are! a! family! of! cationGdependent! glycoproteins! that! bind! cellGsurface!carbohydrates.!!The!extraGcellular!domain!consists!of!a!carbohydrate!recognition!motif,!an! epidermal! growth! factorGlike!motif! and! a! varying! length! of! repeated! complementGregulatory!proteinGlike!motifs!(70).!!The!three!family!members!are!EGselectin,!LGselectin!and! PGselectin.! ! The! first! step! of! leukocyte! trafficking! is! rolling! of! the! circulating!leukocyte!along!the!endothelial!wall!and!this!is!mediated!by!selectins!(see!Figure!1G6).!!LGselectin! is! expressed! by!most! leukocytes! while! EG! and! PGselectin! are! expressed! by!inflamed!endothelial!cells!(71).!!A!ligand!for!all!three!selectins!is!PGselectin!glycoprotein!ligand!1! (PSGLG1).! !LGselectin!also!binds!GlyCAMG1,!MAdCAMG1!and!PNAd.! !Secondary!tethering!can!occur!via!interactions!between!LGselectin!on!one!leukocyte!and!PSGLG1!on!another!in!order!to!capture!circulating!leukocytes!that!do!not!express!selectin!ligands.!
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!
Figure!1G6:!The!steps! involved! in! lymphocyte! trafficking.! !Lymphocyte!capture! is!mediated!by!selectins!and!integrins.! !Rolling!along!the!endothelium!is!mediated!by!selectins.! !Lymphocytes!become! activated! and! arrest,! mediated! by! chemokines! and! integrins,! before! crawling! and!transmigrating!through!the!endothelium.!!Adapted!from!Ley!et!al!(71).!
!There! is! evidence! that! EGselectin! may! be! exploited! by! tumour! cells! to! facilitate!metastasis.! ! Metastatic! CRC! cells! can! roll! and! adhere! to! endothelial! cell! monolayers!expressing! EGselectin! and! highly!metastatic! tumour! cells! bind!more! avidly! than! their!less!metastatic!counterparts!(72).!!!
LGselectin!is!thought!to!be!critically!important!for!lymphocyte!recruitment!to!secondary!lymphoid!tissues!via!high!endothelial!venules!and!is!found!on!naïve!T!cells.!!LGselectin!is!expressed!by!Treg!and!it!has!been!reported!that!only!LGselectin!expressingGTreg!protect!against! the! development! of! lethal! colitis! in! a!murine! bone!marrow! transplant!model!(73).!!
Integrins$The!integrins!are!molecules!composed!of!α!and!β!subunits!that!bind!to!cellGsurface!or!soluble! ligands! and! extracellular!matrix! proteins.! ! Fourteen!members! of! the! integrin!
! 25!
family! are! known! to! be! expressed! by! immune! cells! and! the! β1! and! β2! integrins! are!leukocyteGspecific!(74).!!Their!ligands!include!fibronectin,!vitronectin,!collagen,!laminin!and! members! of! the! IgGsuperfamily! CAMs.! ! Integrins! contribute! to! intercellular!adhesion,! anchorageGdependent! cell! survival! and! regulate! intracellular! events! via!transmission!of!outsideGin!signals!(75).!
Epithelial!cells,! including!those!in!colonic!tissue,!strongly!express!β1!integrins!whereas!
β2!integrins!are!restricted!to!leukocytes!(76).!!Variable!expression!of!integrins!is!seen!in!CRC!tissue.!!αvβ6!has!been!studied!in!relation!to!CRC!metastasis!(77)!where!it!is!involved!in! the! degradation! of! the! extracellular! matrix! during! cancer! progression.! ! The! β1!integrin!has!been! implicated! in!binding!of!CRC!cells! to!hepatocytes!during!metastasis!(78).!
The!α4β7!integrin! is! expressed!by!memory! gutGhoming! lymphocytes! allowing! them! to!bind!to!MAdCAMG1.!!Lymphocytes!homing!to!nonGmucosal!tissues!lack!α4β7!and!express!
α4β1,!allowing!binding!to!VCAMG1!(79).! !The!integrin!α4β7!!is!expressed!by!the!majority!of!intestinal!intraGepithelial!lymphocytes!and!only!a!minority!of!circulating!and!lamina!proprial! lymphocytes! (80).!αEβ7! is!upregulated!by!T! cells! after!entering! the! intestinal!epithelium!and! allows!binding! to! EGcadherin! on! the! epithelial! cell! surface,! promoting!tissue!lymphocyte!retention.!
MAdCAMG1! is! expressed! constitutively! on! endothelial! cells! throughout! the! small!intestine! and! colon! and! can! be! upregulated! at! numerous! other! sites! during!inflammation.!!Aberrant!expression!of!MAdCAMG1!on!hepatic!endothelium!in!ulcerative!colitis!promotes!recruitment!of!gutGtrophic! lymphocytes!resulting! in!chronic!hepatitis!
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(63).! !In!a!murine!model!of!colitis!knockout!of!β7!!on!Treg!led!to!a!reduction!in!colonic!Treg!infiltration!(81).!!Treg!subsets!have!been!characterised!by!virtue!of!their!integrin!profile:! α4β7+! Treg! induce! ILG10Gsecreting! Tr1! lymphocytes! (Type! 1! regulatory! cell)!while! α4β1+! Treg! induce! TGFGßGproducing! Th3! lymphocytes! (T! helper! 3! cell)! (82).!!Similarly,! expression! of! αEβ7! ! identifies! a! population! of! Treg! which! produce! small!amounts!of!cytokines,!yet!are!potently!suppressive!(83).!
Integrins!can!mediate!not!only!arrest!and!firm!adhesion!but!also!the!rolling!process!as!part!of!leukocyte!recruitment.!!Both!α4β7—MAdCAMG1!and!α4β1—VCAMG1!interactions!can! mediate! rolling! in! addition! to! the! aforementioned! selectin! interactions! (71).!!Lymphocyte!arrest!during!the!rolling!process!is!triggered!by!chemokines!and!mediated!by! binding! of! integrins! on! lymphocytes! to! immunoglobulin! superfamily! members!expressed! by! endothelial! cells,! for! example!α4β1!with! VCAMG1! and!αLβ2! !with! ICAMG1!(84).!
Soluble! forms! of! VCAMG1! and! ICAMG1! exist,! their! upregulation! by! endothelial! cells!mediated! by! cytokines! derived! from! the! tumour! epithelium! (85).! ! Serum! levels! of!VCAMG1,! ICAMG1! and! EGselectin! are! significant! prognostic! factors! in! CRC,! perhaps!reflecting!their!role!in!tumour!progression!and!metastasis!(86).!
The! integrin! subunit! αE! (CD103)! is! thought! to! mediate! lymphocyte! retention! in!epithelial!tissues!via!interaction!with!its!ligand,!EGcadherin,!expressed!by!epithelial!cells!(87).!!In!a!study!analysing!Treg!in!four!different!murine!cancer!models,!almost!all!Treg!expressed!CD103!(88).!!The!integrin!subGunit!did!not,!however,!appear!to!be!involved!in!either! homing! or! retention! of! Treg! in! relation! to! the! tumour! tissue.! ! CD103! can! be!
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induced! on! tumourGspecific! T! cells! by! TCR! engagement! and! local! TGFGβ.! ! Interaction!between!CD103!on!T!cells!with!EGcadherin!on!tumour!cells!has!been!shown!to!recruit!CCR5!to!the!immunological!synapse.!!This!has!the!effect!of!reducing!the!sensitivity!of!T!cells!to!CCR5!ligands!and!provides!an!indirect!means!of!lymphocyte!retention!in!tumour!tissues!(89).!
Chemokines$and$chemokine$receptors$Chemokine! receptors! are! a! subGfamily! of! GGproteinGcoupled! receptors! that! are! found!predominantly!on!the!surface!of!leukocytes!and!have!a!sevenGtransmembrane!structure.!!On!binding!cognate!ligand,!receptor!signalling!leads!to!a!range!of!cell!activities!including!cell! migration,! differentiation! and! effector! functions! (90).! ! In! cancer! biology,!chemokineGchemokine! receptor! interactions! are! known! to! be! a!major! determinant! of!macrophage,!natural!killerGcell!and!lymphocytic!infiltration!in!human!carcinomas!(91).!Chemokine! receptors! expressed! on! the! cell! surface! may,! however,! not! be! functional!(92,93).! !Most! chemokine! receptors! recognise!more! than!one! chemokine! i.e.! they! are!promiscuous,! but! only! rarely! can! chemokine! and! receptor! interactions! span! receptor!subclasses.!!Similarly,!many!chemokines!can!bind!to!multiple!receptors.!!See!Table!1G1!for!a!list!of!chemokine!receptors!and!their!ligands.!!Classification!is!based!on!molecular!structure!according!to!the!number!and!spacing!of!conserved!cysteine!residues.! !There!are! four! groups! denoted! by! CXCR,! CCR,! CR! and! CX3CR!where! C! relates! to! a! cysteine!residue,!X!an!intervening!amino!acid!and!R!signifies!a!receptor!as!opposed!to!a! ligand!(L).! !There!are!eleven!members!of!the!CC!group,!seven!of!the!CXC!group!and!only!one!each!of!both!the!CX3C!and!C!groups.!
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The!RNA!profile!of!an!array!of!chemokines!and!chemokine!receptors!was!analysed! in!paired!samples!of!CRC!and!distal!colon!from!eight!patients!undergoing!colonic!resection!(94).! ! CCR1! and! CCR5! together! with! their! ligands! CCL4! and! CCL5! were! found! to! be!strongly! overexpressed! in! the! tumour! tissue! compared! with! the! colon.! ! The! proGangiogenic! chemokines,! CXCL1! and! CXCL8,! were! also! overexpressed! with! their!receptor,!CXCL2.!!!
Table!1G1:!List!of!chemokine!receptors!with!their!ligands!
Receptor! Ligands!CCR1! CCL3,CCL5,CCL7,CCL13,CCL14,CCL15,CCL16,CCL23!CCR2! CCL2,CCL7,CCL8,CCL13,CCL16!CCR3! CCL5,CCL7,CCL8,CCL11,CCL13,CCL15,CCL16,CCL24,CCL26,CCL28!CCR4! CCL17,CCL22!CCR5! CCL3,CCL4,CCL5,CCL8,CCL11,CCL14,CCL16!CCR6! CCL20!CCR7! CCL19,CCL21!CCR8! CCL1!CCR9! CCL25!CCR10! CCL27,CCL28!CXCR1! CXCL6,CXCL7,CXCL8!CXCR2! CXCL1,CXCL2,CXCL3,CXCL5,CXCL6,CXCL7,CXCL8!CXCR3! CXCL9,CXCL10,CXCL11,!CXCL4!(B!isotype)!CXCR4! CXCL12!CXCR5! CXCL13!CXCR6! CXCL16!CXCR7! CXCL12!XCR1! XCL1,XCL2!CX3CR1! CX3CL1!CCXGCKR! CCL19,CCL21,CCL25!D6! CCL2,CCL3L1,CCL4,CCL5,CCL7,CCL8,CCL11,CCL13,CCL14,CCL17,!CCL22!DARC! CCL2,CCL7,CCL8,CCL11,CCL13,CCL14,CCL16,CCL17,CXCL1,CXCL5,!CXCL6,!CXCL7,!CXCL8,!CXCL9,!CXCL11,!CXCL13!!
A! brief! overview! of! the! role! of! individual! chemokine! receptors! in! relation! to! cancer!immune!cell!recruitment!will!now!be!presented.!!Chemokine!receptors!are!detected!on!
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tumourGinfiltrating!leukocytes!but!are!also!found!with!a!more!restricted!distribution!on!tumour! cells! and! tumourGassociated! stroma.! ! I! will! focus! on! the! expression! on!infiltrating!leukocytes:!
CCR1! has! been! found! on! tumourGinfiltrating! leukocytes! in! a! mouse! model! of! breast!cancer.! !The!tumour!infiltrate!was!reduced!by!treatment!with!a!CCR1!antagonist!(95).!!There! are! however! no! reports! of! CCR1Gexpressing! lymphocytes! in! human! CRC.!!!Immature!myeloid!cells!expressing!CCR1!were!recruited!to!tumours!in!a!mouse!model!of!CRC!and!liver!metastases.!!Blockade!of!CCR1!in!this!model!led!to!reduced!metastasis!and!improved!survival!(96).!!
Lymphocytes!infiltrating!CRC!liver!metastases!express!low!levels!of!CCR3,!yet!tumours!express!high! levels!of!CCL24!(97).! !High! levels!of!CCL24!may!not! lead! to!CCR3+!T!cell!enrichment! as! the! CXCR3! ligands,! which! are! also! secreted! by! CRC! metastases,! can!inhibit!CCR3Gmediated!functional!responses!(98).!!!
Approximately!75%!of!Treg!isolated!from!human!peripheral!blood!express!CCR4!(99).!Injection!of!an!adenoviral!vector!encoding!an!array!of!different!chemokines!found!that!CCL17! transduction! induced! tumour! regression! in!a!murine!model!of!CRC,! associated!with!CD8+!cell!infiltration!(100).!!In!a!study!on!gastric!cancer,!tumour!Treg!infiltration!was!found!to!be!positively!correlated!with!CCL17+!or!CCL22+!cell!infiltration!(101).!In!human! ovarian! cancer,! tumour! tissue! and! tumourGassociated! macrophages! express!CCL22!which!can!support!the!recruitment!of!CCR4+!Treg!into!the!tumour!(57).!!!
CCR5+!T!cells!have!been!demonstrated!in!CRC!by!immunohistochemistry!(102)!and!flow!cytometry! (103).! ! The!main! ligands! for!CCR5!are!CCL3,! CCL4! and!CCL5!which! are! all!
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expressed!by!CRC!(102).!!In!a!murine!model!of!pancreatic!cancer,!CCR5!expression!was!demonstrated!on!tumourGinfiltrating!Treg!(104).!!Reduction!of!tumour!CCL5!expression!by!shRNA!was!associated!with!smaller!tumours!and!reduced!tumour!Treg!infiltration.!
Human! CRC! cells! express! CCL20! and! CCR6! in! a! nonGpolarised! manner! and! both!molecules! are! upregulated! compared! with! the! colonic! mucosa! (105).! ! A! CCR6+! Treg!population! is! found! in! human! breast! cancer! and! their! frequency! is! associated!with! a!poor!prognosis!(106).!!!
There!is!little!evidence!for!CCR7Gdependent!TGcell!recruitment!to!CRC.!!In!fact,!there!is!less! expression! of! the! CCR7! ligand,! CCL21,! in! CRC! compared! with! the! colon! (107).!!Peripheral! blood! Treg! do! however! express! high! levels! of! CCR7,! especially! following!Treg!expansion!(108).!!This!probably!directs!their!migration!to!lymphoid!tissues!rather!than!to!sites!of!inflammation,!or!to!tumours.!
Peripheral! blood! T! cells,! including! Treg! express! CCR8! (109).! ! Blockade! of! the! CCR8!ligand,! CCL1,! reduces! the! number! of! tumourGinfiltrating! Treg! by! inhibition! of! Treg!induction!as!well!as!effects!of!recruitment!(110).!!!
CCR9!is!expressed!by!memory!and!effector!lymphocytes!homing!to!the!small!bowel.!!Its!ligand,!CCL25,!is!selectively!expressed!in!the!small!intestine!and!thymus!(111).!!CCR9!is!also!expressed!by!gutGhoming!tolerogenic!plasmacytoid!dendritic!cells!which!are!potent!inducers!of!Treg!(112).!!There!is!little!evidence!for!CCR9!dependent!T!cell!trafficking!to!the!human! colon.! ! CCL25! is! not! expressed! in! the!normal! colon! (113),! although! it! has!been!detected!in!inflamed!and!nonGinflamed!colonic!tissue!in!a!murine!model!of!colitis!
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(114).! ! Our! own! data! show! the! presence! of! CCR9+! T! cells! associated! with! CCL25!expression!in!inflamed!human!colon.!
CCL28!is!expressed!by!the!epithelium!in!human!colon!and!to!a!lesser!extent,!in!the!small!intestine! (115).! ! It! is! the! ligand! for! CCR10! and! its! expression! is! reduced! in! CRC!compared!with!the!colon!(116).!!A!recent!study!has!shown!that!CCL28!is!upregulated!in!hypoxic! ovarian! tumours,! correlating! with! HIFG1α! levels.! ! This,! in! turn,! leads! to!increased!tumour!CCR10+!Treg!infiltration!(117).! !There!is,!as!yet,!no!evidence!for!the!existence!of!this!pathway!in!CRC.!
CXCR1! and! CXCR2! are! closely! related! chemokine! receptors! that! recognise! CXC!chemokines! possessing! an! EGLGR! amino! acid!motif.! ! CXCL8! (also! known! as! ILG8)! and!CXCL6!bind!chiefly!to!CXCR1!while!the!other!EGLGR!chemokines!(CXCL1!to!CXCL7)!bind!to!CXCR2!only.!!Both!CXCR1!and!CXCR2!together!with!their!ligand,!CXCL8,!are!expressed!by! CRC! cell! lines! with! metastatic! potential! (118).! ! CXCR1,! CXCR2! and! CXCL8! are!expressed!by!the!tumour!epithelium!in!human!CRC!(119).!!Marked!induction!of!CXCR1!and!weak!induction!of!CXCR2!on!Treg!has!been!demonstrated!in!response!to!ILG6!(120).!!However,!there!are!no!reports!of!CXCR1G!or!CXCR2G!expressing!Treg!in!CRC.!
It! is! well! established! that! activated! CD4+! cells! express! CXCR3,! mediating! T! cell!trafficking! (121).! ! CXCR3! expression! has! also! been! demonstrated! by! Treg! in! the!inflamed! human! liver,! enabling! Treg! to! bind! and! transmigrate! through! the! hepatic!sinusoidal!endothelium!(122).!!CXCR3+!Treg!isolated!from!human!peripheral!blood!are!suppressive! and! migrate! towards! the! ligand,! CXCL10! (123).! ! CXCR3! can! also! be!upregulated! by! CXCR3G! Treg! following! activation!with! antiGCD3! and! antiGCD28! in! the!presence! of! ILG2.! ! CXCR3+! Treg! have! been! identified! in! human! CRC! (124)! and! the!
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cognate! ligands,! CXCL9! and! CXCL11,! are! overexpressed! by! CRC! compared! with! the!colon!(94).!
CXCR4!mRNA!is!expressed!by!Treg!resident!in!malignant!mesothelioma!and!the!CXCR4!ligand,! CXCL12,! is! expressed! by! the! tumour! tissue! (125).! ! Treg! isolated! from! human!peripheral! blood! were! found! to! not! migrate! towards! CXCL12! (126).! ! However,! on!activation!by!monocyteGderived!DCs,!Treg!upregulated!CXCR4!and!efficiently!migrated!towards!its!ligand.!!!
CXCR5!was! originally! identified! in! Burkitt’s! lymphoma! and! subsequently! found! on! B!cells! and! on! T! cell! subsets.! ! Human! tonsillar! Treg! express! CXCR5! and! it! has! been!suggested!that!this!may!lead!to!migration!to!germinal!centres!(127).!!Human!peripheral!blood!Treg!express!CXCR5!at!relatively!low!levels!(128).!
Human!peripheral!blood!Treg!express!little!CXCR6!(128,129).!!CXCL16!is!expressed!by!human! CRC! and! there! is! a! positive! correlation! between! CXCL16! levels,! lymphocytic!infiltration!and!prognosis!(130).!!!
CXCR7,! like! CXCR4,! binds! to! CXCL12.! ! CXCR7! mediates! chemotaxis! of! cancer! cells!towards!CXCL12!in!vitro!but!there!are!no!reports!of!CXCR7!mediating!tumour!immune!cell!recruitment!(131).!
The!ligand!for!CX3CR1,!CX3CL1!(also!known!as!fractalkine),!is!expressed!by!human!CRC!and!CX3CL1!levels!correlate!with!the!degree!of!lymphocytic!infiltration!into!the!tumour!and!improved!prognosis!(132).!!CX3CR1!is!expressed!by!tumourGresident!NK!cells!and!CD8+! cells.! ! There! is! however! minimal! expression! of! CX3CR1! on! human! peripheral!blood! Treg! (133).! ! Proliferation! of! Treg! in! the! gut! mucosa! may! be! related! to! the!
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presence! of! CX3CR1+! APCs! (134).! ! In! CX3CR1! G/G!mice,! gut! Treg! numbers! and! ILG10!production!by!gut!macrophages!was! reduced.! !XCR1!expression!by!human!peripheral!blood! Treg! has! been! demonstrated! (135).! ! XCR1! is! also! expressed! by! human!DCs,! in!particular! intestinal!DCs,!which!migrate! towards! the!cognate! ligand,!XCL1!and!extend!projections!through!the!colonic!epithelium!to!sample!the!gut!lumen!(136).!
Exploitation$of$chemokine$signalling$by$cancers$Tumour!cells!may!express!a!variety!of!chemokine!receptors!which!have!been!implicated!in!promoting!metastasis.!!Analysis!of!RNA!and!protein!levels!in!primary!and!metastatic!CRC! have! shown! overexpression! of! CCR6! and! CXCR4! in! both! primary! and!metastatic!tumours!compared!to!nonGtumorous!tissue!(137).!!Highest!tissue!levels!of!CCL20!were!found!in!the!liver,!the!most!common!site!for!CRC!metastasis.!!CXCR4Gexpressing!tumour!cells!are!enriched!at!the!site!of!liver!metastasis!compared!to!the!primary!tumour!and!a!CXCR4!inhibitor!reduced!the!development!of!liver!metastasis!in!a!mouse!model!(138).!!!
CXCR3! may! be! expressed! by! CRC! tumour! cells! (139).! ! In! a! mouse! model,! CXCR3!antagonism!was!found!to!reduce!the!incidence!of!lung!but!not!liver!metastases!and!this!was!associated!with!weaker!expression!of!CXCL10!and!CXCL11!in!the!liver!compared!to!the!lung.!




GITR$GITR! (glucocorticoidGinduced! TNFRGrelated! protein)! is! a! member! of! the! TNFR!superfamily!and!is!expressed!mainly!by!lymphocytes.!!Its!ligand,!GITRL,!is!expressed!on!APCs!and!acts!as!a!coGstimulation!signal!for!effector!T!cells!(141).!!GITR!is!expressed!by!Treg!under! the!control!of!Foxp3,!yet! its!expression! is!not!required! for!Treg! to!exhibit!suppressive!activity!(142).! !GITR!is!not!a!specific!marker!for!Treg!as!it!is!expressed!at!similar! levels! by! activated! CD4+! and! CD8+! cells.! ! Triggering! of! GITR!may! enhance! or!inhibit!Treg!suppression.!!In!a!murine!model!of!CRC,!Treg!expressed!increased!levels!of!GITR!compared!with!Treg!isolated!from!the!spleen!(143).!
CTLA:4$Binding! of! CD28! present! on! the! surface! of! T! cells,! with! CD80! or! CD86! on! APCs!constitutes!the!second!coGstimulatory!signal,!resulting!in!T!cell!activation.! !CTLAG4!is!a!cell! surface! receptor! found!on!T! cells! that! also! binds!CD80!or! CD86,! but! provides! an!inhibitory!signal!(144).!!CTLAG4!is!constitutively!expressed!by!Treg,!under!the!control!of!Foxp3! and! deficiency! of! CTLAG4! results! in! impaired!Treg! suppressive! capacity! (145).!!Blockade! of! CTLAG4! both! on! Tconv! and! Treg! has! been! shown! to! enhance! the! antiGtumour!immune!response!(146).!
CD27$CD27! is!a!member!of! the!TNF!receptor!superfamily!and!part!of!a! lymphocyteGspecific!subgroup!comprised!of!CD30,!CD40,!4G1BB!and!OX40.!!Its!ligand!is!CD70,!expressed!on!lymphocytes! and! dendritic! cells.! ! Lymphocytes! upregulate! CD27! following! TCR!engagement,! thereby! enhancing! their! survival.! ! Effector! T! cells! downregulate! CD27,!
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suggesting! that! its! coGstimulatory! effects! occur! early! on! in! the! adaptive! immune!response!(147).!!CD27!expression!has!also!been!used!as!a!marker!of!naïve!and!memory!lymphocytes!while!absence!of!expression!is!seen!in!effector!populations!(148).!
In!a!murine!model!of!CRC,!the!phenotype!of!Treg!from!the!spleen!was!compared!to!that!within! the! tumour!(143).! !There!were!high! levels!of!CD27!expression!by!Treg!both! in!the! tumour! and! spleen.! ! As! the! tumour! progressed,! CD27! expression! on! tumourGinfiltrating!Treg!diminished!yet!remained!at!stable!levels!in!the!spleen.!!
OX40$(CD134)$OX40! is! a!member! of! the! TNF! receptor! superfamily.! ! Knockout! studies! in!mice! have!shown! that! OX40! plays! an! obligatory! and! nonGredundant! role! in! the! generation! of!memory!T! cells! via! the!upregulation! of! cell! survival! genes! (149).! ! Treg! constitutively!express! ! OX40! but! its! use! as! a! Treg!marker! is! limited! as! OX40! is! also! expressed! by!activated!effector!T! cells.! ! Stimulation!of!OX40! in!vivo!can!break! tolerance! to!peptide!antigens! (150),!highlighting! the!potential!of!OX40!as!a! target! for! therapy.! !Treg!OX40!stimulation! abrogates! Treg! suppressive! function! and! inhibits! induction! of! Treg! from!other!T!cells!(151).!!!
CD39$&$CD73$CD39!is!an!ectonucleotidase!that!cleaves!ATP!to!form!AMP!or!ADP.!!Subsequently,!AMP!can!be! rapidly!hydrolysed! to! from!adenosine!by!CD73,! another! ectonucleotidase! (see!Figure!1G7).!!The!catabolism!of!the!triphosphate!to!the!monophosphate!by!CD39!is!the!rateGlimiting! step! for! the! formation!of! adenosine! (152).! ! CD39! is! highly! expressed!by!Treg! in! humans! (153).! ! ExtraGcellular! ATP! promotes! an! inflammatory! response! via!leukocyte!recruitment!and!activation!of!the!inflammasome.!!Activation!of!P2!receptors!
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leads! to! the!production!of! inflammatory!cytokines!via!NFGκB!signalling.! !On! the!other!hand,!pericellular!adenosine!is!immunosuppressive,!an!effect!mediated!at!least!partially!through!the!A2A!adenosine!receptor.!!A2A!receptor!stimulation,!on!Treg!and!effector!T!cells,! limits! the! production! of! lymphocyteGderived! proGinflammatory! cytokines,!independent!of!both!TGFGß!and!ILG10.! !Adoptive!transfer!of!Treg!in!mice!prevents!the!induction! of! colitis! by! effector! T! cells.! ! However,! Treg! failed! to! control! colitis! when!effector!T!cells!lacked!the!A2A!receptor!(154).!!A2A!receptor!binding!is!associated!with!a!rise!in!intracellular!cAMP.!!It!is!possible!that!cAMP!can!be!passed!from!Treg!to!effector!T!cells!via!gap!junctions!on!close!cellGtoGcell!contact!(155).!!While!Treg!are!wellGknown!to! suppress! IFNGγ! production! by! effector! T! cells,! CD39+! Treg! but! not! CD39G! Treg! can!suppress! the! production! of! ILG17! (156).! ! TumourGinfiltrating! ILG17! producing! T! cells!(Th17s),!are!thought!to!carry!a!poor!prognosis!in!CRC!(157).!


























• Treg! are! actively! recruited! to! the! site! of! the! tumour! using! a! specific! combination! of!chemokine!receptors!and!integrins.!!!
• Blockade!of! these!receptors! leads! to!a!reduction! in! tumour!Treg!recruitment,! thereby!enhancing!antiGtumour!immunity!and!providing!a!novel!therapy!for!CRC.!
!
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Tissue! samples! of! CRC! and! adjacent! colon!were!obtained! from!patients! undergoing! a!bowel!resection!as!part!of!their!treatment!for!CRC!at!the!QEHB!after!consent!and!with!approval! from! the! local! research! and! ethics! committee! (LREC! South! Birmingham!2003/242,!renewed!2012).! !Peripheral!blood!samples!were! taken! from!some!patients!undergoing! resection! at! the! time!of! induction!of! anaesthesia.! ! This!was! only!possible!after! LREC! renewal! in! 2012.! Following! bowel! resection,! the! fresh! specimen! was!assessed! by! the! author! and! an! experienced! pathologist! before! samples! of! colonic!mucosa!and!CRC! tissue!were! taken.! !The!pathologist!was!able! to!maximise! the! tissue!yield! that! could! be! donated! for! research! purposes! whilst! ensuring! there! was! no!interference!with!the!clinical!requirements!for!the!specimen.!!In!2!cases!colorectal!polyp!tissue!was!taken!following!resection.!!In!the!majority!of!such!cases,!the!pathologist!felt!that! there!was!no! surplus!polyp! tissue! for! research!purposes!as! the!entire!polyp!was!required!to!be!pathologically!assessed!for!foci!of!adenocarcinoma.! !To!limit!any!crossGcontamination!between! colon! and!CRC! samples,! pieces! of! colonic!mucosa!were! taken!from! a! macroscopically! normal! part! of! the! colon,! a! minimum! of! 10cm! distal! to! the!tumour.!!In!certain!cases,!it!was!possible!to!retrieve!a!TDLN!from!the!mesentery!of!the!resected! tissue.! ! TDLN!were! bisected! and! one! piece!was! used! for! research! purposes.!!The!majority! of! the! CRC,! colon! and! TDLN! tissue!was! placed! in! a! Universal! container!containing!RPMI!1640!medium!(31870,!Life!Technologies!Ltd,!UK)!with!1%!foetal!calf!
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serum! (FCS,! 10270G106,! Life! Technologies! Ltd,! UK),! 5! mg! Gentamicin–125! µg!Amphotericin! B! (RG015G10,! Life! Technologies! Ltd,! UK)! and! 1%!Glutamine–Penicillin–Streptomycin! (GPS,! 10378G016,! Life! Technologies! Ltd,! UK)! in! preparation! for!lymphocyte! isolation.! ! This! medium! will! subsequently! be! referred! to! as! complete!medium! (cRPMI).! ! The! final! antibiotic! concentrations! were:! ! penicillin! 1! U/ml,!streptomycin!1!µg/ml,!gentamicin!10!µg/ml,!amphotericin!B!0.25!µg/ml.!!Smaller!pieces!of!tissue!were!placed!in!Bijou!sample!containers,!either!dry!or!containing!10%!formal!saline!(3036850,!Adams!Healthcare!Ltd,!UK).!!Dry!containers!were!snap!frozen!in!liquid!nitrogen! and! stored! at! G80˚C.! ! Formalised! samples! were! paraffinGembedded! and!processed!into!blocks!for!use!in!immunohistochemistry!experiments.!!Fresh!samples!in!cRPMI! were! taken! back! to! the! laboratory! and! used! immediately! for! the! isolation! of!lymphocytes.!
Tissue!was!also!taken!from!patients!who!underwent!a!liver!resection!for!CRC!metastasis!and!had!given!consent.! ! In! this! case,!blocks!of! tissue!were! taken! from! the!core!of! the!liver!metastasis!and!from!the!distal!liver,!at!least!1!cm!from!the!macroscopic!edge!of!the!metastasis.!!Anonymised!clinical!outcomes!and!pathology!data!were!recorded!allowing!correlation!of!laboratory!findings!with!patient!and!disease!characteristics.!
Approximately! 2! g! of! colonic!mucosa! and! 0.5! g! tumour! tissue!was! sufficient! for! flow!cytometry!experiments!to!quantify!chemokine!receptor!expression!on!Treg.!
Lymphocyte*isolation*from*CRC,*colon*tissue*and*TDLN!
Cell! suspensions! can! be! generated! from! tissue! specimens! by! mechanical! and/or!enzymatic!dissociation.!The!gentleMACS!tissue!dissociator!(Miltenyi!Biotec!Ltd,!UK)!is!a!
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benchtop! instrument! that! automatically! dissociates! tissues! in! a! standardised! fashion.!!Published!protocols!exist!for!the!mechanical!dissociation!of!murine!and!human!tissues!(163).! ! Protocols! for! dissociation!of! implanted!murine! and!human! tumours!using! the!gentleMACS! dissociator! (164,165)! involve! enzymatic! digestion! steps! but! I! avoided!enzymatic! digestion! with! collagenase! and! other! enzymes! that! are! known! to! remove!lymphocyte! surface! molecules.! Protease! contaminations! in! enzyme! preparations! of!DNase!and!collagenase!have!been!shown!to!reduce!expression!of!CD2,!CD4,!CD8,!CD14,!CD16,! CD44! and! CD56! on! peripheral! blood! lymphocytes! (166).! ! A! reduction! in! CD4,!CD8,! CD16! and!CD56! expression!by! lymphocytes! isolated! from!CRC!occurs! after! only!one!hour!of!digestion!with!DNase!and!collagenase!enzymes!(167).!Enzymatic!isolation!of! liverGinfiltrating!lymphocytes!using!collagenase!significantly!reduces!the!expression!of!CXCR3!compared!with!mechanical!isolation!methods!(168)!and!the!use!of!dispase!(a!protease!which! cleaves! fibronectin! and! collagens)! reduces! the! expression!of!CD4!and!CD25!by!lymphocytes!(169).!!Enzymatic!digestion!of!tissues!does!however!increase!the!lymphocyte! yield! compared! to! mechanical! dissociation! alone! without! affecting! cell!viability! (170).! ! EnzymeGbased! isolation! methods! are! also! associated! with! reduced!proliferative!capacity!of!lymphocytes!compared!with!mechanical!isolation.!!It!is!possible!to! conduct! multiGcolour! flow! cytometry! experiments! on! as! few! as! 2500! tumourGinfiltrating!lymphocytes!(TIL)!(171).!!Therefore,!for!phenotyping!experiments,!TIL!were!isolated!by!mechanical!methods!alone.!
The!classical!method!of!lymphocyte!isolation!from!the!gut!describes!the!separation!and!discrimination! of! intraGepithelial! from! lamina! proprial! lymphocytes! (172).! ! Diced!colonic! tissue! is! incubated! in! a! 1! mM! solution! of! dithiothreitol! (DTT)! to! remove!
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adherent! mucus! followed! by! incubation! in! a! 0.75! mM! solution! of!ethylenediaminetetraacetic! acid! (EDTA)! to! dissociate! the! mucosal! epithelium! and!liberate!intraGepithelial!lymphocytes.!!Lamina!proprial!lymphocytes!are!then!isolated!by!collagenase!digestion!of!the!remaining!tissue.! !Adherent!mucus!increases!the!viscosity!of! the! sample! and! therefore! interferes! with! washing! and! filtration! steps.! ! DTT! was!avoided! as! its! use! is! associated! with! the! downregulation! of! numerous! cell! surface!receptors!(173).!!
Once! tissue! samples! had! been! taken! to! the! laboratory,! the! cRPMI! solution! was!discarded!and! the! tissue!placed! in! a! shallow!Petri!dish,!diced! into!2G3!mm! fragments!and! placed! in! CGtubes! (130G096G334,! Miltenyi! Biotec! Ltd,! UK)! for! use! with! the!gentleMACS! dissociator.! ! ! Each! sample! tube! was! run! twice! on! the! gentleMACS!dissociator! using! the!MouseGSpleenG1! protocol! and! then!washed! through! a! fine!mesh!(NYL9087,!John!Staniar!&!Co!Ltd,!UK)!with!cRPMI.! !The!filtrates!from!distal!colon!and!CRC!samples!were!then!placed!in!three!separate!50!ml!centrifuge!tubes!each!and!made!up!to!50!ml!per!tube!with!cRPMI.!!The!tubes!were!centrifuged!at!300!x!g!for!5!minutes,!the!supernatant!decanted!and!cells! resuspended! in!12!ml! iceGcold!cRPMI!solution!per!sample.!!










Figure!2G1:!Discontinuous!Percoll!gradient.!!!The!band!at! the!70/30! interface!was!aspirated! from!each!15!ml! tube.! !The!cells!were!then!washed!in!a!50!ml!centrifuge!tube!by!making!the!volume!up!to!50!ml!with!iceGcold!cRPMI!and!centrifuging!at!300!x!g! for!5!minutes.! !The!supernatant!was!discarded!and!the!cells!resuspended!in!1!ml!of!iceGcold!phosphateGbuffered!saline!supplemented!with!10%!FCS!and!1%!GPS!(cPBS)!in!preparation!for!downstream!applications.!
Selective!use!of!enzymatic!digestion!The!lymphocyte!yield!for!functional!experiments!such!as!suppression!assays!was!more!important! than!the!preservation!of!cell!surface!markers.! !For!these!experiments,!once!the! tissue! had! been! diced! into! 2G3!mm! fragments! and! transferred! to! CGtubes,! 10!ml!digestion!buffer!was!added!to!each!tube!and!the!samples!were!spun!on!the!gentleMACS!machine,! humanGtumorG1! setting.! ! The! CGtubes! were! then! agitated! at! 37˚C! for! 30!minutes.!!The!samples!were!spun!on!the!gentleMACS!machine,!humanGtumor!2!setting,!
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then! agitated! again! for! 30! minutes! at! 37˚C.! ! Finally,! the! samples! were! spun! on! the!gentleMACS!machine,!humanGtumor!3!setting!before!being!washed!through!a!fine!mesh!and! layered! on! a! Percoll! gradient! as! before.! ! This! protocol! is! published! by! Miltenyi!Biotec! for! use! with! their! human! tumor! dissociation! kit! (130G095G929),! a! cocktail! of!enzymes!designed!to!digest!human!tumour!tissue!optimised!for!a!high!yield!of!tumour!cells!and!TILs!while!preserving!cell! surface!epitopes.! !This!kit!was!used! twice!and!an!exceptionally!low!level!of!CD25!expression!was!noted!on!the!isolated!TILs,!an!effect!that!has!been!reported!for!dispase!(169).!!The!reagents!in!the!human!tumor!dissociation!kit!were! therefore! substituted!with! collagenase! II! (20!mg/ml,! C2G22,! VWR! International!Ltd,! UK).! ! The! digestion! buffer! used! was! therefore! RPMI,! 1%! GPS! and! 100µg/ml!collagenase! II.! ! This! buffer! gave! improved! yields! over! mechanical! digestion! while!preserving!surface!CD25.!
Lymphocyte*isolation*from*peripheral*blood!
Blood! from! patients! undergoing! venesection! for! haemochromatosis,! from! healthy!donors!or! from!CRC!patients!was!used! for!phenotyping!and! in!vitro!experiments.! !All!blood!donors!had!given!prior!consent!to!donate!for!research!purposes.!!
Blood!was!carefully! layered!over!an!equal!volume!of!Lymphoprep™!(07801,!Stem!Cell!Technologies!Inc,!Canada).!!The!gradient!was!centrifuged!at!300!x!g!for!30!minutes!with!no! brake.! ! Peripheral! blood! mononuclear! cells! (PBMCs)! were! aspirated! from! the!plasmaGLymphoprep™!interface,!washed!with!PBS!and!pelleted.!!The!PBMCs!were!then!resuspended!in!cRPMI.!
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Lymphocyte*phenotyping!
In!order! to! identify!viable! lymphocytes! isolated!using! the!above!methods,!a! live/dead!fixable! stain! kit! (L10119,! Life! Technologies! Ltd,! UK)! was! used.! ! The! fluorescent! dye!permeates! necrotic! cells! and! reacts! with! free! intracellular! amines,! thereby! labelling!dead! cells! (174).! ! The! nearGinfraGred! live/dead! stain! was! used!whose! excitation! and!emission!maxima!are!750!and!775!nm!respectively.!
The!number!of! live!cells! in! the!1ml!suspension!was!counted!using!a!haemocytometer!and!the!concentration!of!the!cell!suspension!adjusted!to!1!x!106!cells!per!ml!cPBS.!!1!µl!per!ml! live/dead!fixable!stain!was!then!added!to!the!cell!suspension!together!with!20!
µl/ml! of! human! FcR! blocking! reagent! (130G059G901,! Miltenyi! Biotech! Ltd,! UK)! and!incubated!in!the!dark!at!4°C!for!20!minutes.!!An!equal!volume!of!iceGcold!cPBS!was!then!added! to! wash! off! unbound! fluorescent! dye! and! the! samples! were! pelleted! and!resuspended! in! a! volume! of! cPBS! to! provide! 100! µl! cell! suspension! for! each! flow!cytometry! tube! (5! ml! polypropylene! roundGbottomed! Falcon! tubes,! 352002,! BD!Biosciences).!
Cell!surface!labelling!was!performed!by!incubating!cells!with!antibodies!listed!in!Table!2G1! in! 100! µl! cPBS! for! 30! minutes! at! 4°C! in! the! dark! on! a! rocker.! ! One! tube! was!incubated! with! the! isotypeGmatched! controls! (IMC)! for! these! antibodies! at! the! same!concentration.! ! Some! tubes! contained!cells! labelled!with! single!antibodies! in!order! to!perform!colour!compensation.!
!
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Table!2G1:!Cell!surface!antibodies!used!for!TIL!phenotyping!Antigen! Clone! Fluorochrome! Isotype! Manufacturer! Code!CD3! UCHT1! AlexaGFluor!750! Ms!IgG1! Serotec! MCA463P750!CD4! RPAGT4! V500! Ms!IgG1! BD! 560768!CD25! MGA251! V450! Ms!IgG1! BD! 560355!CD127! HILG7RGM21! FITC! Ms!IgG1! BD! 560549!CD127! eBioRDR5! APC! Ms!IgG1! eBioscience! 17G1278G42!CD8! RPAGT8! PEGCF594! Ms!IgG1! BD! 562282!!
In! addition! to! the! above! antibody! cocktail,! each! tube! contained! an! antibody! against!various! cell! surface!markers! such! as! chemokine! receptors! or! integrins! conjugated! to!either!APC!or!PE!fluorochromes!(see!Appendix!III).!!A!cell!surface!marker!could!also!be!stained! with! an! antibody! conjugated! to! FITC! if! the! CD127GFITC! antibody! was!substituted!with!CD127GAPC.!
A!typical!experiment!to!quantify!the!cell!surface!expression!of!the!chemokine!receptors!CCR5,! CCR6! (both! antibodies! are! of! Mouse! IgG1! isotype)! and! CCR7! (Mouse! IgG2a!isotype)! on! T! cell! subsets! would! require! the! following! flow! cytometry! tubes! and!antibody!combinations:!
! !
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TUBE! Antibodies!1 Cells!only!2 IMCs!3 CD3!4 CD4!5 CD25!6 CD127!7 CD!8!8 CD3/CD4/CD25/CD127/CD8/MsIgG1GAPC/MsIgG1GPE!9 CD3/CD4/CD25/CD127/CD8/CCR5GAPC/CCR6GPE!10 CD3/CD4/CD25/CD127/CD8/MsIgG2aGAPC!11 CD3/CD4/CD25/CD127/CCR7!!
Following!incubation!with!the!cell!surface!antibodies,!1!ml!iceGcold!cPBS!was!added!to!each!tube!to!wash!off!unbound!antibody.! !The!cells!were!pelleted!and!resuspended!in!500!µl!cPBS,!ready!for!flow!cytometric!analysis.!
IntraNcellular!staining!In!some!experiments,!the!defined!Treg!population!(CD4+CD25+CD127low)!was!shown!to!express! the! transcription! factor! Foxp3! by! performing! intracellular! staining.! ! In! other!experiments,! additional! intracellular! markers! such! as! Ki67,! CTLAG4! and! Helios! were!labelled!using!the!same!technique.!
Following!cell!surface!staining,!the!cells!were!fixed!and!permeabilised!by!resuspending!in! formalin!and! saponin! solutions! for!5!minutes,!part!of! the!Foxp3! staining!buffer!kit!(00G5523,!eBioscience!Ltd,!UK)! in!place!of!cPBS.! !Cell!were!then!washed,!pelleted!and!
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resuspended! in! 100! µl! of! saponin! wash! buffer.! ! Cells! were! labelled! with! antibodies!against!various! intraGcellular!antigens!or! IMCs!and! incubated! for!30!minutes!at!4˚C! in!the!dark!on!a!rocker.!!Unbound!antibody!was!washed!off!by!adding!1!ml!of!wash!buffer,!pelleting!and!resuspending!in!500µl!cPBS,!ready!for!flow!cytometric!analysis.!
The! following! antibodies! were! used! for! intraGcellular! staining! together! with! their!isotypeGmatched!controls!(see!Table!2G2):!
!
Table!2G2:!Antibodies!used!for!intraGcellular!phenotyping!of!TILs!Antigen! Clone! Fluorochrome! Isotype! Manufacturer! Code!Foxp3! PCH101! PE! Rat!IgG2a! eBioscience! 12G4776G42!CTLAG4! BNI3! APC! Ms!IgG2a! BD! 560938!Helios! 22F6! APC! Hamster!IgG! Biolegend! 137222!Ki67! 35/KiG67! FITC! Ms!IgG1! BD! 612472!!
! !
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Flow!cytometry!The! prepared! samples! were! analysed! using! a! CyAn! ADP! 3Glaser,! 9Gcolour! flow!cytometer!(Beckman!Coulter!Inc,!USA).!!The!machine!is!equipped!with!488nm,!405!nm!and!642!nm!solidGstate!lasers!and!is!able!to!measure!the!following!parameters:!
! Forward!light!scatter,!Side!light!scatter!488!nm!laser:G!FL1:!FITC!!FL2:!PE!FL3:!PEGTexasRed!/!PEGCF594!FL4:!PEGCy5!/!PerCP!FL5:!PEGCy7!/!Alexa!Fluor!750!! 405!nm!laser:G!FL6:!V450,!Pacific!Blue!FL7:!V500,!Pacific!Orange!! 635!nm!laser:G!FL8:!APC!FL9:!APCGCy7!/!nearGIR!Live!Dead!dye!!
Data!analysis!was!performed!using!Summit!software!version!4.3!(Dako,!USA).!
Samples! containing! cells! only,! cells! labelled! with! IMCs! and! cells! labelled! with! single!colours!were!used!to!compensate!for!spectral!overlap.!!!
! $
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Figure! 2G3:! Defining! Tconv! (CD4+CD25G):! Forward! and! side! light! scatter! and! cell! surface!expression! of! CD3! with! absence! of! dead! cell! staining! defined! live! lymphocytes.! ! Of! this!population,!Tconv!were!defined!as!CD4+!and!CD25G.!
!
Flow!cytometric!evaluation!of!the!expression!of!cell!surface!and!intraGcellular!molecules!by!Treg!and!Tconv!compared! to! IMCs!was!done!on!multiple!matched!samples!of!CRC!and!distal!colon.!!The!median!expression!of!each!molecule,!in!terms!of!both!percentage!expression! and!median! fluorescence! intensity! (MFI),!was! calculated! and! comparisons!between! Treg! versus! Tconv! and! Treg! in! CRC! versus! distal! colon! were! carried! out.!!Differences! in! expression! across! matched! samples! were! tested! for! statistical!significance!using!the!Wilcoxin!signedGrank!test.!
Tconv&
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Treg$numbers$The! proportion! of! CD4+! cells! with! a! Treg! phenotype! (CD4+CD25+CD127low)! was!calculated!by!dividing!the!cell!count!of!the!Treg!defined!region!by!the!cell!count!of!CD4+!cells!from!the!CD4+!histogram,!gated!on!live!CD3+!cells.!
In!some!experiments,!the!absolute!number!of!Treg!was!calculated!through!the!addition!of! 20! µl! of! counting! beads! (AccuCheck! PCB100,! Life! Technologies! Ltd,! UK)! to! the!labelled! cell! suspension! immediately! prior! to! flow! cytometry.! ! The! counting! bead!solution!contains!two!different!fluorospheres,!to!provide!an!internal!standard,!of!known!concentration.! ! The! beads! are! detected! in! the! FL2! channel! and! can! therefore! be!enumerated!along!with!the!number!of!cells!in!the!TregGdefined!region.!!The!number!of!Treg! per! microlitre! is! obtained! by! relating! the! number! of! Treg! counted! to! the! total!number!of!fluorescent!bead!events.!!The!Treg!number!is!then!multiplied!by!the!number!of! fluorospheres! per! unit! volume.! ! The! two! different! fluorospheres! (A! and! B)! are! in!equal! proportion! and! therefore! assure! the! accuracy! of! the! assay! by! verifying! that! an!equal!number!of!beads!A!and!B!are!counted.!
!"#$%!!"#$%&'(!!"#$!!"#$% = !"#$%&!!"#$!!"#$%&'!"#$%!!"#$%&!!"#$%!!"#$%&'!(! + !) !!! "#$%&!!"#$%!!"#!!!!
FluorescenceNactivated(cell(sorting((FACS)!
TILs!were! isolated!using!digestion!buffer! as!described! in! the! section!above! (Selective!use! of! enzymatic! digestion)! and! sorted! for! use! in! downstream! experiments! such! as!suppression!assays,!proliferation!assays!and!epigenetic!analysis!of!the!Foxp3!promoter.!!Prior! to! incubation!with! the! live/dead!marker,! cells!were! labelled!with! the! following!antibodies!(see!Table!2G3):!
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Table!2G3:!Antibodies!used!for!cell!surface!labelling!of!cells!to!be!sorted.!Antigen! Clone! Fluorochrome! Isotype! Manufacturer! Code!CD4! OKT4! PECy7! Ms!IgG2b! Biolegend! 317414!CD25! MGA251! APC! Ms!IgG1! BD! 555434!CD127! HILG7RGM21! FITC! Ms!IgG1! BD! 560549!CCR5! CTC5! PE! Ms!IgG1! R&D! FAB1802P!!
Cells! were! sorted! using! a! MoFlo! XDP! HighGSpeed! Cell! Sorter! (ML99030,! Beckman!Coulter! Inc,!USA).! !The!MoFlo!XDP! is! able! to!perform!4Gway! sorts! at! a! rate!of!70,000!sorts!per!second!with!99%!purity!and!can!sort!cells!directly!into!a!96Gwell!plate.! !The!MoFlo!XDP!was!equipped!with!488!nm,!647!nm!and!405!nm!lasers!and!could!therefore,!in!theory,!detect!9!different!colours!exactly!as!described!for!the!CyAn!flow!cytometer.!!However,! the!405!nm!violet! laser!gave!poor! resolution! for!highly!expressed!antigens,!such! as! CD4.! ! For! this! reason,! CD4! and! CD25! were! not! labelled! with! antibodies!conjugated!to! fluorochromes!detected!with! the!violet!405!nm!laser,!namely!V500!and!V450,! as! for! flow! cytometric! analysis.! ! Rather,! CD4! was! labelled! with! a! PECy7Gconjugated! antibody! and! CD25! was! labelled! with! an! APCGconjugated! antibody,! the!fluorochromes!of!which!are!both!excited!by! the! red!647!nm! laser.! !The!405!nm! laser!was! able! to! resolve! live! and!dead! cells! using! the!bright! SYTOX®!Blue!dead! cell! stain!(S34857,!Life!Technologies!Ltd,!UK).!
5!minutes!prior!to!running!the!sample!on!the!cell!sorter,!SYTOX®!Blue!dead!cell!stain!was! added! to! the! sample;! this! penetrates! cells! with! compromised! cell! membranes,!allowing!dead!cells!to!fluoresce!bright!blue!(emission!maxima!at!480!nm)!when!excited!by!405!nm!violet!laser!light.!!
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Gating!strategy!The!gating!strategy!for!cell!sorting!was!different!from!that!used!to!identify!Treg!by!flow!cytometry,!due!to!the!absence!of!a!CD3!label!(see!Figure!2G4).!!Cells!were!3Gway!sorted!in!purity!mode,! either!directly! into! a!96Gwell!plate! (for! suppression!and!proliferation!assays),!or!into!1.5!ml!Eppendorfs!for!subsequent!RNA!or!DNA!extraction.!
!















































PBMCs,!isolated!from!10!ml!of!blood,!were!labelled!with!CellTrace!Violet!dye!(C34557,!Life!Technologies!Ltd,!UK)!by!incubating!the!PBMC!at!a!concentration!of!2!x!106!/!ml!in!RPMI!with!1!µl!/!ml!of!5!mM!CellTrace!Violet!dye!for!20!minutes!at!37˚C.!!Unbound!dye!was!quenched!by!adding!5!times!the!original!staining!volume!of!cRPMI!then!incubating!the!mixture!for!5!minutes!at!4˚C.!!The!cells!were!then!pelleted!and!resuspended!in!100!µl! of! cPBS.! !The! cells!were! incubated!with!CD4GPECy7!and!CD25GAPC!antibodies! (see!Table! 2G3)! for! 30!minutes! at! 4˚C,! washed,! pelleted! and! resuspended! in! 0.5!ml! cPBS.!!CellTrace!violet!dye!binds!to!intracellular!amines!which!on!cell!proliferation,!is!detected!at!reducing!fluorescent!intensity!in!successive!generations!of!cells.!!As!such,!CD4+CD25G!cells!labelled!with!CellTrace!Violet!are!referred!to!as!responder!T!cells!(Tresp).!
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Figure!2G6:!Typical!96Gwell!plate!setGup!for!a!suppression!assay!using!Treg!and!CD4+CD25G!cells!isolated! from! CRC! tissue! coGcultured! with! Tresp! isolated! from! allogeneic! PBMC! at! different!ratios!and!human!Treg!Suppression!Inspector!beads!(bead!:!lymphocyte!ratio!1:2).!
Proliferation+assay!
TILs!were! isolated!using!digestion!buffer! as!described! in! the! section!above! (Selective!use! of! enzymatic! digestion)! and! then! labelled!with! CellTrace! Violet.! ! TILs!were! then!labelled!with! the!nearGinfraGred! live/dead! fixable! stain!kit! (L10119,!Life!Technologies!Ltd,!UK)!for!20!minutes!at!4˚C!followed!by!the!cell!surface!antibodies!listed!in!Table!2G3!for!30!minutes!at!4˚C.!!!





































































The! functional! relevance! of! chemokine! receptors! expressed! by! TILs! was! examined!using! transwell! migration! assays! and! by! visualising! realGtime! chemotaxis! in!microchambers.!!!












Lymphocyte$isolation$from$CRC$for$use$in$transwell$system$TILs!were! isolated!using!digestion!buffer! as!described! in! the! section!above! (Selective!use!of!enzymatic!digestion).! !M! !The!number!of!cells!present! in!the!1.1!ml!suspension!was!counted!using!a!haemocytometer.!!250!µl,!750!µl!and!100!µl!of!the!cell!suspension!were!placed!in!separate!wells!(A,!B!and!C)!of!a!24Gwell!plate!and!the!volume!in!each!well!made!up!to!1!ml!with!RPMI!+!0.1%!BSA.!!1!µl!of!a!1mM!solution!of!Maraviroc!was!added!to!well!A!(final!concentration!of!Maraviroc!=!1!µM)!and!1!µl!of!DMSO!was!added!to!well!B.! ! The! cells! in! well! C! were! untreated! and! used! for! flow! cytometry! analysis.! ! The!Maraviroc! salt! had! been! previously! dissolved! in! DMSO,! hence! the! use! of! DMSO! as! a!vehicle! control.! ! The! cells! were! left! overnight! to! serum! starve! with! or! without! the!presence!of!Maraviroc.!!The!cells!were!then!transferred!to!15!ml!tubes,!10!ml!PBS!was!added!to!wash!the!cells!and!the!cells!were!pelleted.! !The!MaravirocGtreated!cells!were!resuspended!in!150!µl!of!RPMI!+!0.1%!BSA;!the!DMSOGtreated!cells!were!resuspended!in!450!µl!of!RPMI!+!0.1%!BSA.!
One well of a 96-well transwell system
Transwell insert
Upper compartment
5 µm porous membrane
Lower compartment
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The! transwell! plate!was! incubated! at! 37˚C! 5%! CO2! for! 4! hours.! ! The! contents! of! the!lower! chamber! (containing! migrated! cells)! and! the! upper! chamber! (containing! nonGmigrated!cells)!were!then!aspirated!and!placed!in!flow!cytometry!tubes.!!The!following!antibody!cocktail!was!added!to!each!tube:!!5!µl!of!antiGCD4GPE!(555347,!BD),!5!µl!antiGCD25GAPC!(555434,!BD),!5!µl!antiGCD127GFITC!(560549,!BD)!and!2.5!µl!antiGCD8GPacific!Blue! (344718,! Biolegend).! ! Cell! suspension! held! back! prior! to! DMSO! or! Maraviroc!treatment! was! incubated! with! single! antibodies! from! this! cocktail! for! colour!compensation.!!Cells!were!incubated!with!antibodies!for!30!minutes!at!4˚C!then!directly!analysed!by!flow!cytometry!after!the!addition!of!20!µl!of!counting!beads.!
Results!were!expressed!as!a!chemotactic!index,!defined!as:!
Chemotactic*index=* !ℎ!!!"#$%&'(!!"#$%&! !"!!"#$"%&'(" !!"!!!"#$ℎ!"#$%!!"#!$%!!ℎ!"! "#$%&'(!!"!!"#$%&#"!!"!!ℎ!"#$%&!!!ℎ!!!"#$%&'(!!"#$%&!(!"!!"#$"%&'(")!!"!!ℎ!!!"#!$%!!ℎ!"! "#$%&'(!!"! "#$%!!"#$%!
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The! chemotactic! index! for! all! lymphocyte! subsets! migrating! to! media! alone! was!therefore!1,!by!definition.!!Differences!in!the!absolute!numbers!and!percentage!of!cells!across! different! conditions! were! tested! for! statistical! significance! using! the!Wilcoxin!signedGrank!test.!
Fixation$and$staining$of$transwell$inserts$Following!the!transwell!experiment!described!above,!the!5!µm!porous!membranes!were!washed!by!submerging!the! insert! for!5!minutes! in!a!new!96Gwell!plate!with!each!well!containing! 235! µl! PBS.! ! The! cells! remaining! on! the! membranes! were! fixed! by!submerging!the!insert!for!5!minutes!into!wells!containing!4%!paraformaldehyde.! !The!membranes! were! washed! twice! by! submerging! in! PBS! for! 5! minutes.! ! Cells! were!permeabilised!by!submerging!the!insert!into!wells!containing!PBS!+!0.3%!Triton!x100!for! 5! minutes.! ! The! insert! was! then! submerged! into! wells! containing! antiGFoxp3!antibody!solution!(Ab20034,!Abcam!plc!UK,!Dilution=1:100!in!PBS)!for!1!hour!at!room!temperature.! ! The! insert! was! submerged! twice! into! PBS! 0.3%! Triton! x100! for! 5!minutes.! !Cells!were!incubated!in!secondary!antibody!solution!(antiGmouse!IgG1GAlexa!Fluor!488,!A21121,!Life!Technologies!Ltd,!UK,!4!µg/ml!in!PBS)!for!20!minutes!at!room!temperature!then!washed!twice!for!5!minutes!in!PBS!0.3%!Triton!x100.!!The!insert!was!submerged!in!DAPI!solution!for!5!minutes!and!washed!once!more!in!PBS!0.3%!Triton!x100.! !The!membranes!were!punched!out! from!the! transwell! inserts!and!mounted!on!microscope!slides!in!Mowiol!(81381,!SigmaGAldrich!Ltd,!UK).!!Foxp3Gexpressing!cells!on!the!membranes!were! visualised! using! a! LSM510! confocal!microscope! (Zeiss)! and! the!manufacturer’s!software.!
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Chemotaxis!chambers!Lymphocytes!were!suspended!in!a!collagen!gel!and!seeded!into!the!observation!area!of!a!microslide!(µGSlide!Chemotaxis!3D,!80326,!Ibidi).!!The!gel!was!formed!by!mixing!150!µl!of!bovine!collagen! I!solution!(3mg/ml,!C4243,!SigmaGAldrich!Ltd,!UK)!with!20!µl!of!10X!MEM! (M0275,! SigmaGAldrich! Ltd,! UK)! then! neutralising!with! 10! µl! 7.5%! sodium!bicarbonate!solution!(S8761,!SigmaGAldrich!Ltd,!UK)!on!ice.! !90!µl!cell!suspension!was!added! to! the! gel! and! 6! µl! of! the! gel/cell! suspension! mixture! was! placed! in! the!observation!area!of!each!chamber!of! the!microslide.! !The!microslide!was! incubated!at!37˚C! for!at! least!1!hour!until! the!gel!had!set.! !A! chemokine!solution!was!prepared!by!adding!recombinant!chemokine!to!RPMI!+!0.1%!BSA!and!warming!to!37˚C.!!Once!the!gel!had!set,!the!rightGhand!reservoir!of!each!chamber!was!filled!with!RPMI!+!0.1%!BSA.!!The!leftGhand! reservoir!was! filled!with! chemokine! solution! and! the! observation! area!was!imaged!every!3!minutes!using!the!CellIQ!imaging!system!(CM!Technologies,!Finland).!
PBMC%activation%and%coNculture'with'tumour'supernatant!
PBMC! were! isolated! as! described! in! the! above! section:! Lymphocyte! isolation! from!peripheral!blood.! ! 1.6! x!105! cells!were!placed! in! each!well! of! a! flatGbottomed!96Gwell!plate! and! the!well! volume!was!made!up! to! 90! µl!with! cRPMI! containing! 20! IU/ml! of!recombinant!ILG2!(PHC0023,!Life!Technologies!Ltd,!UK).! !10!µl!of!RPMI!+!0.1%!BSA!or!10!µl!of!CRC/colon!supernatant!was!then!added.! !12!µl!of!washed!Human!TGActivator!CD3/CD28!Dynabeads®!(11161D,!Life!Technologies!Ltd,!UK)!were!added!to!each!well,!giving!a!bead!to!cell!ratio!of!3:1.!!CRC/colon!supernatants!had!been!previously!prepared!by! incubating!0.5!g!of!CRC!and!0.5!g!matched!distal!colon!tissue! in!5!ml!RPMI!+!0.1%!BSA!+!1%!GPS! for! 24!hours! at! 37˚C!5%!CO2.! ! The! supernatants!were! then! aspirated,!
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passed!through!a!0.22!µm!sterile!syringe!filter!(SLGP033RS,!Merck!Millipore!Ltd,!UK),!divided!into!aliquots!and!stored!at!G80˚C!ready!for!future!use.!
After! 48! hours! of! coGculture! of! PBMCs! with! beads! ±! supernatant,! the! beads! were!removed!using!a!magnet!and! the! cells!were!washed!and! resuspended! in!90!µl! cRPMI!containing! 20! IU/ml! of! recombinant! ILG2.! ! 10! µl! of! RPMI! +! 0.1%! BSA! or! 10! µl! of!CRC/colon!supernatant!was!again!added!to!the!wells.! !Following!a!further!48!hours!of!culture! of! PBMCs! ±! supernatant,! the! cells! were! washed! and! incubated! with! the!following! antibodies:! AntiGCD3GAlexaFluor750! (MCA463P750,! Serotec),! antiGCD4GFITC!(555346,!BD!Biosciences),! antiGCCR5GAPC! (FAB1802A,!R&D!Systems)! and! a! live/dead!marker.! ! IntraGcellular! staining! used! the! antiGFoxp3GPE! (12G4776G42,! eBioscience)!antibody.! ! Flow! cytometric! analysis! of! CCR5! expression! by! Tconv! (CD3+CD4+Foxp3G)!and!Treg!(CD3+CD4+Foxp3+)!was!performed.!
In! subsequent! experiments,! Treg! and! Tconv! were! isolated! from! PBMC! by!immunomagnetic! separation! and! coGcultured! separately!with! beads! and! supernatant.!Treg! (defined! as! CD4+CD25+! for! these! experiments)! and! Tconv! (CD4+CD25G)! were!isolated! from! PBMC! using! the! Dynabeads®! Regulatory! CD4+/CD25+! T! Cell! Kit!(11363D,! Life! Technologies).! ! 1.6! x! 105! Tconv! and! 1.6! x! 105! Treg! were! placed! in!separate!wells! and! the! volume!made! up! to! 90! µl!with! cRPMI! containing! 20! IU/ml! of!recombinant!ILG2.! !CD3/CD28!beads!and!supernatant!were!added!as!before.! !200!µl!of!culture!supernatant!was!harvested!at!the!end!of!the!experiment!(day!4)!from!wells! in!which!Treg!and!Tconv!had!been!cultured!in!media!with!and!without!activation!beads.!!The! concentrations!of!CCL3,!CCL4!and!CCL5! in! the! culture! supernatant! samples!were!measured! using! a! MixGNGMatch! ELISArray! Kit! (336111,! SABiosciences),! according! to!
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manufacturer’s!instructions.!!Standard!curves!were!not!derived!for!each!chemokine!and!absorbance!was!therefore!the!readGout!in!this!semiGquantitative!assay.!
In!certain!experiments,!neutralising!antibodies!or!the!small!molecular!CCR5!antagonist!(UKG484900)!were!added!to!the!culture!supernatant!to!determine!the!effects!on!CCR5!expression!and!function!by!Treg!and!Tconv.!!UKG484900!was!a!gift!from!Pfizer!Inc,!USA!and!was! used! at! a! concentration! of! 2! µg/ml.! ! The! neutralising! antibodies! used!were!antiGILG1Ra!(MAB280,!R&D!Systems,!used!at!50!µg/ml),!antiGTGFGß1!(Ab10518,!Abcam,!used! at! 50! ng/ml)! and! antiGVEGF! (ABG293GNA,! R&D! Systems,! used! at! 6! µg/ml).!!Differences! in! CCR5! expression! were! tested! for! statistical! significance! using! the!Wilcoxin!signedGrank!test.!
Immunohistochemistry.and.immunofluorescence!
Immunohistochemical! staining! was! carried! out! on! both! formal! saline! fixed! paraffinGembedded! (FFPE)! tissue! and! tissue! which! had! been! snap! frozen! in! liquid! nitrogen.!!Immunohistochemistry! for! target! antigens! preferably! use! FFPE! sections,! as! the!morphology!is!better!preserved!than!that!for!frozen!sections.!!No!staining!was!observed!for! target! chemokines! using! FFPE! sections! and! in! these! cases,! frozen! sections! were!preferred.!
FFPE!sections!5! µm! sections! were! cut! from! FFPE! tissue! blocks.! Sections! were! deparaffinised! and!rehydrated!by!passing!the!sections!through!fresh!solutions!of!Clearene!(3803600,!Leica!GmBH,! Germany)! and! graduated! alcohols.! ! Sections! were! incubated! with! 0.3%!hydrogen!peroxide!solution!in!methanol!for!20!minutes!at!room!temperature!to!block!
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endogenous! peroxidase.! ! Sections! were! then! washed! twice! with! TrisGbuffered! saline!(TBS,!0.5M!Tris!Base,!9%!sodium!chloride,!pH!adjusted!to!8.4!using!hydrochloric!acid)!for!5!minutes.! !Antigen! retrieval!was!performed!by!microwaving! in!preGheated!EDTA!buffer! (0.37! g! EDTA! in! 1! l! distilled! water,! pH! adjusted! to! 8.0! using! 1N! sodium!hydroxide,!0.05%!Tween!20)!for!15!minutes.!!!
Frozen!sections!5! µm! sections! were! cut! from! frozen! tissue! blocks! using! a! cryostat.! ! Sections! were!allowed!to!thaw!for!10!minutes,!fixed!by!placing!in!acetone!for!5!minutes!and!allowed!to!air! dry! for! 30!minutes.! ! Endogenous! peroxidase! was! blocked! by! incubating! sections!with!PeroxidaseGBlocking!Solution!(S202386G2,!Dako!Ltd,!UK)!for!10!minutes!followed!by!washing!in!TBS!twice!for!5!minutes.!
Common!immunohistochemistry!protocol!The! remainder! of! the! protocol! was! universal! to! both! FFPE! and! frozen! sections.!!Endogenous!Fc!receptors!were!blocked!by! incubating!sections! in!10%!casein!solution!(SPG5020,! Vector! Labs! Inc,! USA)! for! 30! minutes.! ! Sections! were! then! incubated! in! a!primary! antibody! solution! to! the! target! antigen! (see! Table! 2G4)! at! a! preGdetermined!dilution!or!an!IMC!solution!at!equal!concentration!for!1!hour!at!room!temperature.!!In!prior! experiments,! serial! sections! were! incubated! with! different! primary! antibody!dilutions!to!determine!the!optimum!dilution!to!maximise!the!sensitivity!and!specificity!of!the!target!antigen!staining.!!The!sections!were!washed!twice!in!TBS!containing!0.1%!TweenG20! for! 5! minutes! and! then! incubated! in! an! HRPGconjugated! development!solution! (Vector! ImmPress,! MPG7500,! Vector! Labs! Inc,! USA)! for! 20!minutes! at! room!temperature.!!Following!a!final!wash!in!TBS!+!0.1%!TweenG20,!sections!were!visualised!
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using! either! ImmPACT! NovaRED! (SKG4805,! Vector! Labs! Inc,! USA)! or! ImmPACT! DAB!(SKG4105,!Vector!Labs! Inc,!USA)!with!or!without! the!addition!of!nickel! to!blacken! the!stain.!!Sections!were!counterGstained!with!Meyer’s!haematoxylin!(S3309,!Dako!Ltd,!UK)!for!1!minute!and!blued!in!warm!tap!water!for!1!minute.!Sections!were!dehydrated!by!passing! through! graduated! alcohol! solutions! then! cleared! by! passing! through! fresh!solutions! of! Clearene! before! mounting! in! DPX! (3808600ED,! Leica! GmBH,! Germany).!!Tissue!expression!was!visualised!using!a!Leica!DM6000!(chromogenic)!microscope!and!the!manufacturer’s!software.!
Table!2G4:!Primary!antibodies!used!for!immunohistochemistry!Antigen! Clone! Isotype! Manufacturer! Code! Working!concentration!Foxp3! 236A/E7! Ms!IgG1! Abcam! Ab20034! 10!µg/ml!CD3! SP7! Rabbit!IgG! Thermo!Scientific! RMG9107! !CD4! 1F6! Ms!IgG1! Thermo!Scientific! MA1G80223! !CD8! SP16! Rabbit!IgG! Thermo!Scientific! MA5G16345! !CCR5! 45531! Ms!IgG2b! R&D!Systems! MAB182! 10!µg/ml!VAPG1! Polyclonal! Rabbit!! SigmaGAldrich! HPA000980! 2!µg/ml!CCL3! Polyclonal! Goat! R&D!Systems! AFG270GNA! 10!µg/ml!CCL4! Polyclonal! Goat! R&D!Systems! AFG271GNA! 10!µg/ml!CCL5! Polyclonal! Goat! R&D!Systems! AFG278GNA! 10!µg/ml!CCL20! Polyclonal! Goat! R&D!Systems! AFG360! 10!µg/ml!IMC! ! Ms!IgG1! Dako! X0931! !IMC! ! Ms!IgG2b! Dako! X0944! !IMC! ! Rabbit! Dako! M0737! !!
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Double!immunohistochemistry!Following! visualisation! of! Foxp3! with! DABGnickel! and! before! counterGstaining! with!haematoxylin,! sections!were!blocked! for! a! second! time! in!10%!casein! solution! for!30!minutes.!!Sections!were!then!incubated!in!a!second!primary!antibody!solution!–!in!this!case,!CCR5!for!1!hour!at!room!temperature.!!Sections!were!washed!then!incubated!with!the!Vector!ImmPress!system!as!before.! !CCR5!staining!was!visualised!using!ImmPACT!NovaRED.! ! No! haematoxylin! counterGstain! was! performed! and! sections! were!dehydrated,!cleared!and!mounted!as!described!above.!
Double!immunofluorescence!Sections!were!incubated!with!a!mixture!of!different!primary!antibodies!simultaneously!for! 1! hour! at! room! temperature.! ! The! primary! antibodies! used! together! were! of!different! isotypes.! ! Sections! were! washed! and! then! incubated! with! a! mixture! of!secondary!antibodies!of!different!species!conjugated! to! fluorochromes!(see!Table!2G5,!all! obtained! from! Life! Technologies)! for! 20! minutes! at! room! temperature.! ! Sections!were! counterGstained!with! DAPI! (Life! Technologies,! D1306)! and!mounted! in!Mowiol!(SigmaGAldrich,! 81381).! ! Tissue! expression! was! visualised! using! a! LSM510! confocal!microscope!(Zeiss)!and!the!manufacturer’s!software.!
! !
! 72!
Table!2G5:!Secondary!antibodies!used!for!immunofluorescence!Host! Reactivity! Isotype! Fluorochrome! Code! Working!concentration!Chicken! Goat! IgG! Alexa!Fluor!488! AG21467! 4!µg/ml!Donkey! Rabbit! IgG! Alexa!Fluor!546! AG10040! 4!µg/ml!Goat! Rabbit! IgG! Alexa!Fluor!633! AG21070! 4!µg/ml!Goat! Mouse! IgG1! Alexa!Fluor!546! AG21123! 4!µg/ml!Goat! Mouse! IgG2b! Alexa!Fluor!633! AG21146! 4!µg/ml!!
Chemokine!capture!and!immunocytochemistry!Endothelial! cells! were! isolated! from! enzymaticallyGdigested! matched! CRC! and! distal!colon!samples!(using!techniques!developed!in!our!lab!by!Elizabeth!Hepburn).!!In!brief,!tissue!samples!were!diced!and!enzymatically!digested!as!described!in!the!above!section!(Selective!use!of!enzymatic!digestion).!!Endothelial!cells!were!positively!isolated!by!first!labelling!cells!with!CD31!microbeads!(130G091G935,!Miltenyi!Biotec!Ltd,!UK)!and!then!passing! labelled!cells! twice! through!a!magnetic!column!(130G042G401,!Miltenyi!Biotec!Ltd,! UK).! ! Isolated! CD31+! cells!were! cultured! in! EBMG2! endothelial! cell!medium! (CCG3156,!Lonza!Ltd,!UK).!
All!chambers!of!a!6Gchamber!microslide!(IBG80606,!Ibidi!GmBH,!Germany)!were!coated!with!ratGtail!collagen!I!(C3867,!SigmaGAldrich!Ltd,!UK)!and!left!to!dry!overnight!at!room!temperature.! !The!chambers!were!washed!with!PBS!and!1!x!105!passage!4!endothelial!cells!in!EBMG2!media!from!either!normal!colon!(NEC)!or!tumour!(TEC)!were!seeded!into!each! chamber.! ! The! slide! was! left! for! 48! hours! for! the! endothelial! cells! to! become!confluent.! !The!media!was!changed!4!hours!after!seeding!and!on!a!further!4!occasions!
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within!a!48Ghour!period.!!Recombinant!chemokine!or!PBS!was!added!to!each!chamber!for!30!minutes!then!washed!out!by!3!changes!of!PBS.!
The! endothelial! cells! were! fixed! by! aspirating! the! media! then! adding! 100! µl! 4%!paraformaldehyde! to! each! chamber! for! 10! minutes! at! room! temperature.! ! The!paraformaldehyde!solution!was!washed!from!the!chambers!by!adding!100!µl!PBS!to!one!side!of! the!chamber!and!aspirating! from!the!other!3! times.! !Endogenous!Fc!receptors!were! blocked!by! adding!100!µl! of! 2.5%!normal! horse! serum! to! each! chamber! for! 20!minutes! at! room! temperature.! ! The!horse! serum!was! then! aspirated! and! solutions!of!primary! antibody! against! CCL3,! CCL4! and! CCL5! or! IMC! in! PBS! were! added! to! each!chamber! at! a! concentration! given! in! Table! 2G4.! ! The! fixed! endothelial! cells! were!incubated!in!primary!antibody!solution!for!1!hour!at!room!temperature.!!The!chambers!were!then!washed!3!times!with!PBS!+!0.1%!TweenG20!solution!followed!by!the!addition!of! 100! µl! of! Alexa! Fluor! 488Glabelled! antiGgoat! secondary! antibody! in! PBS! for! 20!minutes!at! room!temperature!at! the!concentration!given! in!Table!2G5.! !The!chambers!were!washed!three!times!with!PBS!+!0.1%!TweenG20!solution,! then! filled!with!100!µl!PBS! prior! to! visualisation! using! a! LSM510! confocal! microscope! (Zeiss)! and! the!manufacturer’s!software.!
RealNtime%PCR!
Gene!expression!by!realGtime!PCR!was!performed!using!snap!frozen!samples!of!CRC!and!matched! distal! colon! and! the! LightCycler! 480! (Roche! Ltd,! UK).! ! mRNA! levels! were!expressed! relative! to! reference! genes! as! calculated! by! the! 2(GΔΔCt)!method! (relative!quantification).!!!
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RNA!extraction!and!cDNA!synthesis!RNA!was!extracted! from!snapGfrozen! tissue! samples!using! the!Qiagen!RNeasy!minikit!(74104,! Qiagen! GmBH,! Germany)! as! per! manufacturer’s! instructions.! ! The! RNA!concentration! was! adjusted! to! 100! μg/ml! by! addition! of! RNaseGfree! water! following!assessment! of! RNA! quantity! and! quality! by! UV! absorbance! at! 260/280! nm! using! a!nanophotometer!(P300,!Implen!GmBH,!Germany).!!RNA!was!reverse!transcribed!from!3!μg! RNA! using! the! iScript! kit! (170G8891,! Biorad! Inc,! USA)! and! stored! at! G80˚C! until!required.!




Gene! Accession!number! Primer! UPL!Probe!CCL3! ENST00000225245.5|!ENSG00000006075.9! LEFT!RIGHT! AATCTGCCGGGAGGTGTA TGCAACCAGTTCTCTGCATC 40!CCL4! ENST00000250151.3|!ENSG00000129277.7! LEFT!RIGHT! CCCAGCCAGCTGTGGTAT CTGAAGACTTCCTGTCTCTGAGC 85!CCL5! ENST00000366113.3|!ENSG00000161570.3! LEFT!RIGHT! CCTCATTGCTACTGCCCTCT GGTGTGGTGTCCGAGGAATA 16!CCL17! ENST00000219244.4|!ENSG00000102970.5! LEFT!RIGHT! GGCTTCTCTGCAGCACATC GGAATGGCTCCCTTGAAGTA 27!CCL17! ENST00000219244.4|!ENSG00000102970.5! LEFT!RIGHT! GCACACAGAGACTCCCTCCT AGTACTCCAGGCAGCACTCC 81!CCL19! ENST00000311925.2|!ENSG00000172724.7! LEFT!RIGHT! GCCTGCTGGTTCTCTGGAC GGATGGGTTTCTGGGTCAC 27!CCL20! ENST00000409189.3|!ENSG00000115009.7! LEFT!RIGHT! GCTGCTTTGATGTCAGTGCT GAAGAATACGGTCTGTGTATCCAA 39!CCL21! ENST00000259607.2|!ENSG00000137077.3! LEFT!RIGHT! TCCATCCCAGCTATCCTGTT AGCTCCTTTGGGTCTGCAC 13!CCL22! ENST00000219235.4|!ENSG00000102962.4! LEFT!RIGHT! CGTGGTGAAACACTTCTACTGG CCTTATCCCTGAAGGTTAGCAA 51!CCL22! ENST00000219235.4|!ENSG00000102962.4! LEFT!RIGHT! TTCTACTGGACCTCAGACTCCTG TGGCTCAGCTTATTGAGAATCA 37!CXCL9! ENST00000264888.4|!ENSG00000138755.4! LEFT!RIGHT! CCTTAAACAATTTGCCCCAAG TTGAACTCCATTCTTCAGTGTAGC 4!CXCL10! NM_001565.2! LEFT!RIGHT! GAAAGCAGTTAGCAAGGAAAGGT GACATATACTCCATGTAGGGAAGTGA 34!CXCL11! ENST00000306621.3|!ENSG00000169248.3! LEFT!RIGHT! AGTGTGAAGGGCATGGCTA TCTTTTGAACATGGGGAAGC 76!IPO8! ENST00000256079.4|! LEFT! ACAGCACTGCAGGAGGTGTA 87!
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!An!amplicon!was!not!detected!using!primers!designed!by!the!RealTime!Ready!software!for!CCL17,!CCL22!and!CXCL11.! ! This!was!despite!using!2!different!designs! for!CCL17!and!CCL22!and!alteration!of!the!annealing!temperature.!!Furthermore,!the!amplification!curves! for! CCL3,! CCL4! and! CCL5! appeared! only! after! 50! cycles.! In! these! cases,! preGdesigned!primers!and!probes!were!purchased! from!Applied!Biosystems! Inc,!USA! (see!Table!2G7).!!The!primers!and!probes!were!provided!as!a!gene!expression!assay!mix.!
! !





Gene! Accession!number! Assay!ID!CCL3! NM_002983.2! Hs00234142_m1!CCL4! AY312578.1! Hs01031494_m1!CCL5! NM_002985.2! Hs00174575_m1!CCL17! NM_002987.2! Hs00171074_m1!CCL22! NM_002990.4! Hs01574247_m1!CCR5! NM_000579.3! Hs99999149_s1!CXCR3! NM_001142797.1! Hs01847760_s1!S1PR1! NM_001400.4! Hs00173499_m1!BCL2! NM_000633.2! Hs00608023_m1!KLF2! NM_016270.2! Hs00360439_g1!GAPDH! NM_002046.3! Hs03929097_g1!18S! HSRRN18S! Hs03003631_g1!
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RealNtime!PCR!procedure!The! template! cDNA! was! added! to! a! mixture! of! primers,! probes! and! master! mix!(LightCycler!480!Probes!Master,!04!707494!001,!Roche)!with!the!following!volumes!per!well!(of!a!96Gwell!PCR!plate):!
Master!mix! 10!µl!Left!primer! 1!µl! }!Right!primer! 1!µl! }! or!1!µl!Applied!Biosystems!primerGprobe!mix!UPL!probe! 1!µl! }! with!7!µl!PCR!water.!PCR!water! 5!µl! }!Template!cDNA! 2!µl!!!
To!provide!negative!controls,! template!cDNA!was!replaced!with!PCR!water!and!a!–RT!(minus! reverse! transcriptase)! control!where! reverse! transcriptase!was! omitted! from!the!cDNA!synthesis!reaction.!
The!following!programme!was!run!using!the!LightCycler!480:!
PreGincubation:! 1!cycle!! ! ! ! 95˚C!for!10!minutes!Amplification:! 55!cycles!! ! ! ! 95˚C!for!10!seconds!! ! ! ! 59˚C!for!30!seconds!! ! ! ! 72˚C!for!1!second!Cooling:! ! 1!cycle!! ! ! ! 40˚C!for!10!seconds!!
Selection!of!reference!genes!Reference!genes!were!used! to!normalise! the!mRNA! fraction!of!different! samples.! It! is!important! that! the! expression! of! chosen! reference! genes! do! not! vary! between! tissue!samples.! ! It! has! been! shown! that! traditional! choices! of! reference! genes! can! vary!considerably! between! CRC! and! matched! colon! (179–182).! ! The! MIQE! guidelines!
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(Minimum! Information! for! Publication! of! Quantitative! RealGTime! PCR! Experiments)!state!that!normalisation!against!a!single!reference!gene!is!unacceptable!unless!there!is!clear!evidence!for!its!invariant!expression.! !The!number!and!choice!of!reference!genes!must!be!experimentally!determined!(183).!!For!this!reason,!absolute!quantification!of!a!panel! of! 10! different! human! reference! genes! (G6PD,! PPIA,! GAPD,! TBP,! ß2M,! GUSB,!PBGD,!HPRT,!ACTB,!PGK1)!was!performed!for!cDNA!synthesised!from!3!µg!of!RNA!from!8! samples! of! CRC! with! matched! colon.! ! Absolute! quantification! was! performed! in!triplicate! for! each! sample! and! differences! in! absolute! expression! between! matched!samples!were! compared!using! the!WilcoxinGsigned! rank! test.! ! It!has!been! shown! that!both!the!data!range!and!outlying!values!can!have!a!profound!effect!on!such!analyses!and!therefore,!a!stability!measure!algorithm!has!been!developed!based!on!the!principle!that!the!expression!ratio!of! two!control!genes!should!be! identical! in!all! samples! for!stable!genes! (184).! ! The! algorithm! is! known! as! geNorm! and! forms! part! of! commercially!available! software! (qbase+,! Biogazelle,! Belgium).! ! This! software! calculated! the! most!stable! reference! gene! using! the! absolute! quantification! data! from! the! above! panel! of!different!reference!genes.!!Raw!absolute!quantification!Ct!(cycle!threshold)!values!were!converted! into! relative! values! by! subtracting! the! highest! Ct! value! from! all! other! Ct!values! for! each! gene!measured!before! inputting! into! the! geNorm! software.! ! The!data!were!also!fed!into!other!popular!algorithms,!namely!Normfinder!(185)!and!Bestkeeper!(186).!!There!is!currently!no!consensus!as!to!whether!one!algorithm!is!superior!to!the!others.!
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Relative!quantification!cDNA! synthesised! from! 3! µg! of! RNA! from! 8! different! CRC! and!matched! distal! colon!samples!was! analysed! for! differences! in! expression! of! various! targets! (see! Table! 2G6!and! Table! 2G7)! relative! to! chosen! housekeeping! genes,! calculated! by! the! 2(GΔΔCt)!method.!!Each!reaction!was!performed!in!duplicate.!!!
Gene!expression!by!sorted!Treg!and!Tconv!Treg!(CD4+CD127lowCD25high)!and!Tconv!(CD4+CD25G)!were!twoGway!sorted!into!1.5!ml!Eppendorfs! containing! 350! µl! RLT! buffer! (79216,! Qiagen! GmBH,! Germany),! using!methods! as! described! above! (FluorescenceGactivated! cell! sorting! (FACS)).! ! RNA! was!extracted! from!a!minimum!number!of!10,000!sorted!cells!using! the!RNeasy!micro!kit!according!to!manufacturer’s!instructions!(74004,!Qiagen!GmBH,!Germany).!!Total!RNA!was! reverse! transcribed! into! cDNA! using! the! iScript! kit.! ! Gene! expression! of! Foxp3,!CCR5,!S1P1R,!BCL2!and!various!transcription!factors!were!compared!between!Treg!and!Tconv! relative! to! GAPDH,! calculated! by! the! 2(GΔΔCt)! method.! ! Each! reaction! was!performed!in!duplicate.!!!
Determination*of*methylation*at!the$Foxp3$locus!
To!measure! the! percentage! unmethylation! at! the! TSDR,! DNA!was! isolated! from!Treg!and! Tconv,! followed! by! bisulfite! treatment! of! the! DNA! then! quantitative! analysis! of!methylated!alleles!(QAMA)!by!realGtime!PCR.!
DNA!extraction!from!sorted!Treg!and!Tconv!10000!to!20000!CCR5low!Treg,!CCR5high!Treg!and!Tconv!(CD4+CD25G)!were!isolated!from!3!different!CRC!samples!by!FACS!3Gway!sorting!into!1.5ml!Eppendorfs!containing!PBS,!
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as!described!above!(FluorescenceGactivated!cell!sorting!(FACS)).! !The!cell!suspensions!were! pelleted! by! centrifugation! for! 10! minutes! at! 300! x! g! in! a! microfuge,! then!resuspended! in! 200! µl! PBS.! ! DNA!was! extracted! from! the! cell! suspensions! using! the!DNeasy! Blood! &! Tissue! Kit! (69504,! Qiagen! GmBH,! Germany)! according! to!manufacturer’s!instructions.!!!
Bisulfite!conversion!of!extracted!DNA!Treatment! of! DNA!with! sodium! bisulfite! deaminates! unmethylated! cytosine! to! uracil!while!methylated!cytosines!are!not!deaminated!(187).!!This!reaction!is!the!basis!for!the!downstream! identification! of! DNA!methylation.! ! ! DNA! samples!were! bisulfite! treated!using! the! Epitect! Bisulfite! kit! (59104,! Qiagen! GmBH,! Germany)! according! to!manufacturer’s! instructions.! ! The! quantity! and! quality! of! recovered! bisulfiteGtreated!DNA!was!assessed!by!measurement!of!UV!absorbance!at!260/280!nm.!
QAMA!analysis!The!bisulfiteGtreated!TSDR!region!was!amplified!using!primers!as!detailed!in!Table!2G8.!!The!primers!were!designed! so! that! the!TSDR! region!was! amplified! irrespective! of! its!methylation!status.! !A!Taqman®!probe! labelled!with!6Gcarboxyfluorescein!(FAM)!was!designed! to! specifically! bind! to! an! unmethylated! sequence! while! another! Taqman®!probe! labelled!with!4,7,2’GtrichloroG7’phenylG6Gcarboxyfluorescein! (VIC)!was!designed!to! specifically! bind! to! a!methylated! sequence! (see! Table! 2G8).! ! To! achieve!maximum!specificity,! each! probe!was! designed! to! span! 3! CpGs!within! the! TSDR.! ! The! primers,!probes!and!method!have!been!previously!published! (188).! !Primers!and!probes!were!obtained!from!Applied!Biosystems!Inc,!USA.!
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Table!2G8:!!Primers!and!probes!used!for!methylation!analysis!at!the!TSDR!Primer!!/!probe! Sequence! Label! Concentration!Forward!primer! GAAATTTGTGGGGTGGGGTATTTGTTTT G! 1!µM!Reverse!primer! ATCTACATCTAAACCCTATTATCACAACCCCC G! 1!µM!Methylated!probe! TCGGCGTATTCGG VIC! 166!nM!Unmethylated!probe! AGTTTGGTGTATTTGGT FAM! 166!nM!!!
The! template! bisulfiteGtreated! DNA! was! added! to! a! mixture! of! primers,! probes! and!master!mix! (LightCycler!480!Probes!Master,!04!707494!001,!Roche!Ltd,!UK)!with! the!following!volumes!per!well!(of!a!96Gwell!PCR!plate):!
Master!mix! 10!µl!Forward!primer! 1!µl! (20!µM!stock!solution)!Reverse!primer! 1!µl! (20!µM!stock!solution)! !VICGlabelled!probe! 1!µl! (3.32!µM!stock!solution)!FAMGlabelled!probe! 1!µl! (3.32!µM!stock!solution)! !BisulfiteGtreated!DNA! 6!µl!!!
A!negative!control!was!provided!by!substitution!of!DNA!with!PCR!water.!!Treg!DNA!was!placed! in! a! reaction! omitting! the! VICGlabelled! probe! and! Tconv!DNA!was! placed! in! a!reaction!omitting!the!FAMGlabelled!probe!to!provide!single!colour!controls!required!for!colour! compensation.! ! All! samples! and! controls!were! performed! in! duplicate.! ! Roche!recommends!performing!quintuplicate!repeats!for!the!purpose!of!colour!compensation!but! there!was! insufficient!DNA! from!the!sorted!cells! to!achieve! this.! !Therefore!cDNA!derived!from!human!colonic!tissue!was!mixed!either!with!18SGVICG!or!18SGFAMGlabelled!probes!with!associated!primers,!master!mix!and!PCR!water!as!described!above!(RealGtime!PCR!procedure)!in!quintuplicates.!
The!following!programme!was!run!using!the!LightCycler!480:!
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PreGincubation:! 1!cycle!! ! 95˚C!for!10!minutes!Amplification:! 55!cycles!! ! 95˚C!for!15!seconds!! ! 60˚C!for!60!seconds!Colour!!compensation:! 1!cycle!! ! 95˚C!for!10!seconds!40˚C!for!30!seconds!85˚C,!continuous!acquisition!mode!with!5!acquisitions!per!1˚C!Cooling:! 1!cycle!! ! 40˚C!for!10!seconds!!VIC!and!FAM!were!colourGcompensated!using!the!LightCycler!480!software!followed!by!absolute!quantification!of!unmethylated!and!methylated!target!expression.!!The!average!methylated!Ct!was! subtracted! from! the!average!unmethylated!Ct! to!yield!a!∂Ct!value.!!The! percentage! of! unmethylated! DNA! was! estimated! by! plotting! the! ∂Ct! value! on! a!published!standard!curve!(188).!
Protein"detection"by"Western"blotting!
Specific!proteins!were!detected!and!semiGquantified!by!Western!blotting,!using!protein!lysates!from!snap!frozen!samples!of!CRC!and!matched!distal!colon.!
Protein!extraction!from!snap!frozen!samples!Protein!was!extracted!from!20G30!mg!snapGfrozen!tissue!by!incubation!in!iceGcold!lysis!buffer! (CellLytic!MT,!20!µl/mg! tissue,!SigmaGAldrich!Ltd,!UK)!containing!one! tablet!of!Proteinase!Inhibitor!Cocktail!per!10!ml!of!lysis!buffer!(04693159,!Roche!Ltd,!UK).!!The!tissue!was!mechanically!dissociated!in!the!buffer!solution!using!the!GentleMACS!tissue!dissociator,! Programme!RNAG01! (Miltenyi! Biotec! Ltd,! UK).! ! Samples!were! pelleted! at!3000! x! g!with! maximum! brake! and! the! supernatant! collected! and! placed! in! 1.5! ml!Eppendorfs.! ! The! samples!were! then! further! agitated! for! 1! hour! at! 4˚C,! pelleted! in! a!
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microfuge! at! 15000! rpm! for! 30! minutes! at! 4˚C! and! the! supernatant! collected.! ! The!supernatants!(protein!lysates)!were!kept!on!ice.!
Protein!concentration!determination!The! protein! concentrations! of! the! protein! lysates! were! determined! against! a! BSA!standard!using!a!bicinchoninic!acid!(BCA)!assay.!!For!each!lysate,!a!1:5!and!1:10!dilution!was!made!by!adding!10!µl!of!lysate!to!40!µl!of!lysis!buffer,!or!5!µl!of!lysate!to!45!µl!of!lysis!buffer,!respectively.!!The!50!µl!volume!of!each!dilution!was!enough!to!perform!the!assay!for!the!lysate!samples!in!duplicate.! !The!BCA!working!solution!was!prepared!by!adding!50!parts!of!BCA!solution! (B9643,! SigmaGAldrich!Ltd,!UK)! to!1!part! copper! (II)!sulphate! pentahydrate! 4%! solution! (C2284,! SigmaGAldrich! Ltd,! UK).! ! 200! µl! of! BCA!working! solution! was! required! for! each! replicate.! ! A! BSA! solution! of! 1000! µg/ml!(P0914,!SigmaGAldrich!Ltd,!UK)!was!diluted!in!lysis!buffer!to!provide!concentrations!of!0,!200,!400,!600,!800!and!1000!µg/ml.! !200!µl!of!BCA!working!solution!was!placed!in!each!well!of!a!standard!flatGbottomed!96Gwell!plate!using!a!multiGchannel!pipette.!!25!µl!of! the!different!BSA!protein! standard!concentrations!were!added! to! separate!wells! in!duplicate.! !25!µl!of! the!different!protein! lysate!dilutions!were! then!added! to! separate!wells! in!duplicate.! !The!plate!was!incubated!for!30!minutes!at!37˚C.! !Absorbance!from!each!well!was!then!read!at!562!nm.! !A!standard!curve!was!created!by!plotting!the!net!absorbance!at!562!nm!against!the!BSA!standard!concentration!in!µg/ml.!!The!standard!curve!was!used! to!establish! the!protein!concentrations!of!each!protein! lysate! sample.!!The!dilution!(1:5!or!1:10)!which!yielded!absorbances!along!the!plotted!linear!portion!of!the! standard! curve!was! selected! to! calculate! protein! concentrations.! ! Protein! lysates!were!then!diluted!in!cell!lysis!buffer!to!normalise!the!protein!concentration!to!2!mg/ml.!
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Western!blot!technique!
Gel$casting$SDSGPAGE! (sodium! dodecyl! sulphate! polyacrylamide! gel! electrophoresis)! was!performed! to! separate! proteins! in! the! protein! lysate! samples! using! the! MiniGPROTEAN®!Tetra!Cell!system!(Biorad! Inc,!USA).! !A!stacking!gel! (5%!acrylamide)!was!layered!over!a!polymerised!resolving!gel! (12%!acrylamide)!between!2!glass!plates! to!cast!a!1.5!mm!gel.! !The!resolving!gel!was!made!by!mixing!3.4!ml!deionized!water!with!4.0!ml!Protogel!30%!(ECG890,!National!Diagnostics!Ltd,!UK),!2.5!ml!resolving!buffer!(1.5!M! Tris,! pH! 8.8)! and! 0.1! ml! 10%! SDS.! ! 60! µl! 10%! ammonium! persulphate! solution!(A3678,! SigmaGAldrich! Ltd,! UK)! and! 60! µl! of! N,N,N’,N’Gtetramethylethylenediamine!(TEMED,! T9281,! SigmaGAldrich! Ltd,! UK)! was! added! to! the! mixture! to! initiate!polymerisation.! !The!gel!was!poured!between!the!2!glass!plates,! leaving!enough!space!from!the!top!of!the!plates!for!a!stacking!gel!and!comb,!and!30!µl!industrial!methylated!spirits!(IMS)!was!placed!on!top!of!the!gel.!!The!resolving!gel!was!then!left!for!10!minutes!to! set.! ! The! stacking! gel! was! made! by! mixing! 5.7! ml! deionized! water! with! 1.7! ml!Protogel!30%,!2.5!ml!stacking!buffer! (0.5!M!Tris,!pH!6.8)!and!0.1!ml!10%!SDS.! !60!µl!10%!ammonium!persulphate!solution!and!60!µl!of!TEMED!was!added! to! the!stacking!gel!mixture!which!was! then! layered!on! top!of! the! resolving!gel.! !A!10Gwell! comb!was!inserted!into!the!stacking!gel!which!was!then!removed!after!the!gel!had!set.!
Sample$preparation$5!µl!of!5X!SDSGPAGE!sample!buffer!(200!mM!Tris!pH!6.8,!20%!glycerol,!10%!SDS,!0.05%!bromophenol!blue!and!10!mM!ßGmercaptoethanol)!was!added!to!20!µl!of!each!2!mg/ml!protein!lysate!samples!in!a!1.5!ml!Eppendorf.!!The!samples!were!heated!for!2!minutes!at!
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100˚C! then!pelleted! at!maximum!speed! in! a!microfuge! for!1!minute.! ! The! casted! gels!were!assembled!in!the!electrophoresis!apparatus!and!submerged!in!1X!running!buffer!(10X!running!buffer!=!30.3!g!Tris,!144!g!glycine,!10!g!SDS!in!1!litre!distilled!water).!!20!µl! sample! was! added! to! each! lane! in! the! stacking! gel,! with! one! lane! reserved! for! a!protein! ladder! (10! µl! PageRuler! Prestained! Protein! Ladder,! 26616,! Thermo! Scientific!Inc,! USA)! and! one! lane! for! a! negative! (distilled! water)! or! positive! (recombinant!chemokine)!control.! !Electrophoresis!was!performed! for!approximately!30!minutes!at!200! V.! ! In! some! instances,! it!was! found! that! chemokine! protein!was! selfGassociating,!leading! to!multiple! bands! on! developed! blots.! ! Therefore! 8M! urea!was! added! to! the!sample! buffer! to! act! as! a! chaotrope,! thereby! destabilising! hydrophobic! bonds! and!increasing!the!protein!solubility!(189).!
Blot$development$The! resolving! gel! was! removed! from! the! electrophoresis! apparatus! and! placed! on! a!piece! of! filter! paper! soaked! in! transfer! buffer! (28.8! g! glycine,! 6.0! g! Tris,! 400! ml!methanol,!1!g!SDS!in!2!litres!of!distilled!water).!!A!nitrocellulose!membrane!(RPN2020D,!Amersham!HybondGECL,!GE!Healthcare!Ltd,!UK)!was!then!placed!directly!onto!the!gel.!!Another!transfer!bufferGsoaked!filter!paper!was!placed!on!top!of!the!membrane!and!the!filter!paper!sandwich!was!placed!between!2!Scotch!pads!in!the!transfer!apparatus.!!The!apparatus!was!placed!in!the!electrophoresis!tank,!submerged!in!transfer!buffer.!!A!flea!was!placed! in!the!bottom!of! the!tank!and!an! iceGblock!was! inserted!to!the!back!of! the!tank.!!Electrophoresis!was!performed!for!1!hour!at!100!V!with!continuous!stirring.!
The! apparatus! was! disassembled! and! the! membrane! was! removed! and! covered! in!Ponceau! S! solution! (P7170,! SigmaGAldrich! Ltd,! UK)! and! incubated! on! a! rocker! for! 5!
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minutes.! ! The! solution!was! then! rinsed!off! the!membrane! to! ensure! that! protein! had!transferred.!!!The!membrane!was!blocked!by!incubation!with!25!ml!5%!nonGfat!milk!(5!g!nonGfat!milk!powder!in!PBS!+!0.02%!Tween!20)!for!1!hour!at!room!temperature!on!a!rocker.! ! 12.5!ml!milk! solution!was! removed! and! stored! at! 4˚C! and! primary! antibody!against!the!protein!of!interest!was!added!to!the!remaining!12.5!ml!of!milk!solution!and!incubated! overnight! at! 4˚C! on! a! rocker.! ! The! primary! antibodies! used! to! probe! for!proteins!of!interest!are!shown!in!Table!2G9.!
Table!2G9:!!Primary!antibodies!used!for!Western!blotting!Antigen! Clone! Isotype! Manufacturer! Code! Working!concentration!CCL3! Polyclonal! Goat! R&D!Systems! AFG270GNA! 0.1!µg/ml!CCL4! Polyclonal! Goat! R&D!Systems! AFG271GNA! 0.1!µg/ml!CCL5! Polyclonal! Goat! R&D!Systems! AFG278GNA! 0.1!µg/ml!CCL20! Polyclonal! Goat! R&D!Systems! AFG360! 0.1!µg/ml!CXCL9! 49106! Ms!IgG1! R&D!Systems! MAB392! 1!µg/ml!CXCL10! Polyclonal! Goat! R&D!Systems! AFG266GNA! 0.1!µg/ml!CXCL11! Polyclonal! Chicken! Thermo!Scientific! PA1G27877! 1!in!2000!VAPG1! TK8G14! Ms!IgG2a! Gift! from! David! Smith! at! Biotie!Therapies,!Finland! 2!µg/ml!GUSB! Polyclonal! Sheep!IgG! R&D!Systems! AF6144! 1!µg/ml!GAPD! GAPDHG71.1! Ms!IgM! SigmaGAldrich! G8795! 0.05!µg/ml!!
The!milk!solution!containing!primary!antibody!was!poured!off! the!membrane!and!the!membrane!was!washed!3!times!with!50!ml!PBS!+!0.02%!Tween!20!for!5!minutes!on!an!orbital!shaker.!!The!12.5!ml!milk!solution!stored!at!4˚C!was!poured!onto!the!membrane!and!secondary!antibody!conjugated!to!horseradish!peroxidase!(HRP)!was!added!to!the!solution! (see!Table!2G10)!and! incubated! for!1!hour!at! room!temperature!on!a! rocker.!!
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The! secondary! antibody! solution!was! discarded! and! the! 3!washes!with! PBS! +! 0.02%!Tween! 20! repeated.! ! The!membrane!was! covered!with! enhancedGchemiluminescence!substrate! (PIG32109,!Thermo!Scientific! Inc,!USA)! for!1!minute,!before!wicking!off! and!covering! the!membrane! in!plastic!wrap.! ! Films! (CLGXPosure!34088,!Thermo!Scientific!Inc,!USA)!were!placed! inside!cassettes!with!the!covered!membrane!for!a!defined!time!period!(30!seconds!to!40!minutes)!and!were!developed!using!the!Compact!X4!(Xograph!Healthcare!Ltd,!UK).!
Stripping! of! primary! and! secondary! antibodies! from! the! membrane! allows! the!membrane! to! be! reGprobed! for! a! different! protein! of! interest,! a! technique! that! may!prove! useful!when! evaluating!multiple! targets! (190).! ! However,! probing! for! GAPD! in!CRC!protein!lysate!samples,!using!a!membrane!that!had!been!stripped,!resulted!in!weak!or!absent!bands.!!Therefore,!all!Western!blot!experiments!involved!transferring!protein!to!a!new!membrane!for!probing!of!one!protein!at!a!time.!
Table!2G10:!!HRPGlabelled!secondary!antibodies!used!for!Western!blotting.!Host! Reactivity! Isotype! Manufacturer! Code! Working!concentration!Rabbit! Mouse! Polyclonal! Dako! P0161! 0.28!µg/ml!Rabbit! Goat! Polyclonal! Dako! P0160! 0.28!µg/ml!Donkey! Sheep! Polyclonal! R&D!Systems! HAF016! 1!in!1000!Rabbit! Chicken! Polyclonal! Invitrogen! 61G3120! 0.4!µg/ml!!
Band!densitometry!The! density! of! the! developed! Western! blot! bands! is! proportional! to! the! protein!concentration.! ! Measurement! of! band! density! is! therefore! semiMquantitative,! in! that!there! is!no!standard!curve! to!enable!absolute!protein!concentrations! to!be!calculated.!!
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Band!density!was!calculated!using!ImageJ!(Version!1.46r,!NIH,!USA)!which!has!builtGin!gel!image!analysis!functions.! !Differences!in!band!densities!between!CRC!and!matched!colon! samples! were! tested! for! statistical! significance! using! the!Wilcoxin! signedGrank!test.!
Graphical)presentation)and)statistical)analysis!
Data!was!presented! in!graphical! format!using!Prism!version!5.0f! (GraphPad!Software!Inc,! USA)! or! R! version! 2.15.2! (The! R! Foundation! for! Statistical! Computing,! Austria).!!Statistical! analysis! was! performed! using! R! or! SPSS! Statistics! version! 20! (IBM!Corporation,!USA).!!Advice!on!the!statistical!methods!and!testing!used!in!this!thesis!was!obtained!from!Professor!Mohammed!Mohammed!(School!of!Health!Studies,!University!of!Bradford!–!previously!at!Primary!Care!Clinical!Sciences,!University!of!Birmingham).!!P!values!were!given!to!2!significant!figures.!!!
In!general,!differences!between!unrelated!groups!were!tested!for!statistical!significance!using! the!MannGWhitney!U! test!while!differences!between!related!groups!were! tested!using!the!Wilcoxon!signedGrank!test.!!P!values!<0.05!were!considered!to!be!statistically!significant.! ! Asterisks! were! placed! in! figures! to! indicate! statistically! significant!differences,!using!the!following!convention:!




The!expression!of! chemokine!receptors!and! integrins!by!T!cells!will!determine!which!cells!are!recruited!to!tumours.! !Enrichment!of!Treg!has!been!reported! in!CRC!by!both!immunohistochemical! and! flow! cytometric! methods! (52–54,191–193).! ! It! is!hypothesised!that!differences!between!Treg!and!Tconv!in!terms!of!chemokine!receptor!and! integrin! expression,! explain!why! Treg! are! recruited! to! tumours! in! preference! to!Tconv,!thereby!leading!to!Treg!enrichment.!!!
In!this!thesis,!the!term!Treg!refers!to!lymphocytes!expressing!both!CD4!and!CD25!with!low! levels! of! CD127,! i.e.! CD4+CD25+CD127low.! ! Conventional! T! cells! (Tconv)! refers! to!lymphocytes!expressing!CD4!and!low!levels!of!CD25,!i.e.!CD4+CD25G.!
This!chapter!presents!evidence!for!Treg!enrichment!in!CRC!tissue!compared!to!matched!distal! colon,! TDLN!and!peripheral! blood.! ! I! carried!out! a! systematic! and! comparative!analysis!of!the!expression!levels!of!chemokine!receptors,!Treg!markers!and!integrins!by!Treg,!Tconv!and!CD8+!cells.!!!
Findings!
Treg!enrichment!in!CRC!compared!with!distal!colon!Lymphocytes!were!isolated!from!CRC,!colon,!TDLN!and!peripheral!blood!as!described!in!Chapter! 2.! ! There!were! a! total! of! 70! samples! of! CRC! from!70!patients,!with!matched!
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distal! colon! in!60!cases,!matched!TDLN! in!8!cases!and!matched!peripheral!blood! in!7!cases.! ! There! were! also! 2! polyps,! both! of! which! were! reported! as! having! moderate!dysplasia.! !The!proportion!of!CD4+!cells!with!a!Treg!phenotype!(CD4+CD25+CD127low),!referred!to!as!the!Treg!proportion,!was!calculated!for!each!sample!and!compared!across!tissue! compartments! (see! Figure! 3G1).! ! Statistical! significance! was! tested! by! the!Wilcoxin!signedGrank!test!when!comparing!differences!between!the!matched!tissues!of!CRC,!distal!colon!and!TDLN.!!Differences!in!the!Treg!proportion!between!tissue!samples!and!unmatched!blood!samples!were!tested! for!statistical!significance!using! the!MannGWhitney!test.!!There!was!no!significant!difference!in!the!Treg!proportion!of!peripheral!blood! samples! between! control! patients! and! patients! with! CRC! (P=0.49,! MannGWhitney).! ! However,! differences! in! the! Treg! proportion! between! all! other! tissue!compartments!reached!statistical!significance.!
The!absolute!number!of!Treg!present! in!different! tissue!compartments!was!measured!by! flow! cytometry! using! counting! beads,! adjusted! for! tissue! weight.! ! There! was! a!statistically!significant!difference!in!the!number!of!Treg!per!mg!of!tissue!between!CRC!and!matched!distal!colon!(Wilcoxin!signedGrank!test)!–!see!Figure!3G2a.!!!
!
! 92!
!Figure! 3G1:! ! The! proportion! of! CD4+! cells! with! a! Treg! phenotype! in! different! tissue!compartments.! ! ‘BloodGc’!=!peripheral!blood!samples! from!healthy!volunteers!or!HFE!donors.!!‘BloodGcrc’!=!peripheral!blood!from!patients!with!CRC!taken!at!induction!of!anaesthesia.! !DC!=!distal!colon.! !Numbers!in!black!along!xGaxis!represent!number!of!cases!in!each!group.! !Capped!lines!indicate!statistically!significant!differences!between!groups!(Wilcoxin!signedGrank!test).!
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Live!and!apoptotic!cells!The! median! proportion! of! dead! lymphocytes! ±! interquartile! range! (IQR)! differed!significantly! by! sample! type:! 25.9%! (12.8! –! 41.6)! for! CRC! versus! 6.9%! (2.8G10.6)! for!distal!colon!(P<0.01,!Wilcoxin!signedGrank!test).!!AnnexinGV!staining!was!performed!on!one! sample! to! quantify! the! proportion! of! early! apoptotic! cells.! ! 9.9%!of! CRCGisolated!Treg!were!positive! for!AnnexinGV,!which!was!comparable! to! the!proportion! for!Tconv!(9.0%)!and!CD8+!cells!(9.6%),!suggesting!that!the!isolation!procedure!did!not!result!in!a!proportionately!high!level!of!Treg!apoptosis.!!
CD8!:!CD4!ratio!The! ratio! of! CD8! to! CD4! T! cells!was!measured! in! different! tissues! (see! Figure! 3G2b).!There!was!no!difference!between!the!proportion!of!CD8!:!CD4!T!cells!in!34!samples!of!CRC!with!matched!distal!colon.!!The!median!CD8!:!CD4!ratio!!was!0.45!(IQR:!0.32G0.75)!in! CRC! and! 0.50! (IQR:! 0.34G0.82)! in! matched! distal! colon! (P=0.962,! Wilcoxin! signed!rank).!
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n= 7 ; P= 0.016
























































































4 4 35 34
! 95!








Factors!associated!with!the!CRC!Treg!proportion!Patient! factors! (age!at!operation,!gender)!and!CRC! factors!were! tested! for!association!with! the! proportion! of! tumourGinfiltrating! Treg! (see! Table! 3G1).! ! The! CRC! factors!tumour!position,! grade,! stage,! extramural! vascular! invasion! (EMVI)! and! volume!were!
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chosen!as! they! form!part!of! the!standard!dataset!used! for!pathology!reporting!of!CRC!and!were! thus! available! from!hospital! pathology! reports! (194).! ! Survival! and!disease!recurrence!data!were!obtained!from!hospital!correspondence!records.! !MSI!and!KRAS!mutations! were! sought! in! selected! cases! by! immunohistochemistry! or! PCR,!respectively.!!The!decision!to!perform!testing!for!MSI!and!KRAS!mutations!was!made!by!the!pathologists.!!!Patient!age!and!tumour!volume!were!continuous!variables!and!were!thus!divided!into!quartiles!in!order!to!perform!grouped!analysis!testing!for!association!with!the!proportion!of!Treg.! !Associations!were!tested!for!statistical!significance!using!the!MannGWhitney!test!or!KruskallGWallis!test!for!categories!with!twoGgroups!or!more!than!two!groups,!respectively.!!Scatterplots!illustrating!the!relationship!between!patient!age!and!tumour!volume!with!the!Treg!proportion!are!shown!in!Figure!3G4.!
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samples! were! processed! but! no! live! lymphocytes! were! isolated! from! the! metastatic!tissue.!!Given!the!problems!with!live!lymphocyte!yield!and!the!small!differences!in!Treg!infiltration! between! metastatic! and! distal! liver! tissue,! no! further! experiments! were!performed!using!CRC!metastases.! !All! further!data!presented! in! this! chapter! relate! to!primary!CRC!and!colon!tissue.!!
Chemokine!receptor,!integrin!and!Treg!marker!expression!by!TIL!The!expression!of! different! chemokine! receptors,! integrins! and!various!Treg!markers!was! compared! between! CRCGisolated! Treg,! Tconv! and! CD8+! cells.! ! Both! percentage!expression!and!MFI!were!compared.!!Positive!expression!was!defined!relative!to!a!FMO!control! containing! an! IMC! of! the! same! isotype! as! the! antibody! against! the! antigen! of!interest.!!The!FMO!control!region!was!set!at!<1.5%!expression.!!Summary!data!from!64!separate! flow! cytometry! experiments! are! presented.! ! Statistical! significance! was!assessed!by!Wilcoxin!rankedGsign!test!and!was!adjusted!for!multiple!comparisons!using!the!Bonferroni!method.!!Differences!in!chemokine!receptor!expression!by!cell!type!are!shown!in!Figure!3G5.!!Treg!expressed!significantly!more!CCR4!and!CCR5!compared!with!Tconv! in! terms! of! both! percentage! expression! and! MFI.! ! Similarly,! Treg! expressed!significantly! more! CCR5! compared! with! CD8+! cells! in! terms! of! both! percentage!expression!and!MFI!while!CD8+!cells!expressed!more!CCR5!than!Tconv!by!percentage!expression!only.!
Significantly! fewer! Treg! expressed! CCR7! and! CXCR4! compared! with! Tconv.!!Significantly! more! Treg! expressed! CCR6! compared! with! CD8+! cells,! with! a! trend! for!greater!CCR6!percentage!expression!by!Treg!compared!with!Tconv.!!!
The!expression!of!various!Treg!markers!by!TIL!is!summarised!in!Figure!3G6.!
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As!previously!stated,!there!was!significantly!greater!Foxp3!expression!in!terms!of!both!percentage! expression! and!MFI! by! Treg! compared!with! Tconv.! ! Differences! in! Foxp3!expression! between! CD8+! cells! and! either! Treg! or! Tconv! did! not! reach! statistical!significance! due! to! the! small! number! of! cases! (n=3)! in!which! Foxp3! expression!was!measured!in!CD8+!cells.!!There!was!significantly!greater!CD39!expression,!both!in!terms!of! percentage! expression! and! MFI,! by! Treg! compared! with! Tconv! and! significantly!greater!percentage!expression!of!CD27!by!Treg!compared!with!Tconv.!
The!expression!of!different!integrins!by!TIL!is!summarised!in!Figure!3G7.!






























by*Treg*between*CRC,*matched*distal*colon*and*TDLN*The! expression! of! chemokine! receptors,! integrins! and! Treg!markers! by! CRC<isolated!Treg!was!compared!with!Treg!isolated!from!matched!distal!colon!and!TDLN.!!Statistical!significance!was!assessed!by!Wilcoxin! ranked<sign! test! and!was!adjusted! for!multiple!comparisons!using!the!Bonferroni!method.!!!
The!summary!data!for!chemokine!receptor!expression!by!Treg!by!tissue!type!is!shown!in! Figure! 3<8.! ! Significantly! more! CRC<isolated! Treg! expressed! CCR5! compared! with!Treg!isolated!from!matched!distal!colon.! !There!was!no!difference!in!CCR4!expression!but! a! trend! for! increased! CCR6! percentage! expression! by! Treg! isolated! from! CRC!compared! with! Treg! isolated! from! matched! distal! colon.! ! There! were! no! significant!differences!in!Treg!marker!expression!or!integrin!expression!by!Treg!between!CRC!and!matched!distal!colon!or!TDLN!(see!Figure!3<9!and!Figure!3<10).!
However,!unadjusted!P<values!did!demonstrate!significantly! less!expression!of!ß7!and!significantly!more! expression! of! ß1! by! Treg! isolated! from! CRC! compared!with! distal!colon.!!Similarly,!unadjusted!P<values!demonstrated!a!significant!difference!between!the!percentage!expression!of!CD39!by!CRC<isolated!Treg!compared!with!Treg!isolated!from!matched!distal!colon.!
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The!expression!of!chemokine!receptors,!Treg!markers!and!integrins!of!interest!by!Treg!isolated! from! the! peripheral! blood! of! patients! with! CRC! was! compared! with! the!expression! by! Treg! isolated! from! the! peripheral! blood! of! control! subjects! (either!healthy! volunteers! or! HFE! patients)! –! see! Figure! 3H11.! ! Statistical! significance! was!assessed!by! the!MannHWhitney! test! and!was!adjusted! for!multiple! comparisons!using!the! Bonferroni! method.! ! Statistically! significant! differences! in! antigen! expression!between!matched! CRC,! distal! colon! and! TDLN! are! not! represented! in! Figure! 3H11! as!these! have! been! shown! in! previous! figures.! ! Statistically! significant! differences! in!antigen!expression!by!CRCHisolated!Treg!compared!with!Treg!isolated!from!the!blood!of!either!control!subjects!or!patients!with!CRC!are!highlighted!by!capped!lines.!
There!was!significantly!less!percentage!expression!of!CCR5!and!CD39!by!Treg!isolated!from!blood! than! from!Treg! isolated! from!CRC! tissue.! ! There!was! significantly! greater!percentage!expression!of!CCR7!and!CD62L!by!Treg! isolated! from!the!blood!of!control!subjects!compared!to!Treg!isolated!from!CRC!tissue.!
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!
Figure! 3+11:! ! The! expression! of! various!markers! by! Treg! isolated! from! the! blood! of! control! subjects! and! patients! with! CRC.! ! (a)! Median!percentage!expression.! ! (b)!Median!MFI.! !Error!bars!represent! IQR!about! the!median.! !Numbers!along!x+axis! indicate! the!number!of!unique!samples.! ! Capped! lines! indicate! statistically! significant! differences! between! CRC+isolated! Treg! and! Treg! isolated! from! the! blood! of! control!subjects!or!patients!with!CRC.!!‘Blood+c’!=!blood!samples!from!healthy!volunteers!or!HFE!donors.!!‘Blood+crc’!=!blood!from!patients!with!CRC!taken!at!induction!of!anaesthesia.!
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One!chemokine!receptor!that!showed!marked!differences!between!cell!type!and!tissue!distribution,! was! CCR5.! ! In! the! tumour,! CCR5! was! relatively! overexpressed! by! Treg!compared!with!both!Tconv!and!CD8+!cells,!in!terms!of!both!percentage!expression!and!MFI.! ! Representative! flow! cytometry! overlay! histograms! are! shown! in! Figure! 3H12.!!More!Treg! isolated! from!CRC!expressed!CCR5! than!Treg! isolated! from!distal! colon!or!from!peripheral!blood.!!Other!chemokine!receptors,!that!were!relatively!overexpressed!by! CRCHisolated! Treg! compared! with! Tconv! and! CD8+! cells,! were! CCR4! and! CCR6.!!However,!there!was!no!significant!difference!in!the!expression!of!these!two!chemokine!receptors!by!Treg!across!different!tissue!types.!
!
Figure! 3H12:! Flow! cytometry! data! for! CCR5! expression! by! CRCHisolated! Treg! compared!with!CRCHisolated!Tconv!and!IMC!for!a!single!sample.!!Data!representative!of!51!unique!samples.!
Differences)in)CCR5)expression)were)dependent)on)antibody)clone)In!all!50!samples!of!matched!CRC!and!distal!colon,!the!percentage!expression!of!CCR5!was! higher! by! CRCHisolated! Treg! compared! with! Tconv.! ! In! all! 50! samples,! CCR5!percentage! expression!by!CRCHisolated!Treg!was!greater! than! the! expression!by!Treg!
R29
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isolated! from!distal! colon.! !The! clone!of! the!antiHhuman!CCR5!antibody!used! in! these!experiments!was!CTC5.! ! ! In!order!to!determine!if!the!antibody!clone!had!a!bearing!on!the! expression! profile! of! CCR5! by! Treg! and! Tconv,! a! different! antibody! clone! (2D7HCCR5,!BD!Biosciences)!was!used!in!3!separate!experiments.!!Across!the!3!experiments,!the!median!CCR5!percentage! expression!by!CRCHisolated!Treg!was!37.1%! (IQR:! 35.2H53.1)! compared!with! 34.4%! (IQR:! 34H53.3)! for! Tconv.! ! The!median! CCR5! percentage!expression!by!Treg! isolated!from!distal!colon!was!36.9%!(IQR:!22.2H45.4).! !There!was!therefore! no! observed! difference! in! the! percentage! expression! of! CCR5,! as!measured!using! the! 2D7HCCR5! antibody! clone,! between! Treg! and! Tconv!within! CRC! tissue! and!between!CRCHisolated!and!distal!colonHisolated!Treg.!
CCR5)was)overexpressed)by)Treg)compared)to)Tconv)at)the)mRNA)level)In!order!to!determine!if!there!were!differences!in!CCR5!gene!expression!between!CRCHisolated!Treg!and!Tconv,!Treg!and!Tconv!were!isolated!from!CRC!tissue!by!cell!sorting.!!10,000!to!20,000!Treg!and!Tconv!were!sorted!from!4!separate!CRC!samples.!!RNA!was!isolated!from!the!sorted!cells,!cDNA!was!synthesised!and!RTHPCR!was!performed.!!The!expression! of! CCR5! mRNA! and! other! target! mRNAs! were! calculated! relative! to! the!expression! of! GAPDH! mRNA.! ! The! fold! change! in! target! mRNA! expression! was!expressed!as!a! ratio!of! the! target!mRNA!expression!by!Treg!relative! to!GAPDH!to! the!target!mRNA!expression!by!Tconv!relative!to!GAPDH!(see!Figure!3H13).!!The!mean!fold!change!in!Foxp3!mRNA!expression!by!Treg!relative!to!Tconv!was!6.5!(SD=3.1),!serving!as!an!internal!control!for!expected!differences!in!gene!expression!between!the!two!cell!types.! !The!mean! fold!change! in!CCR5!mRNA!expression!was!2.6!(SD=1.0),! suggesting!that! the! increased!cell! surface!expression!of!CCR5!by!Treg!compared! to!Tconv! is! real!
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Figure! 3H13:! ! Mean! fold! change! in! mRNA! expression! by! CRCHisolated! Treg! relative! to! CRCHisolated!Tconv! from!5!unique!samples.! !Error!bars! represent! standard!error!of! the!mean! fold!change.!!Asterisks!represent!statistically!significant!differences!(WilcoxinHsigned!rank!test).!
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CCR5,)Foxp3)double)immunohistochemistry)In! order! to! identify! CCR5Hexpressing! Treg! in! sections! of! CRC,! double!immunohistochemistry! was! performed.! ! Foxp3! was! visualised! with! DABHnickel!(antibody! clone:! 236A/E7),! giving! a! black! nuclear! stain,! and! CCR5! with! NovaRED™!(antibody! clone:! 45531),! giving! a! brown/red! cytoplasmic! and! cell! surface! stain! (see!Figure! 3H14).! ! No! counterHstain! was! used.! ! DoubleHlabelled! CCR5+! Foxp3+! cells! were!identified!in!the!CRC!stroma,!although!CCR5HFoxp3+!cells!were!also!readily!observed.!!
!






Factors)associated)with)CCR5)expression)by)CRCBisolated)Treg)Patient! factors! and! CRC! factors! were! tested! for! association! with! the! percentage!expression!of!CCR5!(antibody!clone:!CTC5)!by!Treg!isolated!from!CRC!(see!Table!3H2).!!Associations! were! tested! for! statistical! significance! using! the! MannHWhitney! test! or!KruskallHWallis! test! for! categories! with! twoHgroups! or! more! than! two! groups,!respectively.! !There!was!no!significant!association!between!the!percentage!expression!of!CCR5!by!Treg!with!any!patient!or!CRC!factors.!





























































Distant!recurrence:!!!!!!False! !47! !53.4! !(42.9H69.7)! !0.57!
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The! data! presented! in! this! chapter! have! demonstrated! that! the! Treg! proportion!was!significantly!increased!in!CRC!compared!with!distal!colon,!TDLN!and!peripheral!blood.!!93.5%!of!Treg!expressed! the! transcription! factor!Foxp3!compared! to!14.2%!of!Tconv!cells.!!The!only!CRC!factor!found!to!be!associated!with!the!CRC!Treg!proportion!was!the!presence!of!KRAS!mutations.!
CCR4!and!CCR5!were!significantly!overexpressed!by!Treg!compared!with!Tconv,!both!in!terms! of! percentage! expression! and! MFI.! ! The! percentage! expression! of! CCR5! was!significantly! greater! by! CRCHisolated! Treg! compared! with! Treg! isolated! from! distal!colon.! ! CCR5! mRNA! was! significantly! more! highly! expressed! by! CRCHisolated! Treg!compared!with!Tconv.! !KLF2!and!CREB1!are!genes! involved!in!the!regulation!of!CCR5!transcription!and!were!also!significantly!more!highly!expressed!by!Treg!compared!with!Tconv.!!There!was!a!trend!for!lower!levels!of!ß7!percentage!expression!by!CRCHisolated!Treg!compared!with!Tconv!and!by!CRCHisolated!Treg!compared!with!Treg!isolated!from!distal!colon.! !However,! these!differences!did!not!reach!statistical! significance!using!PHvalues!adjusted!for!multiple!comparisons.!
Treg)enrichment)in)CRC)There!have!been!numerous!reports!of!increased!numbers!of!Treg!in!the!tumour!tissue!of! various! malignancies! compared! with! healthy! tissue! and! peripheral! blood,! when!analysed!by!flow!cytometric!or!immunohistochemical!methods!(see!Table!3H3).! !There!is! also! evidence! for! an! increased! frequency!of!Treg! in! the!peripheral! blood!of! cancer!patients! compared! to! healthy! controls.! ! With! regard! to! CRC,! immunohistochemical!studies!have!demonstrated!increased!numbers!of!Foxp3+!cells!in!CRC!tissue!compared!
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to!healthy!colon!(54,191,195).!!Flow!cytometry!methods,!which!express!Treg!frequency!as!a!proportion!of!CD4+!cells,!have!shown!a!significantly! increased!Treg!proportion!in!CRC! compared! with! TDLN,! in! TDLN! compared! with! peripheral! blood! and! in! CRC!compared! with! matched! colon! (52,56).! ! By! RTHPCR,! Foxp3! gene! expression! was!increased!in!CRC!compared!with!matched!colon!(196).!!This!is!entirely!in!keeping!with!the! results! presented! in! this! chapter,! demonstrating! that! the! Treg! proportion!significantly! increases! in!a!stepHwise! fashion! from!peripheral!blood,! to!distal!colon,! to!TDLN,!to!CRC.!
!
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Table!3+3:! !Published! literature!providing!evidence!for!Treg! infiltration! in!solid!tumours,!assessed!by! flow!cytometry!and! immunohistochemistry.!!CM=confocal!microscopy;!PB=peripheral!blood;!IHC=immunohistochemistry.!!
Tumour!site! Compartments! Method! Definition! Findings! References!Ovarian! Tumour,!blood!Tumour,!ascites,!TDLN!
FC!FC,!CM! CD4+CD25+!CD3+CD4+CD25+! Increased!frequency!of!Treg!in!tumour!compared!to!PB.!Increased! frequency! of! Treg! in! tumour! tissue! compared! to! healthy!ovarian!tissue!(CM).!!!!
(197)!(57)!





Increased!Treg! frequency! in! tumour!compared! to!gastric!mucosa!and!PB.!!Increased!Treg!frequency!in!cancer!patient!PB!compared!to!PB!of!controls.! ! Higher! proportion! of! Treg! in! TIL! from! patients! with! late!versus!early!stage!disease.!Increased!Treg! frequency! in! cancer! patient! PB! compared! to! controls.!Treg!frequency!decreased!after!resection!and!increased!on!recurrence.!
(203)!!(204)!
Liver! Tumour! IHC!FC! Foxp3!CD4+CD25+! High!numbers!of!intratumoral!Treg!inversely!correlated!with!survival.!!Increased!proportion!of!Treg!in!tumour!compared!to!distal!liver.! (59)!(205)!
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Association)of)Treg)enrichment)with)CRC)factors)Given!the!hypothesis!of!Treg3mediated!suppression!of!the!anti3tumour!response,!it! might! be! expected! that! tumour! Treg! density! increases! with! advancing! CRC!stage.! ! Indeed,! there! is! some! evidence! that! this! is! the! case.! ! In! two!immunohistochemistry!studies!involving!94!and!160!cases,!low!CD8/Foxp3!and!CD3/Foxp3! ratios! were! found! to! be! associated! with! shorter! disease3free! and!overall!survival!in!multivariate!analyses!(195,206).!!In!a!recent!study!of!76!cases!specifically! investigating! the! CD8/Foxp3! ratio! in! CRC,! a! high! CD8/Foxp3! ratio!was!shown!to!be!significantly!associated!with!overall!survival!by!univariate,!but!not! multivariate,! analysis! (207).! ! However,! one! small! immunohistochemical!study,!n=57!(208),!and!two!large!studies!of!967!and!1420!patients!respectively!(53,191)! have! demonstrated! that! high! Treg! frequencies! in! CRC! are! associated!with! improved! survival.! ! In! the! latter! two! studies,! high! Treg! frequency! was!independently! associated! with! improved! survival! in! multivariate! analyses!(53,191).!!The!relationship!between!Treg!frequency!and!survival!has!been!shown!to!be!restricted!to!non3MSI!cancers!(53).!!!
A! smaller! study! of! 40! cases,! showed! that! Treg! infiltration,! measured! by!immunohistochemistry,! was! greater! in! early! as! opposed! to! late3stage! disease,!although!there!was!no!demonstrable!association!with!survival!(54).!!With!regard!MSI! CRC,! an! investigation! of! T! cell! subsets! in! these! cancers! showed! an!association! between! high! Foxp3! densities! and! early! disease! stage,! absence! of!nodal! invasion! and! absence! of! lymphovascular! invasion! (209).! ! Studies! that!report!an!association!between!increased!Treg!frequency!and!improved!survival!highlight!the!beneficial!role!that!Treg!might!play!in!suppressing!a!tumour3driven!
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inflammatory! response! that! drives! tumour! progression.! ! Support! for! this! idea!comes!from!the!APC!min/+!mouse!model,!where!adoptive!transfer!of!Treg!led!to!regression!of!bowel!tumours!(210).!!!
The!absolute!number!of!Treg!may!be!misleading!as!the!suppressive!capacity!of!the! population! as! a! whole! is! more! relevant! than! the! number! of! Treg! cells.!!Addressing! the! suppressive! capacity!of!Treg! in!CRC,! a! study!has!demonstrated!that! Treg! from! CRC! interact! with!mast! cells,! also! present! in! CRC,! resulting! in!downregulation!of!the!suppressive!cytokine,!IL310!(211).!!It!has!been!suggested!that! gut! bacterial! infections! in! early! life! can! protect! against! inflammation3associated! malignancies! such! as! CRC! by! modulating! Treg! function! in! the! gut!(210).! ! CRC! breaks! down! the! normal! mucosal! barrier! function! of! the! gut!resulting! in! increased! exposure! of! the! gastrointestinal! immune! system! to!microbiota!(212).! ! Increased!Treg!numbers! in!the!tumour!may!be!a!reaction!to!this!microbiota!exposure!rather!than!to!an!anti3tumour!immune!response.!!This!association!between!high!Treg!frequency!and!favourable!survival! is!not! limited!to!CRC!–!similar!relationships!have!been!observed!in!lymphoma!(213)!!and!head!and!neck!cancers!(214).!
There!are!therefore!two!sets!of!apparently!contradictory!immunohistochemistry!studies:! ! One! set! provides! evidence! that! high! Treg! density! is! associated! with!worse! prognosis! (195,206,207),! while! the! other! set! suggests! the! opposite!(53,191,208).! ! Further! immunohistochemistry! studies! have! failed! to! provide!evidence!of!an!association!between!Treg!density!and!survival!(54,215,216).!!One!key!difference!between! the! two! sets!of! immunohistochemistry! studies! is! those!demonstrating!a!worse!prognosis!in!association!with!high!Treg!density!reported!
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the! ratio! of! Treg! compared! to! other! lymphocytes,! either! CD3+! or! CD8+! cells,!rather!than!reporting!the!absolute!Treg!count.!!It!is!possible!that!the!ratio!of!Treg!to! non3Treg! T! cells! may! be! of! more! importance! given! that! high! lymphocyte!counts! per! se,! are! associated!with! a! favourable! prognosis! in! CRC! (217).! ! High!Treg!densities,!measured!by!Foxp3!immunostaining,!may!therefore!reflect!dense!lymphocytic!infiltration,!with!proportionately!high!or!low!non3Treg!/!Treg!ratios.!!In! support! of! this! notion,! flow! cytometric! studies,! which! measure! the! Treg!frequency! as! a! proportion! of! CD4+! cells,! have! shown! no! relationship! between!Treg!frequency!and!prognosis!(52,56).!!In!fact,!one!of!these!studies!described!an!increased! Treg! frequency! in! late3stage! as! opposed! to! early3stage! CRC.! ! One!disadvantage!of!flow!cytometric!measurement!of!TILs!in!CRC!is!the!dependence!on! fresh! tissue! which! means! that! often,! the! exophytic! portion! of! a! tumour! is!retrieved! for! TIL! isolation! in! order! to! avoid! compromising! pathological!assessment! and! diagnosis.! ! However,! the! exophytic! portion!may! represent! an!adenomatous! part! of! the! tumour! with! no! frank! malignant! tissue.!!Immunohistochemical! studies,!on! the!other!hand,! can!make!use!of!blocks! from!all!portions!of!the!tumour,!including!the!invasive!margin.!
The!marker!chosen!to!define!Treg!also!poses!difficulties.!!Immunohistochemical!studies! use! a! Foxp3! nuclear! stain! to! define! Treg,! although! a! few! studies! have!used!other!markers! such!as!CD25! (218).! ! It!has!been!shown! that!CD4+CD253!T!cells! may! express! Foxp3! upon! activation! (219,220)! and! it! is! unclear! whether!Foxp3! immunohistochemistry! identifies! activated! CD4+CD25dim,! CD4+CD25high!cells! as!well! as! CD4+CD25+CD127low! Treg.! ! The! data! presented! in! this! chapter!have!shown!almost!universal!expression!of!Foxp3!by!CD4+CD25+CD127low!Treg!
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but!also!significant,!albeit!lower!expression!of!Foxp3!by!CD4+CD253!cells.!!Foxp3!is!also!expressed!by!cells!other!than!T!cells,!notable!cancer!epithelial!cells!(221),!although!it!is!relatively!easy!to!distinguish!these!from!T!cells!if!manual!counting!is!used.!!!
An! increase! in!Treg!density!with!advancing!disease!stage!does!not!preclude!an!important! role! for! Treg! in! the! establishment! and! progression! of! CRC.! ! The!frequency! of! Treg! in! tumours! may! be! homeostatic! in! that! the! frequency! is!balanced! according! to! the! need! for! suppression! of! effector! T! cells.! ! In! this!situation,! the! ratio! of! Treg! to! non3Treg! T! cells! may! be! expected! to! remain!relatively! constant! throughout! disease! progression.! ! Several! studies! do! indeed!suggest! that! there! is! little! alteration! of! Treg! density! by! disease! stage!(54,56,215,216).! !The!data!presented!in!this!chapter!are!consistent!with!this! in!that! there!was! no! difference! in! Treg! proportion! across! different!Dukes! stages.!!There!was!also!no!association!between!Treg!proportion!with!all3cause!mortality,!disease3specific! mortality,! or! local! or! distant! recurrent! disease.! ! A! lack! of!association!may!reflect!the!low!number!of!patients!studied!together!with!the!low!number!of!deaths!and!disease!recurrences.!!Certainly,!these!numbers!rendered!a!multivariate!analysis! inappropriate.! !The!Treg!proportion!measured! in! the! two!moderately! dysplastic! polyps! was! comparable! to! that! seen! in! CRC,! suggesting!that!tumour!Treg!infiltration!occurs!early.!!This!is!consistent!with!another!small!study! showing! that! Treg! infiltration! is! an! early! event! in! the! adenoma3adenocarcinoma!pathway!(222).!!!
In!our!study,!a!significantly! lower!Treg!proportion!was!seen! in!CRC!with!KRAS!mutations!compared!with!wildtype!KRAS!tumours!(P=0.01,!see!Table!331).!!This!
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is!consistent!with!a!previous!study!which!reported!that!the!absolute!number!of!Foxp3+! cells! was! decreased! in! patients! with! KRAS! mutations! compared! with!wildtype!KRAS!while!there!was!no!difference!in!the!absolute!number!of!CD3+!or!CD8+!cells!(215).! !Differences!in!the!ratios!of!Foxp3+!cells!to!CD3+!or!CD8+!cells!were!not!analysed!and!the!difference!in!Foxp3+!cell!number!by!KRAS!status!was!not! defined! as! statistically! significant! (P=0.036),! as! the! P3value! significance!threshold! was! defined! as! ≤0.0009! –! adjusted! for! multiple! comparisons.!!Nevertheless,! no! such! changes! in! Foxp3+! cell! number! were! observed! for! the!other!measured!CRC!molecular! changes,! namely!CIMP! status,! BRAF!mutations,!PIK3CA!mutations!and!LINE31!hypomethylation.! !A! recent! study!of!44!cases!of!CRC! found! no! difference! in! the! number! of! TILs,! broken! down! into! subsets!including! a! Foxp3+! group,! by! KRAS!mutation! (223).! ! Again,! the! proportion! of!Treg! relative! to! CD3+! or! CD8+! cells! was! not! analysed.! ! There! was! also! no!difference!in!the!overall!TIL!count!between!KRAS!mutant!and!wildtype!CRC!in!a!larger! study!of! 198!CRCs! (224).! ! It! is! unclear! as! to!how!a!CRC!KRAS!mutation!could!result! in!a!reduction!in!tumour!Treg!infiltration.! ! It!has!been!shown!than!KRAS! mutant! tumours! undergo! spontaneous! apoptosis! at! a! higher! rate! than!wildtype! tumours! (224).! ! It! is! therefore!possible! that! apoptotic,! as! opposed! to!necrotic! tumours! may! generate! a! weaker! immune! response,! with! an!accompanying! lower! Treg! infiltration.! ! Against! this! idea! is! a! report! that! Treg!accumulate! in! vitro! in! a!DC! /! T! cell! co3culture!when! the!DCs! are! primed!with!apoptotic! tumour! cell! supernatant! (225),! as! opposed! to! necrotic! tumour! cell!supernatant.!
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Others!have!demonstrated!an!increased!Treg!density!in!MSI!CRC!(215,226).!!The!data! presented! in! this! chapter! demonstrates! no! such! increase! in! Treg! density!when! reported! relative! to! CD4+! cells.! ! This! is! consistent!with! other! studies! in!which!the!ratio!of!Foxp3+!cells!to!other!lymphocytes!is!assessed!(53,192,215).!!In!contrast,! an! analysis! of! Foxp3! mRNA! expression! has! shown! that! Foxp3!expression!is!decreased!in!MSI!CRC!compared!with!wildtype!tumours!(196).!
CD8):)CD4)ratio))The!median!CD8!:!CD4!ratio!in!CRC!was!0.45!and!was!not!significantly!different!from! the! ratio! in! the! distal! colon.! ! These! findings! are! consistent! with! some!published!studies!(167,227,228).!!However,!others!have!shown!a!decreased!CD8!:!CD4!ratio!in!CRC!compared!to!colon!tissue,!brought!about!by!an!increase!in!the!absolute! number! of! CD4+! cells! in! CRC! relative! to! matched! colon,! while! the!absolute! number! of! CD8+! cells! was! similar! across! the! two! tissue! types! (229).!!Others! have! shown! that! the! overall! survival,! adjusted! for! tumour! stage! and!patient! age,! was! greater! for! patients! with! higher! tumour! CD8! :! CD4! ratios,!highlighting!the!prognostic!benefit!of!CD8+!cell!infiltration!in!CRC!(227).!
2D7)antibody)blocks)the)ligand?binding)site)The!CTC5!anti3CCR5!monoclonal!antibody,!used!to!generate!the!phenotype!data!presented! in!this!chapter,!recognises!an!epitope!at! the!CCR5!N3terminus!(230).!!The!2D7!clone!recognises!an!epitope!positioned!in!the!second!extracellular!loop!and! blocks! binding! of! RANTES,! MIP31α! and! MIP31ß! (231).! ! The! binding!characteristics!of!a!panel!of!different!monoclonal!antibodies! suggest! that!CCR5!exists! in!several!different!antigenic! forms!on!the!cell3surface!of!primary!T!cells!(232).!!The!heterogeneity!of!cell!surface!CCR5!is!influenced!by!post3translational!
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modifications,!G3protein! coupling! and! the! local! lipid! environment.! ! The! lack! of!expected!differences!in!CCR5!expression!between!T!cell!subtypes!using!the!2D7!antibody!may!thus!be!due!to!the!2D7!clone!not!recognising!the!form!of!the!CCR5!receptor!when!it!is!bound!to!one!of!its!ligands.!!Overexpression!of!CCR5!by!Treg!compared!with!Tconv!using!the!CTC5!clone!may!represent!increased!density!of!cell!surface!CCR5!bound!to!its!ligand!on!Treg!compared!with!Tconv.!!The!affinity!of!different!monoclonal!antibodies!against!CCR5!has!been!studied!and!concluded!that! the! use! of! 2D7! may! underestimate! total! CCR5! surface! expression! under!some!conditions,!while!CTC5!exhibits!high!maximal!binding!levels!and!can!detect!different!conformational!states!of!the!receptor!(232).!!
Chemokine)receptor)expression)by)CRC?isolated)Treg))The!chemokine!receptors!CCR4!and!CCR5!were!overexpressed!on!CRC3isolated!Treg! compared!with!Tconv.! ! Increased! expression! of! CCR4!by! tumour3isolated!Treg!compared!to!Tconv!was!originally!reported!in!a!study!of!TILs!isolated!from!ovarian!cancer!(57).!!Indeed,!CCR4!is!known!to!be!expressed!by!peripheral!blood!Treg!to!a!greater!extent!than!peripheral!blood!Tconv!(99).!!Interestingly,!CCR4+!Treg!appear! to!be!primed! to! suppress! autologous!T! cell! proliferation,!whereas!CCR43! Treg! first! require! activation! in! order! to! be! suppressive.! ! A! study! of!chemokine!receptors!and!integrins!on!T!cell!subsets!isolated!from!CRC!and!distal!colon! has! shown! that! CCR4! is! expressed! at! high! levels! on! Treg! in! CRC! with!significantly! higher! expression! compared! with! Treg! isolated! from! distal! colon!(193).!!
In!a!study!of!pancreatic!cancer,!T!cells!infiltrating!human!pancreatic!cancer!were!found! to! express! more! CCR5! than! T! cells! from! the! normal! donor! transplant!
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pancreatic! tissue! and! the! percentage! of! Treg! expressing! CCR5!was! over! twice!that!of!non3regulatory!T!cells!(104).!!In!a!pancreatic!tumour!mouse!model,!Treg!again! expressed! more! CCR5! than! their! non3regulatory! counterparts! (104).!!Similarly,! CCR5! has! been! shown! to! be! overexpressed! on! Treg! compared! with!non3regulatory!T!cells!in!a!murine!model!of!CRC!(233).!!
Increased!expression!of!CCR5!by!CRC3infiltrating!Treg!compared!with!Tconv!has!not!been!reported!previously!although!high! levels!of!CCR5!have!been!reported!on! TILs! infiltrating! human! CRC! compared! with! matched! colon! (102).! ! CCR5!expression!was! higher! on! CD8+!cells! compared! to! CD4+! cells! 3! the! Treg! subset!was!not!specifically!assessed.! !By!mRNA!analysis,!CCR5!expression!was!greater!in! CRC! tissue! compared! to! distal! colon! (234).! ! A! study! in! CRC,! specifically!assessing!chemokine!receptor!expression!by!Treg,!did!not!report!any!difference!in! CCR5! expression! between! Treg! and! Tconv! compared! across! CRC! and! distal!colon!(193).! !The!CCR5!antibody!clone!was!not!reported!but!as!it!was!obtained!from!BD!Biosciences,!the!clone!must!have!been!either!2D7!or!3A9.!!The!different!antibody! clones! could! explain! the! differences! observed! in! CCR5! expression!between!this!study!and!the!findings!presented!in!this!chapter.!!In!support!of!this!notion,!a!study!assessing!CCR5!expression!by!TIL!in!nasopharyngeal!cancer!using!the! 2D7! clone,! demonstrated! no! significant! difference! in! CCR5! expression!between! Treg! and! Tconv! (235).! ! A! study! in! renal! cell! carcinoma! showed! that!CCR5!was!highly! expressed!on!TIL! (236).! ! The! study!did!not! directly! compare!chemokine!receptor!expression!between!T!cell!subsets,!but!there!was!at!least!a!trend!to!increased!CCR5!MFI!expression,!by!Treg!compared!with!Tconv.!!
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Other! characteristic! phenotypic! differences! between! T! cell! subsets! included!higher!cell!surface!levels!of!CCR6!on!Treg,!although!the!difference!in!percentage!expression!between!Treg!and!Tconv!did!not!reach!statistical!significance.!!CCR6+!Treg! have! been! identified! in! murine! models! of! CRC! (237)! and! in! human!malignancies! (106).! ! It! has! been! suggested! that! CCR6+! Treg! represent! a!population!of!memory!Treg!which!also!express!CD45RO!and!proliferate!rapidly!on! re3stimulation! in! vitro! (238).! ! Twenty3two! matched! CRC! /! distal! colon!samples!were!used!to!analyse!CCR6!expression!on!TIL!compared!to!50!for!CCR5!expression.! ! The!differences! in!CCR6!expression!between!Treg! and!Tconv!may!therefore! reach! statistical! significance! with! greater! sample! number.!!Nevertheless,!the!magnitude!of!the!difference!in!CCR6!expression!between!Treg!and! Tconv! is! less! than! that! observed! for! CCR5! and! there! is! no! accompanying!difference!in!CCR6!expression!in!terms!of!MFI.!!In!the!case!of!integrins,!there!was!a! trend! for! reduced! expression! of! ß7! integrin! by! Treg! isolated! from! CRC!compared!with!Treg!isolated!from!distal!colon,!which!was!statistically!significant!by!unadjusted!P3values.! !This!is!consistent!with!a!recent!study!which!used!flow!cytometry! to! demonstrate! reduced! expression! of! α4ß7! integrin! by! CRC3Treg!compared! to! colonic! Treg! (193).! ! The! investigators! proceeded! to!measure! the!expression! of! the! α4ß7! ligand,! MAdCAM31,! by! RT3PCR! and!immunohistochemistry,! demonstrating! reduced! expression! of! MAdCAM31! by!tumour!tissue!compared!with!matched!colon.!
Potential)therapeutic)benefit)of)CCR5)blockade)Little! CCR5! is! expressed! by! circulating! lymphocytes,! yet! is! expressed! by!lymphocytes! isolated! from! a! variety! of! different! tissues! (239).! ! In! particular,!
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In! Chapter! 3,! data! were! presented! showing! an! increased! expression! of! specific!chemokine!receptors!by!Treg!compared!with!Tconv!and!CD8+!cells.!!CCR4,!CCR5!and!to!a!lesser!extent,!CCR6,!were!expressed!at!higher!levels!by!Treg!than!by!Tconv!and!CD8+!cells.!
If!these!receptors!are!important!for!recruitment,!their!ligands!must!be!expressed!by!the!tumour! tissue.! ! This! chapter! presents! an! analysis! of! chemokine! expression! by! CRC!compared! with! matched! distal! colon! by! RT3PCR,! Western! blotting,! ELISA,!immunohistochemistry!and!flow!cytometry.!
Findings)
CRC)tissue)chemokine)expression)by)RT?PCR)RNA! was! isolated! from! 8! matched! samples! of! CRC! and! distal! colon! and! the! RNA!concentration!was!normalised!to!100!µg/ml!as!described!in!Chapter!2!–!Real3time!PCR.!!All! RNA! samples! had! an! acceptable! purity,! demonstrated! by! a! 260/280! ratio! of!approximately!2.0!(range:!2.04332.266).!
Selection)of)reference)genes)Absolute!quantification!of!the!expression!of!a!panel!of!10!different!reference!genes!was!performed!using!8!matched!CRC/colon! samples! in! triplicate! (see!Figure!431).! ! Simple!
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analysis!for!differences!in!reference!gene!expression!between!CRC!and!distal!colon!was!performed!using!the!Wilcoxon!signed3rank!test.!!This!analysis!demonstrated!significant!differences! in! gene! expression!between!CRC!and!distal! colon! for! the! following! genes:!G6PD,!GAPD,!HPRT!and!PP1A.!!This!suggests!that!these!genes!were!unstably!expressed!across! the! two! tissue! types! and! would! therefore! be! unsuitable! reference! genes.!!However,!other!algorithms!are!available!to!determine!the!most!stably!expressed!genes.!!The! absolute! quantification! data!was! fed! into! the! geNorm! algorithm! (184)! using! the!qbase+! software! (Biogazelle,! Belgium).! ! GeNorm! concluded! that! the! 3! most! stably!expressed! genes! were! IPO8,! PP1A! and! GUS! and! recommended! using! two! reference!genes.!!The!Bestkeeper!software!(186),!concluded!that!the!three!most!stable!reference!genes!were!G6PD,!GUS! and! IPO8.! ! The!Normfinder! software! combines! estimations! of!intragroup!and!intergroup!variation!to!compute!a!stability!value!(185).! !The!reference!gene!with!the!highest!stability!value!was!IPO8.!!!




Figure!431:!!Absolute!quantification!(Cp)!of!reference!genes!by!8!matched!CRC!(blue)!and!distal!colon!(green)!samples,!performed! in!triplicate.! !Sample!RNA!concentration!was!normalised!to!100! µg/ml.! ! Red3capped! lines! indicate! significant! differences! between! matched! samples!(Wilcoxin3signed!rank!test).!
Relative)quantification)of)chemokine)expression)Differences! in! the! gene! expression!of! various! chemokines!were! analysed! in! duplicate!relative!to!GUS!and!IPO8,!calculated!by!the!2(3ΔΔCt)!method.! !Initially,!the!probes!and!primers! used! were! designed! by! RealTime! Ready! software! (Roche),! as! described! in!Table!236.!!Amplicons!were!not!detected!using!the!primers!and!probes!for!the!targets!of!CCL17,!CCL22!and!CXCL11.!!The!annealing!temperature!was!adjusted!from!59˚C!to!55˚C,!
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57˚C! and! 60˚C! to! no! avail.! ! For! CCL17! and! CCL22,! a! different! RealTime! Ready!primer/probe! design! was! selected,! again! without! successful! amplicon! detection.!!Finally,!a!pre3designed!primer3probe!mix!was!purchased!from!Applied!Biosystems!Inc,!USA,!resulting!in!reliable!amplicon!detection!for!all!3!targets.!!The!amplification!curves!appeared!later!than!50!cycles!for!the!RealTime!Ready!designed!probe!and!primers!for!the! targets! CCL3,! CCL4! and!CCL5.! ! Again,! the! annealing! temperature!was! adjusted! to!55˚C,!57˚C!and!60˚C!with!no!associated!improvement!in!the!amplification!curve!profiles.!!Pre3designed!primer/probe!mixes! for!CCL3,!CCL4!and!CCL5! from!Applied!Biosystems!resulted!in!curves!below!40!cycles!for!all!3!targets.!
Following! testing! of! all! the! primer/probe! designs,! the! designs! selected! for! analysing!chemokine! gene! expression! assays! are! described! in!Table! 236,! for! the! following! gene!targets:! CCL19,! CCL20,! CCL21,! CXCL9,! CXCL10,! IPO8,! VAP31! (designed! using! the!RealTime!Ready!software).! !Pre3designed!primer/probe!mix! from!Applied!Biosystems!was! used! for! the! following! targets:! CCL3,! CCL4,! CCL5,! CCL17,! CCL22,! as! described! in!Table!237.!
























































Figure!433:! !Gene!expression!of! the!CCR5! ligands! (CCL3,!CCL4!and!CCL5)! relative! to!GUS!and!IPO8!for!8!samples!of!CRC!with!matched!distal!colon.!!Note!that!the!y3axis!is!split!but!identical!for!all!3!graphs.!!Capped!lines!indicate!significant!differences!in!gene!expression!between!tissue!types!(Wilcoxin!signed3rank!test).!
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!Figure!436:!!Western!blots!for!chemokine!in!single!CRC!sample.!!Molecular!weight!of!chemokine!is!approximately!12!kDa.! ! (a)!Standard!sample!buffer!resulting! in!multiple!bands;! ! (b)!Sample!buffer!containing!8M!urea!prevented!self3association,!yielding!single!band!at!correct!molecular!weight.!
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distinguished! from! non3specific! protein! bands.! ! Semi3quantitative! measurement! of!protein!concentration!was!also!impossible!for!chemokines!in!multimeric!forms.!


















Figure! 438:! ! Band! densities,! as! measured! using! ImageJ,! representing! semi3quantitative!chemokine!concentration!by!CRC!and!matched!distal!colon!tissue.! !Eight!matched!samples! for!CCL3,!CCL4!and!GUSB.!!Four!matched!samples!for!CCL5.!!DC=distal!colon.!!Capped!lines!indicate!statistically!significant!differences!(Wilcoxon!signed3rank!test).!
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Figure! 439:! ! Semi3quantitative! measurement! of! chemokine! concentrations! by! tissue! type,!measured!by!ELISA.! !Data! for!8! samples!of!CRC!with!matched!distal! colon! is! shown.! ! Capped!lines!represent!statistically!significant!differences!(Wilcoxin!signed3rank!test).!!
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Chemokine)immunohistochemistry)Having! established! a! significant! increase! in! CCL3! and! CCL4! in! CRC! compared! with!matched! distal! colon,! at! both! the!mRNA! and! protein! level,! the! protein! expression! in!tissue!sections!was!localised!by!immunohistochemistry.!!Pieces!of!tissue!from!collected!samples!of!CRC!with!matched!distal!colon!had!been!processed!into!FFPE!blocks!or!snap!frozen! and! stored! at! I80˚C,! in! preparation! for! sectioning! and! use! in!immunohistochemistry!experiments.!
The! methods! and! antibodies! used! for! immunohistochemical! staining! are! detailed! in!Chapter! 2.! Immunostaining! for! chemokines! was! first! performed! using! FFPE! tissue!sections,!which!was!unsuccessful.! !No! significant!positive! staining!was! seen! for!CCL3,!CCL4,!CCL5!or!CCL20.! !This!was!surprising!as!the!antibodies!had!been!tested!on!FFPE!human!tissue:!CCL3!and!CCL5!antibodies!(AFI270INA!and!AFI278INA)!on!human!tonsil;!CCL4!antibody!(AFI271INA)!on!human!brain;!CCL20!(AF360)!antibody!on!human!skin.!

















































































































































The! stained! sections! were! all! reviewed! by! a! senior! pathologist! with! an! interest! in!gastrointestinal! pathology.! ! The! control! sections! demonstrated! some! background!staining:!marked! background!was! related! to!mucous!within! the! intestinal! crypts! but!non3specific!background!staining!was!also!present!within!the!epithelial!cell!cytoplasm!and!in!the!stroma!(see!Figure!4310).!!Generally,!all!4!chemokines!were!detected!within!the!epithelial!cytoplasm!of!CRC!tissue!and!absent!from!the!epithelium!of!matched!distal!colon.! ! However,! given! the! background! epithelial! cytoplasmic! staining! observed!with!isotype3matched! antibody,! it!was! difficult! to! conclude! that! any! epithelial! cytoplasmic!chemokine!staining!was!specific.!




Figure! 4315:! ! Immunohistochemistry! of! a! single! CRC! section! for! CCL4,! representative! of! 4!unique!samples.! !Magnification!x400.! !Asterisks! ‘*’! indicate!areas!of!positive!staining!for!CCL4,!localised!to!the!endothelium.!
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The!endothelium!has!the!ability!to!capture!and!present!chemokines!(252).! !Therefore,!positive!endothelial!staining!for!CCL4!may!represent!capture!of!CCL4!produced!not!only!by!the!endothelium!but!also!by!other!cell!types!within!the!tumour!tissue.!











Positive! CD31! staining! was! evident! for! both! NEC! and! TEC! while! isotype3matched!control! antibody! at! the! same! concentration! as! the! target! antibodies! resulted! in! no!staining! (see! Figure! 4316).! ! There!was! no! constitutive! positive! staining! observed! for!CCL4! without! the! prior! addition! of! recombinant! chemokine.! ! However,! following!incubation!with!recombinant!CCL4,!positive!staining!for!this!chemokine!was!observed!on! both! NEC! and! TEC! monolayers.! ! Thus,! it! appears! that! CCL4! can! be! captured! by!endothelial!cells!isolated!from!the!colon!and!CRC.!























Figure!4317:!!Immunocytochemistry!of!HUVEC!for!CCL3,!CCL4!and!CCL5!with!(bottom!row),!and!without! (top! row),! prior! incubation! with! recombinant! chemokines.! ! Images! from! a! single!experiment!are!shown.!
!
In!light!of!the!above!chemokine!capture!experiments,!the!positive!CCL4!staining!of!the!endothelium! in!CRC! sections!may! indeed! represent! capture!of! CCL4! released!by! cells!within!the!tumour.!
Cellular)source)of)CCR5)chemokines)The!analytical!method!of!choice!for!the!detection!of!chemokines!in!defined!cell!subsets!is! flow! cytometry.! ! Published!methodology! evaluating! chemokine! expression! by! flow!cytometry! has! distinguished! constitutive! expression! (directly! detectable)! from!
spontaneous! expression! (detectable! after! culture!with! the! protein! transport! inhibitor,!brefeldin!A)!(253).!!!
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CRC! and! matched! distal! colon! tissue! were! digested! enzymatically! as! described! in!Chapter!2:!Selective!use!of!enzymatic!digestion.!!Half!of!each!sample!was!placed!on!ice!while!the!other!half!was!incubated!with!BD!Golgiplug™,!1!µl!!per!ml!of!!cell!suspension!for!4!hours!at!37˚C.! ! !BD!Golgiplug™ contains!brefeldin!A.! !1!µl!per!ml!near! infra3red!live/dead!fixable!stain!was!then!added!to!the!cell!suspension!together!with!20!µl/ml!of!human! FcR! blocking! reagent! and! samples! were! incubated! in! the! dark! at! 4°C! for! 20!minutes.! ! Brefeldin3treated! and! untreated! samples! were! then! divided! into! equal!volumes!and!placed!in!separate!FACS!tubes.!!The!cell!suspensions!were!incubated!for!30!minutes! at! 4˚C! with! cell3surface! directed! conjugated! antibodies! to! lymphoid! and!myeloid! markers! (CD33PE,! CD43FITC,! CD11b3PECy7),! endothelial! and! fibroblast!markers!(CD313FITC,!CD903PE)!or!an!epithelial!cell!marker!(EpCAM3PE).!!Samples!were!then!washed,!pelleted,! fixed!and!permeabilised!using! the!Foxp3!staining!buffer!kit,! as!described!in!Chapter!2.!!Intra3cellular!staining!was!done!by!incubating!the!samples!with!10!µl!of!conjugated!antibody!to!CCL3,!CCL4,!CCL5!or!isotype3matched!control!antibody!for!30!minutes!at!4˚C!(see!Table!431),!followed!by!washing,!pelleting!and!resuspending!the!samples!in!500µl!cPBS,!ready!for!flow!cytometric!analysis.!
Table!431:!!Conjugated!antibodies!used!for!intra3cellular!chemokine!staining.!Antigen! Clone! Fluorochrome! Isotype! Manufacturer! Code!CCL3! 93342! APC! Ms!IgG2b! R&D!Systems! IC2701A!CCL4! 24006! APC! Ms!IgG2b! R&D!Systems! IC271A!CCL5! 21445! APC! Ms!IgG1! R&D!Systems! IC278A!Isotype!control! APC! Ms!IgG1! R&D!Systems! IC002A!Isotype!control! APC! Ms!IgG2b! R&D!Systems! IC0041A!!
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The! constitutive! and! spontaneous! expression! of! chemokines! by! live! lymphocytes!(CD3+),! myeloid! cells! (CD11b+),! endothelial! cells! (CD31+),! fibroblasts! (CD90+)! and!epithelial! cells! (EpCAM+)! were! evaluated! by! comparing! chemokine! antibody3labelled!samples! with! those! labelled! with! isotype3matched! control! antibody.! ! Dot3plots! were!constructed!with! the!cell! subset!marker! (CD4,!CD11b,!CD31,!CD90,!EpCAM)!on! the!y3axis! and! the! chemokine! on! the! x3axis! (253).! ! Data! from! one! experiment! is! shown! in!Figure!4318.!!All!dot3plots!were!gated!on!live!cells!based!on!non3labelling!with!the!live3dead!marker! and!within! a! forward! scatter3side! scatter! region! appropriate! to! the! cell!type.! ! The! CD4+! dot! plot! was! also! gated! on! CD3+! cells.! ! Positive! expression! of! the!chemokine!of! interest!was!defined!by! setting! the!negative! region! to! include!97.5%!of!the!IMC!staining!population.!!
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!
Figure!4,18:!!Cells!isolated!from!CRC!tissue!were!analysed!for!constitutive!chemokine!expression!and!after!4,hour!culture!with!BD!Golgiplug™ (spontaneous!expression).!!Flow!cytometry!data!from!a!single!sample!are!shown,!representative!of!experiments!with!3!separate!samples.!!All!dot!plots!were!gated!on!live!cells!based!on!non,labelling!by!a!live,dead!marker!and!on!a!forward!scatter,side!scatter!region!appropriate!to!the!cell! type.! ! CD4+! dot! plots! were! also! gated! on! CD3+! cells.! ! Red! circles! represent! positive! chemokine! staining! by! the! cell! type! of! interest.!!Percentages!represent!percentage!expression!by!given!cell!population.!!CD4+!and!CD11b+!cells!shown!above,!CD31+,!CD90+!and!EpCAM+!cells!shown!on!following!page.!
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Correlation*between*chemokine*receptor*and*ligand*expression*The!expression!of!the!CCR5!ligands!(CCL3,!CCL4!and!CCL5)!by!CRC,!measured!by!gene!expression! relative! to! GUS! and! IPO8,! was! compared! to! the! expression! of! CCR5,!measured! on! CRCGisolated! Treg! by! flow! cytometry.! ! Data! for! both! tissue! ligand!expression! and! Treg! receptor! expression! were! available! for! 12! samples! (see! Figure!4G20).!!A!linear!relationship!between!CCL3!and!CCL4!tissue!expression!with!Treg!CCR5!percentage!expression!was!observed.! ! For! each! scatter!plot,! Pearson’s! correlation! coGefficient! (r2)! and! PGvalues! calculated! from!Pearson’s! productGmoment! correlation! are!quoted.! !There!was!no!such!correlation!between!CCR5!percentage!expression!by!CRCGisolated!Tconv!and!CRC!ligand!expression.!!The!expression!of!the!CCR5!ligands!was!then!compared!to!the!CRC!Treg!proportion,!measured!by!flow!cytometry!(see!Figure!4G21).!
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n= 18 ; r2= 0.12 ; P= 0.65
Figure! 4,21:! ! Scatter! plots! depicting! (a)! the! proportion! of! CRC,infiltrating! CD4+! cells! with! a! Treg! phenotype! (Treg! proportion),!measured! by! flow! cytometry,! and! (b)! CRC! tissue! expression! of! foxp3,! measured! by! RT,PCR,! against! CRC! tissue! expression! of!chemokine! ligands,! measured! by! RT,PCR.! ! FC=flow! cytometry.! ! r2=Pearson's! correlation! co,efficient.! ! P,values! calculated! from!Pearson’s!product,moment!correlation.!!Data!from!18!separate!samples!are!shown.!
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Discussion!
The!expression!of!different! chemokines,!notably! the! ligands! for! important! chemokine!receptors! identified! in! Chapter! 3! is! reported! in! this! chapter.! ! Real?time! PCR! was!performed!using!sample!RNA!of!a!standard!concentration!and!measured!quality,!intron?spanning! primers! and! reference! genes! of! proven! stable! expression! across! CRC! and!colon!tissues.!!CRC?isolated!Treg!express!significantly!more!CCR4,!CCR5!and!to!a!lesser!extent,!CCR6!than!Tconv.!!However,!the!ligands!for!CCR4!(CCL17!and!CCL22)!were!not!significantly!overexpressed!by!CRC!compared!with!distal!colon!at!the!mRNA!level.! !An!evaluation!of!CCR5!ligand!gene!expression!demonstrated!that!CCL3!and!CCL4,!but!not!CCL5!were!significantly!overexpressed!by!CRC!compared!with!distal!colon.! !CCL3!and!CCL4,! but! not! CCL5! levels,! as! measured! by! RT?PCR,! also! correlated! with! CCR5!expression!by!CRC?isolated!Treg!and,!for!CCL4,!also!with!CRC!tissue!expression!of!foxp3.!!The! increased! gene! expression! observed! for! CCL3! and! CCL4! by! CRC! compared! with!distal! colon! was! reflected! at! the! protein! level,! as! measured! semi?quantitatively! by!Western! blotting! and! ELISA.! ! Immunohistochemistry! demonstrated! that! endothelial!cells!in!CRC!stroma!stained!positively!for!CCL4,!but!not!for!CCL3!or!CCL5.!
It! has! long! been! known! that! cancers! can! secrete! chemokines! and! this! led! to! the!hypothesis! that! tumours! are! directly! responsible! for! the! recruitment! of! different! cell!types! from!the!blood,!creating!a!tumour!environment!suitable! for!tumour!growth!and!progression! (254).! ! CRC! expression! of! specific! chemokines,! in! conjunction! with! high!levels! of! expression! of! the! cognate! receptor! by! specific! immune! cell! subsets! such! as!Treg,! is! evidence! for! a! chemokine?driven! recruitment! pathway! leading! to! the!enrichment!of!Treg!in!the!tumour.!
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CCR4!chemokines!In!ovarian!carcinoma,!it!was!shown!that!CCR4?expressing!Treg!migrated!to!the!tumour!in! response! to! the! cognate! chemokine! CCL22,! produced! by! tumour! cells! and!macrophages! (57).! ! The! presence! of! the! CCR4! chemokine,! CCL22,! has! been!demonstrated! in! human! colon! by! immunohistochemistry! (255).! ! The! same! study!showed!that!the!human!colon!adenocarcinoma!cell! line!HT?29!expresses!CCL22!at!the!mRNA! level! and! that! both! CCL22!mRNA! and! protein!was! upregulated! by! stimulation!with!TNF?α!or!IL?1α.!!CCL22!gene!expression!by!CRC!tissue!was!demonstrated!by!PCR!in! 5! samples! of! CRC! (102).! ! The! expression! was! weak! compared! to! that! of! other!measured!chemokines!and!CCL22!gene!expression!was!not!increased!in!CRC!compared!with!colon.!!There!was!also!no!demonstrable!mRNA!expression!of!CCL17.!!The!findings!presented! in! this! chapter! show!detectable! CCL17! and! CCL22!mRNA! in! both! CRC! and!unaffected!colon!with!no!significant!difference!between!CRC!and!matched!distal!colon.!!Further! analysis! of! the! expression! of! CCR4! ligands! in! CRC! was! thus! not! performed.!!However,! one! previous! study! reported! increased! CCL22! protein! expression! by! CRC!compared!with!colon!in!78!matched!samples!(256).!!Immunohistochemistry!was!said!to!detect!both!CCL17!and!CCL22!within!the!epithelial!compartment!of!the!tumour.!!
Given! these! conflicting! data! with! regard! to! CCL17! and! CCL22! expression! by! CRC!compared!with!matched!colon!tissue,!a!role!for!the!CCR4!axis!in!the!recruitment!of!Treg!into!CRC!cannot!be!ruled!out.!!CCL17!and!CCL22!expression!by!CD14+!myeloid!cells!has!been! reported! in! oesophageal! (257)! and! gastric! (258)! cancers.! ! Interestingly,! in! both!studies,!there!was!a!significant!correlation!between!the!frequency!of!CCL17+!or!CCL22+!CD14+!cells!and!the!frequency!of!Treg!amongst!TILs,!suggesting!that!expression!of!the!
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CCR4!ligands!led!to!migration!of!Treg!into!the!tumour.!!However,!there!is!also!evidence!that! tumoral! expression! of! CCL17! results! in! tumour! regression! associated! with! the!infiltration! of! CD8+! cells.! ! Adenoviral! vectors! encoding! CCL17! were! injected! into!established! subcutaneous!murine! CRC! (100)! and! resulted! in! delayed! tumour! growth!compared!to!control!and!led!to!tumour!rejection!in!3!out!of!7!mice.!!These!anti?tumour!effects,!were!dependent!on!CD8+!cells!and!injection!of!the!CCL17?vector!led!to!CD8+!cell!recruitment! into! the! tumour! parenchyma.! ! Tumour! infiltration! of! Treg! was! not!measured.! ! However,! the! CCL17?vector! anti?tumour! effects! were! not! abrogated! by!depletion!of!CD4+!cells,!suggesting!that!interruption!of!tumour!Treg!recruitment!did!not!play!a!significant!role!in!the!observed!anti?tumour!effects.!!
CCR5!chemokines!Elevated! levels! of! CCL3,! CCL4! and! CCL5! have! been! reported! in! a! variety! of! different!solid!cancers!and!by!a!variety!of!different!methods!(see!Table!4?2).!!The!data!presented!in!this!chapter!are!consistent!with!this!published!literature,!in!that!CCL3!and!CCL4!were!found!to!be!elevated! in!CRC!compared!to!matched!distal!colon!at!both!the!mRNA!and!protein!level.!!CCL5!was!not!found!to!be!consistently!elevated!in!CRC!compared!to!colon!and!this! is!supported!by!two!studies!measuring!CCL5! levels!by!ELISA!(259,260).! !The!immunohistochemistry! presented! in! this! chapter! shows! positive! staining! for! all! 3!chemokines!within!the!epithelial!component!of!CRC!as!well!as!positive!CRC!endothelial!staining! for! CCL4.! ! Others! have! found! increased! staining! for! these! chemokines! in!tumour!compared!to!normal!tissue!for!other!cancers!(see!Table!4?2).!!With!regard!CCL4,!the!Human!Protein!Atlas!has!systematically!profiled!the!expression!of!this!chemokine!in!human!tissues,!including!healthy!colon!and!CRC!(261).!!It!should!however!be!noted!that!
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the!reliability!of!the!staining!was!defined!as!uncertain!as!only!one!antibody!was!used!to!create!the!profile.!!The!majority!of!CRC!samples!in!the!atlas!stained!positively!for!CCL4!with!membranous!and!cytoplasmic!staining!of!the!tumour!epithelium.!!Weaker!staining!in! the! stroma!was! also! noted,! although! specific! staining! of! the! endothelium!was! not!described.! ! Positive! staining! of! CRC! epithelium! for! CCL4! is! consistent! with! the!immunochemistry! presented! in! Figure! 4?12.! ! The! Human! Protein! Atlas! has! not! yet!profiled!CCL3!or!CCL5!expression.!!!
Despite! the! lack! of! positive! CCL4! staining! of! the! CRC! endothelium! reported! by! the!Human! Protein! Atlas,! localisation! of! CCL4! to! the! endothelium! has! been! clearly!demonstrated! in!head!and!neck!cancers!(235).! !The! flow!cytometry!data!presented! in!this!chapter!supports!the!immunohistochemistry!in!that!the!CCR5!ligands!are!secreted!by!the!tumour!epithelium!as!well!as!cells! in! the!stroma,! the!most! important!of!which,!are!CD90+!fibroblasts.! !The!chemokine!capture!experiments!also!support!the!idea!that!CCL4!can!be!captured!and!presented!by!the!CRC!endothelium.! ! It!has!previously!been!shown!that!endothelial!cell! lines!of!different!origins!have!distinct!binding!patterns!for!different! chemokines,! independent! of! endothelial! cell! chemokine! receptor! expression!(262).!!This!effect!has!been!explained!by!the!differential!composition!of!endothelial!cell!surface! glycosaminoglycans! by! tissue! origin.! ! Chemokine! binding! to! the! endothelium!was! inhibited! by! the! addition! of! soluble! chondroitin! sulphate! and! it! has! been! shown!that! endothelial! cells! differ! in! their! expression! of! glycosaminoglycans,! in! terms! of!length,! charge! density! and! the! degree! of! sulphation! (263).! ! Endothelial! cell! surface!glycosaminoglycan! composition! therefore! results! in! a! further!degree!of! specificity! for!chemokine! presentation,! in! addition! to! tissue?specific! endothelial! cell! chemokine!
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receptor!expression!and!native!endothelial!cell!chemokine!production.!!Endothelial!cells!may! also! express! atypical! chemokine! receptors,! acting! as! molecular! decoys,! which!possess! the! ability! to! bind! specific! chemokines! (264).! ! Differences! in! endothelial! cell!chemokine!receptor!expression!and!cell!surface!glycosaminoglycan!composition!could!account! for! the! observed! differences! in! chemokine! capture! by!NEC,! TEC! and!HUVEC.!!However,! such! differences! in! chemokine! and! glycosaminoglycan! expression!were! not!studied! further.! ! In! summary,! I! have! shown! that! CCR5! chemokines! are! expressed! by!CRC! and! CCL4! can! be! captured,! in! vitro! at! least,! by! the! tumour! endothelium.! ! CCL4!presentation!by!the!tumour!endothelium!places! this!chemokine! in!a!position!where! it!can!engage!circulating!CCR5?expressing!immune!cells,!potentially!playing!an!important!role!in!recruitment!of!such!cells!to!the!tumour.!!!
When!CCR5!was!first!characterised!in!the!early!1990s,!it!was!shown!to!be!the!cognate!receptor! for! CCL3,! CCL4! and! CCL5! (250,265).! ! It! has! since! been! shown! that! other!chemokines! can! bind! to! CCR5! (266),! namely! CCL2,! CCL7,! CCL8,! CCL11,! CCL13.! ! The!expression!of!these!other!CCR5?binding!chemokines!was!not!evaluated.!
A!possible!role!for!the!recruitment!of!CCR5+!Treg!by!tumours!expressing!CCR5!ligands!has!recently!been!demonstrated!in!murine!tumour!models!(104,233).!!!CCL5!production!by!the!Pan02!and!CT26!murine!tumour!cell!lines,!pancreatic!and!colorectal!respectively,!were! disrupted! using! CCL5! small! hairpin! RNA! (shRNA),! giving! rise! to! Pan02low! and!CT26low!cells.!!In!both!studies,!subcutaneously!implanted!tumours!in!immunocompetent!mice!grew!more!slowly!following!injection!of!Pan02low!or!CT26low!cells!compared!with!Pan02!or!CT26!cells.!!When!the!mice!were!culled,!the!tumour!lymphocyte!infiltrate!was!analysed! and! showed! a! reduction! of! approximately! 50%! in! the! Treg! proportion! in!
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Pan02low!and!CT26low!tumours!compared!with!Pan02!and!CT26!tumours.!!In!a!different!study,! inhibition!of!CCL5!in!a!CT26!subcutaneous!tumour!model!was!performed!using!an! anti?CCL5! antibody! given! every! 72! hours! and! starting! 7! days! after! tumour! cell!implantation,! and! resulted! in! delayed! tumour! growth! compared! to! control! antibody!(267).!!Tumour!Treg!infiltration!was!not!measured.!!!
Pan02low! and!Pan02! tumours!were! implanted! into!Rag! ?/?!mice! to! determine! if! there!were!any!intrinsic!differences!in!the!growth!kinetics!of!the!two!cell!lines.!!The!tumours!grew!at! the! same! rate! in! these! immunodeficient!mice,! suggesting! that! the!differences!observed!in!tumour!growth!and!Treg!infiltration!between!Pan02low!and!Pan02!tumours!implanted! into! immunocompetent! mice,! were! dependent! on! a! functioning! immune!system!(104).!!Similarly,!CT26low!and!CT26!cells!were!implanted!into!nude!mice,!which!the!authors!stated!resulted!in!similar!growth!kinetics!(233).! !However,! it!does!appear!that! there! is! some! separation! of! the! growth! curves,! with! slower! growth! for! CT26low!compared! to!CT26!tumours,!after!16!days.! !Nevertheless!CT26low! tumours!grew!more!slowly!than!CT26!tumours!in!immunocompetent!mice!with!less!Treg!infiltration,!again!suggesting! these! differences! required! a! functioning! immune! system.! ! It! is! therefore!likely! that! tumour?derived! CCL5! interacts! with! the! host! immune! system! to! result! in!delayed!tumour!growth!and!modulate!Treg!infiltration.!!However,!as!smaller!differences!in! tumour!growth!between!CT26low!and!CT26!tumours!were!seen! in! immunodeficient!mice,! it! is!also! likely! that!CCL5!has!a!direct!effect!on!tumour!growth.! !Supporting!this!idea,!others!have!shown!that!CT26!cells!proliferate!in!vitro!in!response!to!CCL5!(267).!!The!proliferative!response!was!maximal!at!a!CCL5!concentration!of!50!ng/ml!with!less!proliferation!seen!at!higher!concentrations.! !The!different!roles!that!CCL5!may!play!in!
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terms! of! immune! cell! recruitment! and! direct! effects! on! tumour! growth! are! therefore!complex!and!dependent!on!CCL5!concentration.!
The! three! murine! cancer! models! discussed! above! focus! on! the! interaction! between!CCL5!and!CCR5.!!To!summarise,!delayed!tumour!growth!with!an!associated!reduction!in!the!tumour!Treg!proportion!was!observed!in!Pan02low!and!CT26low!tumours!compared!with!Pan02!and!CT26!tumours!in!immunocompetent!mice.!!However,!an!important!role!for! CCL5! in! modulating! tumour! growth! directly! in! vivo! cannot! be! ruled! out.! ! These!studies!only!looked!at!the!role!of!CCL5!in!modulating!tumour!growth!and!immune!cell!infiltration,! not! other! CCR5! ligands! such! as! CCL3! and! CCL4.! ! Evidence! has! been!presented!in!this!chapter!for!elevated!levels!of!CCL3!and!CCL4!but!not!CCL5!in!human!CRC!compared!with!other!tissues,!and!the!relative!effect!of!blocking!these!chemokines!alone,!or! in!addition! to!CCL5! in!similar!murine! tumour!models! to! the!ones!described,!have!not!been!evaluated.!
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Table! 4*2:! ! Published! literature! describing! chemokine! measurements! in! tumours! and! normal! tissues.! ! IHC=immunohistochemistry;! ISH=in*situ!hybridisation;!HCC=hepatocellular!carcinoma.!Chemokine! Cancer!site! Methods! Findings! References!CCL3! Colorectal! RT*PCR! Increased!in!CRC!tissue!compared!to!colon.! (234)(102)!! Glioma! IHC! CCL3!positive!staining!in!glioma,!increasing!with!tumour!grade.! (268)!! Oral!carcinoma! RT*PCR,!IHC! Increased!in!oral!carcinoma!compared!to!healthy!gingiva.! (269)!! Gastric! RT*PCR,!ELISA! Increased!expression!in!cancer!compared!to!normal!tissue.! (270)!! HCC! IHC! Increased!in!tumour!compared!to!normal!liver.! (271)!! Ovarian! ISH! CCL3!mRNA!expression!seen!predominately!in!tumour!stroma.! (272)!! Pancreas! RT*PCR! Increased!in!pancreatic!cancer!compared!to!normal!pancreas.! (104)!CCL4! Colorectal! RT*PCR,!ELISA! Increased!in!CRC!tissue!compared!to!colon.! (234)(102)(259)!! Breast! ISH! CCL4!mRNA!expression!confined!to!cells!in!stroma.! (273)!! Pancreas! RT*PCR! Increased!in!pancreatic!cancer!compared!to!normal!pancreas.! (104)!! Gastric! IHC,! RT*PCR,!ELISA! Stronger!CCL4!staining!in!cancer!than!normal!epithelial!cells.!!Increased!mRNA!and!protein!expression!compared!to!normal!tissue.! (274)(270)!! Head!&!neck! IHC! CCL4!detected!on!tumour!endothelium.! (235)!! Lung! RT*PCR,! IHC,!ELISA! CCL4!expression!in!non*small!cell!tumours!with!a!lymphocytic!response!compared!to!those!without.!CCL4!produced!by!tumour!cells.! (275)!CCL5! Colorectal! RT*PCR! Increased!in!CRC!tissue!compared!to!colon.! (102)(267)!! Colorectal! ELISA! Reduced!expression!of!CCL5!in!CRC!compared!to!colon.! (259)!
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! Head!&!neck! IHC! Produced!by!the!majority!of!cancers,!localised!to!tumour!cells.! (235)!! Pancreas! RT*PCR! Increased!in!pancreatic!cancer!compared!to!normal!pancreas.! (104)!! Breast! IHC,!ELISA! Increased!in!cancer!compared!to!normal!breast!tissue.! (276)(277)!! Cervical! ELISA! Increased!in!cancer!compared!to!normal!tissue.! (277)!! Lung! RT*PCR,! IHC,!ELISA! CCL5! expression! higher! in! non*small! cell! tumours! with! a! lymphocytic! response!compared!to!those!without.!CCL5!produced!by!tumour!cells.! (275)!! Prostate! RT*PCR! Increased!expression!in!cancer!compared!to!benign!hyperplasia.! (278)!
! 173!
Correlation*of*chemokines*with*Treg4CCR5*and*Treg*proportion*CCL3!and!CCL4!levels,!as!measured!by!RT7PCR,!significantly!correlated!with!the!percentage! expression! of! CCR5! by! CRC7isolated! Treg,! as! measured! by! flow!cytometry.! ! There! was! no! such! correlation! with! CCL5! levels.! ! A! correlation!between!CCR5!expression!by!TILs!with!the!expression!of! its! ligands!in!CRC!has!not!previously!been!reported.!!The!correlation!supports!the!hypothesis!that!high!levels! of! CCL3! and!CCL4! lead! to! the! recruitment! of! CCR5+!Treg.! !However,! the!Treg! proportion! was! not! found! to! correlate! with! CRC! expression! of! CCL3! or!CCL4.! ! Therefore,! these! chemokines! may! indeed! recruit! CCR5+! Treg,! with! the!recruitment!of!CCR57!Treg!being!dependent!on!other!recruitment!pathways.!!The!interactions!between!CCR5!and!its!ligands!are!complex!and!exposure!to!cognate!chemokine! leads! to! CCR5! internalisation! (279).! ! It!may! therefore! be! expected!that!CCR5+!cells!would!internalise!CCR5!after!having!migrated!along!a!chemokine!concentration! gradient.! ! In! vitro! experiments! have! shown! reduced! cell! surface!expression! of! CCR5! by! migrated! T! cells! compared! to! non7migrated! cells! in!transwell!experiments!with!CCL5!present!in!the!bottom!chamber!(280).!!Despite!this,! the! intensity! of! tumour! CCL3! expression,! measured! by!immunohistochemistry,! was! found! to! correlate! with! intra7tumoral! CCR5!expression! (281).! ! In! dry! eye! syndrome,! lacrimal! CCL3,! CCL4! and! CCL5! levels!were! measured! by! ELISA! and! found! to! correlate! significantly! with! CCR5!expression!by! lacrimal!T! cells! (282).! ! In!a!mouse!model!of!periodontitis,!CCL3,!CCL4!and!CCL5!levels!measured!at!multiple!time!points,!significantly!correlated!with!CCR5!expression!by!T!cells!(283).!
!
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It! is! intriguing!that!there!was!a!significant!correlation!between!CCL4!and!foxp3!expression!despite!no!correlation!between!CCL4!and!the!Treg!proportion.!!Treg!(CD4+CD25+CD127low)! highly! express! foxp3! (median! percentage! expression!93.5%,! see! Chapter! 3).! ! However,! activated! non7regulatory! T! cells! can! also!express! foxp3! (284)! 7! the! percentage! expression! of! foxp3! by! the! Tconv!population!(CD4+CD257)!was!15%!(see!Chapter!3).!!Despite!lower!levels!of!foxp3!expression! by! Tconv,! there! are! proportionately! more! Tconv! than! Treg!infiltrating!CRC,!and!Tconv!may!therefore!make!a!more! important!contribution!to!the!total!tissue!foxp3!expression.!!It!has!also!been!demonstrated!that!foxp3!is!expressed!by!tumour!cells!(221,285).!
CCR20*and*other*chemokines*The!ligand!for!CCR6,!CCL20,!is!reportedly!elevated!in!CRC!compared!with!colon!tissue! (286).! ! In! a!murine! subcutaneous! CRC!model,! CCL20!was! expressed! by!tumour!cells!and!tumour7associated!macrophages.! !Tumour7resident!Treg!were!shown! to! express! CCR6! and! intra7tumoral! injection! of! CCL20! led! to! increased!tumour7infiltrating!Treg! compared! to! vehicle! injection! (237).! !However,! as! the!results! in! this! chapter! show,! there!was!no!demonstrable! increase! in!CCL20!by!CRC!compared!to!matched!distal!colon!either!at!the!mRNA!or!the!protein! level.!!For! this! reason,! study! of! the! function! of! the! CCR67CCL20! axis! was! not!undertaken,! although! CCR6! blockade! was! performed! in! a! mouse! model! (see!Chapter!6).!!Immunohistochemistry!did!demonstrate!positive!staining!for!CCL20!in! the! epithelial! component! of! the! tumour.! ! The! ligands! for! CXCR3! (CXCL9,!CXCL10!and!CXCL11)!were!not! found! to!be!significantly!overexpressed!by!CRC!compared! with! matched! distal! colon! by! RT7PCR.! ! Based! on! this! finding,! in!
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conjunction!with!the!lack!of!CXCR3!expression!by!Treg!as!reported!in!Chapter!3,!it! was! decided! not! to! perform! any! further! investigation! of! the! expression! of!CXCR3!ligands.!





In! order! for! chemokine7dependent! migration! of! Treg! to! CRC! to! occur,! chemokine!receptors!need!to!be!expressed!on!the!cell!surface!of!Treg!and!the!cognate!ligands,!by!the! tumour.! ! The! chemokine! receptor! signature! of! CRC7isolated! Treg! was! therefore!established!and!the!presence!of!cognate!chemokines!within!CRC!was!confirmed.! !This!chapter! presents! data! demonstrating! that! CCR5,! present! on! CRC7isolated! Treg,!functions!as!a!chemotactic!receptor!in!vitro.! !CCR5!expression!by!Treg!and!Tconv!was!measured! in! co7culture! experiments! with! tumour! supernatant! to! determine! if! the!tumour!microenvironment!may!be!responsible!for!the!induction!of!cell!surface!CCR5!by!resident!T!cells.! ! It!has!been!shown!that!T!cell!CCR5!expression!correlates!with!T!cell!activation! (287)! and! therefore,! T! cells! were! activated! in! the! presence! or! absence! of!tumour! supernatant.! ! The! suppressive! capacity! of! the! CRC7isolated! Treg! was! then!tested.! ! Finally,! TSDR! analysis! was! performed! on! DNA! obtained! from! CCR5low! and!CCR5high!CRC7isolated!Treg!to!determine!if!these!Treg!subsets!were!nTreg!or!iTreg.!
Findings*
Lymphocyte*migration*assays*The! functional! integrity! of! CCR5,! expressed! by! CRC7isolated! Treg,! was! tested! in! a!transwell! system.! ! Lymphocytes! were! isolated! from! CRC! by! non7enzymatic! methods!followed! by! CD3+! immunomagnetic! separation! as! described! in! Chapter! 2:! Transwell!
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migration!assays.!!T!cells!were!either!treated!with!Maraviroc!or!vehicle!control!(DMSO)!then!placed!in!the!upper!compartment!of!a!transwell!system.!!The!T!cells!were!allowed!to!migrate! towards! recombinant! CCL4! at! a! concentration! of! 20! ng/ml,! placed! in! the!lower!chamber.! !CCL4!was!chosen!over!other!CCR5! ligands!because! it! is!a!specific! for!CCR5!and!the!concentration!of!20!ng/ml!because!this!is!the!optimal!concentration!for!T!cell! migration! responses.! ! It! has! already! been! shown! that! CCL4,! like! CCL3,! was!significantly!overexpressed!by!CRC!compared!with!matched!distal! colon!at! the!mRNA!and! protein! level.! ! Unlike! CCL3,! CCL4! was! also! found! to! localise! to! the! tumour!endothelium!and!correlated!significantly!with!CCR5!expression!by!Treg.!




Figure!571:! !Summary!of!6!transwell!experiments.! !(a)!Mean!chemotactic!index!of!the!absolute!number!of!Treg!/!Tconv!/!CD8+!cells! in!the!lower!chamber!(OUTPUT)!and!the!upper!chamber!(INPUT)! of! the! transwell! apparatus.! ! Conditions! were! DMSO7treated! cells! with! media! alone,!DMSO7treated!cells!with!chemokine! (20!ng/ml!CCL4)!and!Maraviroc! (MVC)! treated!cells!with!chemokine.!!(b)!Composition!of!migrated!cells!in!the!lower!chamber!of!the!transwell!apparatus,!given!as!mean!proportion!of!all! lymphocytes!(%).! !Error!bars!represent!standard!error!of! the!mean.!!Capped!lines!indicate!statistically!significant!differences.!
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Chemotactic index (number of cells migrating relative to media alone)






















































b" Chemotactic index (number of cells migrating relative to media alone)


























There! was! a! trend! for! all! lymphocyte! subsets! to! migrate! in! response! to! chemokine,!represented!by! the!black!OUTPUT!bars!being!greater! than!1.! !The!difference!between!the!number!of!Treg!migrating!in!response!to!chemokine!and!in!response!to!media!alone!reached! statistical! significance.! ! Pre7treatment! of! lymphocytes! with! Maraviroc!abolished!the!migration!to!chemokine!and!the!difference!between!the!number!of!DMSO7treated! Treg! to! Maraviroc7treated! Treg! migrating! to! chemokine! reached! statistical!significance.! ! There! was! also! a! reciprocal,! statistically! significant,! reduction! in! the!number!of!Treg!remaining!in!the!upper!INPUT!chamber!with!chemokine!compared!with!the!number!of!Treg!in!the!upper!chamber!with!media!alone.!!The!Treg!proportion!was!significantly! increased! in! response! to! chemokine! compared! with! media! alone.! ! The!observation!that!migration!of!CRC7isolated!CD3+!lymphocytes!towards!CCL4!results! in!enrichment!of!Treg! in! the! lower!chamber!confirms!a!preferential!migration!response.!!There!was!no!difference! in! the!proportion!of!migrated!CD3+! cells! that!were!Tconv!or!CD8+!in!response!to!chemokine!compared!with!media!alone.!




Figure! 572:! ! Immunofluorescent! staining! of! transwell! membranes! from! a! single! transwell!experiment.! ! Two! representative! fields! of! the! transwell!membrane! from! an! experiment!with!media! alone! (top),! or! chemokine! (bottom),! in! the! lower! chamber.! ! X100!magnification.! ! Blue!staining!=!DAPI.!!Green!staining!=!Foxp3.!!White!arrows!indicate!dual!DAPI!and!Foxp3!staining.!




separate! experiments.! ! The!mean! number!was! reported! ±! SD.! ! The!membranes! from!transwell!experiments!using!DMSO7treated!lymphocytes!with!media!alone!in!the!lower!chamber,! DMSO7treated! lymphocytes! with! chemokine! in! the! lower! chamber! and!Maraviroc7treated!lymphocytes!with!chemokine!in!the!lower!chamber!were!compared.!!There!was!no!difference! in! the!mean!number!of!DAPI+!cells!over! the! three!conditions!(99.1!±!70.1!versus!108.8!±!83.0!versus!98.9!±!66.2,!P=0.94,!Kruskall7Wallis!test).!!The!number! of! DAPI+Foxp3+! cells! were! not! enumerated! and! compared! across! different!conditions!as!the!cells!were!too!few!in!number!(range!176!cells/field).!
3D#chemotaxis#assay#An!attempt!was!made!to!directly!visualise!chemotaxis!of!CRC7isolated! lymphocytes! to!CCR5! ligands! using! a! 37dimensional! microslide! (288).! ! The! microslide,! produced! by!Ibidi!GmbH,!Germany,!allows!for!the!suspension!of!lymphocytes!in!a!collagen!gel!inside!a! narrow! observation! area! that! is! connected! to! two! separate! lateral! reservoirs.! ! The!observation!area!was! filled!with!PBMC!suspended! in!a!gel,!as!described! in!Chapter!2:!Chemotaxis! Chambers.! ! Seeding! the! required! gel! volume! of! 6! µl! into! the!microslide,!without! forming! any! bubbles,! was! technically! challenging.! ! Gel! spilt! into! the! lateral!reservoirs!before!setting.!!It!was!also!difficult!to!establish!a!chemokine!gradient!without!disturbing! the! gel.! ! Chemotaxis! of! PBMCs! towards! CXCL12! was! observed! in! one!experiment! but! was! not! reproduced! in! a! second! experiment.! ! It! was! estimated! that!20,000!lymphocytes!were!needed!per!6!µl!of!gel!to!give!approximately!50!cells!per!field!to!track.!!Given!the!lymphocyte!yields!from!some!human!CRC!samples,!the!technique!is!attractive!as!chemotaxis!may!be!analysed!using!small!cell!numbers.!!Given!the!technical!difficulties! encountered!optimising! the! experiment! to! visualise!PBMC! chemotaxis,! the!use!of!the!slides!for!CRC7isolated!lymphocytes!was!not!pursued.!
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CCR5*induction*





Separated Tconv and Treg co-culture with 


















































































































































































It! was! clear! that! Foxp3! expression! was! upregulated! by! T! cells! post<activation! with!CD3/CD28! beads.! ! Therefore,! the! Treg! phenotype! (CD3+CD4+Foxp3+),! although!appropriate! for! lymphocytes! not! activated! by! beads,! represents! a! different! cell!population!post!bead<activation!(see!Figure!5<4).!!The!increased!percentage!expression!of!CCR5!by!bead<activated!Treg!compared!with!bead<activated!Tconv,!cultured!with!or!without!supernatant,!may!represent!increased!CCR5!expression!by!activated!compared!with!less!activated!T!cells.! !For!this!reason,!Tconv!(CD4+CD25<)!and!Treg!(CD4+CD25+)!were! isolated! from! PBMC! using! immunomagnetic! separation! methods.! ! Following!isolation!of!Tconv!and!Treg,!the!co<culture!experiments!were!repeated!under!the!same!conditions!but!with!Treg!and!Tconv! in!separate!wells.! !This!allowed! for! the!effects!of!bead! activation! and! co<culture! with! supernatants! on! Treg! and! Tconv! to! be! assessed!separately.!!!
As! before,! there!was! increased! percentage! expression! of! CCR5! by! Treg! compared! to!Tconv! for! all! conditions! (see! Figure! 5<3b).! ! There! was! significantly! greater! CCR5!percentage! expression! by! bead<activated! Treg,! cultured!with! or!without! supernatant,!than! by! Treg! cultured! without! beads.! ! There! was! no! difference! in! percentage! CCR5!expression!between!bead<activated!Treg!cultured!with!supernatant!(from!CRC!or!distal!colon)!compared!with!bead<activated!Treg!cultured!without!supernatant.!!There!was!a!small!but!significant!difference!in!percentage!CCR5!expression!by!bead<activated!Tconv!compared!with!Tconv!cultured!without!beads.! !Culture!of!Tconv!with!CRC,!but!not!DC,!supernatant!significantly! increased!percentage!CCR5!expression!compared!with!bead<activated!Tconv! cultured! in!media! alone.! !Bead!activation!and! supernatant! co<culture!made!no!difference!to!CCR5!expression!in!terms!of!MFI!(data!not!shown).!
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!
Figure!5<4:!!Foxp3!expression!by!CD3+CD4+!PBMCs:!(a)!cultured!in!media!alone!for!4!days!and!(b)! post<culture! with! CD3/CD28! beads! for! 48! hours,! followed! by! further! 48! hour! culture! in!media! after! beads! have! been! removed.! ! The! region! ‘R14’! is! in! the! same!position! on!both!dot!plots.! ! ! Flow! cytometry! data! is! from! a! single! experiment! representative! of! 4! separate!experiments.!











on! the! membrane.! ! Bound! protein/antibody! complexes! were! then! visualised! using!Streptavidin<HRP! and! chemiluminescent! detection! reagents.! ! The! intensity! of! light!produced! at! each! spot! on! the! membrane! was! proportional! to! the! amount! of! bound!protein.!!Semi<quantitative!protein!measurements!were!made!by!measuring!the!density!of!the!spots!using!an!ImageJ!macro!(see!Appendix!IV).!!Each!kit!contained!4!membranes!allowing! for! duplicate! semi<quantitative!measurement! of! protein! concentrations! in! 2!matched! CRC/distal! colon! supernatants.! ! Protein! concentrations! in! CRC! supernatants!were!compared!with!matched!distal!colon!supernatants!and!differences!were!tested!for!statistical!significance!using!the!Wilcoxin!signed<rank!test!for!paired!data.! !Unadjusted!P<values!are!reported!in!Table!5<1.!
!
Table! 5<1:! ! Median! supernatant! protein! concentration! (measured! semi<quantitatively! by!densitometry)!by! tissue!type.! !Median!values!represent!2!samples!of!CRC!with!matched!distal!colon!supernatant!with!technical!duplicates.! !P<values!were!calculated!by!the!Wilcoxin!signed<rank!test,!unadjusted!for!multiple!comparisons.!‘*’!represent!significant!differences!at!the!<0.05!level.! ! Blank! entries! represent! no! detectable! protein! and! P<values! were! only! calculated! if!protein!was!detected!for!both!samples!of!CRC!and!distal!colon!supernatant.!
Protein( CRC( DC( P,value(
(
Protein( CRC( DC( P,value(
Activin,A( 11.7( 6.1( *(0.02(
(
IL,17( !( 2.0( !(
ADAMTS,1( 4.4( 0.7( *(0.01(
(
IL,17E( 1.0( 0.9( !(
Amphiregulin( 48.5( 29.8( 0.31(
(
IL,1Ra( 75( 24.7( *(0.044(
ANG( 107.6( 68.7( *(0.001(
(
IL,1ß( 64.7( 33.6( 0.24(
Ang,1( 8.1( 1.2( *(0.002(
(
IL,1α( 2.0( 1.6( !(
Ang,2( 3.4( 1.6( 0.067(
(
IL,2( 1.0( 0.7( !(
! 188!
Artemin( 3.1( 0.3( *(0.009(
(
IL,23( 2.1( 2.3( 0.35(
C5/C5a( 2.5( 20.8( 0.20(
(
IL,27( 2.3( 0.8( 0.086(
CCL1( ( 0.8( !(
(
IL,32a( ( 0.7( !(
CCL2( 4.2( 0.6( *(0.019(
(
IL,4( ( 0.6( !(
CCL3( 3.0( 0.8( 0.054(
(
IL,5( ( 1.1( !(
CCL4( ( ( !(
(
IL,6( 100.5( 90.2( 0.29(
CCL5( 0.5( 0.8( !(
(
IL,8( 110.9( 98.9( 0.26(
CD40L( ( ( !(
(
LAP((TGF,ß1)( 9.2( 6.1( 0.08(
CXCL1( 52( 9.8( 0.19(
(
Leptin( 2.0( 0.4( *(0.028(
CXCL10( 0.9( 1.3( !(
(
MIF( 102.3( 96.1( 0.19(
CXCL11( ( 0.5( !(
(
MMP,8( 93.6( 38.5( 0.14(
CXCL12( ( 1.5( !(
(
MMP,9( 92.6( 46( 0.18(
CXCL16( 17.4( 1( 0.17(
(
NRG1,ß1( 17.2( 6.8( 0.11(
CXCL4( 75.6( 36.5( 0.16(
(
PD,ECGF( 7.3( 2.2( 0.064(
DPPIV( 25.2( 14.2( 0.27(
(
PDGF,AA( 6.5( 0.7( 0.12(
EG,VEGF( 6.2( 2.7( 0.05(
(
PDGF,AB/BB( 4.9( 1.3( !(
EGF( 2.5( 0.3( *(0.026(
(
Persephin( 9.0( 6.7( 0.32(
Endoglin( 3.0( 0.1( !(
(
PIGF( 4.2( 0.7( *(0.015(
Endostatin( 64( 30.3( 0.17(
(
Plasminogen( 2.8( 0.9( 0.057(
Endothelin,1( 5.8( 2.3( 0.099(
(
Prolactin( 1.5( 0.4( *(0.041(
FGF,1( 5.9( 3.6( 0.25(
(
PTX3( 8.5( 5.7( 0.35(
FGF,2( 63.2( 10.9( *(0.022(
(
Serpin,B5( 14.9( 1.0( 0.18(
FGF,4( 2.2( 0.2( *(0.021(
(
Serpin,E1( 110.7( 76.3( 0.17(
FGF,7( 2.9( 0.3( !(
(
Serpin,F1( 56.2( 59.5( 0.14(
G,CSF( 22.1( 23.1( 0.49(
(
SerpinE1( 95.5( 65( 0.30(
GDNF( 1.7( 0.1( !(
(
sICAM1( 35.8( 22.5( 0.31(
GM,CSF( 87.9( 21.4( 0.065(
(
sTREM,1( ( 0.3( !(
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HB,EGF( 6.1( 1.7( 0.11(
(
TIMP,1( 118.8( 91.6( 0.19(
HGF( 43.6( 10.9( 0.06(
(
TIMP,4( 2.3( 0.3( *(0.013(
IFNγ( 1.6( 0.9( 0.28(
(
TNFα( 0.8( ( !(
IGFBP,1( 7.9( 5.4( 0.34(
(
TSP,1( 71.2( 50.3( !(
IGFBP,2( 34.2( 12.3( 0.21(
(
TSP,2( 3.3( 1( *(0.008(
IGFBP,3( 41.3( 0.9( 0.20(
(





Vasohibin( 2.2( 0.8( *(0.020(
IL,12p70( 2.6( 0.7( !(
(
VEGF( 66.1( 25.9( 0.11(
IL,13( 0.3( 0.9( ! VEGF,C( 1.8( 0.5( *(0.043(
IL,16( 12.5( 4.3( 0.22(
(
( !( ( !(!
There! were! 15! proteins! that! were! of! significantly! higher! concentration! in! the! CRC!compared!with!the!distal!colon!supernatant.!!These!were!IL<1Ra,!Activin<A,!ADAMTS<1,!ANG,!Ang<1,!Artemin,!EGF,!FGF<2,!FGF<4,!leptin,!MCP<1,!PIGF,!prolactin,!TIMP<4,!TSP<2,!vasohibin!and!VEGF<C.!!These!proteins!were!too!many!in!number!to!study!the!effects!of!their! inhibition! in! co<culture! experiments.! ! ! IL<1RA! levels! have! been! shown! to! be!increased!in!melanoma!tumours!in!CCR5!</<!mice!compared!with!wildtypes!(289)!and!there! may! therefore! be! an! important! association! between! IL<1RA! levels! and! CCR5!expression.!!TGF<ß1!increases!CCR5!expression!on!peripheral!blood!T!cells!(290).!!TGF<ß1!is!also!upregulated!by!Treg!from!wildtype!mice!following!stimulation!with!CCL5,!but!by!Treg! from!CCR5! </<!mice! (291).! ! In!a!murine!wound!healing!model,!CCR5! </<!mice!displayed!a!reduction!in!TGF<ß1!and!VEGF!at!wound!sites!compared!to!wildtype!mice!(292)! and! it! is! known! that! CCL5<mediated! angiogenesis! depends! both! on! CCR5! and!VEGF!expression!(293).!!TGF<ß1!and!VEGF!were!expressed!at!higher!levels!in!CRC!than!in! distal! colon! supernatants,! although! the! differences! did! not! reach! statistical!
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significance.!!However,!based!on!the!above!cited!literature!and!the!supernatant!protein!levels,! it!was!decided!to!study!the!effects!of! inhibition!of!IL<1Ra,!TGF<ß1!and!VEGF!on!cell!surface!CCR5!expression!in!the!supernatant!co<culture!model.!
Inhibition)of)supernatant)proteins)Neutralising! antibodies! to! IL<1Ra,! TGF<ß1! and! VEGF!were! added! to! wells! containing!separated! Tconv! and! Treg!with! activating! beads! ±! CRC! supernatant.! ! IMC! antibodies!were!added!to!a!control!well!with!Tconv!or!Treg!under!the!same!conditions.!!There!was!no!difference!in!CCR5!expression!by!activated!cells!cultured!with!CRC!supernatant!and!the!above!neutralising!!antibodies!to!IL<1Ra,!TGF<ß1!or!VEGF!compared!with!activated!cells!cultured!with!CRC!supernatant!and!IMC!antibodies!(data!not!shown).!




Figure!5<5:! !Tconv!and!Treg!were!cultured!in!separate!wells!with!activation!beads.! !(a)!At!the!end! of! the! experiment! (day! 4),! culture! supernatants! were! harvested! and! semi<quantitative!measurement! of! CCL3,! CCL4! and! CCL5! concentrations!were! performed.! ! Data! represents! the!mean!absorbance!of!2!separate!experiments!with!error!bars!showing!the!standard!error!of!the!mean.! !Tconv!and!Treg!were!cultured! in! the!presence!or!absence!of!activation!beads!and!UK<484900! (a! CCR5! inhibitor)! and! CCR5! expression! was! measured! by! flow! cytometry:! (b)!percentage!CCR5!expression,!(c)!MFI.!!Data!represents!the!findings!from!one!experiment.!
! !
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Figure!5<6:!!Expression!of!Foxp3,!CTLA<4!and!CD39,!in!terms!of!(a)!percentage!expression!and!(b)! MFI,! by! CCR5low! and! CCR5high! Treg,! isolated! from! CRC.! ! The! data! from! 4! separate!experiments!are!shown.!!MFI!=!median!fluorescence!intensity.!
!Suppression! assays! were! used! to! assess! the! ability! of! Treg,! isolated! from! CRC,! to!suppress! the! proliferation! of! allogeneic! PBMC<isolated! CD4+CD25<! responder! T! cells!(Tresp)!was!assessed.! !The!methods!are!described!in!detail! in!Chapter!2:! !Suppression*
assay.! ! Treg! and! Tconv! were! isolated! from! CRC! by! cell! sorting! with! a! purity! of!approximately! 95%.! ! CCR5low! Treg! and! CCR5high! Treg! were! isolated! separately! with!lower! purities! of! approximately! 70%! and! 80%! respectively! (see! Chapter! 2:!
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Fluorescence0activated* cell* sorting* (FACS).! ! A! total! of! 5! suppression! assays! were!performed!successfully.!!Representative!results!from!one!experiment,!of!which!enough!Treg!were! isolated! to!perform!3!different!Treg! :!Tresp! ratios,! is! shown! in!Figure!5<7.!!Following! 72! hours! of! culture,! 75%! of! Tresp! proliferated! in! response! to! Treg!Suppression!Inspector!beads!alone.!!Both!CRC<isolated!CCR5low!Treg!and!CCR5high!Treg!suppressed! proliferation! of! Tresp! in! a! dose<dependent! manner! while! CRC<isolated!Tconv!did!not.!!Ten!experiments!using!Treg!isolated!from!CRC!and!4!experiments!using!Treg!isolated!from!PBMCs!were!performed!in!the!process!of!optimising!the!suppression!assay! before! the! assay! could! be! performed! successfully.! ! The! co<culture! time! was!reduced!from!5!days!to!3!days!to!limit!the!proliferation!of!Tresp.!!Most!importantly,!the!cell!:!bead!ratio!was!changed!from!1!:!1!to!2!:!1!to!reduce!the!stimulus!for!proliferation!of!Tconv!to!a!level!at!which!proliferation!can!be!suppressed.!
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Figure! 5<7:! ! Suppression! assay! using! CCR5low! and! CCR5high! Treg! isolated! from! one! sample! of!CRC.! ! Data! is! representative! of! 5! separate! experiments.! ! (a)! Tresp! proliferation! following! 72!hours! of! culture! with! or! without! Treg! Suppression! Inspector! beads.! (b)! Tresp! proliferation!following!72!hours!of! culture!with!Treg!Suppression! Inspector!beads!and!either!CRC<isolated!CCR5low!Treg,!CCR5high!Treg!or!Tconv.!!Numbers!at!the!top<right!of!each!histogram!indicates!the!percentage!of!proliferating!cells.!
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suppression! by! CCR5low! Treg,! CCR5high! Treg! and! Tconv!were! compared! using! pooled!data! for! Treg! :! Tresp! ratios! of! 1:1! and! 1:2.! ! Differences! were! tested! for! statistical!significance!using!the!Wilcoxon!signed<rank!test.!!Both!CCR5low!Treg!and!CCR5high!Treg!suppressed! Tresp! proliferation! significantly! more! then! Tconv,! P=0.043! and! P=0.018,!respectively! and! CCR5high! Treg! were! significantly! more! potent! suppressors! of!proliferation!compared!with!CCR5low!Treg!(P=0.018).!
!Table! 5<2:! ! Summary! of! 5! separate! suppression! assays.! ! The! percent! suppression! of! Tresp!proliferation!is!shown!for!CRC<isolated!CCR5low!Treg,!CCR5high!Treg!and!Tconv!at!different!Treg!:!Tresp! ratios.! ! The! number! of! Treg/Tconv! represents! the! number! of! sort! events! given! by! the!MoFlo!XDP!High<Speed!Cell!Sorter,!rather!than!the!absolute!number!of!sorted!viable!cells.!






A( 1:1( 10000( 28.5( 32.1( 0.0(
B( 1:1( 5000( 75.1( 81.4( ,16.0(
C( 1:1( 10000( 58.8( 83.6( 16.7(
D( 1:1( 10000( 6.7( 46.6( ,1.3(
C( 1:2( 5000( 45.3( 77.7( 11.6(
D( 1:2( 5000( 8.7( 34.3( 16.8(
E( 1:2( 5000( 55.1( 72.2( ,0.7(
C( 1:4( 2500( 29.7( 60.9( ,2.7(
D( 1:4( 2500( 0.0( 6.0( ,9.4(
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In!vitro!proliferation!of!CRC6isolated!Treg!and!Tconv!Treg! are! enriched! in! CRC! compared! to! distal! colon! and! peripheral! blood! (see! Figure!3<11).! ! Selective! recruitment! of! Treg! by! CRC!may! explain! this! observed! enrichment.!!However,!at! least!two!other!possibilities!exist:! !Treg!may!proliferate!more!than!Tconv!within!the!tumour;!and!Treg!may!be!induced!from!Tconv.!!Regarding!the!former,!Ki67!expression! by! CRC<isolated! Treg! and! Tconv,! was! measured! by! flow! cytometry! (see!Figure!5<8a+b).!!Ki67!protein!is!a!marker!of!proliferation,!expressed!in!all!active!phases!of! the! cell! cycle,! but! not! by! resting! cells! (294).! ! There! was! a! statistically! significant!increase!in!Ki67!percentage!expression!by!Treg!compared!with!Tconv,!suggesting!that!Treg!were! proliferating!more! than!Tconv!within! the! tumour.! ! Bcl2!mRNA!expression!was!measured!relative! to!GAPDH!mRNA!expression!by!Treg!and!Tconv,! isolated! from!CRC!by!cell! sorting! (see!Figure!5<8c).! !Bcl2! is!an! important!anti<apoptosis!gene! (295)!and! was! expressed! at! slightly! higher! levels! by! Treg! than! by! Tconv,! although! this!difference!did!not!reach!statistical!significance.!!!
To! test!whether! CRC<isolated! Treg! proliferated!more! than! Tconv,! cells!were! labelled!with!CellTrace™!Violet!then!isolated!from!CRC!and!peripheral!blood!by!cell!sorting!and!a! proliferation! assay! was! performed! as! described! in! Chapter! 2:! ! Proliferation! assay.!!CD4+CD25<!cells!(Tresp)!were!isolated!from!the!peripheral!blood!of!a!different!donor!to!the!CRC!sample.!!10!000!cells!of!each!subtype!were!sorted!and!proliferation!in!response!to!Treg!Suppression!Inspector!beads!for!72!hours!was!measured!by!flow!cytometry!(see!Figure! 5<8d).! ! Peripheral! blood! Tresp! (CD4+CD25<)! proliferated! in! response! to! Treg!Suppression!Inspector!beads!more!than!CRC<isolated!Tconv!(CD4+CD25<).!Treg!did!not!proliferate!in!response!to!beads!at!all.!
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Figure!5<8:! !Ki67! expression! in! terms!of! (a)! percentage! expression! and! (b)!MFI,! by!Treg! and!Tconv,! isolated! from! CRC.! ! Data! from! 7! experiments! shown.! ! (c)! Relative! expression! of! Bcl2!mRNA!to!GAPDH!mRNA!by!Treg!and!Tconv,! isolated! from!CRC.! !Data! from!4!experiments!are!shown.! ! (d)! Proliferation! assay! comparing! proliferation! of! peripheral! blood! CD4+CD25<! cells!(Tresp)!to!CCR5low!Treg,!CCR5high!Treg!and!Tconv,!isolated!from!CRC.!!Numbers!at!the!top<right!of!each!histogram!indicates!the!percentage!proliferation.!!Data!represents!lymphocytes!isolated!from!one!sample!of!CRC!and!unmatched!peripheral!blood.! !Capped! line! indicates!a!significant!difference!(Wilcoxin!signed<rank!test).!!MFI!=!median!fluorescence!intensity.!



































































Figure!5<9:!!Helios!expression!by!Tconv!and!Treg!isolated!from!CRC,!in!terms!of!(a)!percentage!expression!and!(b)!median!fluorescence!intensity.!!Data!from!4!unique!CRC!samples!are!shown.!!(c)! Percentage! of! unmethylated! DNA! at! the! TSDR! by! cell! type.! ! The! mean! percentage! of!unmethylated! DNA! is! plotted! for! Tconv,! CCR5low! Treg! and! CCR5high! Treg,! isolated! from! 4!different! CRC! samples.! ! Error! bars! represent! the! range! of! percentage! of! unmethylated! DNA.!!Capped!lines!represent!a!statistically!significant!difference!(Wilcoxon!signed<rank!test).!
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The! functional! properties! of! CRC<isolated! Treg,! in! terms! of! the! ability! to! undergo!chemotaxis!in!response!to!CCR5!ligands,!suppressive!capacity!and!proliferative!capacity!have!been!presented!in!this!chapter.!!TSDR!analysis!supports!the!idea!that!CRC<resident!Treg!are!nTreg,!rather!than!iTreg.!!Finally,!in!vitro!experiments!using!peripheral!blood!lymphocytes! have! demonstrated! that! surface! CCR5! expression! can! be! induced! by!culture!with!CD3/CD28!activation!beads,!an!effect!that!can!be!modified!by!the!addition!of!CRC!or!distal!colon!supernatant.!
CRC6isolated!Treg!migrate!towards!CCL4!The!proportion!of!migrated!lymphocytes!with!a!Treg!phenotype!increased!significantly!with! chemokine! compared! with! media! alone.! ! Reciprocally,! there! was! a! significant!reduction! in! the! proportion! of! non<migrated! cells! with! a! Treg! phenotype! with!chemokine! compared! with! media! alone,! and! these! effects! were! abolished! by! pre<incubation!of!the! lymphocytes!with!Maraviroc.! !Thus!Treg!are!preferentially!recruited!by!CCL4,!most!likely!as!a!consequence!of!their!higher!levels!of!expression!of!CCR5!than!Tconv.! Given! that! CCR5! is! preferentially! expressed! by! Treg! than! Tconv,! and! CRC!expresses! more! CCL3! and! CCL4! than! matched! colon! tissue,! it! is! likely! preferential!recruitment! of! Treg! that! accounts! for! their! higher! frequencies! in! CRC! tissue! in! vivo.!Tconv! and! CD8+! cells! showed! similar! migratory! responses! to! CCL4,! reflecting! their!comparable!levels!of!CCR5!(see!Figure!5<1).!
Evidence!from!animal!models!suggests!that!CCR5+!Treg!migrate!towards!their!ligands!in!vivo.! ! Intravenous! recombinant! CCL5! administered! to! rats! in! a! renal! allograft!model!resulted! in! egress! of! CCR5+! Treg! and! prompt! graft! rejection! (296)! and! intra<tumoral!
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injection!of! recombinant!CCL4!and!CCL5! resulted! in! accumulation!of!CCR5+!Treg! in! a!mouse!melanoma!model! (297).! ! Patients! treated!with!Maraviroc! show!reduced!T! cell!chemotaxis! and! CCR5! internalisation! in! response! to! CCL5! in! vitro! and! a! reduced!incidence! of! visceral! graft<versus<host! disease! (298).! ! It! was! postulated! that! these!clinical! outcomes! are! a! consequence! of! reduced! tissue! recruitment! of! CCR5+! Th1!effector!T!cells.!!The!data!presented!in!this!chapter!are!consistent!with!the!above!study!(298),!in!that!Maraviroc!was!able!to!inhibit!chemotaxis!of!CCR5+!human!T!cells!towards!their!cognate!chemokines.!
The! cells! expressing! CCR5! in! human! CRC! include! lymphocytes! and! macrophages,!supporting!the!hypothesis!of!CCL5<dependent!recruitment!of! lymphocytes! to! tumours!(267)!and!also!the!tumour!epithelium!(103).!!
The! transwell! assays! were! only! performed! using! CCL4.! ! The! conclusions! regarding!migration<dependent! Treg! enrichment! can! therefore! not! be! justified! with! regard! to!other! CCR5! ligands,! although! there! is! no! reason! to! suspect! that! other! CCR5! ligands!would!not!behave!similarly.!!The!lymphocyte!yield!from!each!CRC!sample!only!provided!enough! lymphocytes! to! perform! a! transwell! assay! using! one! chemokine! at! one!concentration.!!The!summary!of!6!transwell!experiments!shown!in!Figure!5<1!therefore!required! 6! separate! CRC! samples.! Chemotaxis! of! human! T! cells! towards! CCL4! at!concentrations!of!between!10<100!ng/ml!has!been!previously!reported!(177,178,299).!!The! chemotactic! response! is! often! biphasic!with! respect! to! chemokine! concentration!(300)!and!it!was!therefore!fortunate!that!there!was!a!consistent!chemotactic!response!to! the! chosen! concentration! of! 20! ng/ml.! ! A! more! pronounced! difference! in! the!migration! of! Treg! compared! to! Tconv! may! have! been! observed! with! a! different!
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chemokine!concentration,!although!this!was!not!tested.!!Others!have!performed!similar!chemotaxis! assays! by! allowing! a! pooled! T! cell! population! to! migrate! towards!chemokines!and!then!analysing!the!phenotypic!differences!of!migrated!cells!(120,301).!!One!possible!explanation!for!an!enrichment!of!Treg!among!migrated!T!cells!would!be!T!cell!upregulation!of!CD25!by!the!process!of!migration.! ! If! this!were! the!case!however,!CD25!expression!would! also!be! expected! in! those! cells! that!migrated! to!media! alone.!!Others!have!shown!that!enrichment!of!CD25+!T!cells!in!the!migrated!T!cell!fraction!was!only! observed! when! chemokines! were! used,! for! which! the! cognate! receptors! were!overexpressed! by! CD4+CD25+! T! cells! (301).! ! This! study! of! chemotaxis! of! peripheral!blood! lymphocytes! demonstrated! Treg! enrichment! through! migration! towards! the!ligands! for!CCR4!and!CCR8.! !This!was!consistent!with! the!greater!expression!of!CCR4!and! CCR8! by! peripheral! blood!Treg! compared!with! Tconv.! ! No! Treg! enrichment!was!noted! through!migration! towards! CCR5! ligands! but! this! is! consistent!with! low! CCR5!expression!by!peripheral!blood!Treg!(see!Figure!3<11).!!
Immunofluorescent!staining!of!the!transwell!membrane!was!unsuccessful!in!that!there!were!too!few!Foxp3+!cells!to!enumerate.!!The!transwell!membrane!was!not!designed!to!quantify! migration! in! this! manner! but! it! was! attempted! to! allow! quantification! of!Foxp3+!cells!by!immunofluorescence!rather!than!CD4+CD25+!cells,!as!measured!by!flow!cytometry.! ! Staining! of! the! transwell!membrane! is! performed! as! part! of! the! classical!Boyden!chamber!assay!in!which!migrated!cells!become!trapped!on!the!underside!of!the!membrane,! a! valuable! technique! for! low! cell! input! numbers! (302).! ! Such! Boyden!chamber! assays! were! not! performed! as! they! would! not! have! permitted! the!identification!of!different!lymphocyte!subsets.!
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Induction!of!cell!surface!CCR5!Functional!studies!of!CCR5+!lymphocytes!is!hampered!by!the!fact!that!peripheral!blood!T! cells! express! a! low! level! of! CCR5! (303).! ! Ten!day! culture! of! PBMC!with! IL<2! alone,!stimulation!with!PHA!(phytohaemagglutinin)!and!IL<2,!and!stimulation!with!CD3/CD28!beads!are!all!described!methods!to!induce!CCR5!expression!by!T!cells!(304).!!CD3/CD28!bead!stimulation!leads!to!only!a!modest!increase!in!CCR5!expression!at!the!cell!surface!(303).!!However,!this!was!the!preferred!method!used!for!the!experiments!presented!in!this!chapter!due!to!its!simplicity.!!Given!that!media!required!replacement!every!2!days,!CRC/colon!supernatant!was!in!too!short!supply!to!allow!for!10<day!culture.!!Stimulation!with! CD3/CD28! beads! is! more! physiological! than! PHA! stimulation! (305)! and! PHA<stimulated! T! cells! have! been! shown! to! be! exhibit! impaired! function! in! terms! of!proliferative! capacity! and! cytokine! production! (306).! ! The! results! presented! in! this!chapter!demonstrated!an!upregulation!of!CCR5!by!Treg,!and! to!a! lesser!extent!Tconv,!following! activation! by! CD3/CD28! beads.! ! This! is! consistent! with! a! study!measuring!CCR5!mRNA!in!cultures!of!Tconv!and!Treg!pre<!and!post<activation!with!CD3!and!IL<2!(307).! ! The! addition! of! CRC! or! distal! colon! supernatant! to! the! co<culture! resulted! in!increased! expression! of! surface! CCR5! by! Tconv,! but! not! by! Treg.! ! The! supernatants!contain! many! different! cytokines! and! growth! factors,! only! some! of! which! were!measured!(see!Table!5<1).!!Neutralisation!of!IL<1Ra,!TGF<ß1!and!VEGF!did!not!have!any!obvious! inhibitory! effect! on! CCR5! induction! by! supernatant! co<culture.! ! Others! have!reported!CCR5!induction!by!an!array!of!different!cytokines!including:!IL<2,!IL<4,!IL<10,!IL<15! and! IFN<γ! (308).! ! These! were! not! readily! detected! in! the! CRC! or! distal! colon!supernatants! and! their! inhibition! was! therefore! not! tested! in! the! co<culture!experiments.!!!!
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Chemokine!production!by!T!cells! (CCL3,!CCL4,!CCL5)!directly!downregulates!CCR5!on!the! surface! of! T! cells! in! an! autocrine! manner! (309).! ! Nevertheless! it! is! possible! for!activated!T! cells,! to! express! high! levels! of! CCR5!whilst! expressing! increased! levels! of!CCR5!ligands!at!the!same!time!(310)(311).!!Freshly<isolated!Treg!from!peripheral!blood!express! CCR5! but! rapidly! downregulate! the! receptor! on! expansion! ex! vivo! (312).!!Activated!Tconv! produced! notably!more! CCL3,! CCL4! and! CCL5! than!Treg! (see! Figure!5<5).!!It!was!therefore!thought!possible!that!lower!CCR5!expression!by!Tconv!compared!with!Treg!may!be! a!direct! result! of! greater!Tconv!expression!of! cognate! chemokines,!acting! in! an! autocrine! fashion! to! internalise! the!CCR5! receptor.! ! ! Culture!of! activated!Tconv! and! Treg! in! the! presence! of! the! human! CCR5! small! molecular! antagonist! UK<484900! was! performed! to! test! this! idea.! ! CCR5! inhibition! resulted! in! only! a! small!increase! in! CCR5! expression! by! Tconv.! ! If! chemokine! internalisation! of! CCR5!significantly!contributed!to!the!differences!in!CCR5!expression!by!Treg!and!Tconv,!CCR5!inhibition!ought!to!result!in!similar!levels!of!CCR5!expression!by!the!two!cell!subsets.!!It!is!therefore!unlikely!that!differential!expression!of!CCL3,!CCL4!and!CCL5!by!Tconv!and!Treg!can!explain!the!associated!differences!in!CCR5!expression.!
Treg!suppression!and!proliferation!The!suppression!assays!presented!in!this!chapter!have!demonstrated!that!Treg!isolated!from!CRC!can!suppress!the!proliferation!of!allogeneic!peripheral!blood!T!cells.! !This!is!consistent!with!other!studies!that!have!isolated!Treg!from!CRC!tissue!and!assessed!the!ability!of!these!cells!to!suppress!proliferation!of!allogeneic!T!cells!in!vitro!(48,52).!!It!is!important!to!note!that!Treg!are!known!to!be!susceptible!to!apoptosis!(313)!and!dead!or!dying! cells! may! result! in! false! suppression! seen! in! suppression! assays! (175).! ! Treg!
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sorted! from!CRC!were! selected!by! their! absence!of! staining!with! a! live/dead!marker.!!However,! their! viability! post<sorting! and! following! co<culture! with! Tresp! was! not!performed.!
With!regard!the!suppression!assay!data!presented! in! this!chapter,!CCR5high!Treg!were!significantly!more!effective!at! suppressing!allogeneic!T!cell!proliferation! than!CCR5low!Treg.! ! A! study! comparing! the! suppressive! capacity! of!murine!CD103+<! versus!CD103<!Treg! in! a!model! of!CRC,!demonstrated! that!CD103+!Treg! suppressed! the! in! vivo! anti<tumour! function! of! CD8+! cells!more! than! CD103<! Treg! (314).! ! This!was! the! result! of!CD103+!Treg!expressing!significantly!more!CCR5!than!CD103<!Treg,!enabling!these!cells!to!migrate!efficiently!into!the!tumour!tissue.!!There!was!no!difference!however!in!the!in*
vitro! suppressive! capacity! of! CD103+<! and! CD103<! Treg,! isolated! from! the! spleens! of!tumour<bearing!mice.! !The!percentage!expression!of!surface!CCR5!was!approximately!28%!for!the!CD103+!Treg!and!5%!for!the!CD103<!Treg!populations.! !The!CD103+!Treg!population!was!therefore!not!highly!enriched!for!CCR5+!Treg.!!The!suppressive!capacity!of!Treg! from!CCR5! </<!mice!was! compared! to! that! of!Treg! from!wildtype!mice! (307).!!CCR5</<! Treg! were! as! effective! as! wildtype! Treg! at! suppressing! wildtype! Tresp!proliferation.! !However,! the!cell!surface!expression!of!CCR5!by!wildtype!Treg!was!not!measured.!!A!similar!study!compared!the!suppressive!capacity!of!Treg!isolated!from!the!spleens!of!CCR2</<,!CCR4</<,!CCR5</<!and!CCR7</<!mice!to!Treg!isolated!from!wildtype!mice!(315).!!There!was!no!difference!in!the!suppressive!capacity!between!wildtype!Treg!and!the!Treg!isolated!from!any!of!the!knockout!mice.!
In!a!recent!study!investigating!the!role!of!Treg!in!psoriasis,!peripheral!blood!CCR5+!Treg!and! unsorted! Treg! from! healthy! volunteers! were! compared! for! differences! in!
! 206!
phenotype! and! suppressive! capacity! (316).! ! CCR5+! Treg! expressed! higher! levels! of!Foxp3,! measured! by! both! PCR! and! flow! cytometry.! ! More! importantly,! CCR5+! Treg!demonstrated!a!higher!suppressive!capacity!than!the!unsorted!Treg!at!all!Treg!:!Tresp!ratios!examined! (1:1,!1:2!and!1:4).! !The!suppression!assays!presented! in! this! chapter!are! entirely! in! keeping!with! the! findings! from! this! recent! study.! ! There! are! no! other!studies! that! have! directly! compared! the! suppressive! capacity! of! Treg! by! CCR5!expression.! ! CCR5low! Treg! are! still! capable! of! supressing! T! cell! proliferation,! just! less!than! their! CCR5high! counterparts.! ! It! thus! appears! that! CCR5high! Treg! represent! a!population!of!activated!highly!potent!Treg.! !The!reason!that!similar! findings!were!not!observed!when! comparing! CCR5</<! Treg! to!wildtype! Treg,! probably! results! from! the!lack!of!CCR5high!Treg!in!the!wildtype!Treg!pool.!
Live! Treg! isolated! from! CRC! did! not! proliferate! in! vitro.! ! This! is! consistent! with! the!reports!of!others!(48,52).!!In!contrast,!CRC<resident!Treg!were!shown!to!express!higher!levels!of!Ki67!compared!with!Tconv,!suggesting! that! tumour<resident!Treg!proliferate!more!than!Tconv!in!vivo.!!It!is!indeed!possible!that!Treg!readily!proliferate!in!vivo!while!displaying! anergic!behaviour! in! vitro! (317).! !A! study!of!TILs! in! an!orthotopic!murine!brain! tumour!model! demonstrated! higher! levels! of! Ki67! by! Treg! compared! to! Tconv!(318).! !Tumour<resident!Treg!may! receive! stronger!antigen! signals! than!Tconv,! given!that! Treg! respond! to! self<antigens! and! Tconv! do! not! (319).! ! Tolerised!DCs! have! also!been!shown!to!allow!the!selective!expansion!of!Treg!(320).! !Therefore,! in!spite!of! the!lack!of!proliferation!of!CRC<isolated!Treg!in!response!to!mitogens!in!vitro,!it!cannot!be!ruled! out! that! Treg! are! highly! proliferative! within! the! tumour! microenvironment! in!vivo.!
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CRC6isolated!Treg!are!naturally6occurring!Treg!Treg!may!be!classified!as!naturally<occurring!thymic!emigrants!(nTreg)!or!induced!from!other! T! cells! (iTreg).! ! It! has! been! shown! that! nTreg! express! the! transcription! factor!Helios! while! induced! Treg! do! not! (321),! allowing! Helios! to! be! used! as! a!marker! for!nTreg.! ! The!median! percentage! expression! of! Helios! by! Treg! isolated! from! CRC!was!75.2%,!suggesting! that! this!Treg!population!was!mostly!nTreg.! !However,! it!has!since!been!shown!that!Helios!can!be!expressed!by!activated!and!proliferating!CD4+!and!CD8+!cells! (44)! as! well! as! by! iTreg,! induced! by! peptide! presented! by! APCs! (322).! ! It! is!interesting!to!note!that!although!this!latter!study!found!that!all!thymic!Treg!expressed!Helios,! the!transcription!factor!was!only!expressed!by!70%!of!Treg! in!the!periphery!–!similar!to!the!level!expressed!by!CRC<isolated!Treg.!!
An! evolutionary! conserved! element! within! the! Foxp3! locus,! known! as! the! TSDR,! is!selectively! unmethylated! in! nTreg! but! not! in! Tconv! or! iTreg! (45).! ! Therefore,! by!bisulfite! treatment!of!DNA!isolated! from!T!cells!and!RT<PCR,! it!was!possible! to!assess!TSDR! unmethylation! and! hence,! identify! nTreg! as! opposed! to! iTreg! (188).! ! CCR5low!Treg,!CCR5high!Treg!and!Tconv!from!4!separate!samples!of!CRC!were!analysed.!!Despite!the! small! sample! number,! it! does! appear! that! both! CCR5low<! and! CCR5high! Treg! are!nTreg.!!It!has!previously!been!reported!that!Treg!isolated!from!CRC!are!nTreg!by!TSDR!methylation! analysis! (193),! but! this! study! did! not! qualify! Treg! by! CCR5! expression!status.!!The!idea!that!tumour<infiltrating!Treg!are!nTreg!is!further!supported!by!studies!on!the!T!cell!receptor!repertoire!of!both!Treg!and!Tconv.! !It!would!be!expected!that!if!Treg!were! induced! from!Tconv! in! tumours,! the! T! cell! repertoire! of! both! cell! subsets!would! be! similar.! ! This! has! been! tested! in! mouse! tumour! models,! concluding! that!
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tumour<infiltrating!Treg!are!nTreg!(323).!!A!similar!analysis!has!not!been!performed!in!human!CRC.!





Evidence! has! so! far! been! presented! that! naturally<occurring! CCR5high! Treg! exist! in!human! CRC! tissue! and! that! these! cells! are! suppressive! and! migrate! towards! their!cognate! chemokine! in! vitro.! ! To! test! the! hypothesis! that! this! Treg! population! is!specifically! recruited! to! CRC,! a! murine! model! of! CRC! was! used! in! conjunction! with!strategies!to!inhibit!CCR5.!!A!recent!study!has!shown!that!intra<tumoral!injection!of!the!CCR6! ligand,! CCL20,! resulted! in! increased! tumour! Treg! infiltration! compared! with!controls! (237).! ! Therefore,! in! one! experiment,! CCR6!was! inhibited! and! its! effects! on!Treg!recruitment!assessed.!
Different!murine!models!of!CRC!The! ideal! murine! model! of! human! CRC! would! replicate! all! aspects! of! human! CRC!including! sequential! development! of! genetic! alterations! with! ensuing! changes! in!cellular! behaviour,! leading! to! tumour! progression! and!metastasis.! ! Furthermore,! the!ideal! model! would! replicate! the! host! responses! typically! seen! in! the! human! and!maintain!sensitivity!towards!therapeutics!(324).!!Practicalities!require!predictable!and!consistent! tumour! take! within! a! narrow! timeframe.! ! With! regard! this! latter! point,!chemically<induced!cancer!models!would!be!inappropriate!for!CCR5!inhibition!models!due! to! the! long! timeframe! and! low! incidence! of! cancer! development.! ! In! terms! of!genetically!modified!mice,!a!popular!murine!CRC!model!is!the!APC!min/+!model!which!has! a! dominant! mutation! in! the! APC! gene! (325).! ! Unfortunately,! the! location! of! the!
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tumours!in!the!majority!of!APC!min/+!mouse!variants!is!the!small!intestine!rather!than!the! colon! and! the! tumours! are! adenomas! rather! than! adenocarcinomas.! ! The!development!of!CRC!in!this!model!is!not!predictable!and!takes!time!to!develop.!!This!is!the!main!reason!why!studies!on!drug!efficacy! in!mouse!models!make!use!of!allografts!and!xenografts!(326).!!Subcutaneous!(sc)!implantation!of!murine!carcinoma!cells!allows!for!rapid!consistent!tumour!formation!and!is!accessible!to!allow!monitoring!of!tumour!growth.! ! However! the! sc! microenvironment! may! differ! from! that! of! the! colon,!influencing!the!interaction!with!the!host!immune!system,!levels!of!cytokines!and!growth!factors! and! response! to! therapeutic! agents! (327).! ! To! mimic! the! human! CRC!microenvironment,! orthotopic!models! of! CRC! have! been! developed,! injecting!murine!CRC!cell! lines! into! the! caecal!pole!via! laparotomy! (328),! colonic!wall! via! colonoscopy!(329)! or! into! the! rectal! wall! under! direct! visualisation! (330).! ! The! experiments!described! in! this!chapter!used!an!sc!allograft!model,!principally! to!obtain!comparable!tumours! in! all! grafted!mice!prior! to! treatment!with!CCR5! inhibitors.! !The! sc! allograft!model!was! also! chosen! to! enable! easy!monitoring! of! tumour! growth! and! to! facilitate!recovery!of!whole!tumour!tissue!for!analysis!at!the!end!of!the!experiment.!
Monitoring!tumour!growth!Traditionally,!tumour!growth!in!murine!cancer!models!has!been!monitored!by!calliper!measurements!of!the!tumour!axes!(331).!!Bioluminescent!imaging!(BLI)!of!tumours!has!been!shown!to!detect!impalpable!tumours!containing!as!few!as!10!000!cells!at!sc!sites!(332).!!The!principal!of!tumour!BLI!is!as!follows:!!Tumour!cells!expressing!the!enzyme!
luciferase,! convert! a! substrate! known! as! luciferin! into! light! via! a! chemiluminescent!reaction! (333).! ! Photons! from! this! reaction! are! then! detected! by! an! imaging! system.!!
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Tumour! cell! lines! are!modified! to! express! luciferase!prior! to! sc! implantation! in!mice.!!Luciferin! is! given! to!mice,! typically!by! intraperitoneal! (ip)! injection,!prior! to! imaging.!!Imaging! of! the! tumour! can! therefore! be! performed! non<invasively! at! multiple! time!points.! ! The! technique! is! useful! to! allow! imaging! of! impalpable! tumours! and! detect!metastasis!(332,334).!!Measurements!of!tumour!burden!by!BLI!has!also!been!shown!to!correlate!well!with!calliper!measurements!(331).!
Inhibition!of!CCR5!Studies!investigating!the!role!of!CCR5!in!mouse!models!of!human!disease!are!hampered!by! the! fact! that! no! selective! antagonist! of! murine! CCR5! currently! exists! (335).! ! A!neutralising!antibody!to!murine!CCR5!is!also!not!available.!!In!contrast,!a!human!CCR5!small!molecular!antagonist,!Maraviroc,!has!been!approved!for!the!treatment!of!patients!with!HIV!infection,!acting!by!inhibition!of!viral!entry!through!the!CCR5!receptor!(336).!!The!drug!has!an!excellent!safety!profile,!is!highly!selective!for!CCR5!and!is!administered!orally!(337).!!Maraviroc!possesses!no!activity!however!against!murine!CCR5!(338).!
Met8RANTES)Met<RANTES! is! a! functional! antagonist! of! CCR5.! ! Essentially,! met<RANTES! is!recombinant! human! RANTES! (CCL5)! with! an! additional! methionine! at! the! amino!terminus!(339).!!Met<RANTES!has!been!shown!to!antagonise!the!chemotactic!effects!of!the! natural! ligands! for! CCR5! as! well! as! reducing! the! inflammatory! infiltrate! in! a! rat!chronic!allograft!rejection!model!(340)!and!a!murine!breast!cancer!model!(341).! !The!drug! acts! by! inhibiting! passage! of! internalised! CCR5! into! recycling! endosomes,!preventing! re<expression! of! the! receptor! at! the! cell! surface! (342).! ! However,! met<
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RANTES! is! not! a! specific! CCR5! antagonist,! as! it! also! binds! and! inhibits! signalling!through!CCR1!and!CCR3!(343).!
TAK8779)TAK<779!is!a!small!molecular!weight!non<peptide!antagonist!of!human!CCR5!that!was!developed! for! its! activity! against! R5!HIV<1! virus! replication! (344).! ! TAK<779! inhibits!murine! as! well! as! human! CCR5,! but! is! not! specific! for! this! receptor.! ! TAK<779! also!antagonises! murine! CCR2,! CCR5! and! CXCR3! (345,346).! ! TAK<779! has! been! used! to!antagonise! murine! CCR5! in! a! model! of! pancreatic! cancer,! whereby! CCR5! blockade!reduced!the!infiltration!of!Treg!into!sc!tumours!(104).!!The!use!of!TAK<779!has!resulted!in! reduced! inflammatory! cell! infiltration! over! vehicle! in! colitis,! transplant! and!autoimmune!animal!models!(346–348).!




Cell!lines!CT26! (a! N<nitroso<N<methylurethrane! induced! undifferentiated! colon! carcinoma! cell!line,! strain! =! BALB/c)! and! CMT93! (a! methyl! azoxymethanol! acetate! induced! rectal!carcinoma! cell! line,! strain! =! C57BL/6)! were! purchased! from! the! ATCC! via! LGC!Standards,! UK.! ! CT26! and!CMT93! cell! lines!were! transduced! to! express! luciferase,! as!detailed! below.! ! Luciferase<expressing! B16<F10! cells! (B16<F10<Luc,! a! melanoma! cell!line,!strain!=!C57BL/6)!was!provided!by!Professor!Antal!Rot!(University!of!Birmingham,!UK).!
Mice!BALB/c!and!C57BL/6!wildtype!mice!were!purchased!from!Charles!River,!UK.!!Following!a! materials! transfer! agreement! with! Pfizer! Inc,! USA,! hCCR5KI! mice! embryos! were!reconstituted!and!a!mixture!of!homozygous!hCCR5,!heterozygous!hCCR5!and!wildtype!offspring!were!shipped!from!Charles!River,!MA,!USA!to!the!University!of!Birmingham,!UK.! ! hCCR5! KI! mice! were! bred,! genotyped! using! an! automated! genotyping! service!
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(Transnetyx! Inc.,! USA)! and! homozygote! offspring! were! used! in! subsequent!experiments.!!!
CCR5!inhibitors!Met<RANTES!was!a!gift! from!Dr!Amanda!Proudfoot,!Merck<Serono,!Switzerland.! !TAK<779!(Repository!reference:!ARP968)!was!obtained!from!the!Centre!for!AIDS!Reagents,!NIBSC! and!was!donated!by! the!AIDS!Research! and!Reference!Programme,!Division!of!AIDS,!NIAID,!NIH.!!UK<484900!was!a!gift!from!Pfizer!Inc,!USA.!
CCR6!inhibitor!CCR6!was!inhibited!using!a!rat!anti<mouse!CCR6!neutralising!antibody!(Clone:!140706,!MAB590<100,!R&D!Systems).! !This! antibody!has!been!previously! shown! to!neutralise!murine! CCR6,! without! resulting! in! cell! depletion,! in! vivo.! ! Following! one! antibody!injection,! its! presence! could! be! detected! on! the! surface! of! CD4+! cells,! an! effect! that!persisted!for!at!least!8!days!(350).!!!
Luciferase!transduction!of!murine!CRC!cell!lines!A!murine!stem!cell!virus!(MSCV)!was!used!as!a!retroviral!luciferase!expression!vector.!!Gag! (packaging! genes),! pol! (reverse! transcriptase)! and! env! (envelope! genes)! were!removed! and! replaced! by! the! insert! gene.! ! The! viral! vector! still! contained! the! long<terminal!repeat!required!for! insertion! into!the!host!genome,!packaging!signal!(ϕ)!and!the!transcription!and!processing!elements! i.e.! the!promoter!associated!with!the! insert!gene.! !Gag,!pol!and!env!genes!were!integrated!into!the!packaging!cell! line!to!minimise!the! chance!of! creating! a! replication<competent! retrovirus.! ! The! insert! gene! contained!luciferase! and! promoter! RNA! together! with! the! PAC! gene! to! convey! resistance! to!
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puromycin.! ! The! MSCV<luciferase! puromycin<resistance! plasmid! was! provided! by!Professor!Antal!Rot!(University!of!Birmingham,!UK).!
Transfection)of)packaging)cell)line)The! packaging! cell! line! (Phoenix! Ampho! cells,! ATCC,! USA)! was! seeded! into! a! 6<well!plate!at!a!density!of!2x106!cells!per!well! in!4!ml!DMEM!and!left!overnight!at!37˚C!5%!CO2.!!10!µg!plasmid!DNA!in!500!µl!DMEM!was!mixed!with!20!µl!Lipofectamine®!2000!(11668,! Life! Technologies! Ltd,! UK)! in! 500! µl! DMEM! and! left! for! 20!minutes! at! room!temperature.!!The!Phoenix!Ampho!cells!were!washed!with!3!ml!of!DMEM!and!then!4!ml!of!DMEM!+!1!ml!DNA/Lipofectamine®!mixture!was!added!to!each!well.!!The!cells!were!incubated!overnight!at!37˚C!5%!CO2.!!The!medium!in!each!well!was!replaced!with!4!ml!IMDM!+!20%!FCS!and!the!cells!were!incubated!for!a!further!24!hours,!this!time!at!32˚C!5%!CO2.! !The!viral!supernatant!was!harvested!every!24!hours!for!5!days!and!replaced!with!fresh!media.! !The!viral!supernatant!was!centrifuged!for!10!minutes!at!200!x!g! to!remove!cells,!placed!in!1!ml!aliquots!and!stored!at!<80˚C.!
Transduction)of)CT26)and)CMT93)cells)CT26!or!CMT93!cells!were!seeded! into!4!wells!of!a!6<well!plate!at!a!density!of!1x105!cells!per!well!in!4!ml!DMEM!+!10%!FCS.!!Cells!were!cultured!overnight!so!that!they!were!50%! confluent.! ! 1! ml! viral! supernatant! was! thawed! and! 4! µg! Polybrene®! (AL<118,!Sigma<Aldrich! Ltd,! UK)! was! added.! ! The! media! from! each! well! was! aspirated! and!replaced!with!2!ml!of!DMEM!10%!FCS!supplemented!with!4!µg/ml!Polybrene®.! !The!cells!were! incubated! for! 5!minutes! at! 37˚C.! ! 2!ml! of! viral! supernatant! supplemented!with!Polybrene®!was!added! to!3!of! the!4!wells.! !A! further!2!ml!of!DMEM!+!10%!FCS!supplemented!with!4µg/ml!Polybrene®!was!added!to!the!fourth!control!well.!!The!well<
! 217!
plate!was! centrifuged! for! 1! hour! at! 300! x!g! at! room! temperature.! ! The! supernatants!were!aspirated!from!each!well!and!replaced!with!4!ml!DMEM!+!10%!FCS.! !The!media!was!aspirated!and!replaced!at!24!and!48!hours!followed!by!puromycin!selection.!
Puromycin)selection)At! the! same! time! as! CT26! or! CMT93! cells! were! seeded! into! a! 6<well! plate! for!transduction,!1!x!105!cells!were!seeded!into!12!wells!of!a!24<well!plate!in!preparation!for!a!puromycin!sensitivity!assay.! !1!ml!of!DMEM!+!10%!FCS!was!added!to!each!well,!supplemented! with! puromycin! (A11138,! Life! Technologies! Ltd,! UK)! at! the! following!concentrations!(µg/ml):!!20,!15,!10,!7.5,!5,!2.5,!1.25,!0.63,!0.32,!0.16,!0.! !The!cells!were!cultured! for! 72! hours! in! this! media! at! 37˚C! 5%! CO2.! ! The! cells! were! detached! by!trypsinisation! and!100!µl! of! cell! suspension! from!each!well!was! placed! in! a! separate!well!of!a!96<well!plate!in!triplicate.!!10!µl!of!MTT!reagent!(V13154,!Vybrant®!MTT!Cell!Proliferation!Assay!Kit,!Life!Technologies!Ltd,!UK)!was!added!to!each!well,!mixed!gently!on!an!orbital! shaker! for!1!minute!and! then! incubated!at!37˚C! for!4!hours.! !Dissolving!solution!was!added!and!the!absorbance!from!each!well!was!read!at!570!nm.!
A! puromycin! concentration! of! 1.25! µg/ml! effectively! killed! non<transduced! CT26! cells,! 0.32!µg/ml! for! non<transduced! CMT93! cells.! ! 3! of! the! 4! wells! of! the! 6<well! plate! containing!transduced!CT26!(CT26<Luc)!or!CMT93!(CMT93<Luc)!cells!had!puromycin!added!at!the!above!concentration! plus! two! higher! concentrations.! ! For! example,! for! the! CT26<Luc! cells,! one!well!had!puromycin!added!at!a!concentration!of!1.25!µg/ml,!the!second!well!at!2.5!µg/ml,!the!third!well! at! 5! µg/ml! and! the! fourth!well! had! no! puromycin! added.! ! The! cells!were! cultured! for! a!further!72!hours!and!live!cells!cultured!in!the!highest!puromycin!concentration!were!harvested!and!further!cultured!in!DMEM!+!10%!FCS.!!Stable!luciferase!expression!was!tested!by!splitting!
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Figure! 6<1:! Luciferase<transduced! CT26! cells! (CT26<Luc).! ! Control! cells! (bottom)! did! not!express!luciferase!while!expression!was!seen!by!CT26<Luc!cells!selected!in!puromycin!(top).!
!
Tumour!cell!in!vitro!proliferation!assays!To!test!the!effects!of!CCR5!inhibitors!on!tumour!cell!proliferation!in!vitro,!1!x!104!CT26<Luc,!CMT93<Luc!or!B16<F10<Luc!cells!were!seeded!into!wells!of!a!96<well!plate!in!200!µl!of!DMEM!+!10%!FCS.!!Met<RANTES,!TAK<779,!UK<484900!and!PBS!were!added!to!wells!at!different!drug!concentrations!in!triplicate.!!The!cells!were!then!cultured!for!24!hours!at!37˚C!5%!CO2!at!which!point!they!had!grown!to!40<50%!confluence.!!20!µl!of!CellTiter!96®!Aqueous!One!Solution!(G3580,!Promega!Inc,!USA),!an!MTT!reagent,!was!added!to!each!well! using! a!multi<channel! pipette.! ! The!well<plate!was! incubated! at! 37˚C! for! 3!hours!and!absorbance!from!each!well!was!then!read!at!490!nm.!
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The!murine!pharmacokinetics!of!met<RANTES!and!TAK<779!are!not!known!and!it!was!not!possible!to!assay!drug!levels!in!the!serum!or!tissues.!!Individual!doses!of!drug!given!to!mice!were!10!µg!met<RANTES,!150!µg!TAK<779!and!200!µg!UK<484900,!as!has!been!used! previously! (104,297,341,347,349).! ! Complete! inhibition! of! radiolabelled! CCL5!binding! to! CCR5! has! been! observed! at! 100! nM! for! both! met<RANTES! and! TAK<779!(339,344),!representing!drug!concentrations!of!8!pg/ml!and!53!pg/ml!respectively.!!The!pharmacokinetics!of!UK<484900!in!the!mouse!has!been!studied!(349)!and!a!twice<daily!sc!dose!of!200!µg!leads!to!complete!inhibition!of!CCR5!with!a!nadir!serum!concentration!of!10!nM!(equivalent!to!6.5!ng/ml).!!The!drug!concentrations!of!met<RANTES,!TAK<779!and!UK<484900!used!in!the!in!vitro!proliferation!experiments!were!therefore!likely!to!be!higher!than!those!found!in!the!tissues!in!vivo.!!!
Subcutaneous!tumour!models!of!CRC!Tumour!cell!suspensions!were!aspirated!and!expelled!through!a!25<gauge!needle,!then!mixed!with! 0.4%!Trypan!blue! solution! (T8154,! Sigma<Aldrich! Ltd,!UK).! ! Cell! viability!was! evaluated!using! a! haemocytometer.! ! All! cell! lines!were!95%!viable! after! passage!through!a!25<gauge!needle!and!this!gauge!needle!was!therefore!used!for!sc!injection!of!tumour!cells.!!At!the!start!of!the!experiment,!day!0,!CT26<Luc!cells!were!injected!sc!into!the!left!flank!of!female!BALB/c!mice!at!a!density!of!5!x!105!cells!in!100!µl!of!PBS.!!This!density!was!shown!in!pilot!experiments!to!produce!a!tumour!less!than!1.25!cm!x!1.25!cm! 10! days! post<injection.! ! CMT93<Luc! were! rejected! by! female! mice! in! pilot!experiments!and!by!some!male!mice!when!injected!in!PBS.!!It!was!found!that!injection!in! extra<cellular! matrix! gel! (ECM,! E6909,! from! Engelbreth<Holm<Swarm! murine!sarcoma,! Sigma<Aldrich! Ltd,!UK)! resulted! in! viable! tumours! 10!days! post<injection! in!
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male!mice.! !Therefore,!CMT93<Luc!cells!were! injected!sc!at!day!0! into!the! left! flank!of!male!C57BL/6!mice!at!a!density!of!1!x!106!cells! in!100!µl!ECM!gel.! !B16<F10<Luc!cells!were! injected!sc!at!day!0! into!the! left! flank!of!hCCR5!KI!mice!at!a!density!of!2.5!x!105!cells! in!100!µl!of!PBS,!as!used!previously!by!other! investigators!(351).! !All!mice!were!weighed!on!day!0.!
Tumours!were!barely!palpable!at!day!7.!!Tumour!engraftment!was!therefore!ensured!by!BLI!and!was!confirmed!in!all!cases.!!Tumour!growth!was!monitored!by!regular!calliper!measurements!and!BLI,!according! to! the!experiment!schedule!(see!Figure!6<2).! !From!day!7!up!to!and!including!day!17,!mice!were!injected!with!either!10!µg!met<RANTES!ip!once!daily,!150!µg!TAK<779!sc!once!daily!or!200!µg!UK<484900!sc!twice!daily.!!In!some!experiments,!met<RANTES!was!delivered!by!an!osmotic!pump,! in!which!case!the!daily!total!infusion!was!10!µg.!!Mice!were!culled!at!day!17!following!cardiac!puncture.!!200!µl!blood!was!placed!in!a!sterile!Eppendorf.!!These!blood!samples!were!centrifuged!at!350!x!




Sample!preparation!In!some!cases,!a!small!piece!of!tumour!tissue!was!taken!and!placed!in!formal!saline!or!snap! frozen! and! stored! at! <80˚C,! for! later! immunohistochemical! or! protein! analysis,!respectively.! !Whole!tumour!and!spleen!tissue!in!10!ml!cRPMI!was!transferred!into!C<tubes! (Miltenyi! Biotech)! and! spun! on! the! gentleMACS! dissociator! using! the! Mouse<Spleen<1!protocol.!!Dissociated!samples!were!then!passed!through!a!70!µm!cell!strainer!(08<771<2,!Corning!Inc,!USA),!pelleted!and!resuspended!in!500!µl!cRPMI.!!500!µl!blood!samples!were!mixed!with!5!ml!red!cell!lysis!buffer!(R7757,!Sigma<Aldrich!Ltd,!UK)!and!agitated!for!5!minutes.!!The!blood!/!lysis!buffer!mixture!was!then!washed!twice!with!20!ml! PBS! and! resuspended! in! 500! µl! cRPMI.! ! 0.5! µl! of! near<IR! live/dead! fixable! stain!(L10119,!Life!Technologies!Ltd,!UK)!and!20!µl!mouse!serum!(M5905,!Sigma<Aldrich!Ltd,!UK)!were!added!to!tumour,!spleen!and!blood!samples.!!Samples!were!incubated!for!20!minutes!at!4˚C!in!the!dark.! !1!ml!of! ice<cold!cRPMI!was!added!to!each!sample!and!the!samples!were!pelleted.!!Blood!and!tumour!samples!were!resuspended!in!500!µl!cRPMI!and! spleen! samples! were! resuspended! in! 2! ml! of! cRPMI.! ! 1.5! ml! of! the! spleen! cell!suspensions! were! discarded! or! used! for! single! colour! compensation! controls.! ! Cell!















surface! labelling! was! performed! by! incubating! 500! µl! of! cell! suspensions! with! the!antibodies!listed!in!Table!6<1!(excluding!the!anti<foxp3!antibody)!for!45!minutes!at!4˚C!in! the! dark! on! the! rocker.! ! The! hCCR5! antibody!was! used! for! experiments! involving!hCCR5!KI!mice,!otherwise! the!mCCR5!was!used.! ! Intra<cellular!staining! for! foxp3!was!performed! as! described! in! Chapter! 2:! Intra<cellular! staining,! using! a! rat! anti<mouse!foxp3!antibody!as!listed!in!Table!6<1.!!!
!
Table! 6<1:! ! Cell! surface! and! intra<cellular! antibodies! used! for! labelling! of! blood,! spleen! and!tumour!lymphocytes.!!mCCR5!=!murine!CCR5;!hCCR5!=!human!CCR5.!
Antigen! Clone! Fluorochrome! Isotype! Manufacturer! Code!CD3! 145<2C11! PE<Cy7! Hamster!IgG! Biolegend! 100320!CD4! RM4<5! V500! Rat!IgG2a! BD! 560782!CD8! 53<6.7! PE<CF594! Rat!IgG2a! BD! 562283!mCCR5! HM<CCR5! APC! Hamster!IgG! Biolegend! 107012!DX5! DX5! FITC! Rat!IgM! Biolegend! 108906!CXCR3! CXCR3<173! BV421! Hamster!IgG! Biolegend! 126521!hCCR5! CTC5! APC! Ms!IgG1! R&D! FAB1802A!Foxp3! FJK<16s! PE! Rat!IgG2a! eBioscience! 12<5773!!













The!proportion!and!absolute!number!of! live!CD3+! cells! that!were!CD4+!or!CD8+!were!evaluated.!!The!proportion!and!absolute!number!of!live!CD3+!CD4+!cells!that!were!Treg!or!Tconv!were!evaluated.!!CCR5!expression!by!different!cell!subsets!was!measured.!









normalised!to!300!µg/ml.! !Serum!and!tumour!concentrations!of!CCL3,!CCL4,!CCL5!and!VEGF!were!measured!using!a!Mix<N<Match!ELISArray!Kit!(336111,!SABiosciences)!and!a!mouse!VEGF!ELISA!kit!(MMV00,!R&D!Systems!Inc,!USA),!according!to!manufacturer’s!instructions.! ! Standard! curves!were! not! derived! for! each! chemokine! and! absorbance!was!therefore!the!read<out!in!this!semi<quantitative!assay.!!!
Immunohistochemistry!A! tissue! microarray! was! constructed! from! FFPE! tumour! samples.! ! Sections! were!deparaffinised!and!rehydrated!and!immunohistochemistry!was!performed!according!to!the! methods! described! in! Chapter! 2:! Common! immunohistochemistry! protocol.!!Sections!were!stained!for!CD31!(rabbit!anti<mouse!CD31,!sc<28188,!Santa!Cruz!Inc,!USA,!dilution!1/50)!or!isotype<control!antibody!at!the!same!concentration.!!
Results!
Chemokine!receptor!expression!by!tumour!cell!lines!Chemokine! receptor! expression! by! cultured! tumour! cell! lines! was! assessed! by! flow!cytometry!(see!Figure!6<4).! !Approximately!one<third!of!CT26<Luc!cells!were!found!to!express!surface!CCR5!and!a!smaller!proportion!expressed!surface!CCR6.! !B16<F10<Luc!cells! expressed! both! surface! murine! CCR5! and! murine! CCR1,! but,! as! expected,! not!human!CCR5.!!None!of!the!cell!lines!expressed!surface!murine!CXCR3.!
!
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!Figure! 6<4:! ! Chemokine! receptor! expression! by! tumour! cell! lines,! as! measured! by! flow!cytometry.! ! Quoted! figures! represent! percentage! chemokine! receptor! expression! by! cell! line!compared!with!isotype!control!antibody.!!!
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B16<F10<Luc! proliferation! at! a! dose! of! 500! µg/ml! of! UK<484900,! although! this!difference! did! not! reach! statistical! significance.! ! TAK<779! significantly! inhibited! the!proliferation!of!CT26<Luc!cells!at!all!studied!doses.!
!Figure! 6<5:! ! In! vitro! proliferation! of! tumour! cell! lines.! ! (a)! CT26<Luc! proliferation! in! media!containing!different!concentrations!of!met<RANTES!(black)!and!TAK<779!(blue).! !Proliferation!of!B16<F10<Luc!(black)!and!CMT93<Luc!(blue)! in!media!containing!different!concentrations!of!UK<484900.! ! Data! represent! the! mean! absorbance! of! triplicate! repeats.! ! The! error! bars!represent!the!standard!error!of!the!mean.!
!
CCR5!expression!by!TILs!CCR5!expression!by!TILs!isolated!from!control!group!tumours!at!day!17!were!analysed!by! flow! cytometry.! ! Percentage! and! MFI! expression! by! Treg! was! compared! with!expression! by! Tconv! and! CD8+! TILs! (see! Figure! 6<6a+b).! ! Tumour! Treg! expressed!significantly!more!CCR5,! in! terms!of!both!percentage!expression!and!MFI,! than!Tconv!for!all!three!cell!lines.!!Treg!also!expressed!significantly!more!CCR5!than!CD8+!cells!with!respect! to!B16<F10<Luc! tumours.! !Tumour<isolated!Treg! expressed! significantly!more!CCR5! than! lymphocytes! isolated! from! spleen! and! blood,! in! term! of! both! percentage!expression!and!MFI!(see!Figure!6<6c+d).!
Effect of UK-484900 on B16-F10-Luc 
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Figure!6,7:!!The!effects!of!sc!osmotic!pump!delivery!of!PBS!(control!group,!n=3)!or!met,RANTES!(treatment! group,! n=5)! in!CT26,Luc! tumour,bearing!BALB/c!wildtype!mice.! ! Tumour! growth!was!measured!by!(a)!BLI!and!(b)!tumour!weight!post,resection.!!Mean!values!are!shown.!!Error!bars! represent! the! standard! error! of! the!mean.! ! Capped! lines! indicate! statistically! significant!differences!(Mann,Whitney!test).!!sc!=!subcutaneous.!
!
It!was! surprising! that! tumours! in! the! treatment! group!were! larger! than! those! in! the!control! group.! ! As!met,RANTES! has! previously! been! reported! to! have! partial! agonist!activity! (352,353),! it!was!hypothesised! that!met,RANTES!may!have!exhibited!a!CCL5,like!direct!stimulation!of!CT26,Luc!cell!proliferation!in!this!experiment.!!Therefore,!the!
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experiment! was! repeated! using! ten! 8,week! old! female! BALB/c! mice! but! on! this!occasion,!met,RANTES!was!delivered!by!a!continuous!infusion!of!met,RANTES!ip.!!This!was!achieved!by!performing!laparotomies!on!all!mice!at!day!7,!then!implanting!osmotic!pumps,! containing! either! PBS! or! met,RANTES,! into! the! peritoneal! cavity.! ! The! main!results! from!this!experiment!are! shown! in!Figure!6,8.! !Again,!met,RANTES! treatment!resulted!in!significantly!larger!tumours!by!BLI!and!calliper!measurement!compared!to!the! control! group,! although! this!was! not! reflected! in! a! significant! increase! in! tumour!weight!post,resection.!!!
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!
!!!!!!!!!!!!!!!Figure!6,8:!!The!effects!of!ip!osmotic!pump!delivery!of!PBS!(control!group,!n=5)!or!met,RANTES!(treatment!group,!n=5)!in!CT26,Luc!tumour,bearing!BALB/c!wildtype!mice.! !Tumour!growth!was!measured!by!(a)!BLI,!(b)!calliper!measurements!and!(c)!tumour!weight!post!resection.!!Mean! values! are! shown.! ! Error! bars! represent! the! standard! error! of! the!mean.! ! Asterisks! ‘*’! indicate! statistically! significant! differences! in!tumour!growth!at!a!given!time!point!(Mann,Whitney!test,!P<0.05).!!ip!=!intra,peritoneal.!
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With!delivery!of!met1RANTES!by!the!ip!route!as!opposed!to!the!sc!route,!there!was!no!difference! in! tumour! Treg! proportion! and! no! difference! in! TIL! CCR5! expression!between!the!control!and!treatment!groups.!
CCR5$inhibition$with$met.RANTES$and$TAK.779$by$repeated$injection$It! was! hypothesised! that! delivery! of! met1RANTES! by! repeated! injection! might! have!different! effects! on! tumour! growth! and! Treg! infiltration! compared! to! delivery! by!continuous! infusion.! ! The! experiment! was! therefore! repeated! using! 27! 81week! old!female!BALB/c!mice!(9!mice!in!each!group),!giving!PBS!(control!group)!or!met1RANTES!by!once!daily!ip!injection.!!A!second!treatment!group!received!TAK1779!by!once!daily!sc!injection.!!The!main!results!from!this!experiment!are!shown!in!Figure!619.!!Delivery!of!met1RANTES!by!once!daily!injection!resulted!in!significantly!delayed!tumour!growth!by!BLI,!calliper!measurement!and!tumour!weight!post1resection!compared!with!controls.!!TAK1779! treatment! also! resulted! in! significantly! delayed! tumour! growth.! ! However,!neither!drug!treatment!was!associated!with!a!change!in!the!tumour!Treg!proportion!or!a! change! in!CCR5!expression!by!TIL! subsets! compared!with! controls.! !There!were!no!differences!in!the!absolute!numbers!of!tumour1infiltrating!Treg!or!other!TILs!between!treatment!groups.!
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!
Figure! 6+9:! ! Once! daily! injection! of! PBS! (control! group,! black,! n=8),!met+RANTES! (red,! n=9)! or! TAK+779! (blue,! n=8)! in! CT26+Luc! tumour+bearing!BALB/c!wildtype!mice.! !Tumour!growth!was!measured!by!(a)!BLI,!(b)!calliper!measurements!and!(c)!tumour!weight!post!resection.!!Mean! values! are! shown.! ! Error! bars! represent! the! standard! error! of! the!mean.! ! Asterisks! ‘*’! indicate! statistically! significant! differences! in!tumour!growth!at!a!given!time!point!(Mann+Whitney!test).! !Capped!lines!indicate!statistically!significant!differences!between!groups!(Mann+Whitney!test).!
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A!different!cell!line,!B162F102Luc!was!therefore!used!to!establish!tumours!in!hCCR5!KI!mice,!which!grew!progressively!in!the!time!period!of!the!experiment!schedule!and!were!not!rejected.!!Despite!B162F102Luc!not!being!a!CRC!cell!line,!B162F102Luc!tumours!were!enriched!with!Treg!and! the!pattern!of!CCR5!expression!by!TIL!subsets!was!similar! to!that!seen!in!CT262Luc!and!CMT293!tumours!(see!Figure!626)!as!well!as! in!human!CRC!(see!Figure!325).!!B162F102Luc!tumours!were!therefore!established!in!10!female!hCCR5!KI!mice,!aged!729!weeks,!and!mice!were!then!treated,!as!before,!with!either!twice!daily!sc! PBS! (control! group)! or! twice! daily! sc! UK2484900! (treatment! group).! ! The! results!from!this!experiment!are!shown!in!Figure!6211.! !Treatment!with!UK2484900!made!no!difference! to! the! tumour! growth! or! the! tumour! Treg! proportion! compared! with!controls.! ! There! was! however! significantly! greater! CCR5! percentage! expression! by!tumour2infiltrating!Treg!in!the!treatment!group!compared!with!controls!(Figure!6211e)!and! a! significantly! greater! CD8! :! CD4! ratio! in! the! treatment! group! compared! with!controls! (see! Figure! 6211f).! ! There! were! no! differences! in! the! absolute! numbers! of!tumour2infiltrating!Treg!or!other!TILs!between!treatment!groups.!
In! spite! of! the! tumour! growth! now! being! progressive! with! no! observed! tumour!rejection,!in!conjunction!with!specific!human!CCR5!inhibition!provided!by!UK2484900,!the!model!did!not!demonstrate!delayed! tumour!growth!with!associated!reduced!Treg!infiltration!as!has!been!previously!published!in!CCR5!2/2!models!(104,233).!!!
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!
Figure! 6,11:! ! Twice! daily! injection! of! PBS! (control! group,! n=5)! or! UK,484900! (red,! n=5)! in! B16,F10,Luc! tumour,bearing! hCCR5! KI!mice.!!Tumour!growth!was!measured!by!(a)!BLI,!(b)!calliper!measurements!and!(c)!tumour!weight!post!resection.! !Mean!values!are!shown.! !Error!bars!represent!the!standard!error!of!the!mean.!!Capped!lines!indicate!statistically!significant!differences!between!groups!(Mann,Whitney!test).!
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Caliper measurement of tumour size

































































In! order! to! determine! if! CCR5! inhibition! is! required! from! the! time! of! tumour! cell!injection!to!produce!such!effects,!B16?F10?Luc!tumours!were!established!in!10!female!hCCR5!KI!mice,!aged!7?9!weeks,!and!treatment!with!either!twice!daily!sc!PBS!(control!group)! or! twice! daily! sc! UK?484900! (treatment! group)!was! commenced! from! day! 0.!!The!duration!of!the!experiment!was!10!days,!at!which!point!mice!were!culled!and!blood,!spleen!and!tumour!tissue!were!analysed!as!before.!!The!results!from!the!experiment!are!shown!in!Figure!6?12.!
Treatment!of!hCCR5!KI!mice!with!UK?484900,!commencing!at! the!time!of! tumour!cell!injection,! resulted! in! significantly! delayed! tumour! growth! compared! with! controls.!!There!was!no!difference!in!the!tumour!Treg!proportion!between!control!and!treatment!groups.!!Unlike!the!previous!experiment,!where!treatment!was!commenced!7!days!post?tumour! cell! injection,! there!was! neither! a! difference! in! CCR5! expression! by! tumour?isolated!Treg!nor!in!the!tumour!CD8!:!CD4!ratio!between!control!and!treatment!groups.!!There!was!also!no!difference!in!the!proportion!of!live!lymphocyte?gated!cells!that!were!DX5+! (NK! cells)! or! in! the! proportion! of! live! CD3+! cells! that! were! DX5+! (NKT! cells)!between!control!and!treatment!groups!(data!not!shown).!
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!Figure! 6,12:! ! Twice! daily! injection! of! PBS! (control! group,! n=6)! or! UK,484900! (red,! n=7)! in! B16,F10,Luc! tumour,bearing! hCCR5! KI!mice.!!Treatment!was!commenced!at!the!time!of!tumour!cell!injection.!!Tumour!growth!was!measured!by!(a)!BLI,!(b)!calliper!measurements!and!(c)!tumour!weight!post,resection.!!Mean!values!are!shown.!!Error!bars!represent!the!standard!error!of!the!mean.!!Asterisks!‘*’!represent!statistical!significant!differences!in!tumour!growth!at!a!specific!time!point!(Mann,Whitney!test).!!Capped!lines!indicate!statistically!significant!differences!between!groups!(Mann,Whitney!test).!
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CCR5$ligand$concentrations$in$serum$and$tumour$tissue$Small!pieces!of!tumour!tissue!and!serum!were!obtained!from!4!control!mice!and!4!UK<484900<treated!mice!from!the!experiment!described!in!the!previous!paragraph.!!Semi<quantitative! measurements! of! CCL3,! CCL4! and! CCL5! concentrations! in! serum! and!tumour! protein! lysates! were! performed.! ! There! was! a! trend! for! higher! levels! of! all!
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measured!chemokines!in!the!tumours!of!mice!treated!with!UK<484900!compared!with!controls!(see!Figure!6<14),!with!the!difference!in!CCL5!reaching!statistical!significance.!!Similarly,!CCL5! levels!were!significantly!higher! in! the!serum!of!mice! treated!with!UK<484900!compared!with!controls.!!Serum!levels!of!CCL3!and!CCL4!were!undetectable.!
!
Figure!6<14:! ! Tumour! (a)! and! serum! (b)! levels! of! CCL3,! CCL4! and!CCL5! from!hCCR5!KI!mice!treated!with!PBS!(Controls,!n=4)!or!UK<484900!(n=4)!were!measured!semi<quantitatively.! !(c)!Tumour!and!serum!levels!of!VEGF!from!the!same!mice.!!Mean!values!are!shown!with!error!bars!representing! the! standard! error! of! the! mean.! ! Capped! lines! indicate! statistically! significant!differences!(Mann<Whitney!test).!































































































There!was!a!trend!for!lower!tumour!and!serum!VEGF!levels!in!UK<484900!treated!mice!compared! with! controls,! although! these! differences! did! not! reach! statistical!significance.!
CD31$immunohistochemistry$A!tissue!microarray!was!constructed!from!FFPE!tumour!samples!and!stained!for!CD31!by! immunohistochemistry.! ! Unfortunately,! there! was! scant! CD31+! endothelium!observed!within!the!small! tissues!samples,!rendering!a!comparison!of!staining!density!between!control!and!treatment!groups!impossible!(see!Figure!6<15).!!
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Figure!6+16:!!One+off!tail!vein!injections!of!rat!IgG2a!(control!group,!n=4)!or!rat!anti+mouse!CCR6!antibody!(treatment!group,!n=5)!at!day!7!in!CT26+Luc! tumour+bearing!BALB/c!mice.! !Tumour!growth!was!measured!by! (a)!BLI,! (b)! calliper!measurements!and! (c)! tumour!weight!post!resection.!!Mean!values!are!shown.!!Error!bars!represent!the!standard!error!of!the!mean.!!
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Tumour!establishment!in!mice!with!the!colorectal!cancer!cell!lines,!CT26!and!CMT93,!or!with! the! melanoma! cell! line! B16>F10,! resulted! in! tumour! growth! that! could! be!measured!over!a!17>day!period.!!The!tumours!harboured!lymphocytes!of!which!a!high!proportion!were! Treg! and! similar! to! the! findings! in! human! CRC,! the! Treg! expressed!significantly!more! cell! surface!CCR5! than! their!Tconv! counterparts.! ! Thus,! the!mouse!models! used! in! this! chapter! appeared! appropriate! to! investigate! the! role! of! CCR5! in!recruitment! of! Treg! into! tumours.! ! Murine! CCR5!was! antagonised!with!met>RANTES!and!TAK>779!while!human!CCR5!was!antagonised!with!UK>484900!in!hCCR5!KI!mice.!!One! limitation!of! these!mouse!models!was!the! inability! to!assay!drug! levels! to!ensure!adequate!concentrations!in!the!serum!and!tissues.!
Tumour!growth!Both! met>RANTES! and! TAK>779! treatment! resulted! in! significantly! smaller! tumours!compared! to! controls! when! given! by! once! daily! injection! and! this! is! consistent! with!previous!published!data!based! in!different!murine! tumour!models!(104,267,297,341).!!The!previous!studies!hypothesised!that!tumour!growth!was!delayed!as!a!direct!result!of!reduced! tumour! Treg! infiltration.! ! However,! in! our! models,! CT26! cells! express! both!CCR5!and!CCR1!and!therefore!a!direct!effect!of!met>RANTES!and!TAK>779!on!tumour!cell! growth! cannot! be! ruled! out.! ! Others! have! shown! that! in! vitro! CCL5! treatment! of!CT26!cells!increases!proliferation!compared!to!vehicle,!an!effect!that!can!be!inhibited!by!TAK>779! (267).! ! In! vitro! experiments! presented! in! this! chapter! showed! that! met>RANTES! had! no! effect! on! CT26! proliferation! but! direct! tumour! cell! effects! are! still!possible! in! vivo.! ! To! determine! if! this! is! indeed! the! case,! tumours! could! have! been!
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established!in!immunodeficient!mice!and!then!treated!with!either!met>RANTES!/!TAK>779! or! vehicle.! ! This! was! not! done! due! to! the! costs! of! purchasing! and! maintaining!immunodeficient! mice.! ! Delayed! lung,! melanoma! and! lymphoma! tumour! growth! has!been! observed! in! CCR5>/>!mice! (289,297,354)! compared! to!wildtypes! supporting! the!idea! that! CCR5! expressed!by!host! cells! is! responsible! for! the!delayed! tumour! growth!because!injected!tumour!cells!may!still!express!CCR5.! !In!a!tissue!injury!mouse!model,!delayed! wound! healing! is! observed! in! CCR5! >/>! mice! compared! with! wildtypes,!associated!with! impaired!recruitment!of!endothelial! cells!and!reduced! tissue! levels!of!VEGF! (355).! ! There! was! a! trend! for! lower! tumour! and! serum! VEGF! levels! in! mice!treated! with! CCR5! inhibitors! (see! Figure! 6>14c)! and! this! could! have! contributed! to!delayed!tumour!growth.!
Delivery!of!met>RANTES!by!continuous!infusion!paradoxically!led!to!increased!tumour!growth!compared!to!control!mice.!!This!may!be!explained!by!the!partial!agonist!activity!of! met>RANTES.! ! The! ligands! for! CCR5! stimulate! internalisation! of! the! receptor,! but!met>RANTES! also! stimulates! internalisation,! in! a! manner! that! is! not! consistent! with!competitive!antagonism!(352).!!In!this!sense,!met>RANTES!is!an!atypical!antagonist.!!It!has!also!been!shown!that!cell>surface!bound!met>RANTES!can!be!metabolised!to!CCL5!by! endogenous! aminopeptidases,! leading! to! agonist! effects! (339,352).! ! Tumour! CCL5!expression! is! associated!with! tumour! growth! (104,233)! and! intratumoral! injection!of!CCL5!leads!to!an!increase!in!tumour!Treg!infiltration!(297).!!It!is!therefore!possible!that!met>RANTES! in! the! osmotic! pumps! was! enzymatically! converted! to! CCL5! over! the!course!of!the!experiments,!leading!to!the!observed!increased!tumour!growth!and!Treg!
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infiltration!compared!with!control!mice.!There!are!no!published!reports!using!delivery!of!met>RANTES!by!osmotic!pump.!
Timing!of!drug!therapy!Treatment! of! hCCR5! KI! mice! with! UK>484900! led! to! significantly! delayed! tumour!growth!compared!to!control!mice,!but!only!when!treatment!was!commenced!at!the!time!of! tumour! cell! injection.! ! No! such! effect! on! tumour! growth! was! observed! when!treatment!was!delayed!until! tumour!engraftment!was!established!at!day!7.! !Published!studies!demonstrating!delayed!tumour!growth!with!met>RANTES!treatment!compared!to! controls! (297,341)! commenced! drug! at! the! same! time! as! tumour! cell! injection!whereas!reports!of!delayed!tumour!growth!with!TAK>779!commenced!drug!treatment!2!weeks! (104)! or! 72! hours! (267)! post>tumour! cell! injection;! although! the! experiment!schedule!was!notably!longer!(31!days!and!10!weeks,!respectively)!than!the!schedule!for!the!experiments!described!in!this!chapter.!!It!is!thus!possible!that!the!lack!of!difference!in! tumour! growth! rates! between! UK>484900! treated! mice! and! controls! when! drug!treatment! was! delayed! until! day! 7,! can! be! explained! by! the! relatively! rapid! and!progressive!tumour!growth!and!hence,!short!experiment!schedule,!of!the!model.!
Lymphocyte!infiltration!The! proportion! of! Treg! in! the! CT26>Luc! tumours! increased! with! met>RANTES! by!continuous!sc!infusion.!!If!met>RANTES!was!enzymatically!modified!to!CCL5!during!the!course! of! this! experiment,! augmented! tumour! CCL5! levels! may! have! resulted! in!increased! Treg! infiltration.! ! This! would! be! consistent! with! published! data!demonstrating! increased! Treg! infiltration! in! CT26! tumours! treated! by! intratumoral!injection!of!CCL5!(297).!!Outside!of!this!infusional!met>RANTES!experiment,!there!was!
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no! difference! in! the! tumour! Treg! proportion! between! treatment! and! control! groups,!across! 5! different! experiments! involving! 3! different! tumour! cell! lines! and! 3! different!CCR5!inhibitors.!!This!suggests!that!Treg!were!not!actively!recruited!to!the!tumour!site!by!a!CCR5>dependent!mechanism.!!These!data!contradict!the!findings!of!Tan!et!al!(104),!who!demonstrated!that!CCR5!inhibition!with!TAK>779!in!a!murine!model!of!pancreatic!cancer! led! to! reduced! tumour!Treg! infiltration! compared!with!PBS! treatment.! ! There!are!however! some!unanswered!questions! regarding! the!Tan!et! al! study.! !The! tumour!Treg!proportion!in!control!mice!was!74%!compared!with!49%!in!TAK>779!treated!mice.!!In!a!different!experiment!using!the!same!wildtype!Pan02!cell! line,!but!with!a!different!experiment!duration!of!7!more!days,!control!group!mice!had!a!tumour!Treg!proportion!of!43%.! !Quite!apart! from!the!extraordinarily!high!tumour!Treg!proportion!of!74%!in!control!mice,!the!reduction!in!Treg!proportion!to!49%!in!treatment!mice!is!still!higher!than!the!tumour!Treg!proportion!in!control!mice!from!other!experiments.!!!
Knockdown!of!CCL5!expression!in!tumours!has!also!been!associated!with!a!reduction!in!tumour! Treg! infiltration! (104,233).! ! CCL5! knockdown! does! not! necessarily! abolish!CCR5! signalling! because! other! ligands! can! activate! CCR5! and! CCL5! binds! to! other!receptors,! notably! CCR1! and! CCR3.! ! Knockdown! of! CCL5! will! also! affect! signalling!through! these! receptors! with! consequent! effects! on! tumour! growth! and! in! Treg!infiltration.!!In!tumour!cell!migration!experiments,!CCR1!and!CCR5!were!found!to!act!in!a!redundant!manner! i.e.!both!receptors!needed!to!be!antagonised!to! inhibit!migration!(356).! ! Even! though! intratumoral! injection! of! CCL5! increases! (297)! and! CCL5!knockdown!decreases!(104,233)! tumour!Treg! infiltration,! inhibition!of!CCR5!may!still!have!no!effect!on! tumour!Treg!recruitment,!as!Treg!may!be!recruited!via!other!CCL5>
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binding! chemokine! receptors.! ! Tumour! and! serum! levels! of! CCL5! were! significantly!greater!in!mice!treated!with!UK>484900!than!controls!(seeFigure!6>14),!an!effect!which!could! lead! to! increased! signalling! through! CCR1! and! CCR3.! ! Chemokine! receptor>deficient! mice! are! known! to! exhibit! increased! tissue! and! serum! levels! of! cognate!chemokines,!an!effect!that!has!been!described!as!chemokine!receptor!scavenging!(357).!!In!relation!to!tumour!progression!rather!than!Treg!infiltration,!CCR5!inhibition!by!TAK>779! only! partially! inhibited! tumour! progression! compared! to! anti>CCL5! treatment,!suggesting! that! anti>CCL5! treatment!may! inhibit!more! signalling! pathways! than! anti>CCR5!treatment.!!!
Reduced! tumour! Treg! infiltration! has! been! reported! in! CCR5! >/>! models! (233,297).!!While!these!studies!do!suggest!a!role!for!CCR5!in!the!recruitment!of!Treg!to!tumours,!it!is! important!to!remember!that!these!mice!have!developed!in!the!absence!of! the!CCR5!gene.! ! Loss! of! CCR5! activity!may!mask! the! role! of! the! gene! in! the! adult! state! due! to!compensatory!changes! in!the!expression!of!other!genes!during!development!(358).! !A!general!limitation!surrounding!the!use!of!knockout!mice!is!known!as!the!‘flanking!allele!problem’.! ! The! embryonic! stem! cells! populating! the! germline! transmit! their! genetic!background! as!well! as! the! null!mutation.! ! Thus,! the! null!mutation! is! flanked! by! two!embryonic!stem!cell!alleles!while!the!wildtype!locus!is!flanked!by!two!C57BL/6!alleles.!!The!possibility!therefore!exists!that!an!apparent!effect!of!a!null!mutation!could!be!due!to! a! flanking! embryonic! stem! cell! gene! (359).! ! While! CCR5! >/>! mice! have! a! normal!lifespan! and! behaviour,! there! is! an! immune! phenotype! attributed! to! these! mice!characterised!by!an!increased!number!of!CD4+!and!NKT!cells!in!the!gut,!associated!with!increased! levels!of! IL>4,! IL>5!and! IL>10!and! reduced! levels!of! IFN>γ! (360).! ! Studies! in!
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CCR5!>/>!mice!have!also!demonstrated!reduced!migration!of!macrophages!and!NK!cells!compared!with!wildtypes! (361,362).! ! In! a!murine! graft>versus>host! disease!model,! T!cells!from!wildtype!and!CCR5!>/>!mice!were!adoptively!transferred!to!wildtype!mice!at!the! time! of! bone!marrow! transplant! (307).! ! It!was! demonstrated! that! CCR5! >/>! Treg!were! suppressive! and! proliferated! in! vitro,! in! a! similar! manner! to! wildtype! Treg.!!However,!after!one!week,!CCR5!>/>!failed!to!infiltrate!target!organs!while!wildtype!Treg!did! not,! suggesting! that! CCR5! is! critical! to! the! recruitment! of! Treg! to! sites! of!inflammation.! ! Despite! the! lack! of! difference! between!wildtype! and! CCR5! >/>! Treg! in!vitro,!it!is!possible!that!functional!differences!exist!in!vivo.!!For!example,!CCR5!>/>!Treg!may!have!an!enhanced!propensity!to!undergo!apoptosis.!
Treg!may!be!recruited!to!tumours!via!CCL5>independent!chemokine!receptors!and!it!is!important!to!appreciate!that!20>50%!of!the!tumour>infiltrating!Treg!population!do!not!express!CCR5!(Figure!6>6).!!Furthermore,!Treg!recruitment!to!tumours!may!be!entirely!chemokine>independent! and! the! reduction! in! tumour! Treg! proportion! observed! in!CCL5!knock>down!tumours!and! in!CCR5! >/>!mice!may!relate! to!secondary!effects! that!disruption!of!chemokine!signalling!has!on!the!tumour!microenvironment.!!
CD8!:!CD4!ratio!There! was! a! significantly! higher! tumoral! CD8! :! CD4! ratio! in! mice! treated! with! UK>484900!compared!to!controls!(see!Figure!6>11f).!!This!is!unlikely!to!reflect!differences!in!T!cell!subset!recruitment!given!that!CCR5!expression!by!CD8+!cells!was!significantly!greater! than!Tconv! across! tumours! from!all! cell! lines! and! across! tissue! types! (Figure!6>6).! ! One! possible! explanation! for! this! finding! relates! to! apoptosis.! ! Co>culture! of!tumour! cells!with! CCL5! leads! to! apoptosis! of! CD8+! cells! but! not! CD4+! cells,! thereby!
! 251!





I! found! that! the! proportion! of! tumour>infiltrating! CD4+! cells! with! a! Treg! phenotype!(Treg!proportion)!was!significantly!increased!in!CRC!compared!with!distal,!uninvolved!colon.! ! This! is! consistent!with! published!data! (52,53,192,195),! although! reports! have!published! different! conclusions! regarding! the! association! between! tumour! Treg!enrichment!and!cancer!stage!in!CRC.!!I!measured!CRC>Treg!infiltration!as!a!proportion!of!CD4+!cells!with!a!Treg!phenotype!by!flow!cytometry.! !Consistent!with!other!studies!that!have!taken!the!same!approach,!there!was!no!demonstrable!association!between!the!Treg!proportion!and!disease!stage!(56).! !There!may!be!several!reasons!to!explain!this.!!Firstly,! the!method!we! have! used! is! robust!making! it! likely! that!my! conclusions! are!correct.! !Measuring!the!proportion!of!Treg!in!the!tumour!does!not!assess!the!absolute!numbers! of! Treg!but! rather! the! balance!between!Treg! and!other! cell! types.! ! In! other!settings,! including! chronic! inflammatory! disease,! increases! in! tissue! Treg! parallel!increases!in!effector!cells!and!it!may!be!the!functional!balance!which!is!more!important!in!determining!outcome!rather!than!absolute!or!relative!numbers.!!!Furthermore,!Treg!may!play!different!functional!roles!at!different!stages!of!disease!progression!making!it!unlikely! that! there! will! be! a! simple! linear! relationship! between! Treg! numbers! and!disease!stage.!
The!presence!of!Treg!in!tumour!tissue!is!likely!to!be!a!consequence!of!recruitment!from!blood! with! a! possible! contribution! also! from! local! proliferation! or! apoptosis.! ! To!
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examine! the!mechanisms! by!which! Treg! are! recruited! to! the! tumour,! I! carried! out! a!!systematic! examination! of! chemokine! receptors! expressed! on! the! cell! surface! of!tumour>isolated!Treg,!Tconv!and!CD8+!(Chapter!3).! !Treg!expressed!significantly!more!CCR5,!in!terms!of!percentage!expression!and!MFI,!than!Tconv!and!CD8+!cells!and!CRC>isolated!Treg!expressed! significantly!more!CCR5! than!Treg! isolated! from!distal! colon.!!Tumour>isolated!Treg!also! expressed! significantly!more!CCR4! than!Tconv! in! terms!of!both! percentage! expression! and! MFI,! although! there! was! no! difference! in! CCR4!expression! between! CRC>isolated! and! distal! colon>isolated! Treg.! ! Thus,! high! levels! of!CCR5!expression!appear!to!be!characteristic!of!CRC>infiltrating!Treg.!
Having! established! the! chemokine! receptor! signature! of! tumour>infiltrating! Treg,! the!corresponding!ligands!were!measured!in!CRC!and!matched!distal!colon!tissue!(Chapter!4).! !RT>PCR!analysis!of!chemokine!expression!demonstrated!that!the!ligands!for!CCR4!(CCL17! and! CCL22)! were! not! overexpressed! by! CRC! compared! with! matched! distal!colon,! consistent! with! the! CCR4! expression! data! that! showed! no! difference! between!Treg!infiltrating!CRC!and!distal!colon.!!Thus,!it!appears!unlikely!that!CCR4!is!involved!in!the!preferential!recruitment!of!Treg!to!CRC!compared!with!distal!colon.!!However,!two!of! the! ligands! for! CCR5! (CCL3! and! CCL4)! were! significantly! overexpressed! by! CRC!compared!with!distal!colon,!both!at!the!mRNA!and!protein!levels.!!CCL4!localised!to!the!tumour! endothelium,! suggesting! that! this! chemokine! may! play! a! key! role! in! the!recruitment! of! CCR5+! lymphocytes! to! the! tumour.! ! The! cellular! source! of! the! CCR5!ligands!was!difficult!to!identify!but!was!probably!secreted!by!tumour!cells,! fibroblasts!and!CD11b+!monocytes/macrophages.!!In!Chapter!5,!I!demonstrated!that!CRC>isolated!T!cells! migrate! towards! CCL4! in! vitro! and! that! Treg! are! enriched! in! the! migrating!population! confirming! that! CRC>associated! Treg! show! preferential! migration! in!
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response!to!CCR5!activation,!and!providing!more!evidence!that!this!pathway!is!involved!in!Treg!recruitment!into!CRC.!!I!then!went!on!to!demonstrate!that!the!CRC>isolated!Treg!were! able! to! suppress! allogeneic! T! cell! proliferation! in! vitro! and! that! they! had! the!characteristics! of! naturally>occurring! Treg! (nTreg),! as! demonstrated! by! the! highly!unmethylated!TSDR!locus!of!Treg!DNA.!!!
The$active$specific$recruitment$of$Treg$to$CRC!




Figure! 7>1:! ! The! active! recruitment! of! T! cells! to! CRC.! ! Treg! express! significantly! more! cell!surface! CCR5! than! Tconv! and! CD8+! cells.! ! Tumour! cells,! stromal! cells! and! tumour>associated!macrophages! (CD11b+! cells)! express! CCR5! ligands,! some! of! which! can! be! captured! and!presented!by!the!tumour!endothelium.!
!
The!data!presented!so!far!support!a!role!of!CCR5!in!recruitment!but!as!they!are!based!on!expression!studies!of! tumour! tissue!and! in!vitro!experiments,! they!cannot!provide!proof!that!this!is!the!important!pathway!in!vivo.!!For!this!I!used!murine!cancer!models!in! which! CCR5! could! be! pharmacologically! inhibited.! CCR5!was! inhibited! using!met>
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RANTES! and! TAK>779! in!wildtype!mice.! ! Unfortunately,! neither! of! these! compounds!specifically! antagonises!CCR5! and! the! only! available! specific! antagonist! of! CCR5! (UK>484900)!is!selective!for!human!and!not!murine!CCR5.!!To!enable!me!to!use!UK>484900,!I! needed! mice! expressing! human! CCR5! which! I! was! able! to! access! through! a!collaboration!with!Pfizer,!who!provided!mice!in!which!murine!CCR5!had!been!replaced!by!human!CCR5!(hCCR5!KI!mice).!!I!implanted!B16>F10!(a!melanoma!cell!line)!into!the!hCCR5!KI!mice!(Chapter!6).! !Akin!to!the!findings!from!human!CRC,!Treg!isolated!from!murine!tumours!expressed!significantly!more!cell!surface!CCR5!than!Tconv.!!However,!the! inhibition!of!CCR5!using!met>RANTES,!TAK>779!and!UK>484900!did!not! lead! to!a!significant! reduction! in! tumour! Treg! infiltration! compared!with! control!mice! despite!resulting!in!a!significant!delay!in!tumour!growth.!!This!finding!suggests!that!at!least!in!this!model,!Treg!are!not! recruited! to! tumours,! to!any!significant!degree,!via! the!CCR5!axis.!!!
Although!the!expression!of!high!levels!of!functional!CCR5!by!Treg!and!the!presence!of!cognate!ligands!in!the!tumour!suggest!a!role!for!these!molecules!in!the!recruitment!of!Treg!to!the!tumour!site,!this!does!not!necessarily!have!to!be!the!case.!!It!is!possible!that!CCR5!expression!may!be!a!marker!for!the!expression!of!other!chemokine!receptors!or!integrins! involved! in! the!recruitment!process.! !Treg!may!be!recruited!by!mechanisms!independent!of!chemokine!receptors.!!Selective!proliferation!of!Treg!within!the!tumour!tissue,! enhanced! Treg! survival! and! reduced! Treg! egress! could! all! explain! Treg!enrichment!in!tumours!(see!Figure!7>2).!!Others!have!cited!induction!of!Treg!from!other!T!cells!as!an!important!mechanism!leading!to!Treg!enrichment!(365).!!However,!I!found!that!the!tumour!Treg!TSDR!locus!was!highly!unmethylated,!consistent!with!the!findings!
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of! others! (193),! suggesting! that! Treg! induction! is! unlikely! to! be! the! sole!mechanism!leading!to!Treg!enrichment!in!human!CRC.!!
!
Figure! 7>2:! ! Mechanisms! of! Treg! enrichment! in! CRC.! ! (a)! Treg! recruitment! via! enhanced!expression!of!undefined!receptors!(X>R)!by!Treg!compared!with!Tconv!interacting!with!cognate!ligand.! ! CCR5! expression! may! be! linked! to! the! expression! of! such! receptors.! ! (b)! Selective!proliferation!of!Treg!within!the!tumour!tissue.!!Activated!proliferating!Treg!may!express!CCR5.!!(c)!Enhanced!egress!of!Tconv!from!the!tumour!tissue!to!the!lymphatics!compared!with!Treg.!
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Although!I! found!that!CRC>isolated!Treg!did!not!proliferate! in!vitro!(see!Figure!5>8),! I!did! observe! a! significantly! greater! percentage! expression! of! Ki67,! a! proliferation!marker,!by!Treg!compared!with!Tconv.!!This!suggests!that!within!the!tumour!tissue!in!vivo,! Treg! are! proliferating!more! than! Tconv! >! a! process! that! could! lead! to! the! Treg!enrichment!observed!in!tumours.!!Higher!levels!of!Ki67!expression!by!tumour>resident!Treg!compared!with!Tconv!have!previously!been!demonstrated!both!in!human!cancer!(366)!and!murine!cancer!models!(318).! !This!idea!could!be!tested!further!in!future!by!an! in! situ! BrdU! incorporation! experiment,! thereby! detecting! and! comparing!proliferation!of!Treg!with!Tconv,!isolated!from!murine!tumours.!
Regulation!of!CCR5!expression!Expression! of! CCR5! is! associated! with! T! cell! activation! and! proliferation! (287,367).!!Treg! that!have!migrated! into! tumours!may!become!activated!and!proliferate,! thereby!leading!to!both!Treg!enrichment!and!upregulation!of!CCR5!expression.!!The!factors!that!lead! to! expression! of! CCR5! on! the! cell! surface! are! complex! and! involve! receptor!internalisation,! receptor! recycling!and!gene! transcription.! ! It!was!shown! in!Chapter!5!that! activation! of! Tconv,! and! to! a! greater! extent! Treg,! increased! surface! CCR5!expression!(see!Figure!5>3).! !Furthermore,!my!finding!that!Tconv!secreted!more!CCR5!ligands!than!Treg!cells!raises!the!possibility!that!ligand>induced!internalisation!of!CCR5!could!explain!the!differences!in!CCR5!expression!between!Tconv!and!Treg!(see!Figure!5>5).! !If!this!were!the!case,!antagonism!of!CCR5!would!be!expected!to!increase!surface!CCR5! expression! and! limit! the! differences! in! expression! between! Tconv! and! Treg.!!Antagonism!did! increase!Tconv! surface! expression!but! not! to! the! levels! observed! for!
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Treg.! ! It! is! therefore! likely! that!other!processes! regulating!CCR5!expression!are!more!important!than!the!autocrine!internalisation!of!CCR5!via!its!ligands.!!!
There! was! a! two>fold! increase! in! CCR5! mRNA! expression! by! CRC>isolated! Treg!compared!with!Tconv! (see!Figure!3>13).! !This! is! consistent!with! the!results!of!a!gene!microarray! study! based! on! peripheral! blood>isolated! Treg! and! Tconv! (368).! ! The!transcription!factors!KLF>2!(287)!and!CREB>1!(367)!which!regulate!CCR5!transcription,!were!also!expressed!at!higher!levels!by!Treg!compared!with!Tconv.!!CREB>1!is!induced!on!T!cell!activation!and!then!binds!to!the!foxp3!promoter,!promoting!and!maintaining!the!Treg!phenotype!(369).! !KLF2!knock>down!inhibits!CCR5!expression!by!activated!T!cells!and!also!controls!S1PR1!transcription!(370).!!However,!it!is!not!clear!why!CREB>1!and!KLF2!expression!were!higher!in!Treg!compared!with!Tconv.!!S1P1R!is!the!principal!S1P!receptor!regulating!T!cell!trafficking,!acting!to!permit!egress!of! lymphocytes!from!lymphoid!organs!into!the!circulation!(371).!!Interestingly,!S1PR1!mRNA!was!expressed!at! significantly! lower! levels! by! CRC>isolated! Treg! than! by! Tconv,! suggesting! that!reduced!egress!of!Treg!from!CRC!may!occur,!compared!with!Tconv.!
In! a! murine! model! of! peritonitis,! there! were! significantly! higher! levels! of! CCR5!chemokines!in!the!peritoneal!exudate!of!CCR5!>/>!mice!compared!with!wildtypes!(372).!!This!is!similar!to!the!findings!from!tumour!lysates!and!serum!in!B16>F10>Luc!tumour>bearing! hCCR5! KI!mice! treated!with! either! UK>484900! or! control! PBS! injection! (see!Figure!6>14).!!It!was!shown!that!apoptotic!T!cells!express!more!surface!CCR5!than!live!cells! and! effectively! scavenge! and! sequester! CCR5! ligands! from! sites! of! inflammation!(372).! ! This! may! serve! an! important! role! as! part! of! the! resolution! phase! of!inflammation.! ! Annexin>V! staining! of! CRC>isolated! T! cell! subsets!was! performed,! but!
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only! for! one! sample.! ! The!proportion!of!Annexin>V! staining! cells! in! the! live!Treg! and!Tconv!subsets!were!equivalent!(~9>10%).!!This!experiment!would!need!to!be!repeated!to! be! certain,! but! it! would! appear! that! differences! in! the! fraction! of! apoptotic! cells!within!T!cell!subsets! is!unlikely! to!explain!the!difference! in!CCR5!expression!between!Treg!and!Tconv.!!
Lack%of%effect%of%CCR5!inhibition'in'the'murine'model'!
There!are! several! lines!of! evidence! that!CCR5! inhibition!would! lead! to! a! reduction! in!Treg!infiltration!in!murine!tumours.! !Firstly,!CCL5!knockdown!in!tumour!cell!lines!has!been!shown!to!lead!to!delayed!tumour!growth!with!reduced!Treg!infiltration!compared!with! wildtype! cell! lines! (104,291).! ! Secondly,! tumour! growth! in! CCR5! >/>! mice! is!delayed!with!associated!reduced!Treg! infiltration!compared!with!wildtype!mice.! !This!experiment!has!been!performed!using!the!colorectal!cancer!cell!line!CT26!(291)!and!the!melanoma!B16!cell! line! (297).! !CCR5! >/>!mice!are!also! less! susceptible! to! carcinogen>induced!lung!cancer!(354).!!Thirdly,!inhibition!of!CCR5!using!TAK>779!has!been!shown!to!reduce!tumour!Treg!infiltration!compared!with!vehicle!control!in!a!pancreatic!cancer!model!(104).!!It!was!therefore!surprising!that!neither!CCR5!inhibition!in!wildtype!mice!with!met>RANTES!or!TAK>779!nor!with!UK>484900!in!hCCR5KI!mice!led!to!a!detectable!reduction! in! tumour!Treg! infiltration.! !CCR5! inhibition!did!however! lead! to!a!delay! in!tumour!growth!in!keeping!with!previously!published!findings!(104,267,291).!
The!question!that!needs!to!be!addressed!is!therefore!how!did!CCR5!inhibition!lead!to!a!delay! in! tumour!growth!but!no!associated! reduction! in! tumour!Treg! infiltration.! !The!problems!with!specificity!of!CCR5!antagonism!by!met>RANTES!and!TAK>779!have!been!
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discussed! in! Chapter! 6.! ! It! is! possible! that! co>inhibition! of! CCR1! (met>RANTES)! or!CXCR3!(TAK>779)!could!affect!the!recruitment!of!other!T!cell!subsets!so!that!the!Treg!proportion!effectively!remained!unchanged!compared!with!control!mice.!!Experiments!designed! to! test! this! could! involve! treating!mice!with! specific! inhibitors! of! CCR1! and!CXCR3.! ! Small!molecular! antagonists! to!CCR1! (J113863!and!BX471,!Tocris!Bioscience!Inc,! USA)! and! neutralising! antibodies! (CXCR3>173,! Biolegend! Inc,! USA)! and! small!molecular! antagonists! (AMG487,! Tocris! Bioscience)! to! CXCR3! do! exist! and! therefore!such! experiments! are! feasible.! ! CXCR3! inhibition! has! been! shown! to! inhibit! the!implantation!and!growth!of!tumours!in!a!lung!metastasis!mouse!model!(139).!!Similarly,!mice!treated!with!a!CCR1!antagonist!developed!less!marked!metastases!in!a!CRC!liver!metastasis! model! associated! with! reduced! tumour! infiltration! of! immature! myeloid!cells!(96).!!Off>target!effects!of!met>RANTES!and!TAK>779!treatment!could!therefore!be!responsible!for!the!observed!delay!in!tumour!growth!compared!with!control!mice.!!This!does!not!explain!the!delayed!tumour!growth!observed!in!UK>484900>treated!hCCR5KI!mice!however.!!B16>F10>Luc!cells!do!obviously!not!express!human!CCR5!and!there!was!no!difference!in!the!in!vitro!proliferation!of!B16>F10>Luc!tumour!cells!when!cultured!in!the!presence!or!absence!of!UK>484900!(see!Figure!6>5).!!This!suggests!that!UK>484900!does!not!have!a!direct!inhibitory!effect!on!tumour!cell!growth,!but!in!order!to!test!this!in!vivo,!the!compound!would!have!to!be!administered!to!tumour>bearing!immunodeficient!mice.!Inhibition!of!CCR5!by!UK>484900!could!lead!to!changes!in!migration!of!other!cells!into! tumours,! by! inhibition! of! CCR5>dependent!migration.! ! On! the! other! hand,! CCR5!inhibition!may!lead!to!increased!recruitment!via!other!chemokine!receptors.!!Inhibition!of!CCR5!by!UK>484900! led!to! increased!tumour!and!serum!levels!of!CCL5!(see!Figure!6>14).!!Enhanced!migration!of!other!cell!types!into!the!tumour!via!CCR1!may!ensue,!as!
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has!been!shown!for!NK!cells!in!a!murine!model!of!hepatitis!(373).!!Others!have!shown!that!there!is!a!significant!increase!in!CD4+,!CD8+!and!NK!cell!infiltration!into!tumours!in!CCR5!>/>!compared!to!wildtype!mice!(289),!although!this!was!not!observed!in!the!UK>484900!/!hCCR5KI!tumour!model.!!Other!studies!have!shown!a!reduced!number!of!NK!cells! infiltrating! tumours! in!CCR5! >/>!mice!compared!to!wildtypes!(362).! ! In!a!murine!peritonitis! model,! peritoneal! accumulation! of! macrophages! was! delayed! in! CCR5! >/>!mice!compared!with!wildtypes!(374).! !There!is!increased!tumour!infiltration!of!CD19+!cells!in!CCR5!>/>!mice!compared!with!wildtypes!(289).!!Such!an!influx!of!CD4+,!CD8+,!NK!and!CD19+!cells!with!delayed!infiltration!of!macrophages!could!result!in!a!reduction!in!tumour!growth!while!having!no!effect!on!the!Treg!proportion.!!The!infiltration!of!CD8+!and!NK!cells!was!measured!in!various!CRC!tumour!models!and!no!difference!was!seen!between! mice! receiving! CCR5! inhibitors! and! controls.! ! However,! the! infiltration! of!CD19+! cells! and!macrophages! was! not! assessed.! ! Inflamed!mucosa! in! CCR5! >/>! mice!express! significantly! higher! levels! of! the! Th2! cytokines! IL>4,! IL>5! and! IL>10! but!significantly!less!IFN>γ!than!wildtypes!(360).! !Such!a!skew!to!Th2!cytokines!may!have!occurred!in!the!mice!treated!with!CCR5!inhibitors,!although!this!was!not!measured,!and!may!have!led!to!the!observed!differences!in!tumour!growth.!
As!well! as! a! postulated! role! in!Treg! recruitment,! CCR5! is! important! for! tumour!CD4+!and!CD8+!cell! function!(375).! ! In!a!study!comparing!tumour!growth!of!Pan02!and!LLC!cell!lines!in!CCR5!>/>!mice!versus!wildtypes,!tumour!growth!was!significantly!increased!in!the!CCR5!>/>!mice!(375),!in!direct!contrast!to!aforementioned!studies!(291,297).!!The!presence!of!intact!CCR5!led!to!increased!tumour!CD4+!and!CD8+!cell!infiltration.!!Intact!CCR5! was! also! necessary! for! CD8+! cross>priming,! a! process! dependent! on! CD40L!expression!by!CD4+!cells.!
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CCR5! also! mediates! recruitment! of! endothelial! progenitor! cells! and! promotes!angiogenesis.! ! Following! corneal! injury,! neovascularisation!was! inhibited! in! CCR5! >/>!mice! compared! with! wildtypes,! associated! with! lower! levels! of! tissue! VEGF! (355).!!Endothelial!progenitor!cells!are!recruited!to!tumours!from!the!bone>marrow!in!a!CCR5>dependent!manner,!where!they!lead!to!the!formation!of!neovessels!(376).! ! In!a!recent!study,!endothelial!progenitor!cell!recruitment!was!measured!in!a!wound!healing!mouse!model! (377).! ! CCR5! >/>! displayed! reduced! wound! healing! compared! with! wildtypes.!!Furthermore,! bone!marrow! cells! from!wildtype!mice! restored!normal! vascularisation!and!wound! healing!when! transferred! to! CCR5! >/>!mice.! ! Thus,! CCR5! inhibition! could!reduce! tumour!neovessel! formation! through!blockade!of! endothelial! cell! recruitment,!thereby! inhibiting! tumour! growth! independent! of! effects! on! Treg! recruitment.! ! An!unsuccessful!attempt!was!made!to!detect!differences!in!tumour!CD31+!endothelial!cell!density! between!UK>484900! and!PBS! treated!mice! by! immunohistochemistry.! ! There!was!however!a!trend!for!lower!levels!of!tumour!and!serum!VEGF!in!UK>484900!treated!mice! compared!with! controls,! suggesting! that!CCR5>mediated!neovascularisation!may!indeed!be!important!in!the!models!I!studied.!
The! one! published! study! demonstrating! reduced! tumour! Treg! infiltration! by!pharmacological!inhibition!of!CCR5!used!TAK>779!in!a!murine!pancreatic!cancer!model!(104).!!The!results!from!this!study!directly!contradict!the!findings!presented!in!Chapter!6!whereby!CCR5!antagonism!had!no!demonstrable!effect!on!tumour!Treg!infiltration.!!In!this!pancreatic!cancer!model!however,!the!tumour!Treg!proportion!in!control!mice!was!74%!compared!with!49%!in!TAK>779!treated!mice.!!In!a!different!experiment!using!the!same! wildtype! Pan02! cell! line,! albeit! with! an! experiment! duration! of! 7! more! days,!control! group! mice! had! a! tumour! Treg! proportion! of! 43%.! ! Quite! apart! from! the!
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extraordinarily!high!tumour!Treg!proportion!of!74%!in!control!mice,! the!reduction! in!Treg! proportion! to! 49%! in! treatment! mice! is! still! higher! than! the! tumour! Treg!proportion!in!control!mice!from!other!experiments.!!Aside!from!this!anomaly,!there!are!other!potential!explanations!for!the!differences!between!the!results!from!Chapter!6!and!published!findings.!!Firstly,!Treg!recruitment!to!tumours!in!the!pancreatic!cancer!model!may! indeed! depend! on! CCR5,! while! those! in! the! CRC! models! do! not.! ! Secondly,! the!CRC/melanoma! tumours! grow!more! quickly! and! thus! the! CRC!models!may! not! have!continued!for!a!long!enough!duration!to!observe!any!effects!from!CCR5!inhibition.! !By!the! time! CRC/melanoma! tumours! were! established! at! day! 7! and! CCR5! inhibition!commenced,!maximal!Treg!infiltration!may!have!already!occurred!whilst!it!was!still!an!on>going!process! in! the!pancreatic! cancer!model.! !Nevertheless,! no! reduction! in!Treg!infiltration! from!CCR5! inhibition!was! seen! using! 3! different! cell! lines! and! 3! different!CCR5! antagonists.! ! Even! if! the! caveats! concerning! the! finding! of! reduced! Treg!infiltration!by!treatment!with!TAK>779!in!the!pancreatic!cancer!model!are!accepted,!an!explanation! is! still! required! as! to!why! a! reduction! in! Treg! infiltration! is! observed! in!CCR5!>/>!mice!compared!with!wildtypes.!!There!are!at!least!four!potential!explanations.!!Firstly,! CCR5!may! indeed! be! important! in! the! recruitment! of! Treg! to! tumours! and! a!reduction! in!tumour!Treg! infiltration!with!CCR5!antagonists!was!not!observed!for! the!reasons!stated!above.!!Secondly,!it!has!recently!been!shown!that!Treg!accumulate!in!the!thymus! in!CCR5!>/>!mice,!associated!with! !a!reduction! in!S1PR1!expression!compared!with!wildtype!mice!(378).! ! !Without!expression!of!S1P1R,!Treg! fail! to!egress! from!the!thymus.! ! A! similar! effect! was! demonstrated! by! inhibition! of! CCL4! in! wildtype! mice,!although! CCR5! antagonism! was! not! tested.! ! Thymic! accumulation! of! Treg! was! not!measured!in!the!CRC/melanoma!tumour!models.!!If!reduced!S1PR1!expression!is!part!of!
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the! CCR5! >/>! Treg! phenotype! and! can! not! be! reproduced! by! CCR5! antagonism,! this!would! explain! the! reduced! tumour! Treg! infiltration! observed! in! CCR5! >/>! mice!compared!with!wildtypes! that! is! not!mimicked!by!CCR5! antagonism.! ! Thirdly,! T! cells!from! CCR5! >/>! mice! secrete! lower! levels! of! IL>2! and! NFAT! following! activation!compared!with!T! cells! from!wildtype!mice! (379).! ! This!was! also! observed! for!T! cells!isolated! from! patients! with! the! CCR5Δ32! mutation! compared! with! healthy! subjects.!!Accordingly,!T!cell!proliferation!was!noted! to!be!greater! in!CCR5+!human!T!cells! than!CCR5>! T! cells.! ! It! is! therefore! entirely! possible! that! tumour>resident! Treg! are! more!proliferative! in! wildtype! mice! compared! to! CCR5! >/>! mice,! leading! to! the! observed!differences!in!Treg!infiltration.!!Fourthly,!lower!VEGF!levels!have!been!reported!in!CCR5!>/>!mice!compared! to!wildtypes!(355,377)!and!Treg!have!also!been!shown!to!express!the! VEGF! receptor! (VEGFR)! (380).! ! VEGFR+! Treg! proliferate! in! response! to! VEGF!treatment!and!VEGF!blockade!inhibits!such!proliferation.!
Limitations!
The! limitations! of! the! different! methods! used! have! been! discussed! in! the! relevant!chapters.! ! With! regard! chemokine! receptor! expression! by! human! CRC>isolated!lymphocytes,! one! limitation! relates! to! the! static! nature! of! the! assessment.! ! In! other!words,! chemokine! receptor! expression! was! measured! on! lymphocytes! that! had!migrated! into! the! tumour! tissue!and! in! the!peripheral!blood!and! it! is!only!possible! to!infer,! not! prove,! the! kinetics! of! chemokine! receptor! expression! and! function! by!lymphocytes!as! they!move! from!the!periphery! into! the! tumour! in!vivo.! !Furthermore,!changes! in! expression! by! retained! and! egressing! lymphocytes! cannot! be! assessed! in!such! a! study.! ! High! levels! of! surface! chemokine! receptor! expression! by! migrated!
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lymphocytes!may!indeed!point!to!a!role!for!these!receptors!in!trafficking!to!the!tumour.!!However,!chemokine!receptors!that!have!mediated!migration!may!be!downregulated!or!internalised! post>migration! and! thus! not! be! detected! by! such! experiments.! ! The!expression!of!chemokine!receptors!on!migrated! lymphocytes!may!also!be!functionally!neutral! markers! of! activated! cells! capable! of! migrating.! ! Nevertheless,! systematic!examination!of! chemokine!receptor!expression! in!cells! from!tumour! tissue! is!a!useful!way!to!highlight!possible!important!receptors!worthy!of!further!study.!
CRC>isolated! T! cells! were! shown! to! migrate! towards! a! CCR5! ligand! in! vitro!demonstrating!that!the!CCR5!receptor!is!functional.!!However,!this!may!not!adequately!reflect!the!situation!in!vivo.!!The!capacity!of!T!cells!to!migrate!towards!CCR5!ligands!in!vivo!may!be!overwhelmed!by!the!capacity!of!the!cells!to!migrate!towards!other!ligands.!!For! example,! it! has! been! shown! that! CXCR3! ligands! are!more! chemotactic! for! T! cells!than!CCR5!ligands,!yet!in!vivo!CXCL10!and!CCL5!have!comparable!chemotactic!activity!and!are!more!potent!than!other!CCR5!and!CXCR3!ligands!(381).!!CRC>isolated!Treg!were!able!to!suppress!autologous!T!cell!proliferation!showing!that!they!are!functional!in!vitro!but!this!does!not!prove!that!they!are!functional!within!the!tumour!microenvironment!in!vivo.! !The!relative!importance!of!Treg>mediated!suppression!of!effector!TILs!in!vivo!is!unclear.! ! TILs! have! a! tendency! to! be! anergic! as! a! consequence! of! several! distinct!mechanisms,!only!one!of!which!involves!Treg>mediated!suppression.! !Defects! in!T!cell!priming! occur! due! to! a! lack! of! activating! antigen! and! co>stimulation! signals,! or! an!enhanced!negative!signal,!such!as!signalling!through!PD>1,!TGF>ß!or!CTLA>4!(382).!!DC!function! is! deficient! in! tumours,! driven! by! a! variety! of! different! mechanisms.! ! More!recently,! the! hypoxic! and! acidic! environment! of! tumours! has! been! shown! to! induce!reversible! anergic! states! in!T! cells! (383).! !The! relative! contribution!of!Treg>mediated!
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suppression! to! the! mix! of! different! processes! that! lead! to! defective! effector! T! cell!function!in!the!tumour,!may!be!less!important!than!has!previously!been!considered.!
The!cell!surface!phenotype!(CD4+CD25+CD127low)!was!used!to!define!Treg!in!this!thesis.!!It! identifies! a! population! of! cells! that! were! able! to! suppress! cell! activation! in! vitro,!although! in!vitro! function!does!not!necessarily! translate! to! in!vivo!activity.! !Tumours!harbour! other! suppressive! T! cells! that! do! not! conform! to! the! Treg! phenotype.! ! For!example,!within! the! tumour!CD4+foxp3>! cell!population!are!LAG3+!and!LAP+!cells! that!are!also!suppressive.!!In!fact,!the!majority!of!CRC>isolated!CD4+LAP+!cells!are!foxp3>!and!have!been! shown! to! suppress!T! cell! responses!with! approximately!50! times! as!much!potency! as! traditional! Treg! (384).! ! It! is! unclear! whether! CD4+LAP+!cells! are! actively!recruited!to!the!tumour!or!are!induced!from!other!T!cells!but!they!offer!another!potent!mechanism! to! suppress! the! anti>tumour! immune! response,! and! in! the! context! of! this!thesis,!could!be!recruited!to!tumours!via!a!CCR5>independent!pathway.!
The!limitations!of!the!murine!tumour!models!have!already!been!discussed.!!A!failure!to!observe!a!reduction!in!Treg!migration!with!CCR5!inhibition!does!not!necessarily!mean!that! CCR5>dependent! Treg!migration! to! tumours! is! not! important.! ! Rather! that! there!was!no!significant!difference!in!tumour!Treg!infiltration!between!treatment!and!control!groups! in! this! chosen! tumour!model,! using! this! particular! tumour! cell! line,! over! this!time!schedule!in!these!specific!mice.!!I!was!only!able!to!quantify!Treg!infiltration!at!one!time!point!and!the!kinetics!of!Treg!migration,!retention!and!subsequent!egress!was!not!measured.! ! Thus,! it! is! possible! that! CCR5! inhibition! did! lead! to! reduced!migration! of!Treg!into!the!tumours,!but!this!did!not!lead!to!an!overall!reduction!in!Treg!numbers!due!
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to! changes! in! Treg! egress! or! proliferation! of! tumour>resident! Treg.! ! None! of! these!effects!were!measured.!!!
Finally,! given! the! degree! of! redundancy! in! the! chemokine! system,! inhibition! of! one!receptor!alone!may!not!lead!to!a!dramatic!reduction!in!immune!cell!recruitment!if!other!receptors! then! come! into! play.! ! Furthermore,! my! finding! of! increases! in! tissue! and!serum! CCL5! in! UK>484900! treated! mice! demonstrates! the! complex! consequences! of!inhibiting!the!chemokine!network.!!Humans!with!a!CCR5Δ32!mutation!are!healthy!and!carry!no!increased!susceptibility!to!infectious!disease,!with!the!exception!of!West!Nile!Virus!infection!despite!showing!defective!CCR5>mediated!lymphocyte!migration!in!vitro!(385).!!In!order!to!significantly!diminish!tumour!Treg!recruitment,!it!may!be!necessary!to!inhibit!a!combination!of!chemokine!receptors!and!integrins.!!To!test!this!approach!in!animal!experiments!requires!multiple! treatment!arms!using!different!combinations!of!neutralising!antibodies!or!receptor!antagonists.!!
Future&work!
Despite!the!lack!of!reduction!in!tumour!Treg!infiltration!with!CCR5!inhibition,!there!was!an!associated!delay!in!tumour!growth.! !Thus!CCR5!inhibition!may!still!potentially!play!an! important! therapeutic! role! as! part! of! the! armoury! against! CRC.! ! One! possible!mechanism! by! which! CCR5! antagonism! delays! tumour! growth! is! inhibition! of!endothelial! progenitor! cell! recruitment! to! the! tumour! and! thus,! a! disruption! in! the!tumour!vasculature.! !Blocking!angiogenesis!using!anti>VEGF!therapy!(386)! is!effective!in!the!treatment!of!metastatic!CRC!(9).!!It!would!therefore!be!interesting!to!explore!the!effects! of! CCR5! inhibition! in! primary! and! metastatic! models! of! CRC.! ! Targeting! the!
! 270!
tumour! vasculature! through! anti>VEGF! therapy! may! have! an! additive! or! synergistic!effect!when!combined!with!CCR5!inhibition.!!It!is!also!possible!that!CCR5!inhibition!may!reduce!the!local!recurrence!rates!following!resection!of!primary!CRC!and!this!could!be!tested!in!an!animal!model.!!However,!CCR5!inhibition!in!mice!delays!skin!healing!(377)!and!the!application!of!such!a!therapy!may!have!to!occur!within!a!time>frame!that!avoids!delays!in!the!healing!of!operative!wounds!and!bowel!anastomoses.!
Regarding! Treg! recruitment,! the! phenotype! of! tumour>! and! colon>! associated!endothelium,!isolated!from!human!CRC,!could!be!studied!to!determine!differences!in!the!expression! of! important! chemokines! and! other!molecules.! ! Such! experiments! require!successful! isolation! of! endothelial! cells,! a! technically! challenging! process,! which!probably!explains!the! limited!number!of!studies! in!this!area!previously!(387).! !Whilst!chemokine!receptor!expression!on!migrating!lymphocytes!may!be!downregulated!post>migration,!there!is!arguably!more!stable!expression!of!important!endothelial!receptors!and! ligands.! ! Differences! in! tumour>! and! colon>associated! endothelium! have! the!potential! to! explain! differential! recruitment! of! Treg! and! Tconv.! ! It! is! also! not!understood! why! Treg! may! proliferate! more! than! Tconv! in! the! tumour.! ! It! has! been!suggested! that! Treg! may! receive! stronger! antigen! signals! in! tumours! than! Tconv,!driving!proliferation!(319).! !CD11c+!DCs!have!been!isolated!from!murine!tumours!and!shown!to!stimulate!Treg!proliferation! in!a!dose>dependent!manner,!dependent!on!the!presence!of!TGF>ß!(388).!!Such!an!effect!was!not!observed!for!lymph!node>isolated!DCs.!!Immunohistochemical! studies! have! demonstrated! a! correlation! between! Treg!frequency!and!the!ratio!of!plasmacytoid!to!myeloid!DCs!(389).!!However,!the!potential!role!of!DCs!in!selective!Treg!proliferation!and!maintenance!in!human!CRC!is!unclear!and!would!be!a!suitable!topic!for!further!research.!!
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Inhibition!of!CCR5!reduces!the!proliferation!and!migration!of!serum>starved!CRC!cells!in! vitro! (267).! ! This! has! led! to! a! phase! I! trial,! in! which! patients! with! hepatic! CRC!metastases!are!treated!with!Maraviroc!(390).!!This!trial!is!primarily!designed!to!assess!the!safety!and!tolerability!of!8!weeks!of!continuous!Maraviroc!therapy!in!patients!with!metastatic!CRC.!!Even!though!the!basis!for!this!trial!is!an!inhibitory!effect!of!Maraviroc!on!the!proliferation!and!migration!of!CRC!tumour!cells,!such!a!phase!I!trial!could!lead!the!way!for!phase!II!trials!investigating!the!role!of!Maraviroc!in!the!inhibition!of!tumour!recruitment!of!immune!cells!and!tumour!angiogenesis.!
Conclusion!
The!work!presented!in!this!thesis!has!demonstrated!a!Treg>specific!chemokine!receptor!signature!in!human!CRC.! !CCR5!was!expressed!at!higher!levels!by!Treg!than!by!Tconv.!!The!cognate!ligands!for!CCR5!were!identified!in!CRC,!at!increased!levels!compared!with!matched! colon.! ! CRC>isolated! Treg! were! chemotactic! to! CCR5! ligands! and! were!suppressive! in! vitro.! ! Despite! this! supportive! evidence! for! the! CCR5! axis! having! a!potential!role!in!the!recruitment!of!Treg!to!tumours,!CCR5!inhibition!in!murine!tumour!models! did! not! lead! to! any! differences! in! tumour! Treg! infiltration.! ! However,! CCR5!inhibition! did! result! in! delayed! tumour! growth! compared! with! controls.! ! Possible!reasons! for! the! lack! of! effect! of! CCR5! inhibition! on! tumour! Treg! recruitment,! and!explanations!as!to!why!CCR5!inhibition!altered!tumour!growth,!were!discussed.!!
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Appendix(I:((Abbreviations!!ACTB! ß>actin!ADAMTS! A!disintegrin!and!metalloproteinase!with!thrombospondin!motifs!AJCC! American!Joint!Committee!on!Cancer!Akt! From!AKT8,!the!transforming!retrovirus!responsible!for!formation!of!thymoma!in!AKR!mice!ANG! Angiogenin!Ang>1/2! Angiopoietin>1/2!APC! Adenomatous!polyposis!coli!APC! Allophycocyanin!ATCC! American!Type!Culture!Collection!B!cell! Lymphocytes! which! mature! in! the! bone! marrow! (or! Bursa! of!Fabricus!in!birds)!B16>F10>Luc! Luciferase>expressing!B16>F10!cells!BCL2! B>cell!lymphoma!2!BLI! Bioluminescent!imaging!BMI! Body!mass!index!BMPR1A! Bone!morphogenetic!protein!receptor,!type!1A!BRAF! v>Raf!murine!sarcoma!viral!oncogene!homologue!B1!BSA! Bovine!serum!albumin!CAM! Cell!adhesion!molecules!CD! Cluster!of!differentiation!CIMP! CpG!island!methylator!phenotype!CMT93! Colon!mouse!tumour!93!CMT93>Luc! Luciferase>expressing!CMT93!cells!cPBS! Complete! PBS:! PBS! containing! 10%! foetal! calf! serum! and! 1%!Glutamine>Penicillin>Streptomycin.!CRC! Colorectal!cancer!
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Cre! Causes!recombination!CREB1! cAMP!responsive!element!binding!protein!1!cRPMI! Complete!RPMI!media:!RPMI!containing!1%!foetal!calf!serum,!5!mg!Gentamicin,!125!µg!Amphotericin!B!and!1%!Glutamine>Penicillin>Streptomycin.!CT26! Colon!tumour!26!CT26>Luc! Luciferase>expressing!CT26!cells!DAPI! 4',6>diamidino>2>phenylindole!DARC! Duffy!antigen/chemokine!receptor!DC! Dendritic!cell!DC! Distal!colon!DCC! Deleted!in!colorectal!cancer!DMEM! Dulbecco’s!modified!Eagle’s!medium!DMSO! Dimethyl!sulfoxide!DPPIV! Dipeptidyl!peptidase>4!DPX! Di>N>Butyle!Phthalate!in!Xylene!DTT! Dithiothreitol!E>selectin! Endothelium>selectin!ECM! Extra>cellular!matrix!(gel)!EDTA! Ethylenediaminetetraacetic!acid!EG>VEGF! Endocrine!gland>derived!vascular!endothelial!growth!factor!EGF! Epidermal!growth!factor!EGFR! Epidermal!growth!factor!EMVI! Extramural!vascular!invasion!Env! Envelope!(gene)!EPIC! European!Prospective!Investigation!into!Cancer!and!Nutrition!ERK! Extracellular!signal>regulated!kinase!ES! Embryonic!stem!(cells)!FAM! 6>carboxyfluorescein!
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MAdCAM>1! Mucosal!addressin!cell!adhesion!molecule!1!MAPK! Mitogen>activated!protein!kinase!mCCR5! Murine!CCR5!MEK! !(MAPK)!ERK!kinase!MFI! Median!fluorescent!intensity!mg! Milligrams!MHC! Major!Histocompatibility!Complex!MIF! Macrophage!migration!inhibitory!factor!MIQE! Minimum! Information! for! Publication! of! Quantitative! Real>Time!PCR!Experiments!ml! Millilitre!MMP! Matrix!metalloproteinase!Ms! Mouse!MSCV! Murine!stem!cell!virus!MSI! Microsatellite!instability!mTOR! Mammalian!target!of!rapamycin!MTT! 3>(4,5>Dimethylthiazol>2>yl)>2,5>diphenyltetrazolium!bromide!MVC! Maraviroc!N! Normality!of!a!solution!n! Number!(of!subjects!/!cases)!ng! Nanograms!NICE! National!Institute!for!Health!and!Care!Excellence!NRG1! Neuregulin!NSAID! Non>steroidal!anti>inflammatory!drug!nTreg! Naturally>occurring!Treg!ORF! Open>reading!frame!P>selectin! Platelet>selectin!PAC! Puromycin!N>acetyl!transferase!
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PBGD! Porphobilinogen!deaminase!PBMC! Peripheral!blood!mononuclear!cell!PBS! Phosphate>buffered!saline!PCR! Polymerase!chain!reaction!PD>ECGF! Platelet>derived!endothelial!cell!growth!factor!PDGF! Platelet>derived!growth!factor!PE! Phycoerythrin!PGK1! Phosphoglycerate!kinase!1!PHA! Phytohaemagglutinin!PI3K! Phosphoinositide!3>kinase!PIGF! Placental!growth!factor!PLC! Public!limited!company!PMS2! Post>meiotic!segregation!2!PNAd! Peripheral!node!addressin!Pol! Polymerase!gene!PPIA! Peptidylprolyl!Isomerase!A!PSGL>1! P>selectin!glycoprotein!ligand!1!PTEN! Phosphatase!and!tensin!homologue!PTX3! Pentraxin>3!QAMA! Quantitative!analysis!of!methylated!alleles!QEHB! Queen!Elizabeth!Hospital!Birmingham,!UK!RAF! Rapidly!accelerated!fibrosarcoma!RPMI! Roswell!Park!Memorial!Institute!(cell!media)!RT! Reverse!transcriptase!S1P! Sphingosine>1>phosphate!S1PR1! Sphingosine>1>phosphate!receptor!1!Sc! Subcutaneous!SD! Standard!deviation!
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SDS! Sodium!dodecyl!sulphate!SDS>PAGE! Sodium!dodecyl!sulphate!polyacrylamide!gel!electrophoresis!sICAM1! Soluble!ICAM>1!Smad! SMA!(small!body!size)!–!MAD!(mothers!against!decapentaplegic)!ß2M! ß2>microglobulin!STK11! Serine/threonine!kinase!11!sTREM>1! Soluble!TREM>1!T!cell! Lymphocytes!which!mature!in!the!thymus!TBP! TATA!box!binding!protein! ! !TBS! Tris>buffered!saline!Tconv! Conventional!T!cell!TDLN! Tumour>draining!lymph!node!TEMED! N,N,N’,N’>tetramethylethylenediamine!TGF! Tansforming!growth!factor!Th3! T!helper!3!cell!TIL! Tumour!infiltrating!lymphocyte!TIMP! Tissue!inhibitor!of!metalloproteinases!TNF! Tumour!necrosis!factor!TP53! Tumour!protein!p53!Tr1! Type!1!regulatory!cell!Treg! Regulatory!T!cell!TREM>1! Triggering!receptor!expressed!on!myeloid!cells>1!Tresp! Responder! T! cells! (labelled! CD4+CD25>! cells! used! in! suppression!assays)!TSDR! Treg>specific!determining!region!TSP>1/2! Thrombospondin>1/2!UC! Ulcerative!colitis!UICC! International!Union!Against!Cancer!
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UK! United!Kingdom!uPA! Urinary!plasminogen!activator!V! Volts!VAP>1! Vascular!adhesion!protein>1!VCAM>1! Vascular!cell!adhesion!molecule!1!VCAM>1! Vascular!cell!adhesion!protein!1!VEGF! Vascular!endothelial!growth!factor!VIC! 4,7,2’>trichloro>7’phenyl>6>carboxyfluorescein!VLA>4! Very!late!antigen>4!Wnt! Wingless>related!integration!site!µg! Micrograms!µl! Microlitre
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Appendix(II:((Sample(data!!Neo! ! Neo>adjuvant!chemo>!or!radiotherapy!Pos!LN! Number!of!positive!lymph!nodes!/!total!number!of!lymph!nodes!KRAS! ! Presence!or!absence!of!a!KRAS!mutation!Died! ! Patient!died!during!the!follow>up!period!CRC>related! Death!was!related!to!CRC!LR! ! Local!recurrence!during!follow>up!period!DR! ! Distant!recurrence!during!follow>up!period!AdenoCa! Adenocarcinoma!Mod! ! Moderate!Mdys! ! Moderate!dysplasia!WB! ! Western!blot!PCR! ! Used!to!obtain!RNA!for!real>time!PCR!IHC! ! Immunohistochemistry!(FFPE);!>c!for!chemokines!using!frozen!sections!P! ! Phenotyping!(flow!cytometry)!B! ! Matched!blood!sample!used!for!phenotyping!LN! ! Matched!TDLN!used!for!phenotyping!Super! ! Used!to!obtain!supernatant;!*!supernatant!used!in!protein!array!Supp! ! Suppression!assay!Transwell! Transwell!migration!(chemotaxis)!assays!RNA! ! Cell>sorted!to!obtain!RNA!DNA! ! Cell>sorted!to!obtain!DNA!for!TSDR!analysis!
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' ' ' ' ' ' ' ' ' ' ' ' ' ' '
1400' F' 64' No' Left' AdenoCa' Mod' B' 3' 0' 0' Positive' 0/24' Clear' Unknown' Unknown' 42000' No'
'
No' No' WB,'PCR'
1409' M' 58' No' Rectum' AdenoCa' Mod' C' 4' 1' 1' Positive' 2/26' Clear' Wildtype' Unknown' 36000' Yes' Yes' No' No' WB,'PCR'




1423' F' 74' No' Right' AdenoCa' Mod' C' 3' 1' 0' Positive' 1/28' Clear' Unknown' Unknown' 24000' No'
'
No' No' PCR'
1432' M' 73' No' Left' AdenoCa' Mod' D' 4' 0' 1' Positive' 0/24' Clear' Wildtype' Unknown' 144000' No'
'
No' No' IHC,'PCR'
1447' F' 81' No' Right' Mucinous' Mod' D' 4' 2' 1' Positive' 7/10' Clear' Unknown' Unknown' 78000' Yes' Yes' No' No' WB,'IHC,'PCR'
1489' M' 72' No' Left' AdenoCa' Mod' B' 2' 0' 0' Negative' 0/18' Clear' Unknown' Unknown' 1800' Yes' No' No' No'
'
1490' M' 36' No' Left' AdenoCa' Poor' B' 4' 0' 0' Negative' 0/44' Clear' Unknown' MSI' 29700' No'
'
No' No' PCR'
1522' M' 76' No' Right' AdenoCa' Mod' A' 2' 0' 0' Negative' 0/24' Clear' Unknown' Unknown' 2500' No'
'
No' No' WB'
1523' M' 60' No' Rectum' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/7' Clear' Unknown' MSS' 5000' Yes' No' No' No'
'
1536' F' 64' No' Rectum' AdenoCa' Mod' D' 3' 0' 1' Positive' 0/30' Clear' Wildtype' Unknown' 38350' No'
'
No' No' PCR'








1588' M' 64' No' Left' AdenoCa' Mod' C' 3' 1' 0' Negative' 2/14' Clear' Unknown' Unknown' 15540' No'
'
No' No' P'
1622' F' 85' No' Right' AdenoCa' Poor' B' 4' 0' 0' Negative' 0/19' Clear' Unknown' Unknown' 78000' Yes' No'
' '
P'
1645' F' 63' No' Right' AdenoCa' Mod' C' 4' 2' 0' Positive' 4/23' Clear' Wildtype' Unknown' 9000' No'
'
No' Yes' P'
1673' F' 87' No' Left' AdenoCa' Mod' C' 3' 1' 0' Positive' 3/20' Clear' Unknown' Unknown' 13440' No'
'
No' No' P'





1691' M' 76' Yes' Left' AdenoCa' Mod' D' 3' 1' 1' Negative' 1/17' Clear' Unknown' Unknown' 7000' No'
'
No' Yes' P'
1692' M' 78' No' Rectum' AdenoCa' Mod' B' 4' 0' 0' Positive' 0/23' Clear' Unknown' Unknown' 33000' No'
'
No' No' P'
1712' F' 86' No' Right' Mucinous' Mod' C' 4' 1' 0' Negative' 2/24' Clear' Unknown' Unknown' 26400' Yes' No' No' No' P'
1733' M' 66' No' Left' AdenoCa' Mod' C' 3' 1' 0' Positive' 1/25' Clear' Wildtype' Unknown' 13000' No'
'
No' Yes' P'
1753' F' 88' No' Right' AdenoCa' Mod' B' 4' 0' 0' Negative' 0/24' Clear' Unknown' Unknown' 204000' No'
'
No' No' P'
1757' M' 68' Yes' Rectum' AdenoCa' Poor' D' 4' 2' 1' Positive' 4/8' Involved' Mutation' Unknown' 20000' Yes' Yes'
' '
P'






' ' ' ' ' ' ' ' ' ' ' ' ' ' '
1861' M' 63' No' Left' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/14' Clear' Unknown' Unknown' 5250' No'
'
No' No' P,'PCR'
1877' F' 31' No' Rectum' AdenoCa' Poor' C' 2' 2' 0' Positive' 13/28' Clear' Unknown' MSS' 7500' No'
'
No' No' P,'IHC,'PCR'
1912' F' 65' No' Right' Mucinous' Mod' B' 3' 0' 0' Negative' 0/30' Clear' Unknown' Unknown' 56000' No'
'
No' No' P,'PCR'
1931' M' 69' No' Right' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/29' Clear' Unknown' Unknown' 26400' Yes' No'
' ' '
1932' F' 69' No' Rectum' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/26' Clear' Unknown' Unknown' 13860' Yes' Yes' Yes' Yes' P,'PCR'
1945' M' 65' No' Rectum' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/44' Clear' Unknown' Unknown' 61875' No'
'
No' No' P,'PCR'
1970' M' 73' No' Rectum' AdenoCa' Mod' A' 1' 0' 0' Negative' 0/35' Clear' Unknown' Unknown' 2925' No'
'
No' No' P'
2014' F' 71' No' Rectum' AdenoCa' Mod' A' 2' 0' 0' Negative' 0/18' Clear' Unknown' Unknown' 2250' No'
'
No' No' P'
2052' F' 78' No' Right' Mucinous' Mod' B' 3' 0' 0'
'
0/23' Clear' Unknown' Unknown' 61875' No'
'
No' No' P,'IHC'
2062' M' 66' No' Right' AdenoCa' Mod' B' 3' 0' 0'
'
0/24' Clear' Unknown' MSI' 390000' No'
'
No' No' IHC'




2141' M' 73' No' Right' AdenoCa' Mod' A' 2' 0' 0' Negative' 0/10' Clear' Unknown' Unknown' 4050' No'
'
No' No' P'




2220' M' 52' No' Left' AdenoCa' Mod' D' 4' 2' 1' Positive' 10/65' Clear' Wildtype' Unknown' 61200' Yes' Yes' No' No' WB'
2239'
'
80' No' Rectum' Adenoma' Mdys'
' ' ' ' ' ' ' ' ' ' ' ' ' ' '
2242' F' 56' No' Right' AdenoCa' Poor' C' 2' 1' 0' Negative' 1/11' Clear' Wildtype' MSI' 7875' No'
'
No' No' WB,'IHC'
2255' M' 78' No' Left' AdenoCa' Mod' D' 4' 2' 1' Positive' 6/12' Clear' Wildtype' Unknown' 1512' No'
'
No' No' P'
2265' M' 83' No' Rectum' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/20' Clear' Unknown' Unknown' 76950' No'
'
No' No' P'
2268' M' 32' No' Right' AdenoCa' Mod' C' 4' 2' 0' Positive' 9/24' Clear' Wildtype' MSI' 72000' No'
'
No' No' Super'
2287' F' 70' No' Right' AdenoCa' Poor' D' 3' 2' 1' Negative' 9/13' Clear' Wildtype' MSI' 1331000' Yes' Yes' No' No' P,'WB'




2312' F' 29' No' Rectum' AdenoCa' Mod' D' 3' 1' 1' Positive' 2/20' Clear' Mutation' MSS' 147000' Yes' Yes' No' No'
'
2315' F' 85' No' Right' Mucinous' Mod' B' 3' 0' 0' Negative' 0/29' Clear' Mutation' MSS' 12500' No'
'
No' No' P'
2337' M' 82' No' Rectum' AdenoCa' Mod' C' 2' 1' 0' Negative' 1/25' Clear' Wildtype' MSS' 18480' No'
'
No' No' P,'WB,'PCR'
2359' M' 80' Yes' Rectum' AdenoCa' Mod' C' 3' 1' 0' Positive' 1/20' Clear' Unknown' Unknown' 30375' No'
'
No' No' PCR'
2381' M' 64' No' Rectum' AdenoCa' Mod' C' 3' 1' 0' Negative' 1/69' Clear' Unknown' Unknown' 13750' No'
'
No' No' P,'PCR'
2385a' F' 73' No' Right' AdenoCa' Poor' C' 4' 1' 0' Negative' 2/24' Clear' Mutation' MSI' 27000' Yes' Yes' Yes' Yes' P'
2385b' F' 73' No' Rectum' AdenoCa' Mod' C' 2' 1' 0' Negative' 2/24' Clear' Unknown' MSI' 4375' Yes' Yes' Yes' Yes' P,'WB'
2431' F' 78' No' Right' Mucinous' Mod' C' 4' 2' 0' Positive' 4/28' Clear' Unknown' Unknown' 135000' No'
'
No' No' WB'
2449' F' 70' No' Left' AdenoCa' Mod' C' 4' 1' 0' Negative' 1/37' Clear' Mutation' Unknown' 17500' No'
'
No' No' P,'B'
2450' F' 70' No' Left' AdenoCa' Mod' C' 4' 1' 0' Negative' 1/37' Clear' Mutation' Unknown' 17500' No'
'
No' No' WB'
2455' F' 67' No' Rectum' AdenoCa' Poor' D' 3' 1' 1' Positive' 1/10' Clear' Mutation' Unknown' 30000' Yes' Yes' No' No'
'
2492' F' 82' No' Right' AdenoCa' Poor' C' 3' 2' 0' Negative' 10/17' Clear' Wildtype' Unknown' 47500' Yes' Yes' No' Yes'
'




2578' F' 75' No' Left' AdenoCa' Mod' B' 3' 0' 0' Positive' 3/35' Clear' Mutation' MSS' 36000' No'
'
No' No' P'
2623' M' 56' Yes' Rectum' Mucinous' Mod' C' 3' 1' 0' Negative' 1/20' Clear' Mutation' MSS' 11040' No'
'
Yes' No' Supp'
2691' M' 63' No' Left' AdenoCa' Mod' C' 3' 1' 0' Positive' 2/35' Clear' Mutation' Unknown' 56400' No'
'
No' No' P,'B'
2731' M' 50' No' Left' AdenoCa' Mod' C' 3' 1' 0' Positive' 1/12' Clear' Wildtype' MSS' 52500' No'
'
No' No' P,'PCR'




2742' M' 76' No' Right' AdenoCa' Mod' A' 2' 0' 0'
'
0/23' Clear' Wildtype' MSI' 481500' No'
'
No' No' P,'B,'PCR,'LN'
2767' F' 61' No' Left' AdenoCa' Mod' A' 2' 0' 0' Positive' 0/17' Clear' Wildtype' Unknown' 10080' No'
'
No' No' P'
2768' F' 85' No' Right' AdenoCa' Mod' A' 2' 0' 0' Negative' 0/12' Clear' Wildtype' Unknown' 73125' No'
'
No' No' P'
2787' M' 52' No' Rectum' AdenoCa' Mod' A' 2' 0' 0' Negative' 0/22' Clear' Mutation' Unknown' 7500' No'
'
No' No' P,'B'
2799' M' 76' No' Left' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/26' Clear' Wildtype' MSS' 25200' No'
'
No' No' P'
2815' M' 69' No' Rectum' AdenoCa' Mod' C' 3' 2' 0' Positive' 7/23' Clear' Wildtype' Unknown' 6480' No'
'
No' No' P'
2896' M' 44' No' Rectum' AdenoCa' Poor' B' 4' 0' 0' Negative' 0/23' Clear' Wildtype' MSI' 56250' No'
'
No' No' P'
2928' M' 62' No' Rectum' AdenoCa' Mod' C' 2' 1' x' Negative' 1/13' Clear' Wildtype' Unknown' 5400' No'
'
No' No' P'
2929' M' 71' No' Rectum' AdenoCa' Mod' B' 3' 0' 0' Positive' 0/15' Clear' Mutation' Unknown' 16000' No'
'
No' No' P'
2996' M' 71' No' Right' AdenoCa' Mod' C' 4' 1' 0' Positive' 3/17' Clear' Mutation' Unknown' 364000' No'
'
No' No' P,'PCR,'LN'
3047' F' 81' No' Right' AdenoCa' Mod' C' 4' 1' 0' Negative' 1/26' Clear' Mutation' Unknown' 135000' No'
'
No' No' P,'Supp'
3086' F' 87' No' Right' AdenoCa' Poor' C' 3' 1' 0' Negative' 1/39' Clear' Wildtype' MSI' 300000' No'
'
No' No' P,'Transwell,'PCR'
3152' F' 59' No' Rectum' AdenoCa' Mod' A' 2' 0' 0' Negative' 0/29' Clear' Wildtype' Unknown' 36000' No'
'
No' No' P,'Transwell'
3161' F' 83' No' Rectum' AdenoCa' Mod' C' 3' 1' 0' Positive' 1/16' Clear' Wildtype' Unknown' 10500' No'
'
No' No' P,'Transwell'
3192' M' 61' No' Rectum' AdenoCa' Mod' C' 4' 2' 0' Positive' 7/19' Clear' Mutation' Unknown' 31500' No'
'
No' No' P,'Transwell'











Right' AdenoCa' Mod' B' 3' 0' 0' Negative' 0/29' Clear' Mutation' Unknown' 31500' No'
'
No' No' P'





Right' AdenoCa' Mod' B' 3' 0' 0' Positive' 0/15' Clear' Wildtype' Unknown' 16800' No'
'
No' No' P,' Transwell,' IHCCc,'LN'
3319' M' 62'
'















Right' AdenoCa' Poor' A' 2' 0' 0' Positive' 0/21' Clear' Wildtype' MSI' 50000' No'
'
No' No' P,' Supp,' IHCCc,' B,'LN'
3359' M' 60'
'










Right' AdenoCa' Poor' C' 4' 1' 0' Positive' 3/15'
'










Right' AdenoCa' Mod' C' 3' 2' 0' Negative' 5/28' Clear' Mutation' Unknown' 36000' No'
'
No' No' RNA'
3654' F' 87' No' Right' AdenoCa' Mod' C' 3' 2' 0' Negative' 5/14' Clear' Unknown' MSI' 128800' Yes' Yes' No' No' P,'RNA'
3705' M' 71'
'




























































































Right' AdenoCa' Mod' C' 3' 1' 0' Positive' 3/30' Clear' Unknown' Unknown' 16000' No'
'
No' No' Supp,'RNA,'DNA'
1678' M' 65' No'
'
AdenoCa'
' ' ' ' ' ' ' ' ' ' ' ' ' ' '
P'
1897' F' 49' No'
'
AdenoCa'
' ' ' ' ' ' ' ' ' ' ' ' ' ' '
P'
2746' M' 62' No'
'
AdenoCa'




Appendix(III:!Antibodies*used*for*flow*cytometry!!Antigen! Clone! Fluorochrome! Isotype! Manufacturer! Code!CD3! UCHT1! AlexaCFluor!750! Ms!IgG1! Serotec! MCA463P750!CD4! RPACT4! V500! Ms!IgG1! BD! 560768!CD25! MCA251! V450! Ms!IgG1! BD! 560355!CD127! HILC7RCM21! FITC! Ms!IgG1! BD! 560549!CD127! eBioRDR5! APC! Ms!IgG1! eBioscience! 17C1278C42!CD8! RPACT8! PECCF594! Ms!IgG1! BD! 562282!CCR1! 53504! APC! Ms!IgG2b! R&D!Systems! FAB145A!CCR2! 48607! APC! Ms!IgG2b! R&D!Systems! FAB151A!CCR3! 61828! APC! Rat!IgG2a! R&D!Systems! FAB155A!CCR4! 205410! APC! Ms!IgG2b! R&D!Systems! FAB1567A!CCR5! CTC5! APC! Ms!IgG1! R&D!Systems! FAB1802A!CCR5! CTC5! PE! Ms!IgG1! R&D!Systems! FAB1802P!CCR5! 2D7CCCR5! PE! Ms!IgG2a! BD! 560935!CCR6! 11A9! PE! Ms!IgG1! BD! 551773!CCR7! 150503! APC! Ms!IgG2a! R&D!Systems! FAB197A!CCR8! 191704! APC! Rat!IgG2b! R&D!Systems! FAB1429A!CCR9! 112509! AlexaCFluor!647! Ms!IgG2a! BD! 557975!CCR10! 314305! PE! RatIgG2a! R&D!Systems! FAB3478P!CXCR1! 42705! APC! MsIgG2a! R&D!Systems! FAB330A!CXCR2! 48311! APC! MsIgG2a! R&D!Systems! FAB331A!CXCR3! 49801! APC! MsIgG1! R&D!Systems! FAB160A!CXCR4! 12G5! PE! MsIgG2a! R&D!Systems! FAB170P!CXCR5! 51505! APC! MsIgG2b! R&D!Systems! FAB190A!CXCR6! K041E5! APC! MsIgG2a! Biolegend! 356006!CX3CR1! 528728! FITC! MsIgG1! R&D!Systems! FAB5204F!
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XCR1! Polyclonal! FITC! Goat! R&D!Systems! FAB857F!CD27! CLBC27/1! PE! MsIgG2a! Caltag! MHCD2704!CD39! eBioA1! PE! MsIgG1! eBioscience! 12C0399!CD45RA! F8C11C13! PE! MsIgG1! Serotec! MCA88PE!CD62L! DREGC56! PE! MsIgG1! BD! 555544!CD69! FN50! APC! MsIgG1! BD! 555533!CD73! AD2! PE! MsIgG1! BD! 550257!PDC1! EH12.1! PECy7! MsIgG1! BD! 561272!GARP! 855151! PE! RatIgG2a! R&D!Systems! FAB6055P!GITR! 110416! APC! MsIgG1! R&D!Systems! FAB689A!OX40! ACT35! PE! MsIgG1! BD! 555838!TGFCLAP! 27232! PE! MsIgG1! R&D!Systems! FAB2463P!CD103! BerCACT8! PE! MsIgG1! BD! 550260!α1! SR84! PE! MsIgG1! BD! 559596!α2! HAS3! PE! MsIgG2a! R&D!Systems! FAB1233P!α3! IA3! PE! MsIgG1! R&D!Systems! FAB1345P!α4! 7.2R! APC! MsIgG1! R&D!Systems! FAB1354A!α5! 238307! PE! MsIgG1! R&D!Systems! FAB1864P!α6! GoH3! PE! RatIgG2a! R&D!Systems! FAB13501P!αL! 345913! APC! MsIgG1! R&D!Systems! FAB3595A!αM! 238446! APC! MsIgG2b! R&D!Systems! FAB16991A!αV! 13C2! PE! MsIgG1! Abcam! Ab82530!αX! ICRF!3.9! APC! MsIgG1! R&D!Systems! FAB1777A!ß1! P5D2! PE! MsIgG1! R&D!Systems! FAB17781P!ß2! 212701! PE! MsIgG1! R&D!Systems! FAB1730P!ß3! 256809! PE! MsIgG2a! R&D!Systems! FAB2266P!ß7! 473207! PE! MsIgG1! R&D!Systems! FAB4669P!Foxp3! PCH101! PE! Rat!IgG2a! eBioscience! 12C4776C42!CTLAC4! BNI3! APC! Ms!IgG2a! BD! 560938!Helios! 22F6! APC! Hamster!IgG! Biolegend! 137222!
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Ki67! 35/KiC67! FITC! Ms!IgG1! BD! 612472!CD3! UCHT1! PE! Ms!IgG1! BD! 555333!CD4! RPACT4! FITC! Ms!IgG1! BD! 555346!CD11b! ICRF44! PECy7! Ms!IgG1! BD! 557743!CD31! 9G11! FITC! Ms!IgG1! R&D!Systems! FAB3567F!CD90! ThyC1A1! PE! Ms!IgG2a! R&D!Systems! FAB2067P!EpCAM! 158206! PE! Ms!IgG2b! R&D!Systems! FAB9601P!IMC! MOPCC21! PECy7! MsIgG1! BD! 557872!IMC! C! AlexaCFluor!750! Ms!IgG1! Serotec! MCA928P750!IMC! X40! V500! Ms!IgG1! BD! 560787!IMC! MOPCC21! V450! Ms!IgG1! BD! 560373!IMC! 11711! FITC! Ms!IgG1! R&D!Systems! IC002F!IMC! X40! PECCF594! Ms!IgG1! BD! 562292!IMC! C! FITC! Goat! R&D!Systems! IC108F!IMC! 11711! PE! Ms!IgG1! R&D!Systems! IC002P!IMC! 20102! PE! Ms!IgG2a! R&D!Systems! IC003P!IMC! 133303! PE! Ms!IgG2b! R&D!Systems! IC0041P!IMC! eBR2a! PE! Rat!IgG2a! eBioscience! 12C4321!IMC! 11711! APC! Ms!IgG1! R&D!Systems! IC002A!IMC! 20102! APC! Ms!IgG2a! R&D!Systems! IC003A!IMC! 133303! APC! Ms!IgG2b! R&D!Systems! IC0041A!IMC! 54447! APC! Rat!IgG2a! R&D!Systems! IC006A!IMC! 141945! APC! Rat!IgG2b! R&D!Systems! IC013A!
! 323!
Appendix(IV:((ImageJ(macro!ImageJ' macro' to' read' Proteome'Profiler™)spots%(R&D%systems)!
 
// ImageJ macro to read Proteome Profiler spots (Cytokine A panel) 
by Steve Ward, 2013 
 
myImageID=getImageID(); 
if (isOpen("Results")) {  
       selectWindow("Results");  
       run("Close");  
   }  
 if (isOpen("ROI Manager")) { 
     selectWindow("ROI Manager"); 
     run("Close"); 
  } 
run("8-bit"); 
 
        if (getPixel(0, 0) != 0)  
                run("Invert");  
setTool("Point"); 
beep(); 
waitForUser("Steve Ward's Protein Array Plug-in","Please click in 
centre of TOP LEFT dot then click on OK…"); 
s = selectionType(); 
if( s != 10 ) { 
    exit("The selection wasn't a point selection."); 
} else { 
    getSelectionCoordinates(xPoints,yPoints); 
    xstart = xPoints[0]; 




waitForUser("Steve Ward's Protein Array Plug-in","Please click in 
centre of TOP RIGHT dot then click on OK…"); 
s = selectionType(); 
if( s != 10 ) { 
    exit("The selection wasn't a point selection."); 
} else { 
    getSelectionCoordinates(xPoints,yPoints); 
    xend = xPoints[0]; 
    yend = yPoints[0]; 
} 
startl = sqrt(((xend-xstart)*(xend-xstart)) + ((yend-ystart)*(yend-
ystart))); 
diffh = (yend-ystart); 
rang = -(asin(diffh / startl)*57.2957795); 
! 324!
rangrad=-(asin(diffh / startl)); 
 





run("Size...", "width=x constrain interpolation=Bilinear"); 
 
beep(); 
waitForUser("Steve Ward's Protein Array Plug-in","Please click in 
centre of TOP LEFT dot again then click on OK…"); 
s = selectionType(); 
if( s != 10 ) { 
    exit("The selection wasn't a point selection."); 
} else { 
    getSelectionCoordinates(xPoints,yPoints); 
    xoffset = xPoints[0]; 




makeOval(5+(xoffset-13), 13+(yoffset-20), 16, 19); run("Add to 
Manager"); roiManager("Add"); 
roiManager("Show All"); 
run("Set Measurements...", "  mean redirect=None decimal=0"); 
roiManager("Select",0); 
roiManager("Rename", "Ref"); 
makeOval(26+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",1); roiManager("Rename", 
"Ref"); 
makeOval(60+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",2); roiManager("Rename", 
"C5/C5a"); 
makeOval(81+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",3); roiManager("Rename", 
"C5/C5a"); 
makeOval(103+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",4); roiManager("Rename", 
"CD40L"); 
makeOval(126+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",5); roiManager("Rename", 
"CD40L"); 
makeOval(159+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",6); roiManager("Rename", "G-
CSF"); 
makeOval(182+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",7); roiManager("Rename", "G-
CSF"); 
makeOval(204+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",8); roiManager("Rename", "GM-
CSF"); 
makeOval(225+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",9); roiManager("Rename", "GM-
CSF"); 
! 325!
makeOval(259+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",10); roiManager("Rename", 
"GROa"); 
makeOval(281+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",11); roiManager("Rename", 
"GROa"); 
makeOval(304+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",12); roiManager("Rename", 
"I309"); 
makeOval(328+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",13); roiManager("Rename", 
"I309"); 
makeOval(359+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",14); roiManager("Rename", 
"sICAM1"); 
makeOval(382+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",15); roiManager("Rename", 
"sICAM1"); 
makeOval(403+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",16); roiManager("Rename", 
"IFNg"); 
makeOval(425+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",17); roiManager("Rename", 
"IFNg"); 
makeOval(459+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",18); roiManager("Rename", 
"Ref"); 
makeOval(482+(xoffset-13), 13+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",19); roiManager("Rename", 
"Ref"); 
makeOval(60+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",20); roiManager("Rename", 
"IL-1a"); 
makeOval(81+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",21); roiManager("Rename", 
"IL-1a"); 
makeOval(103+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",22); roiManager("Rename", 
"IL-1b"); 
makeOval(126+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",23); roiManager("Rename", 
"IL-1b"); 
makeOval(159+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",24); roiManager("Rename", 
"IL-1ra"); 
makeOval(182+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",25); roiManager("Rename", 
"IL-1ra"); 
makeOval(204+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",26); roiManager("Rename", 
"IL-2"); 
makeOval(225+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",27); roiManager("Rename", 
"IL-2"); 
makeOval(259+(xoffset-13), 44+(yoffset-20), 16, 19); 
! 326!
roiManager("Add"); roiManager("Select",28); roiManager("Rename", 
"IL-4"); 
makeOval(281+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",29); roiManager("Rename", 
"IL-4"); 
makeOval(304+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",30); roiManager("Rename", 
"IL-5"); 
makeOval(328+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",31); roiManager("Rename", 
"IL-5"); 
makeOval(359+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",32); roiManager("Rename", 
"IL-6"); 
makeOval(382+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",33); roiManager("Rename", 
"IL-6"); 
makeOval(403+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",34); roiManager("Rename", 
"IL-8"); 
makeOval(425+(xoffset-13), 44+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",35); roiManager("Rename", 
"IL-8"); 
makeOval(60+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",36); roiManager("Rename", 
"IL-10"); 
makeOval(81+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",37); roiManager("Rename", 
"IL-10"); 
makeOval(103+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",38); roiManager("Rename", 
"IL-12p70"); 
makeOval(126+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",39); roiManager("Rename", 
"IL-12p70"); 
makeOval(159+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",40); roiManager("Rename", 
"IL-13"); 
makeOval(182+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",41); roiManager("Rename", 
"IL-13"); 
makeOval(204+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",42); roiManager("Rename", 
"IL-16"); 
makeOval(225+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",43); roiManager("Rename", 
"IL-16"); 
makeOval(259+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",44); roiManager("Rename", 
"IL-17"); 
makeOval(281+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",45); roiManager("Rename", 
"IL-17"); 
makeOval(304+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",46); roiManager("Rename", 
! 327!
"IL-17E"); 
makeOval(328+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",47); roiManager("Rename", 
"IL-17E"); 
makeOval(359+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",48); roiManager("Rename", 
"IL-23"); 
makeOval(382+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",49); roiManager("Rename", 
"IL-23"); 
makeOval(403+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",50); roiManager("Rename", 
"IL-27"); 
makeOval(425+(xoffset-13), 66+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",51); roiManager("Rename", 
"IL-27"); 
makeOval(60+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",52); roiManager("Rename", 
"IL-32a"); 
makeOval(81+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",53); roiManager("Rename", 
"IL-32a"); 
makeOval(103+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",54); roiManager("Rename", 
"IP-10"); 
makeOval(126+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",55); roiManager("Rename", 
"IP-10"); 
makeOval(159+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",56); roiManager("Rename", "I-
TAC"); 
makeOval(182+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",57); roiManager("Rename", "I-
TAC"); 
makeOval(204+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",58); roiManager("Rename", 
"MCP-1"); 
makeOval(225+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",59); roiManager("Rename", 
"MCP-1"); 
makeOval(259+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",60); roiManager("Rename", 
"MIF"); 
makeOval(281+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",61); roiManager("Rename", 
"MIF"); 
makeOval(304+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",62); roiManager("Rename", 
"MIP-1a"); 
makeOval(328+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",63); roiManager("Rename", 
"MIP-1a"); 
makeOval(359+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",64); roiManager("Rename", 
"MIP-1b"); 
! 328!
makeOval(382+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",65); roiManager("Rename", 
"MIP-1b"); 
makeOval(403+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",66); roiManager("Rename", 
"SerpinE1"); 
makeOval(425+(xoffset-13), 89+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",67); roiManager("Rename", 
"SerpinE1"); 
makeOval(5+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",68); roiManager("Rename", 
"Ref"); 
makeOval(28+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",69); roiManager("Rename", 
"Ref"); 
makeOval(60+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",70); roiManager("Rename", 
"RANTES"); 
makeOval(81+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",71); roiManager("Rename", 
"RANTES"); 
makeOval(103+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",72); roiManager("Rename", 
"SDF-1a"); 
makeOval(126+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",73); roiManager("Rename", 
"SDF-1a"); 
makeOval(159+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",74); roiManager("Rename", 
"TNFa"); 
makeOval(182+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",75); roiManager("Rename", 
"TNFa"); 
makeOval(204+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",76); roiManager("Rename", 
"sTREM-1"); 
makeOval(225+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",77); roiManager("Rename", 
"sTREM-1"); 
makeOval(460+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",78); roiManager("Rename", 
"Negative"); 
makeOval(483+(xoffset-13), 109+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",79); roiManager("Rename", 
"Negative"); 
 
array1 = newArray("0");;  
for (i=1;i<roiManager("count");i++){  
        array1 = Array.concat(array1,i);  
         
}  





//headings=String.getResultsHeadings; replace(headings, "Mean\\(", 
""); replace(headings, "\\)",""); print(headings);  
text = getInfo();  
lines = split(text, "\n");  





for (i=1;i<columns.length;i++) { 
arrayR = Array.concat(arrayR,getResult(columns[i],0));  
columns[i]=replace(columns[i], "Mean\\(", "");  
columns[i]=replace(columns[i], "\\)",""); 
}   
for (i=0;i<columns.length;i++) {print(columns[i]);} 
for (i=0;i<columns.length;i++) {print(arrayR[i]);} 
 
selectWindow("Results");  
  run("Close");  
for (i=1;i<columns.length-1;i++) { 
subbk= (arrayR[i])-bkground; 
if (subbk >= 0.0)   
     setResult(columns[i], 0, subbk); 




// ImageJ macro to read Proteome Profiler spots (Angiogenesis 
Array), by Steve Ward 2013 
myImageID=getImageID(); 
if (isOpen("Results")) {  
       selectWindow("Results");  
       run("Close");  
   }  
 if (isOpen("ROI Manager")) { 
     selectWindow("ROI Manager"); 
     run("Close"); 




        if (getPixel(0, 0) != 0)  
                run("Invert");  
setTool("Point"); 
beep(); 
waitForUser("Steve Ward's Protein Array Plug-in","Please click in 
centre of TOP LEFT dot then click on OK…"); 
s = selectionType(); 
if( s != 10 ) { 
    exit("The selection wasn't a point selection."); 
} else { 
    getSelectionCoordinates(xPoints,yPoints); 
    xstart = xPoints[0]; 





waitForUser("Steve Ward's Protein Array Plug-in","Please click in 
centre of TOP RIGHT dot then click on OK…"); 
s = selectionType(); 
if( s != 10 ) { 
    exit("The selection wasn't a point selection."); 
} else { 
    getSelectionCoordinates(xPoints,yPoints); 
    xend = xPoints[0]; 
    yend = yPoints[0]; 
} 
startl = sqrt(((xend-xstart)*(xend-xstart)) + ((yend-ystart)*(yend-
ystart))); 
diffh = (yend-ystart); 
rang = -(asin(diffh / startl)*57.2957795); 
rangrad=-(asin(diffh / startl)); 
 





run("Size...", "width=x constrain interpolation=Bilinear"); 
 
beep(); 
waitForUser("Steve Ward's Protein Array Plug-in","Please click in 
centre of TOP LEFT dot again then click on OK…"); 
s = selectionType(); 
if( s != 10 ) { 
    exit("The selection wasn't a point selection."); 
} else { 
    getSelectionCoordinates(xPoints,yPoints); 
    xoffset = xPoints[0]; 




makeOval(5+(xoffset-13), 12+(yoffset-20), 16, 19); run("Add to 
Manager"); roiManager("Add"); 
roiManager("Show All"); 
run("Set Measurements...", "  mean redirect=None decimal=0"); 
roiManager("Select",0); 
roiManager("Rename", "Ref"); 
makeOval(24+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",1); roiManager("Rename", 
"Ref"); 
makeOval(43+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",2); roiManager("Rename", 
"BLANK"); 
makeOval(62+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",3); roiManager("Rename", 
"BLANK"); 
makeOval(88+(xoffset-13), 12+(yoffset-20), 16, 19); 
! 331!
roiManager("Add"); roiManager("Select",4); roiManager("Rename", 
"Activin-A"); 
makeOval(107+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",5); roiManager("Rename", 
"Activin-A"); 
makeOval(126+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",6); roiManager("Rename", 
"ADAMTS-1"); 
makeOval(145+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",7); roiManager("Rename", 
"ADAMTS-1"); 
makeOval(172+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",8); roiManager("Rename", 
"ANG"); 
makeOval(191+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",9); roiManager("Rename", 
"ANG"); 
makeOval(210+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",10); roiManager("Rename", 
"Ang-1"); 
makeOval(229+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",11); roiManager("Rename", 
"Ang-1"); 
makeOval(256+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",12); roiManager("Rename", 
"Ang-2"); 
makeOval(275+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",13); roiManager("Rename", 
"Ang-2"); 
makeOval(294+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",14); roiManager("Rename", 
"Plasminogen"); 
makeOval(313+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",15); roiManager("Rename", 
"Plasminogen"); 
makeOval(340+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",16); roiManager("Rename", 
"AR"); 
makeOval(359+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",17); roiManager("Rename", 
"AR"); 
makeOval(378+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",18); roiManager("Rename", 
"Artemin"); 
makeOval(397+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",19); roiManager("Rename", 
"Artemin"); 
makeOval(423+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",20); roiManager("Rename", 
"BLANK"); 
makeOval(442+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",21); roiManager("Rename", 
"BLANK"); 
makeOval(461+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",22); roiManager("Rename", 
! 332!
"Ref"); 
makeOval(480+(xoffset-13), 12+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",23); roiManager("Rename", 
"Ref"); 
 
// Row B 
makeOval(5+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",24); roiManager("Rename", 
"CoagF3"); 
makeOval(24+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",25); roiManager("Rename", 
"CoagF3"); 
makeOval(43+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",26); roiManager("Rename", 
"CXCL16"); 
makeOval(62+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",27); roiManager("Rename", 
"CXCL16"); 
makeOval(88+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",28); roiManager("Rename", 
"DPPIV"); 
makeOval(107+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",29); roiManager("Rename", 
"DPPIV"); 
makeOval(126+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",30); roiManager("Rename", 
"EGF"); 
makeOval(145+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",31); roiManager("Rename", 
"EGF"); 
makeOval(172+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",32); roiManager("Rename", 
"EG-VEGF"); 
makeOval(191+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",33); roiManager("Rename", 
"EG-VEGF"); 
makeOval(210+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",34); roiManager("Rename", 
"Endoglin"); 
makeOval(229+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",35); roiManager("Rename", 
"Endoglin"); 
makeOval(256+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",36); roiManager("Rename", 
"Endostatin"); 
makeOval(275+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",37); roiManager("Rename", 
"Endostatin"); 
makeOval(294+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",38); roiManager("Rename", 
"Endothelin-1"); 
makeOval(313+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",39); roiManager("Rename", 
"Endothelin-1"); 
makeOval(340+(xoffset-13), 38+(yoffset-20), 16, 19); 
! 333!
roiManager("Add"); roiManager("Select",40); roiManager("Rename", 
"FGF-1"); 
makeOval(359+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",41); roiManager("Rename", 
"FGF-1"); 
makeOval(378+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",42); roiManager("Rename", 
"FGF-2"); 
makeOval(397+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",43); roiManager("Rename", 
"FGF-2"); 
makeOval(423+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",44); roiManager("Rename", 
"FGF-4"); 
makeOval(442+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",45); roiManager("Rename", 
"FGF-4"); 
makeOval(461+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",46); roiManager("Rename", 
"FGF-7"); 
makeOval(480+(xoffset-13), 38+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",47); roiManager("Rename", 
"FGF-7"); 
 
// Row C 
makeOval(5+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",48); roiManager("Rename", 
"GDNF"); 
makeOval(24+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",49); roiManager("Rename", 
"GDNF"); 
makeOval(43+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",50); roiManager("Rename", 
"GM-CSF"); 
makeOval(62+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",51); roiManager("Rename", 
"GM-CSF"); 
makeOval(88+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",52); roiManager("Rename", 
"HB-EGF"); 
makeOval(107+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",53); roiManager("Rename", 
"HB-EGF"); 
makeOval(126+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",54); roiManager("Rename", 
"HGF"); 
makeOval(145+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",55); roiManager("Rename", 
"HGF"); 
makeOval(172+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",56); roiManager("Rename", 
"IGFBP-1"); 
makeOval(191+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",57); roiManager("Rename", 
"IGFBP-1"); 
! 334!
makeOval(210+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",58); roiManager("Rename", 
"IGFBP-2"); 
makeOval(229+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",59); roiManager("Rename", 
"IGFBP-2"); 
makeOval(256+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",60); roiManager("Rename", 
"IGFBP-3"); 
makeOval(275+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",61); roiManager("Rename", 
"IGFBP-3"); 
makeOval(294+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",62); roiManager("Rename", 
"IL-1b"); 
makeOval(313+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",63); roiManager("Rename", 
"IL-1b"); 
makeOval(340+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",64); roiManager("Rename", 
"IL-8"); 
makeOval(359+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",65); roiManager("Rename", 
"IL-8"); 
makeOval(378+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",66); roiManager("Rename", 
"LAP (TGF-b1)"); 
makeOval(397+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",67); roiManager("Rename", 
"LAP (TGF-b1)"); 
makeOval(423+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",68); roiManager("Rename", 
"Leptin"); 
makeOval(442+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",69); roiManager("Rename", 
"Leptin"); 
makeOval(461+(xoffset-13), 57+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",70); roiManager("Rename", 
"MCP-1"); 
makeOval(480+(xoffset-13), 57+(yoffset-20), 16, 19); 





makeOval(5+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",72); roiManager("Rename", 
"MIP-1a"); 
makeOval(24+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",73); roiManager("Rename", 
"MIP-1a"); 
makeOval(43+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",74); roiManager("Rename", 
"MMP-8"); 
makeOval(62+(xoffset-13), 76+(yoffset-20), 16, 19); 
! 335!
roiManager("Add"); roiManager("Select",75); roiManager("Rename", 
"MMP-8"); 
makeOval(88+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",76); roiManager("Rename", 
"MMP-9"); 
makeOval(107+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",77); roiManager("Rename", 
"MMP-9"); 
makeOval(126+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",78); roiManager("Rename", 
"NRG1-b1"); 
makeOval(145+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",79); roiManager("Rename", 
"NRG1-b1"); 
makeOval(172+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",80); roiManager("Rename", 
"PTX3"); 
makeOval(191+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",81); roiManager("Rename", 
"PTX3"); 
makeOval(210+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",82); roiManager("Rename", 
"PD-ECGF"); 
makeOval(229+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",83); roiManager("Rename", 
"PD-ECGF"); 
makeOval(256+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",84); roiManager("Rename", 
"PDGF-AA"); 
makeOval(275+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",85); roiManager("Rename", 
"PDGF-AA"); 
makeOval(294+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",86); roiManager("Rename", 
"PDGF-AB/BB"); 
makeOval(313+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",87); roiManager("Rename", 
"PDGF-AB/BB"); 
makeOval(340+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",88); roiManager("Rename", 
"Persephin"); 
makeOval(359+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",89); roiManager("Rename", 
"Persephin"); 
makeOval(378+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",90); roiManager("Rename", 
"CXCL4"); 
makeOval(397+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",91); roiManager("Rename", 
"CXCL4"); 
makeOval(423+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",92); roiManager("Rename", 
"PIGF"); 
makeOval(442+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",93); roiManager("Rename", 
! 336!
"PIGF"); 
makeOval(461+(xoffset-13), 76+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",94); roiManager("Rename", 
"Prolactin"); 
makeOval(480+(xoffset-13), 76+(yoffset-20), 16, 19); 




// Row E 
makeOval(5+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",96); roiManager("Rename", 
"Serpin-B5"); 
makeOval(24+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",97); roiManager("Rename", 
"Serpin-B5"); 
makeOval(43+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",98); roiManager("Rename", 
"Serpin-E1"); 
makeOval(62+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",99); roiManager("Rename", 
"Serpin-E1"); 
makeOval(88+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",100); roiManager("Rename", 
"Serpin-F1"); 
makeOval(107+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",101); roiManager("Rename", 
"Serpin-F1"); 
makeOval(126+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",102); roiManager("Rename", 
"TIMP-1"); 
makeOval(145+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",103); roiManager("Rename", 
"TIMP-1"); 
makeOval(172+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",104); roiManager("Rename", 
"TIMP-4"); 
makeOval(191+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",105); roiManager("Rename", 
"TIMP-4"); 
makeOval(210+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",106); roiManager("Rename", 
"TSP-1"); 
makeOval(229+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",107); roiManager("Rename", 
"TSP-1"); 
makeOval(256+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",108); roiManager("Rename", 
"TSP-2"); 
makeOval(275+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",109); roiManager("Rename", 
"TSP-2"); 
makeOval(294+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",110); roiManager("Rename", 
"uPA"); 
! 337!
makeOval(313+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",111); roiManager("Rename", 
"uPA"); 
makeOval(340+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",112); roiManager("Rename", 
"Vasohibin"); 
makeOval(359+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",113); roiManager("Rename", 
"Vasohibin"); 
makeOval(378+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",114); roiManager("Rename", 
"VEGF"); 
makeOval(397+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",115); roiManager("Rename", 
"VEGF"); 
makeOval(423+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",116); roiManager("Rename", 
"VEGF-C"); 
makeOval(442+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",117); roiManager("Rename", 
"VEGF-C"); 
makeOval(461+(xoffset-13), 96+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",118); roiManager("Rename", 
"BLANK"); 
makeOval(480+(xoffset-13), 96+(yoffset-20), 16, 19); 





makeOval(5+(xoffset-13), 122+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",120); roiManager("Rename", 
"Ref"); 
makeOval(24+(xoffset-13), 122+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",121); roiManager("Rename", 
"Ref"); 
makeOval(461+(xoffset-13), 122+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",122); roiManager("Rename", 
"Negative"); 
makeOval(480+(xoffset-13), 122+(yoffset-20), 16, 19); 
roiManager("Add"); roiManager("Select",123); roiManager("Rename", 
"Negative"); 
 
array1 = newArray("0");;  
for (i=1;i<roiManager("count");i++){  
        array1 = Array.concat(array1,i);  
         
}  




//headings=String.getResultsHeadings; replace(headings, "Mean\\(", 
""); replace(headings, "\\)",""); print(headings);  
text = getInfo();  
! 338!
lines = split(text, "\n");  





for (i=1;i<columns.length;i++) { 
arrayR = Array.concat(arrayR,getResult(columns[i],0));  
columns[i]=replace(columns[i], "Mean\\(", "");  
columns[i]=replace(columns[i], "\\)",""); 
}   
for (i=0;i<columns.length;i++) {print(columns[i]);} 





for (i=1;i<columns.length-1;i++) { 
subbk= (arrayR[i])-bkground; 
if (subbk >= 0.0)   
     setResult(columns[i], 0, subbk); 
else setResult(columns[i], 0,0); 
